Albemarle má 5. srpna po uzavření trhu oznámit výsledky za 2. čtvrtletí; odhady počítají s EPS 3,35 USD a tržbami 1,59 miliardy USD. Těžit má z vyšších objemů lithia a úspor nákladů, ale tlak vyvíjejí nižší ceny lithia.
Key Takeaways ALB is set to report Q2 2026 earnings on Aug. 5, with estimates pointing to sharp year-over-year growth.Albemarle gains from higher lithium volumes and cost-saving and productivity actions.ALB faces pressure from lower lithium prices despite healthy energy storage demand and expansion efforts. Albemarle Corporation (ALB - Free Report) is slated to report second-quarter 2026 results after the closing bell on Aug. 5. ALB is likely to have benefited from its cost and productivity actions and higher volumes in its Energy Storage unit in the second quarter.
The Zacks Consensus Estimate for second-quarter earnings has been revised upward over the past 60 days. The consensus estimate for earnings is pegged at $3.35 per share, suggesting a 2,945.5% year-over-year rise. The Zacks Consensus Estimate for second-quarter revenues is currently $1.59 billion, indicating a roughly 19.2% increase from the year-ago quarter.
Image Source: Zacks Investment Research
ALB beat the Zacks Consensus Estimate for earnings in three of the last four quarters. It has a trailing four-quarter earnings surprise of 74.5%, on average.
Image Source: Zacks Investment Research
Q2 Earnings Whispers for ALBOur proven model predicts an earnings beat for ALB this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. That is just the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
ALB has an Earnings ESP of +2.21% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Factors Shaping ALB’s Q2 ResultsALB is expected to have gained from higher lithium volumes in the June quarter. Healthy customer demand, capacity expansion and plant productivity improvements are expected to have supported volumes. ALB saw higher sales volumes (up 14% year over year) in its Energy Storage unit in the first quarter on the strength of its integrated conversion facilities. The consensus estimate for Energy Storage sales for the second quarter is pegged at $1,192 million, suggesting a 66% year-over-year growth.
Cost-saving, pricing and productivity initiatives are also expected to have aided ALB’s performance in the second quarter, supporting margins. Efforts to drive operating efficiency and improve the utilization of raw materials are likely to aid the company’s results.
Albemarle is taking aggressive cost-saving and productivity actions. The company delivered roughly $450 million in cost and productivity improvements in 2025, having surpassed its initial target of $300-$400 million. It expects additional cost and productivity improvements of $100-$150 million in 2026, with $40 million already delivered.
While the Specialties segment faces challenges from the ongoing volatility in petrochemicals and oil & gas markets due to geopolitical tensions, higher bromine prices as well as benefits of cost and productivity actions, are expected to have supported results in the quarter to be reported.
Falling lithium market prices are weighing on ALB stock. Lithium prices have pulled back amid slowing demand for electric vehicles (EVs) in China, an inventory glut and prospects of increased supply from mine restarts and capacity additions. EV orders have slowed in China, the world’s biggest lithium consumer, while demand in energy storage systems remains healthy. Some impacts of the price retreat are expected to reflect on the company’s performance in the June quarter.
Albemarle Stock’s Price Performance and ValuationALB’s shares are down 16.1% year to date, underperforming the Zacks Chemical - Diversified industry’s 17.6% increase and the S&P 500’s rise of 9.5%. Its peers Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) and Rio Tinto Group (RIO - Free Report) have lost 2.6% and gained 19.8%, respectively, over the same period.
ALB’s YTD Price Performance Image Source: Zacks Investment Research
ALB is currently trading at a forward price-to-sales ratio of 2.17, above the industry. It is trading at a discount to Sociedad Quimica and a premium to Rio Tinto. Albemarle currently has a Value Score of C. Sociedad Quimica and Rio Tinto have a Value Score of B and A, respectively.
ALB’s P/S F12M Vs. Industry, SQM and RIO Image Source: Zacks Investment Research
Investment Thesis for ALB StockAlbemarle is well-positioned to capitalize on the substantial growth opportunity in the battery-grade lithium market, supported by the global transition toward EVs. The market for lithium batteries and energy storage remains strong, especially for EVs, offering significant opportunities for the company to develop innovative products and expand capacity. The company is strategically executing its projects aimed at boosting its global lithium conversion capacity. It remains focused on investing in high-return projects to drive productivity.
ALB also remains committed to driving shareholder value by leveraging healthy cash flows and strong liquidity. However, the pullback in lithium prices casts a pall on its prospects.
Conclusion: Hold Onto ALB Stock for NowAlbemarle is gaining from higher lithium volumes driven by project ramp-ups, as well as initiatives to expand global lithium conversion capacity and enhance productivity. The company is well-placed to gain from long-term growth in the battery-grade lithium market.
Rising earnings estimates and a strong growth outlook are other positives. However, retreating lithium prices could dampen its prospects. Its stretched valuation also might not offer an attractive entry point at this time. Investors who already own ALB shares may consider maintaining their positions while awaiting greater visibility following the company’s upcoming earnings release.
Amplia uzavřela s Eli Lilly dohodu o klinické spolupráci a dodávkách pro testování narmafotinibu s olomorasibem u pokročilého NSCLC. Studie fáze 1b/2b má hodnotit bezpečnost a účinnost této kombinace jako léčby druhé linie.
HIGHLIGHTS Amplia has executed a Clinical Trial Collaboration & Supply Agreement (CTCSA) with Eli Lilly & Company, to evaluate the Company's investigational FAK inhibitor narmafotinib in combination with Lilly's late‑stage investigational next generation KRAS inhibitor olomorasib The collaboration is underpinned by narmafotinib's growing base of clinical evidence and a strong scientific rationale that FAK activation is a key driver of resistance to KRAS G12C inhibitors The collaboration further extends narmafotinib beyond pancreatic and ovarian cancer into NSCLC, broadening Amplia's clinical footprint and addressable opportunity Melbourne, Australia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces that it has entered into a Clinical Trial Collaboration and Supply Agreement (“CTCSA”) with Eli Lilly & Company (“Lilly”), to evaluate the combination of Amplia's investigational FAK inhibitor, narmafotinib, with Lilly's investigational KRAS G12C inhibitor, olomorasib. The Phase 1b/2b clinical trial will evaluate the safety and efficacy of this novel targeted therapy combination as a second line treatment in patients with advanced stage non-small cell lung cancer (NSCLC).
Velcí držitelé UNI dál akumulují: Binance hlásí pětileté maximum odtoků a průměr 10 největších výběrů přesáhl 7 200 UNI měsíčně. To naznačuje nákupy při poklesech.
Large Uniswap (UNI) holders are accumulating the token despite its recent pullback from a local high.
According to CryptoQuant analyst Darkfost, Binance has recorded its highest level of major UNI withdrawals in five years.
Darkfost said the monthly average of the 10 largest UNI withdrawal transactions from Binance has reached its highest level since 2021. The trend suggests that some of the exchange’s biggest participants are continuing to accumulate UNI during periods of price weakness.
The analyst noted that the monthly average of these top-10 withdrawals has surpassed 7,200 UNI. On some days, the combined withdrawals from the 10 largest transactions exceeded 10,000 UNI.
According to the analysis, the largest outflows have increased during periods of sharp declines in UNI prices. This suggests that large investors may be using market dips as opportunities to accumulate.
“These outflows therefore suggest that UNI accumulation is continuing, particularly among the largest players on Binance,” Darkfost wrote.
He added that despite UNI’s extended decline from its all-time high, some investors remain confident in Uniswap’s long-term growth potential and the future value of its native token.
UNI Still Down 90% from Previous Peak For context, UNI is among the major altcoins that have yet to reclaim their previous cycle highs. The token is still trading more than 91% below its 2021 all-time high of around $45.
Meanwhile, the latest accumulation trend comes after one of UNI’s sharpest corrections in recent years. The token dropped to $2.316 on June 6, 2026, marking its lowest level in roughly five years.
The decline came just days after Standard Chartered projected that UNI could reach $100 by 2030. After hitting its low, UNI recovered strongly and climbed to $4.577 five days ago before losing momentum and pulling back.
According to CoinMarketCap data, UNI is trading at $3.84 at the time of writing, down 5.45% over the past 24 hours. Despite the daily decline, the token remains up 21.7% over the past month and 52% over the past two months. However, it is still down 32% year-to-date.
Uniswap Fee Switch Boosts Network Activity Notably, UNI’s recent recovery happened after Uniswap v4 activated its fee switch, which led to a jump in network activity.
According to Santiment, UNI’s price rose about 19%, from $3.83 to $4.54, between July 29 and July 31 after the fee switch and buy-and-burn system launched. The price later dropped back near $4.07 as the first wave of excitement faded.
Uniswap (UNI) chart by Santiment The increase was not caused solely by price movements. On-chain activity also grew. New addresses nearly doubled, reaching 510 on July 30 and 582 on July 31, compared with the usual July range of 250–320.
Active addresses also increased, reaching 2,341 and 2,457 on those days, above the normal range of 1,300–1,700. Whale activity picked up too, with 142 transactions worth more than $100,000 recorded on July 30.
Santiment said that continued network growth, even after UNI’s price cooled, could be a sign of stronger adoption, not just a short-term price boost.
DisClamier: This content is informational and should not be considered financial advice. The views expressed in this article may include the author's personal opinions and do not reflect The Crypto Basic opinion. Readers are encouraged to do thorough research before making any investment decisions. The Crypto Basic is not responsible for any financial losses.
Spoluzakladatel NEAR Protocol Illia Polosukhin navrhl Sovereign Fund se 30 miliony $NEAR, který by financoval validátory, poskytovatele zabezpečení a veřejné statky. Pokud model uspěje, NEAR může přejít na fixní nabídku tokenů.
NEAR Protocol co-founder Illia Polosukhin has put forward a proposal to establish a Sovereign Fund seeded with 30 million $NEAR tokens, in what would mark a significant shift in how the network funds its core operations and incentivises participants.
The fund is designed to generate yield, which would then be distributed to validators, security providers, and public goods projects. If the model proves sustainable, it could pave the way for NEAR to eventually adopt a fixed token supply, ending the current inflationary issuance model.
A Break From Inflation-Driven RewardsThe proposal reflects a broader push within the NEAR ecosystem to rethink its tokenomics. Polosukhin has publicly dismissed community proposals to burn tokens held by the NEAR Foundation, arguing that simple token burns have historically failed to deliver meaningful benefits to markets or network ecosystems. Instead, he advocates for a fixed maximum supply model similar to Bitcoin's, which would cap total $NEAR tokens and move away from the current inflationary approach to rewarding validators.
This is not the first time the network has moved in this direction. On October 30, 2025, NEAR's inflation rate was cut from 5% to 2.5% annually, roughly halving new token issuance from around 64 million to 32 million $NEAR per year, with the long-term effect of reducing sell pressure from validator rewards. Then, on February 23, 2026, the NEAR Intents fee conversion mechanism activated, routing 100% of Intents fees into open-market $NEAR purchases.
Community Input Before Any VoteThe Sovereign Fund proposal remains in its early stages. The plan is open for community feedback before any formal governance vote takes place, and it also aims to improve treasury transparency through on-chain governance mechanisms.
The community will ultimately determine whether the Sovereign Fund advances to a formal vote. The move away from short-term mechanisms in favour of a fixed supply model represents a meaningful departure from conventional tokenomics, and signals a focus on sustainability that could influence how other blockchain networks approach supply management.
Sources:
CryptoNews: Near Protocol Co-Founder Rejects Token Burn Proposal, Advocates Fixed Supply Model
ChangeNow: NEAR Protocol Overview in 2026
NEAR Foundation: Supporting Community Proposals to Upgrade NEAR Tokenomics
Spotify (SPOT - Free Report) came out with quarterly earnings of $3.03 per share, missing the Zacks Consensus Estimate of $3.27 per share. This compares to a loss of $0.48 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -7.34%. A quarter ago, it was expected that this music-streaming service operator would post earnings of $3.72 per share when it actually produced earnings of $4.04, delivering a surprise of +8.6%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Spotify, which belongs to the Zacks Internet - Software industry, posted revenues of $5.55 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 0.01%. This compares to year-ago revenues of $4.76 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Spotify shares have lost about 16.3% since the beginning of the year versus the S&P 500's gain of 11%.
What's Next for Spotify?While Spotify has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Spotify was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $3.70 on $5.7 billion in revenues for the coming quarter and $14.45 on $22.51 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the bottom 40% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Arteris, Inc. (AIP - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 6.
This company is expected to post quarterly loss of $0.05 per share in its upcoming report, which represents a year-over-year change of +54.6%. The consensus EPS estimate for the quarter has been revised 7.7% lower over the last 30 days to the current level.
Arteris, Inc.'s revenues are expected to be $23.45 million, up 42.1% from the year-ago quarter.
Sysco ve 4. fiskálním čtvrtletí zvýšila tržby o 4,7 % na 22,1 miliardy USD a upravený zisk na akcii o 3,4 % na 1,53 USD. Pro fiskální rok 2027 čeká růst upraveného EPS o 9 % až 11 %.
HOUSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) (“Sysco” or the “company”) today announced financial results for its 13-week fourth fiscal quarter and its fiscal year ended June 27, 2026.
Key financial results for the fourth quarter of fiscal year 2026 include the following (comparisons are to the same period in fiscal year 2025):
Sales increased 4.7%; U.S. Foodservice volume increased 2.5%, U.S. local volume increased 2.6%;Gross profit increased 3.7% to $4.1 billion;Operating income increased 10.6% to $983 million, and adjusted operating income increased 4.1% to $1.1 billion1;Net earnings increased 3.8% to $551 million, and adjusted net earnings increased 2.5% to $734 million1;EBITDA increased 5.4% to $1.2 billion1, and adjusted EBITDA increased 4.7% to $1.3 billion1;EPS2 increased 4.5% to $1.15, and adjusted EPS1,2 increased 3.4% to $1.53, inclusive of higher incentive compensation costs of $11 million, as previously disclosed, representing a $0.01 impact to EPS;Introduction of fiscal year 2027 guidance of 6%-7% sales growth and 9%-11% adjusted EPS1 growth on a 53-week basis; andIncluded in the 2027 guidance is approximately $100 million of efficiency improvements driven by an artificial intelligence (AI)-powered transformation of business processes and customer engagement. “Sysco delivered strong results in the fourth quarter of fiscal year 2026, including positive case growth across our local, national, and international businesses. This included local volume growth of 2.6% in our USFS segment, as well as local volume growth of 4.5% in our International segment. Continued productivity gains from our supply chain enabled year over year profit growth across each of our four business segments,” said Kevin Hourican, Sysco’s Chair of the Board and Chief Executive Officer. “We have clear positive momentum in our business domestically and internationally. We are excited about the progress and the opportunity to improve further through the AI-driven business process transformation underway at Sysco. These efforts will improve how we serve our customers and expand our operating margins.”
“We exceeded our previously communicated guidance for the quarter and the year, as our company specific initiatives drove tangible results across our business. For the year, we generated robust cash flows and returned $1.2 billion to our shareholders through dividends and share repurchase. We expect positive momentum to continue in FY27 and are introducing guidance on a 53-week basis that includes sales growth of 6%-7% and adjusted EPS growth of 9%-11%. Today, we are also announcing incremental cost out efforts which we expect, when combined with our Q3 update, to deliver a combined $100 million of net cost savings in FY27.” said Brandon Sewell, Sysco’s Interim Chief Financial Officer.
1 Non-GAAP financial measure, refer to the reconciliations of all non-GAAP financial measures to the nearest corresponding GAAP financial measure included at the end of this release.
2 Earnings per share (EPS) is shown on a diluted basis, unless otherwise specified.
Key financial results for fiscal year 2026 include the following (comparisons are to the same period in fiscal year 2025):
Sales increased 3.9%; U.S. Foodservice volume increased 1.4%, U.S. local volume increased 1.7%;Gross profit increased 4.5% to $15.6 billion;Operating income increased 0.2% to $3.1 billion, and adjusted operating income increased 2.6% to $3.6 billion1;Net earnings decreased 3.9% to $1.8 billion, and adjusted net earnings increased 1.4% to $2.2 billion1;Cash flow from operations increased 5.1% to $2.6 billion and free cash flow1 increased 16.3% to $2.1 billion on a year-over-year basis;EBITDA decreased 0.7% to $4.0 billion1, and adjusted EBITDA increased 2.2% to $4.4 billion1;EPS2 decreased 1.9% to $3.66, and adjusted EPS1,2 increased 3.4% to $4.61, inclusive of higher incentive compensation costs of $100 million, as previously disclosed, representing a $0.16 impact to EPS; andWe returned approximately $1.2 billion of capital to shareholders via $1.0 billion of dividends and $200 million of share repurchases. Fiscal Year 2027 Productivity and Cost Savings Initiatives
Sysco is also advancing a multi-year AI-enabled business transformation program designed to further improve productivity, operating efficiency, and customer service across the enterprise. In fiscal year 2027, the company expects combined cost-outs of approximately $100 million, including the carry-forward benefit from previously announced actions. Efforts reflect initiatives focused on enhanced inventory management and forecasting accuracy, improved coding efficiency, routing optimization and back-office automation. Together, Sysco expects these AI-related initiatives and previously announced cost-out efforts to deliver bottom line benefits in fiscal year 2027, supporting the company’s outlook for continued profit growth and margin expansion.
Fourth Quarter Fiscal Year 2026 Results (comparisons are to the same period in fiscal year 2025)
Total Sysco
Sales for the fourth quarter increased 4.7% to $22.1 billion.
Gross profit increased 3.7% to $4.1 billion, and gross margin decreased 17 basis points to 18.7%. Product cost inflation was 2.8% at the total enterprise level, as measured by the estimated change in Sysco’s product costs, primarily in the meat and fresh produce categories. The increase in gross profit for the fourth quarter was primarily driven by continued positive momentum in U.S. local volume growth, positive mix shift from improved Sysco Brand penetration, strategic sourcing efficiencies, and effective management of product cost inflation.
Operating expenses increased 1.7%, primarily driven by acquisition-related costs, sales headcount and capacity investments, partially offset by cost-out efficiencies. Adjusted operating expenses increased 3.6%1.
Operating income increased 10.6% to $983 million, and adjusted operating income increased 4.1% to $1.1 billion1.
U.S. Foodservice Operations
The U.S. Foodservice Operations segment results reflected positive case growth across local and national customers, improved mix shift from improved Sysco Brand penetration, and supply chain productivity improvements, partially offset by planned investments in sales headcount and expanded capacity.
Sales for the fourth quarter increased 4.4% to $15.4 billion. Total case volume within U.S. Foodservice increased 2.5% for the fourth quarter, while local case volume within U.S. Foodservice increased 2.6%.
Gross profit increased 3.0% to $3.0 billion, and gross margin decreased 26 basis points to 19.2%.
Operating expenses increased 3.3%, and adjusted operating expenses increased 4.7%1.
Operating income increased 2.4% to $1.0 billion, and adjusted operating income increased 0.1% to $1.1 billion1.
International Foodservice Operations
The International Foodservice Operations segment delivered continued sales growth and volume gains, marking its eleventh consecutive quarter of double-digit adjusted operating income growth.
Sales for the fourth quarter increased 6.7% to $4.2 billion. On a constant currency basis3, sales for the fourth quarter increased 5.6% to $4.1 billion. Foreign exchange rates increased both International Foodservice Operations sales by $46 million and total Sysco sales by $47 million during the quarter.
Gross profit increased 7.3% to $909 million, and gross margin increased 12 basis points to 21.7%. On a constant currency basis3, gross profit increased 6.0% to $898 million. Foreign exchange rates increased both International Foodservice Operations gross profit by 1.3% and total Sysco gross profit by 0.3% during the quarter.
Operating expenses increased 8.4%, and adjusted operating expenses increased 4.8%1. On a constant currency basis3, adjusted operating expenses increased 3.4%. Foreign exchange rates increased both International Foodservice Operations operating expenses by 1.4% and total Sysco operating expenses by 0.3% during the quarter.
Operating income increased 2.1% to $148 million, and adjusted operating income increased 15.7% to $228 million1. On a constant currency basis3, adjusted operating income increased 14.7% to $226 million. Foreign exchange rates increased both International Foodservice Operations operating income by 1.0% and total Sysco operating income by 0.3% during the quarter.
Fiscal Year 2026 Results (comparisons are to fiscal year 2025)
Total Sysco
Sales for fiscal year 2026 increased 3.9% to $84.6 billion.
Gross profit increased 4.5% to $15.6 billion, and gross margin increased 10 basis points to 18.5%. Product cost inflation was 3.0% at the total enterprise level, as measured by the estimated change in Sysco’s product costs, primarily in the meat and seafood categories. The increase in gross profit for the year was primarily driven by positive volumes, strategic sourcing efficiencies, and effective management of product cost inflation.
Operating expenses increased 5.6%, primarily driven by sales headcount and capacity investments, higher incentive compensation, and acquisition-related costs, partially offset by cost-out efficiencies. Adjusted operating expenses increased 5.1%1.
Operating income increased 0.2% to $3.1 billion, and adjusted operating income increased 2.6% to $3.6 billion1.
3 Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results. These adjusted measures are non-GAAP financial measures. Reconciliations of all non-GAAP financial measures to the nearest corresponding GAAP financial measure are included at the end of this release.
U.S. Foodservice Operations
Sales for fiscal year 2026 increased 3.2% to $58.8 billion. Total case volume within U.S. Foodservice increased 1.4% for fiscal year 2026, while local case volume within U.S. Foodservice increased 1.7%.
Gross profit increased 3.3% to $11.2 billion, and gross margin increased 2 basis points to 19.1%.
Operating expenses increased 4.9%, and adjusted operating expenses increased 4.7%1.
Operating income increased 0.1% to $3.5 billion, and adjusted operating income increased 0.7% to $3.7 billion1.
International Foodservice Operations
Sales for fiscal year 2026 increased 7.6% to $16.0 billion. On a constant currency basis3, sales for fiscal year 2026 increased 4.1% to $15.5 billion. Foreign exchange rates increased both International Foodservice Operations sales by 3.5% and total Sysco sales by 0.6% during the year.
Gross profit increased 9.4% to $3.4 billion, and gross margin increased 34 basis points to 21.2%. On a constant currency basis3, gross profit increased 5.4% to $3.3 billion. Foreign exchange rates increased both International Foodservice Operations gross profit by 4.0% and total Sysco gross profit by 0.9% during the year.
Operating expenses increased 10.0%, and adjusted operating expenses increased 7.8%1. On a constant currency basis3, adjusted operating expenses increased 3.4%. Foreign exchange rates increased both International Foodservice Operations operating expense by 4.4% and total Sysco operating expense by 1.0% during the year.
Operating income increased 5.9% to $463 million, and adjusted operating income increased 16.4% to $681 million1. On a constant currency basis3, adjusted operating income increased 14.0% to $667 million. Foreign exchange rates increased both International Foodservice Operations operating income by 2.4% and total Sysco operating income by 0.5% during the year.
Balance Sheet, Cash Flow and Capital Spending
As of the end of the quarter, the company had a cash balance of $1.8 billion and total liquidity4 of $4.8 billion.
Debt to net earnings was approximately 7.7 times, and Net Debt to adjusted EBITDA1 was approximately 2.7 times.
During the fiscal year, Sysco returned $1.2 billion to shareholders via $200 million of share repurchases and $1.0 billion of dividends.
Cash flow from operations was $2.6 billion for fiscal year 2026, which was 5.1% higher compared to the prior year. Free cash flow1 for fiscal year 2026 was $2.1 billion, which was 16.3% higher compared to the prior year.
Capital expenditures, net of proceeds from sales of plant and equipment, for fiscal year 2026 were $524 million.
4 Available liquidity includes cash and cash equivalents, available borrowing capacity under our revolving credit facility, less outstanding drawings under our commercial paper program, as of the applicable reporting date.
Conference Call & Webcast
Sysco will host a conference call to review the company’s fourth quarter and full fiscal year 2026 financial results on Tuesday, August 4, 2026, at 10:00 a.m. Eastern Time. A live webcast of the call, accompanying slide presentation and a copy of this news release will be available online at investors.sysco.com.
Key Highlights: 13-Week Period Ended52-Week Period Ended Financial Comparison (1):June 27, 2026ChangeJune 27, 2026ChangeGAAP: Sales$22.1 billion4.7%
$84.6 billion3.9%
Gross Profit$4.1 billion3.7%
$15.6 billion4.5%
Gross Margin18.7%
-17 bps18.5%
10 bpsOperating Expenses$3.2 billion1.7%
$12.5 billion5.6%
Operating Income$983 million10.6%
$3.1 billion0.2%
Operating Margin4.4%
23 bps3.7%
-14 bpsNet Earnings$551 million3.8%
$1.8 billion-3.9%
Diluted Earnings Per Share$1.15
4.5%
$3.66
-1.9%
Non-GAAP (2): Adjusted Operating Expenses$3.0 billion3.6%
$12.0 billion5.1%
Adjusted Operating Income$1.1 billion4.1%
$3.6 billion2.6%
Adjusted Operating Margin5.2%
-3 bps4.3%
-6 bpsEBITDA$1.2 billion5.4%
$4.0 billion-0.7%
Adjusted EBITDA$1.3 billion4.7%
$4.4 billion2.2%
Adjusted Net Earnings$734 million2.5%
$2.2 billion1.4%
Adjusted Diluted Earnings Per Share$1.53
3.4%
$4.61
3.4%
Case Growth: U.S. Foodservice2.5%
1.4%
Local2.6%
1.7%
Sysco Brand Sales as a % of Cases (3): U.S. Broadline35.5%
-4 bps35.4%
-59 bpsLocal46.4%
30 bps45.8%
-45 bps Note:(1) Individual components in the table may not sum to the totals due to rounding.(2) Reconciliations of all non-GAAP financial measures to the nearest respective GAAP financial measures are included at the end of this release.(3) Amounts reflect the impact of current customer classifications; prior period history has been reclassified to match the current period customer classification. Forward-Looking Statements
Statements made in this press release or in our earnings call for the fourth quarter of fiscal year 2026 include statements that are forward-looking or that express management’s beliefs, expectations or hopes and are forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements include, among other things, our future financial performance and results, business strategy, plans, goals and objectives, including certain outlook, business trends, our dividend and share repurchase programs, our expectation of future macroeconomic conditions and other statements that are not historical facts, including our expectations regarding foot traffic and volume growth, and benefits to gross margins; and our expectations regarding our future growth, including growth in sales and earnings per share; as well as statements about the expected timing and completion of the proposed transaction with Jetro Restaurant Depot and the anticipated benefits of such proposed transaction, including estimated synergies, and plans, impact on Sysco and expectations for Sysco after completion of the proposed transaction.
Such forward-looking statements reflect the views of management at the time such statements are made and are subject to a number of risks, uncertainties, estimates, and assumptions, including those outside of Sysco’s control. Risks and uncertainties include without limitation: the impact of geopolitical, economic and market conditions and developments, including changes in global trade policies and tariffs and foreign conflicts; risks related to our business initiatives; periods of significant or prolonged inflation or deflation and their impact on our product costs, volume, foot traffic, and profitability generally; risks related to our efforts to implement our transformation initiatives and meet our other long-term strategic objectives; risks of interruption of supplies and increase in product costs; risks related to changes in consumer eating habits; and impact of natural disasters or adverse weather conditions, public health crises, adverse publicity or lack of confidence in our products, and product liability claims as well as risks and uncertainties associated with our proposed transaction with Jetro Restaurant Depot, including but not limited to, the occurrence of any event, change or other circumstances that could give rise to the right of either or both parties to terminate the merger agreement; the risk that regulatory approvals may not be obtained or other closing conditions may not be satisfied in a timely manner or at all, as well as the risk that regulatory approvals are obtained subject to conditions that are not anticipated; the risk of other delays in closing the transaction; the possibility that any of the anticipated benefits and projected synergies of the transaction will not be realized or will not be realized within the expected time period; and the risk that the proposed transaction and its announcement could have an adverse effect on the market price of the common stock of Sysco. Should one or more of these risks or uncertainties materialize, or underlying assumptions prove incorrect, actual results may vary materially from those indicated in our forward-looking statements. Therefore, you should not place undue reliance on any of the forward-looking statements contained herein. For more information on these risks and other concerning factors that could cause actual results to differ from those expressed or forecasted, see our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and other filings with the SEC. We do not undertake to update our forward-looking statements, except as required by applicable law.
About Sysco
Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare meals away from home. This includes restaurants, healthcare and educational facilities, lodging establishments, entertainment venues, and more. Sysco operates 333 distribution centers, in 10 countries, with 75,000 colleagues serving approximately 670,000 customer locations. The company generated sales of more than $84 billion in fiscal year 2026 that ended June 27, 2026.
As the world’s largest food-away-from-home distributor, Sysco offers customized supply chain solutions, bespoke specialty product offerings, and culinary support to drive customers to innovate and optimize their operations. We act as a trusted business partner to our customers, helping them grow through our industry-leading portfolio that includes fresh produce, premium proteins, specialty products, sustainably focused items, equipment and supplies, and innovative culinary solutions.
For more information, visit www.sysco.com. For important news and key information for Sysco investors, visit the Investor Relations section of the company’s website at investors.sysco.com.
SYY-INVESTORS
Sysco Corporation and its Consolidated Subsidiaries
CONSOLIDATED RESULTS OF OPERATIONS
(In Millions, Except for Share and Per Share Data) 13-Week Period Ended 52-Week Period Ended Jun. 27, 2026 Jun. 28, 2025 Jun. 27, 2026 Jun. 28, 2025 (Unaudited) (Unaudited) (Unaudited) Sales$22,124 $21,138 $84,553 $81,370Cost of sales 17,990 17,152 68,914 66,401Gross profit 4,134 3,986 15,639 14,969Operating expenses 3,151 3,097 12,544 11,881Operating income 983 889 3,095 3,088Interest expense 205 166 717 635Other expense (income), net 58 6 102 38Earnings before income taxes 720 717 2,276 2,415Income taxes 169 186 519 587Net earnings$551 $531 $1,757 $1,828 Net earnings: Basic earnings per share$1.15 $1.10 $3.67 $3.74Diluted earnings per share 1.15 1.10 3.66 3.73 Average shares outstanding 479,019,305 482,335,556 479,117,877 488,144,333Diluted shares outstanding 480,232,028 483,381,310 480,612,203 489,825,648 Sysco Corporation and its Consolidated Subsidiaries
CONSOLIDATED BALANCE SHEETS
(In Millions, Except for Share Data) Jun. 27, 2026 Jun. 28, 2025 (Unaudited) ASSETS Current assets Cash and cash equivalents$1,786 $1,071 Accounts receivable, less allowances of $13 and $17 5,865 5,502 Inventories 5,338 5,053 Prepaid expenses and other current assets 427 338 Income tax receivable 21 4 Total current assets 13,437 11,968 Plant and equipment at cost, less accumulated depreciation 5,974 6,084 Other long-term assets Goodwill 5,225 5,231 Intangibles, less amortization 952 1,080 Deferred income taxes 506 497 Operating lease right-of-use assets, net 1,389 1,131 Other assets 914 783 Total other long-term assets 8,986 8,722 Total assets$28,397 $26,774 LIABILITIES AND SHAREHOLDERS’ EQUITYCurrent liabilities Accounts payable$6,640 $6,512 Accrued expenses 2,456 2,268 Accrued income taxes 60 51 Current operating lease liabilities 166 136 Current maturities of long-term debt 1,201 949 Total current liabilities 10,523 9,916 Long-term liabilities Long-term debt 12,315 12,360 Deferred income taxes 456 345 Long-term operating lease liabilities 1,285 1,049 Other long-term liabilities 1,152 1,247 Total long-term liabilities 15,208 15,001 Commitments and contingencies Noncontrolling interest — 27 Shareholders’ equity Preferred stock, par value $1 per share Authorized 1,500,000 shares, issued none — — Common stock, par value $1 per share Authorized 2,000,000,000 shares, issued
765,174,900 shares 765 765 Paid-in capital 2,114 1,986 Retained earnings 13,748 13,061 Accumulated other comprehensive loss (1,014) (1,098)Treasury stock at cost, 286,631,270 and 287,678,658 shares (12,947) (12,884)Total shareholders’ equity 2,666 1,830 Total liabilities and shareholders’ equity$28,397 $26,774 Sysco Corporation and its Consolidated Subsidiaries
CONSOLIDATED CASH FLOWS
(In Millions) 52-Week Period Ended Jun. 27, 2026 Jun. 28, 2025 (Unaudited) Cash flows from operating activities: Net earnings$1,757 $1,828 Adjustments to reconcile net earnings to cash provided by operating activities: Share-based compensation expense 118 93 Depreciation and amortization 976 945 Operating lease asset amortization 153 141 Amortization of debt issuance and other debt-related costs 46 15 Deferred income taxes 10 (13)Provision for losses on receivables 73 85 Goodwill impairment — 92 Other non-cash items (40) (100)Additional changes in certain assets and liabilities, net of effect of businesses
acquired: Increase in receivables (469) (206)Increase in inventories (293) (330)Increase in prepaid expenses and other current assets (25) (22)Increase in accounts payable 354 143 Increase (decrease) in accrued expenses 214 (14)Decrease in operating lease liabilities (215) (177)Decrease in accrued income taxes (7) (62)(Increase) decrease in other assets (29) 18 Increase in other long-term liabilities 15 74 Net cash provided by operating activities 2,638 2,510 Cash flows from investing activities: Additions to plant and equipment (700) (906)Proceeds from sales of plant and equipment 176 214 Acquisition of businesses, net of cash acquired (189) (40)Purchase of marketable securities (61) (32)Proceeds from sales of marketable securities 54 29 Other investing activities 23 18 Net cash used for investing activities (697) (717)Cash flows from financing activities: Bank and commercial paper borrowings, net (263) 45 Other debt borrowings including senior notes 1,252 1,254 Other debt repayments including senior notes (908) (549)Proceeds from stock option exercises 137 110 Stock repurchases (200) (1,250)Dividends paid (1,037) (1,000)Debt issuance costs (108) — Other financing activities (32) (22)Net cash used for financing activities (1,159) (1,412)Effect of exchange rates on cash, cash equivalents and restricted cash (14) 22 Net increase in cash, cash equivalents and restricted cash 768 403 Cash, cash equivalents and restricted cash at beginning of period 1,349 945 Cash, cash equivalents and restricted cash at end of period$2,117 $1,348 Supplemental disclosures of cash flow information: Cash paid during the period for: Interest$670 $629 Income taxes, net of refunds (1) 477 640 (1) Cash paid for income taxes, net for fiscal year 2026 and 2025 includes $227 million and $190 million, respectively, of cash paid for the purchase of federal tax credits. Sysco Corporation and its Consolidated Subsidiaries
Non-GAAP Reconciliation (Unaudited)
Impact of Certain Items The discussion of our results includes certain non-GAAP financial measures, including EBITDA and adjusted EBITDA, that we believe provide important perspective with respect to underlying business trends. Other than EBITDA and free cash flow, any non-GAAP financial measures will be denoted as adjusted measures to remove (1) restructuring charges; (2) expenses associated with our various transformation initiatives; (3) severance charges; and (4) acquisition-related costs consisting of: (a) intangible amortization expense and (b) acquisition costs and due diligence costs related to our acquisitions. Adjustments provided herein for fiscal year 2026 results of operations also remove the impact of a charge associated with a legal matter, amortization expense associated with debt issuance costs on a bridge loan facility, and a loss on deal contingent rate lock transactions entered into to mitigate interest rate risk on future permanent debt that could potentially be issued to finance the purchase of Jetro Restaurant Depot. No similar charges were applicable in fiscal year 2025. Adjustments provided herein for fiscal year 2025 results of operations also remove the impact of a goodwill impairment charge. No similar charge was applicable in fiscal year 2026. The results of our operations can be impacted due to changes in exchange rates applicable in converting local currencies to U.S. dollars. We measure our results on a constant currency basis. Constant currency operating results are calculated by translating current-period local currency operating results with the currency exchange rates used to translate the financial statements in the comparable prior-year period to determine what the current-period U.S. dollar operating results would have been if the currency exchange rate had not changed from the comparable prior-year period. We also measure our sales growth for our International Foodservice Operations excluding the impact of our joint venture in Mexico which was divested in the second quarter of fiscal year 2025. Management believes that adjusting its operating expenses, operating income, operating margin, interest expense, other (income) expense, net earnings and diluted earnings per share to remove these Certain Items, presenting its results on a constant currency basis, and adjusting its sales results to exclude the impact of its joint venture in Mexico provides an important perspective with respect to our underlying business trends and results. It provides meaningful supplemental information to both management and investors that (1) is indicative of the performance of the company’s underlying operations and (2) facilitates comparisons on a year-over-year basis. Sysco has a history of growth through acquisitions and excludes from its non-GAAP financial measures the impact of acquisition-related intangible amortization, acquisition costs and due-diligence costs for those acquisitions. We believe this approach significantly enhances the comparability of Sysco’s results for fiscal year 2026 and fiscal year 2025. Set forth on the following page is a reconciliation of sales, operating expenses, operating income, interest expense, other (income) expense, net earnings and diluted earnings per share to adjusted results for these measures for the periods presented. Individual components of diluted earnings per share may not be equal to the total presented when added due to rounding. Adjusted diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding. The non-GAAP financial measures shown in the following tables should not be used as a substitute for the most comparable GAAP financial measures in assessing the company’s financial performance for the periods presented. An analysis of any non-GAAP financial measure should be used in conjunction with results presented in accordance with GAAP. Sysco Corporation and its Consolidated Subsidiaries
Non-GAAP Reconciliation (Unaudited)
Impact of Certain Items
(Dollars in Millions, Except for Share and Per Share Data) 13-Week
Period Ended
Jun. 27, 2026 13-Week
Period Ended
Jun. 28, 2025 Change in
Dollars %/bps
ChangeSales (GAAP)$22,124 $21,138 $986 4.7%Impact of currency fluctuations (1) (47) (47) (0.3)Comparable sales using a constant currency basis
(Non-GAAP)$22,077 $21,138 $939 4.4% Cost of sales (GAAP)$17,990 $17,152 $838 4.9% Gross profit (GAAP)$4,134 $3,986 $148 3.7%Impact of currency fluctuations (1) (12) (12) (0.3)Comparable gross profit adjusted for Certain Items
using a constant currency basis (Non-GAAP)$4,122 $3,986 $136 3.4% Gross margin (GAAP) 18.69% 18.86% -17 bpsImpact of currency fluctuations (1) (0.02) -2 bpsComparable gross margin adjusted for Certain Items
using a constant currency basis (Non-GAAP) 18.67% 18.86% -19 bps Operating expenses (GAAP)$3,151 $3,097 $54 1.7%Impact of restructuring and transformational project costs (2) (80) (75) (5) (6.7)Impact of acquisition-related costs (3) (77) (39) (38) (97.4)Impact of goodwill impairment — (92) 92 NMOperating expenses adjusted for Certain Items (Non-GAAP) 2,994 2,891 103 3.6 Impact of currency fluctuations (1) (8) (8) (0.3)Comparable operating expenses adjusted for Certain Items
using a constant currency basis (Non-GAAP)$2,986 $2,891 $95 3.3% Operating expense as a percentage of sales (GAAP) 14.24% 14.65% -41 bpsImpact of certain item adjustments (0.71) (0.97) 26 bpsAdjusted operating expense as a percentage of sales
(Non-GAAP) 13.53% 13.68% -15 bps Operating income (GAAP)$983 $889 $94 10.6%Impact of restructuring and transformational project costs (2) 80 75 5 6.7 Impact of acquisition-related costs (3) 77 39 38 97.4 Impact of goodwill impairment — 92 (92) NMOperating income adjusted for Certain Items (Non-GAAP) 1,140 1,095 45 4.1 Impact of currency fluctuations (1) (3) (3) (0.3)Comparable operating income adjusted for Certain Items
using a constant currency basis (Non-GAAP)$1,137 $1,095 $42 3.8% Operating margin (GAAP) 4.44% 4.21% 23 bpsOperating margin adjusted for Certain Items (Non-GAAP) 5.15% 5.18% -3 bpsOperating margin adjusted for Certain Items
using a constant currency basis (Non-GAAP) 5.15% 5.18% -3 bps Interest expense (GAAP)$205 $166 $39 23.5%Impact of bridge loan amortization (4) (30) — (30) NMInterest expense adjusted for Certain Items (Non-GAAP)$175 $166 $9 5.4% Other expense (GAAP)$58 $6 $52 NMImpact of deal contingent rate lock transactions (4) (54) — (54) NMOther expense adjusted for Certain Items (Non-GAAP)$4 $6 $(2) (33.3)% Net earnings (GAAP)$551 $531 $20 3.8%Impact of restructuring and transformational project costs (2) 80 75 5 6.7 Impact of acquisition-related costs (3) 77 39 38 97.4 Impact of goodwill impairment — 92 (92) NMImpact of bridge loan amortization (4) 30 — 30 NMImpact of deal contingent rate lock transactions (4) 54 — 54 NMTax impact of restructuring and transformational project costs (5) (19) (14) (5) (35.7)Tax impact of acquisition-related costs (5) (19) (7) (12) NMTax impact of goodwill impairment (5) — (10) 10 NMTax impact of bridge loan amortization (5) (7) — (7) NMTax impact of deal contingent rate lock transactions (5) (13) — (13) NMImpact of other non-routine tax adjustments — 10 (10) NMNet earnings adjusted for Certain Items (Non-GAAP)$734 $716 $18 2.5% Diluted earnings per share (GAAP)$1.15 $1.10 $0.05 4.5%Impact of restructuring and transformational project costs (2) 0.17 0.16 0.01 6.3 Impact of acquisition-related costs (3) 0.16 0.08 0.08 100.0 Impact of goodwill impairment — 0.19 (0.19) NMImpact of bridge loan amortization (4) 0.06 — 0.06 NMImpact of deal contingent rate lock transactions (4) 0.11 — 0.11 NMTax impact of restructuring and transformational project costs (5) (0.04) (0.03) (0.01) (33.3)Tax impact of acquisition-related costs (5) (0.04) (0.01) (0.03) NMTax impact of goodwill impairment (5) — (0.02) 0.02 NMTax impact of bridge loan amortization (5) (0.01) — (0.01) NMTax impact of deal contingent rate lock transactions (5) (0.03) — (0.03) NMImpact of other non-routine tax adjustments — 0.02 (0.02) NMDiluted earnings per share adjusted for Certain Items
(Non-GAAP) (6)$1.53 $1.48 $0.05 3.4% Diluted shares outstanding 480,232,028 483,381,310 (1) Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on the current year results.(2) Fiscal year 2026 includes $29 million related to restructuring costs and severance charges, partially offset by the reversal of costs associated with a legal matter and $72 million related to various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy. Fiscal year 2025 includes $26 million related to restructuring and severance charges and $49 million related to various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy.(3) Fiscal year 2026 includes $39 million of intangible amortization expense and $38 million in acquisition and due diligence costs. Fiscal year 2025 includes $36 million of intangible amortization expense and $3 million in acquisition and due diligence costs.(4) Fiscal year 2026 includes amortization expense associated with debt issuance costs on a bridge loan facility and a loss on deal contingent rate lock transactions, both of which are related to the planned acquisition of Jetro Restaurant Depot.(5) The tax impact of adjustments for Certain Items are calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred.(6) Individual components of diluted earnings per share may not equal the total presented when added due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding.NM Represents that the percentage change is not meaningful. Sysco Corporation and its Consolidated Subsidiaries
Non-GAAP Reconciliation (Unaudited)
Impact of Certain Items
(Dollars in Millions, Except for Share and Per Share Data) 52-Week
Period Ended
Jun. 27, 2026 52-Week
Period Ended
Jun. 28, 2025 Change in
Dollars %/bps
ChangeSales (GAAP)$84,553 $81,370 $3,183 3.9%Impact of Mexico joint venture sales — (207) 207 0.3 Comparable sales excluding Mexico joint venture (Non-GAAP)$84,553 $81,163 $3,390 4.2% Sales (GAAP)$84,553 $81,370 $3,183 3.9%Impact of currency fluctuations (1) (527) (527) (0.6)Comparable sales using a constant currency basis (Non-GAAP)$84,026 $81,370 $2,656 3.3% Cost of sales (GAAP)$68,914 $66,401 $2,513 3.8% Gross profit (GAAP)$15,639 $14,969 $670 4.5%Impact of currency fluctuations (1) (127) (127) (0.9)Comparable gross profit adjusted for Certain Items
using a constant currency basis (Non-GAAP)$15,512 $14,969 $543 3.6% Gross margin (GAAP) 18.50% 18.40% 10 bpsImpact of currency fluctuations (1) (0.04) -4 bpsComparable gross margin adjusted for Certain Items
using a constant currency basis (Non-GAAP) 18.46% 18.40% 6 bps Operating expenses (GAAP)$12,544 $11,881 $663 5.6%Impact of restructuring and transformational project costs (2) (287) (183) (104) (56.8)Impact of acquisition-related costs (3) (232) (160) (72) (45.0)Impact of goodwill impairment — (92) 92 NMOperating expenses adjusted for Certain Items (Non-GAAP) 12,025 11,446 579 5.1 Impact of currency fluctuations (1) (111) (111) (1.0)Comparable operating expenses adjusted for Certain Items
using a constant currency basis (Non-GAAP)$11,914 $11,446 $468 4.1% Operating expense as a percentage of sales (GAAP) 14.84% 14.60% 24 bpsImpact of certain item adjustments (0.62) (0.53) -9 bpsAdjusted operating expense as a percentage of sales
(Non-GAAP) 14.22% 14.07% 15 bps Operating income (GAAP)$3,095 $3,088 $7 0.2%Impact of restructuring and transformational project costs (2) 287 183 104 56.8 Impact of acquisition-related costs (3) 232 160 72 45.0 Impact of goodwill impairment — 92 (92) NMOperating income adjusted for Certain Items (Non-GAAP) 3,614 3,523 91 2.6 Impact of currency fluctuations (1) (16) (16) (0.5)Comparable operating income adjusted for Certain Items
using a constant currency basis (Non-GAAP)$3,598 $3,523 $75 2.1% Operating margin (GAAP) 3.66% 3.80% -14 bpsOperating margin adjusted for Certain Items (Non-GAAP) 4.27% 4.33% -6 bpsOperating margin adjusted for Certain Items using a constant
currency basis (Non-GAAP) 4.28% 4.33% -5 bps Interest expense (GAAP)$717 $635 $82 12.9%Impact of bridge loan amortization (4) (30) — (30) NMInterest expense adjusted for Certain Items (Non-GAAP)$687 $635 $52 8.2% Other expense (GAAP)$102 $38 $64 NMImpact of deal contingent rate lock transactions (4) (54) — (54) NMOther expense adjusted for Certain Items (Non-GAAP)$48 $38 $10 26.3% Net earnings (GAAP)$1,757 $1,828 $(71) (3.9)%Impact of restructuring and transformational project costs (2) 287 183 104 56.8 Impact of acquisition-related costs (3) 232 160 72 45.0 Impact of goodwill impairment — 92 (92) NMImpact of bridge loan amortization (4) 30 — 30 NMImpact of deal contingent rate lock transactions (4) 54 — 54 NMTax impact of restructuring and transformational project costs (5) (69) (42) (27) (64.3)Tax impact of acquisition-related costs (5) (56) (37) (19) (51.4)Tax impact of goodwill impairment (5) — (10) 10 NMTax impact of bridge loan amortization (5) (7) — (7) NMTax impact of deal contingent rate lock transactions (5) (13) — (13) NMImpact of other non-routine tax adjustments — 10 (10) NMNet earnings adjusted for Certain Items (Non-GAAP)$2,215 $2,184 $31 1.4% Diluted earnings per share (GAAP)$3.66 $3.73 $(0.07) (1.9)%Impact of restructuring and transformational project costs (2) 0.60 0.37 0.23 62.2 Impact of acquisition-related costs (3) 0.48 0.33 0.15 45.5 Impact of goodwill impairment — 0.19 (0.19) NMImpact of bridge loan amortization (4) 0.06 — 0.06 NMImpact of deal contingent rate lock transactions (4) 0.11 — 0.11 NMTax impact of restructuring and transformational project costs (5) (0.14) (0.09) (0.05) (55.6)Tax impact of acquisition-related costs (5) (0.12) (0.08) (0.04) (50.0)Tax impact of goodwill impairment (5) — (0.02) 0.02 NMTax impact of bridge loan amortization (5) (0.01) — (0.01) NMTax impact of deal contingent rate lock transactions (5) (0.03) — (0.03) NMImpact of other non-routine tax adjustments — 0.02 (0.02) NMDiluted earnings per share adjusted for Certain Items
(Non-GAAP) (6)$4.61 $4.46 $0.15 3.4% Diluted shares outstanding 480,612,203 489,825,648 (1) Represents a constant currency adjustment which eliminates the impact of foreign currency fluctuations on the current year results.(2) Fiscal year 2026 includes $71 million related to restructuring costs, severance charges, and costs associated with a legal matter and $216 million related to various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy. Fiscal year 2025 includes $57 million related to restructuring and severance charges and $126 million related to various transformation initiative costs, primarily consisting of changes to our business technology strategy.(3) Fiscal year 2026 includes $147 million of intangible amortization expense and $85 million in acquisition and due diligence costs. Fiscal year 2025 includes $133 million of intangible amortization expense and $27 million in acquisition and due diligence costs.(4) Fiscal year 2026 includes amortization expense associated with debt issuance costs on a bridge loan facility and a loss on deal contingent rate lock transactions, both of which are related to the planned acquisition of Jetro Restaurant Depot.(5) The tax impact of adjustments for Certain Items is calculated by multiplying the pretax impact of each Certain Item by the statutory rates in effect for each jurisdiction where the Certain Item was incurred.(6) Individual components of diluted earnings per share may not add up to the total presented due to rounding. Total diluted earnings per share is calculated using adjusted net earnings divided by diluted shares outstanding.NM Represents that the percentage change is not meaningful. Sysco Corporation and its Consolidated Subsidiaries
Segment Results
Non-GAAP Reconciliation (Unaudited)
Impact of Certain Items on Applicable Segments
(Dollars in Millions) 13-Week
Period Ended
Jun. 27, 2026 13-Week
Period Ended
Jun. 28, 2025 Change in
Dollars %/bps
ChangeU.S. FOODSERVICE OPERATIONS Sales (GAAP)$15,406 $14,759 $647 4.4%Gross profit (GAAP) 2,958 2,872 86 3.0%Gross margin (GAAP) 19.20% 19.46% -26 bps Operating expenses (GAAP)$1,912 $1,851 $61 3.3%Impact of restructuring and transformational project costs (1) 5 (19) 24 NMImpact of acquisition-related costs (2) (18) (18) — — Operating expenses adjusted for Certain Items (Non-GAAP)$1,899 $1,814 $85 4.7% Operating income (GAAP)$1,046 $1,021 $25 2.4%Impact of restructuring and transformational project costs (1) (5) 19 (24) NMImpact of acquisition-related costs (2) 18 18 — — Operating income adjusted for Certain Items (Non-GAAP)$1,059 $1,058 $1 0.1% INTERNATIONAL FOODSERVICE OPERATIONS Sales (GAAP)$4,191 $3,927 $264 6.7%Impact of currency fluctuations (3) (46) (46) (1.1)Comparable sales using a constant currency basis
(Non-GAAP)$4,145 $3,927 $218 5.6% Gross profit (GAAP)$909 $847 $62 7.3%Impact of currency fluctuations (3) (11) (11) (1.3)Comparable gross profit using a constant currency basis
(Non-GAAP)$898 $847 $51 6.0% Gross margin (GAAP) 21.69% 21.57% 12 bpsImpact of currency fluctuations (3) (0.03) -3 bpsComparable gross margin using a constant currency basis
(Non-GAAP) 21.66% 21.57% 9 bps Operating expenses (GAAP)$761 $702 $59 8.4%Impact of restructuring and transformational project costs (4) (57) (34) (23) (67.6)Impact of acquisition-related costs (2) (23) (18) (5) (27.8)Operating expenses adjusted for Certain Items (Non-GAAP) 681 650 31 4.8 Impact of currency fluctuations (3) (9) (9) (1.4)Comparable operating expenses adjusted for Certain Items
using a constant currency basis (Non-GAAP)$672 $650 $22 3.4% Operating income (GAAP)$148 $145 $3 2.1%Impact of restructuring and transformational project costs (4) 57 34 23 67.6 Impact of acquisition-related costs (2) 23 18 5 27.8 Operating income adjusted for Certain Items (Non-GAAP) 228 197 31 15.7 Impact of currency fluctuations (3) (2) (2) (1.0)Comparable operating income adjusted for Certain Items
using a constant currency basis (Non-GAAP)$226 $197 $29 14.7% SYGMA Sales (GAAP)$2,231 $2,164 $67 3.1%Gross profit (GAAP) 175 170 5 2.9%Gross margin (GAAP) 7.84% 7.86% -2 bps Operating expenses (GAAP)$145 $143 $2 1.4%Operating income (GAAP) 30 27 3 11.1% OTHER Sales (GAAP)$296 $288 $8 2.8%Gross profit (GAAP) 79 69 10 14.5%Gross margin (GAAP) 26.69% 23.96% 273 bps Operating expenses (GAAP)$66 $151 $(85) (56.3)%Impact of goodwill impairment — (92) 92 NMOperating expenses adjusted for Certain Items (Non-GAAP)$66 $59 $7 11.9% Operating income (loss) (GAAP)$13 $(82) $95 NMImpact of goodwill impairment — 92 (92) NMOperating income adjusted for Certain Items (Non-GAAP)$13 $10 $3 30.0% GLOBAL SUPPORT CENTER Gross profit (GAAP)$13 $28 $(15) (53.6)% Operating expenses (GAAP)$267 $250 $17 6.8%Impact of restructuring and transformational project costs (5) (28) (22) (6) (27.3)Impact of acquisition-related costs (6) (36) (3) (33) NMOperating expenses adjusted for Certain Items (Non-GAAP)$203 $225 $(22) (9.8)% Operating loss (GAAP)$(254) $(222) $(32) (14.4)%Impact of restructuring and transformational project costs (5) 28 22 6 27.3 Impact of acquisition-related costs (6) 36 3 33 NMOperating loss adjusted for Certain Items (Non-GAAP)$(190) $(197) $7 3.6% TOTAL SYSCO Sales (GAAP)$22,124 $21,138 $986 4.7%Gross profit (GAAP) 4,134 3,986 148 3.7%Gross margin (GAAP) 18.69% 18.86% -17 bps Operating expenses (GAAP)$3,151 $3,097 $54 1.7%Impact of restructuring and transformational project costs (1) (4) (5) (80) (75) (5) (6.7)Impact of acquisition-related costs (2) (6) (77) (39) (38) (97.4)Impact of goodwill impairment — (92) 92 NMOperating expenses adjusted for Certain Items (Non-GAAP)$2,994 $2,891 $103 3.6% Operating income (GAAP)$983 $889 $94 10.6%Impact of restructuring and transformational project costs (1) (4) (5) 80 75 5 6.7 Impact of acquisition-related costs (2) (6) 77 39 38 97.4 Impact of goodwill impairment — 92 (92) NMOperating income adjusted for Certain Items (Non-GAAP)$1,140 $1,095 $45 4.1% (1) Primarily represents severance charges and transformation initiative costs, partially offset by the reversal of costs associated with a legal matter.(2) Fiscal year 2026 and fiscal year 2025 include intangible amortization expense and acquisition costs.(3) Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results.(4) Includes restructuring and transformation costs primarily in Europe.(5) Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy.(6) Represents due diligence costs.NM Represents that the percentage change is not meaningful. Sysco Corporation and its Consolidated Subsidiaries
Segment Results
Non-GAAP Reconciliation (Unaudited)
Impact of Certain Items on Applicable Segments
(Dollars in Millions) 52-Week
Period Ended
Jun. 27, 2026 52-Week
Period Ended
Jun. 28, 2025 Change in
Dollars %/bps
ChangeU.S. FOODSERVICE OPERATIONS Sales (GAAP)$58,803 $56,965 $1,838 3.2%Gross profit (GAAP) 11,239 10,875 364 3.3%Gross margin (GAAP) 19.11% 19.09% 2 bps Operating expenses (GAAP)$7,721 $7,359 $362 4.9%Impact of restructuring and transformational project costs (1) (49) (45) (4) 8.9 Impact of acquisition-related costs (2) (90) (71) (19) (26.8)Operating expenses adjusted for Certain Items (Non-GAAP)$7,582 $7,243 $339 4.7% Operating income (GAAP)$3,518 $3,516 $2 0.1%Impact of restructuring and transformational project costs (1) 49 45 4 8.9 Impact of acquisition-related costs (2) 90 71 19 26.8 Operating income adjusted for Certain Items (Non-GAAP)$3,657 $3,632 $25 0.7% INTERNATIONAL FOODSERVICE OPERATIONS Sales (GAAP)$16,042 $14,905 $1,137 7.6%Impact of Mexico joint venture sales — (207) 207 1.5 Comparable sales excluding Mexico joint venture (Non-GAAP)$16,042 $14,698 $1,344 9.1% Sales (GAAP)$16,042 $14,905 $1,137 7.6%Impact of currency fluctuations (3) (523) (523) (3.5)Comparable sales using a constant currency basis
(Non-GAAP)$15,519 $14,905 $614 4.1% Gross profit (GAAP)$3,401 $3,109 $292 9.4%Impact of currency fluctuations (3) (125) (125) (4.0)Comparable gross profit using a constant currency basis (Non-GAAP)$3,276 $3,109 $167 5.4% Gross margin (GAAP) 21.20% 20.86% 34 bpsImpact of currency fluctuations (3) (0.09) -9 bpsComparable gross margin using a constant currency basis
(Non-GAAP) 21.11% 20.86% 25 bps Operating expenses (GAAP)$2,938 $2,672 $266 10.0%Impact of restructuring and transformational project costs (4) (148) (74) (74) (100.0)Impact of acquisition-related costs (2) (70) (74) 4 5.4 Operating expenses adjusted for Certain Items (Non-GAAP) 2,720 2,524 196 7.8 Impact of currency fluctuations (3) (111) (111) (4.4)Comparable operating expenses adjusted for Certain Items
using a constant currency basis (Non-GAAP)$2,609 $2,524 $85 3.4% Operating income (GAAP)$463 $437 $26 5.9%Impact of restructuring and transformational project costs (4) 148 74 74 100.0 Impact of acquisition-related costs (2) 70 74 (4) (5.4)Operating income adjusted for Certain Items (Non-GAAP) 681 585 96 16.4 Impact of currency fluctuations (3) (14) (14) (2.4)Comparable operating income adjusted for Certain Items
using a constant currency basis (Non-GAAP)$667 $585 $82 14.0% SYGMA Sales (GAAP)$8,623 $8,410 $213 2.5%Gross profit (GAAP) 671 662 9 1.4%Gross margin (GAAP) 7.78% 7.87% -9 bps Operating expenses (GAAP)$577 $581 $(4) (0.7)%Operating income (GAAP) 94 81 13 16.0% OTHER Sales (GAAP)$1,085 $1,090 $(5) (0.5)%Gross profit (GAAP) 281 266 15 5.6%Gross margin (GAAP) 25.90% 24.40% 150 bps Operating expenses (GAAP)$251 $339 $(88) (26.0)%Impact of goodwill impairment — (92) 92 NMOperating expenses adjusted for Certain Items (Non-GAAP)$251 $247 $4 1.6% Operating income (loss) (GAAP)$30 $(73) $103 NMImpact of goodwill impairment — (92) 92 NMOperating income adjusted for Certain Items (Non-GAAP)$30 $19 $11 57.9% GLOBAL SUPPORT CENTER Gross profit (GAAP)$47 $57 $(10) (17.5)% Operating expenses (GAAP)$1,057 $930 $127 13.7%Impact of restructuring and transformational project costs (5) (90) (64) (26) (40.6)Impact of acquisition-related costs (6) (72) (15) (57) NMOperating expenses adjusted for Certain Items (Non-GAAP)$895 $851 $44 5.2% Operating loss (GAAP)$(1,010) $(873) $(137) (15.7)%Impact of restructuring and transformational project costs (5) 90 64 26 40.6 Impact of acquisition-related costs (6) 72 15 57 NMOperating loss adjusted for Certain Items (Non-GAAP)$(848) $(794) $(54) (6.8)% TOTAL SYSCO Sales (GAAP)$84,553 $81,370 $3,183 3.9%Gross profit (GAAP) 15,639 14,969 670 4.5%Gross margin (GAAP) 18.50% 18.40% 10 bps Operating expenses (GAAP)$12,544 $11,881 $663 5.6%Impact of restructuring and transformational project costs (1) (4) (5) (287) (183) (104) (56.8)Impact of acquisition-related costs (2) (6) (232) (160) (72) (45.0)Impact of goodwill impairment — (92) 92 NMOperating expenses adjusted for Certain Items (Non-GAAP)$12,025 $11,446 $579 5.1% Operating income (GAAP)$3,095 $3,088 $7 0.2%Impact of restructuring and transformational project costs (1) (4) (5) 287 183 104 56.8 Impact of acquisition-related costs (2) (6) 232 160 72 45.0 Impact of goodwill impairment — 92 (92) NMOperating income adjusted for Certain Items (Non-GAAP)$3,614 $3,523 $91 2.6% (1) Primarily represents severance charges, transformation initiative costs, and costs associated with a legal matter.(2) Fiscal year 2026 and fiscal year 2025 include intangible amortization expense and acquisition costs.(3) Represents a constant currency adjustment, which eliminates the impact of foreign currency fluctuations on current year results.(4) Includes restructuring and transformation costs primarily in Europe.(5) Includes various transformation initiative costs, primarily consisting of changes to our business technology strategy.(6) Represents due diligence costs.NM Represents that the percentage change is not meaningful. Sysco Corporation and its Consolidated Subsidiaries
Non-GAAP Reconciliation (Unaudited)
Free Cash Flow
(In Millions)
Free cash flow represents net cash provided from operating activities less purchases of plant and equipment and includes proceeds from sales of plant and equipment. Sysco considers free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business after the purchases and sales of buildings, fleet, equipment and technology, which may potentially be used to pay for, among other things, strategic uses of cash including dividend payments, share repurchases and acquisitions. However, free cash flow may not be available for discretionary expenditures, as it may be necessary that we use it to make mandatory debt service or other payments. Free cash flow should not be used as a substitute for the most comparable GAAP financial measure in assessing the company’s liquidity for the periods presented. An analysis of any non-GAAP financial measure should be used in conjunction with results presented in accordance with GAAP. In the table that follows, free cash flow for each period presented is reconciled to net cash provided by operating activities.
52-Week
Period Ended
Jun. 27, 2026 52-Week
Period Ended
Jun. 28, 2025 52-Week
Period Change
in DollarsNet cash provided by operating activities (GAAP)$2,638 $2,510 $128 Additions to plant and equipment (700) (906) 206 Proceeds from sales of plant and equipment 176 214 (38)Free Cash Flow (Non-GAAP)$2,114 $1,818 $296 Sysco Corporation and its Consolidated Subsidiaries
Non-GAAP Reconciliation (Unaudited)
Impact of Certain Items on Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA)
(Dollars in Millions)
EBITDA represents net earnings (loss) plus (i) interest expense, (ii) income tax expense and benefit, (iii) depreciation and (iv) amortization. The net earnings (loss) component of our EBITDA calculation is impacted by Certain Items that we do not consider representative of our underlying performance. As a result, in the non-GAAP reconciliations below for each period presented, adjusted EBITDA is computed as EBITDA plus the impact of Certain Items, excluding certain items related to interest expense, income taxes, depreciation and amortization. Sysco's management considers growth in this metric to be a measure of overall financial performance that provides useful information to management and investors about the profitability of the business, as it facilitates comparison of performance on a consistent basis from period to period by providing a measurement of recurring factors and trends affecting our business. Additionally, it is a commonly used component metric used to inform on capital structure decisions. Adjusted EBITDA should not be used as a substitute for the most comparable GAAP financial measure in assessing the company’s financial performance for the periods presented. An analysis of any non-GAAP financial measure should be used in conjunction with results presented in accordance with GAAP. In the tables that follow, adjusted EBITDA for each period presented is reconciled to net earnings.
13-Week
Period Ended
Jun. 27, 2026 13-Week
Period Ended
Jun. 28, 2025 Change in
Dollars % ChangeNet earnings (GAAP)$551 $531 $20 3.8%Interest (GAAP) 205 166 39 23.5 Income taxes (GAAP) 169 186 (17) (9.1)Depreciation and amortization (GAAP) 252 234 18 7.7 EBITDA (Non-GAAP)$1,177 $1,117 $60 5.4%Certain Item adjustments: Impact of restructuring and
transformational project costs (1) 77 74 3 4.1 Impact of acquisition-related costs (2) 38 3 35 NMImpact of deal contingent rate lock
transactions (3) 54 — 54 NMImpact of goodwill impairment — 92 (92) NMEBITDA adjusted for Certain Items
(Non-GAAP) (4)$1,346 $1,286 $60 4.7%Other expense (income), net, as
adjusted (Non-GAAP) (5) 4 6 (2) (33.3)Depreciation and amortization, as
adjusted (Non-GAAP) (6) (210) (197) (13) (6.6)Operating income adjusted for Certain
Items (Non-GAAP)$1,140 $1,095 $45 4.1% (1) Fiscal year 2026 and fiscal year 2025 include charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy, excluding charges related to accelerated depreciation. In addition, fiscal year 2026 includes the reversal of charges associated with a legal matter.(2) Fiscal year 2026 and fiscal year 2025 include acquisition and due diligence costs.(3) Fiscal year 2026 includes a loss on deal contingent rate lock transactions related to the planned acquisition of Jetro Restaurant Depot.(4) In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $8 million and $8 million or non-cash stock compensation expense of $24 million and $19 million in fiscal year 2026 and fiscal year 2025, respectively.(5) Fiscal year 2026 represents $58 million in GAAP other expense (income), net less $54 million in expense from a loss on deal contingent rate lock transactions entered into to mitigate interest rate risk on future permanent debt that could potentially be issued to finance the purchase of Jetro Restaurant Depot. Fiscal year 2025 represents $6 million in GAAP other expense (income), net.(6) Fiscal year 2026 includes $252 million in GAAP depreciation and amortization expense, less $42 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. Fiscal year 2025 includes $234 million in GAAP depreciation and amortization expense, less $37 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions.NM Represents that the percentage change is not meaningful. 52-Week
Period Ended
Jun. 27, 2026 52-Week
Period Ended
Jun. 28, 2025 Change in
Dollars % ChangeNet earnings (GAAP)$1,757 $1,828 $(71) (3.9)%Interest (GAAP) 717 635 82 12.9 Income taxes (GAAP) 519 587 (68) (11.6)Depreciation and amortization (GAAP) 976 945 31 3.3 EBITDA (Non-GAAP)$3,969 $3,995 $(26) (0.7)%Certain Item adjustments: Impact of restructuring and
transformational project costs (1) 280 179 101 56.4 Impact of acquisition-related costs (2) 84 27 57 NMImpact of deal contingent rate lock
transactions (3) 54 — 54 NMImpact of goodwill impairment — 92 (92) NMEBITDA adjusted for Certain Items
(Non-GAAP) (4)$4,387 $4,293 $94 2.2%Other expense (income), net, as adjusted
(Non-GAAP) (5) 48 38 10 26.3 Depreciation and amortization, as
adjusted (Non-GAAP) (6) (821) (808) (13) (1.6)Operating income adjusted for Certain
Items (Non-GAAP)$3,614 $3,523 $91 2.6% (1) Fiscal year 2026 and fiscal year 2025 include charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy, excluding charges related to accelerated depreciation. In addition, fiscal 2026 includes charges associated with a legal matter.(2) Fiscal year 2026 and fiscal year 2025 include acquisition and due diligence costs.(3) Fiscal year 2026 includes a loss on deal contingent rate lock transactions related to the planned acquisition of Jetro Restaurant Depot.(4) In arriving at adjusted EBITDA, Sysco does not exclude interest income of $27 million and $29 million or non-cash stock compensation expense of $118 million and $93 million for fiscal year 2026 and fiscal year 2025, respectively.(5) Fiscal year 2026 represents $102 million in GAAP other expense (income), net less $54 million in expense from a loss on deal contingent rate lock transactions entered into to mitigate interest rate risk on future permanent debt that could potentially be issued to finance the purchase of Jetro Restaurant Depot. Fiscal year 2025 represents $38 million in GAAP other expense (income), net.(6) Fiscal year 2026 includes $976 million in GAAP depreciation and amortization expense, less $155 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions. Fiscal year 2025 includes $945 million in GAAP depreciation and amortization expense, less $137 million of Non-GAAP depreciation and amortization expense primarily related to acquisitions.NM Represents that the percentage change is not meaningful. Sysco Corporation and its Consolidated Subsidiaries
Non-GAAP Reconciliation (Unaudited)
Net Debt to Adjusted EBITDA
(In Millions)
Net Debt to Adjusted EBITDA is a non-GAAP financial measure frequently used by investors and credit rating agencies. It is an important measure used by management to evaluate our access to liquidity, and we believe it is a representation of our financial strength. Our Net Debt to Adjusted EBITDA ratio is calculated using a numerator of our debt minus cash and cash equivalents, divided by the sum of the most recent four quarters of Adjusted EBITDA. In the table that follows, we have provided the calculation of our debt and net debt as a ratio of Adjusted EBITDA.
Jun. 27, 2026Current maturities of long-term debt $1,201 Long-term debt 12,315 Total Debt (GAAP) 13,516 Cash & Cash Equivalents (1,786)Net Debt (Non-GAAP) $11,730 Net Earnings for the previous 12 months (GAAP) $1,757 Adjusted EBITDA for the previous 12 months (Non-GAAP) (1) $4,387 Total Debt/Net Earnings Ratio (GAAP) 7.69 Total Debt/Adjusted EBITDA Ratio (Non-GAAP) 3.08 Net Debt/Adjusted EBITDA Ratio (Non-GAAP) 2.67 Note:(1) Refer to non-GAAP reconciliation at the end of this release. Sysco Corporation and its Consolidated Subsidiaries
Non-GAAP Reconciliation (Unaudited)
Impact of Certain Items on Earnings Before Interest, Taxes, Depreciation and Amortization (Trailing Twelve Months)
(In Millions)
13-Week
Period Ended
Jun. 27, 2026 13-Week
Period Ended
Mar. 28, 2026 13-Week
Period Ended
Dec. 27, 2025 13-Week
Period Ended
Sep. 27, 2025 TotalNet earnings (GAAP)$551 $340 $389 $477 $1,757Interest (GAAP) 205 168 173 171 717Income taxes (GAAP) 169 105 121 124 519Depreciation and amortization (GAAP) 252 251 240 233 976EBITDA (Non-GAAP)$1,177 $864 $923 $1,005 $3,969Certain Item adjustments: Impact of restructuring and
transformational project costs (1) 77 93 55 55 280Impact of acquisition-related costs (2) 38 13 23 10 84Impact of deal contingent rate lock
transactions (3) 54 — — — 54EBITDA adjusted for Certain Items
(Non-GAAP) (4)$1,346 $970 $1,001 $1,070 $4,387 (1) Includes charges related to restructuring and severance, as well as various transformation initiative costs, primarily consisting of supply chain transformation costs and changes to our business technology strategy, excluding charges related to accelerated depreciation. In addition, the 13-week period ended Jun. 27, 2026 includes the reversal of charges associated with a legal matter that were included in the 13-week period ended Mar. 28, 2026.(2) Includes acquisition and due diligence costs.(3) Includes a loss on deal contingent rate lock transactions related to the planned acquisition of Jetro Restaurant Depot.(4) In arriving at adjusted EBITDA, Sysco does not adjust out interest income of $8 million or non-cash stock compensation expense of $24 million in Q4 fiscal year 2026, interest income of $6 million or non-cash stock compensation expense of $31 million in Q3 fiscal year 2026, interest income of $5 million or non-cash stock compensation expense of $33 million in Q2 fiscal year 2026, nor interest income of $6 million or non-cash stock compensation expense of $31 million in Q1 fiscal year 2026. Projected Adjusted EPS Guidance
Adjusted earnings per share is a non-GAAP financial measure; however, we cannot predict with certainty the magnitude or scope of certain items that would be included in the most directly comparable GAAP measure for the relevant future periods, and such items may be significant. Due to these uncertainties, we cannot provide a quantitative reconciliation of projected adjusted EPS to the most directly comparable GAAP financial measure without unreasonable effort. However, we expect to calculate adjusted earnings per share for future periods in the same manner as the reconciliations provided for the historical periods herein.
CoreCivic získala novou pětiletou smlouvu s ICE na využití zařízení Prairie Correctional Facility v Minnesotě s kapacitou 1 600 lůžek. Po plném spuštění očekává roční výnosy kolem 75 milionů USD.
BRENTWOOD, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it has been awarded a new contract with U.S. Immigration and Customs Enforcement ("ICE") to utilize the Company's 1,600-bed Prairie Correctional Facility located in Appleton, Minnesota, a facility that has been idle since 2010.
The new contract commences on August 11, 2026, for a term of five years. The agreement provides for a fixed monthly payment plus an incremental per diem payment based on detainee populations. Taking into account start-up activities and the phased commencement of intake operations, we currently expect an immaterial impact to earnings for the remainder of 2026. Once the facility is fully activated, we expect this facility to generate total annual revenue of approximately $75 million. We expect to begin receiving detainees in the fourth quarter of 2026, with the full ramp estimated to be complete in the second quarter of 2027.
Patrick D. Swindle, CoreCivic's Chief Executive Officer, commented, "We are pleased to announce the new contract at our Prairie Correctional Facility. While this facility has been idle since 2010, we have made investments to help ensure an efficient reactivation in the event of a new contract. The geographic location of this facility, similar to our other recent contract awards, improves our ability to support our government partner throughout the United States."
About CoreCivic
CoreCivic is a diversified, government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. CoreCivic provides a broad range of solutions to government partners that help build safer, healthier, and more productive communities one person at a time through residential corrections, detention, and reentry management, complementary service offerings to the corrections industry that include pharmaceutical, transportation, and alternatives to incarceration, and government real estate solutions. CoreCivic is the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and one of the largest operators of such facilities in the United States. CoreCivic has been a flexible and dependable partner for government for more than 40 years. CoreCivic’s employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good. Learn more at www.corecivic.com.
This press release includes statements as to our beliefs and expectations of the outcome of future events that are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. These forward-looking statements may include such words as "anticipate," "estimate," "expect," "project," "plan," "intend," "believe," "may," "will," "should," "can have," "likely," and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. Such forward-looking statements may be affected by risks and uncertainties in CoreCivic's business and market conditions. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from the statements made. Important factors that could cause actual results to differ are described in the filings made from time to time by CoreCivic with the Securities and Exchange Commission ("SEC") and include the risk factors described in CoreCivic's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 20, 2026. Except as required by applicable law, CoreCivic undertakes no obligation to update forward-looking statements made by it to reflect events or circumstances occurring after the date hereof or the occurrence of unanticipated events.
, /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on August 3, 2026, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on September 16, 2026, to shareholders of record as of the close of business on August 21, 2026.
About Viatris
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai, China, and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.
Forward-Looking Statements
This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include statements that the Viatris Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock, payable on September 16, 2026, to shareholders of record as of the close of business on August 21, 2026. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: failure to achieve the intended benefits of our strategic initiatives and priorities; goodwill or impairment charges or other losses; any changes in or difficulties with the Company's manufacturing facilities; failure to achieve expected or targeted future financial and operating performance and results; Viatris' or its partners' ability to develop, manufacture, and commercialize products; any regulatory, legal or other impediments to Viatris' ability to bring new products to market; products in development and/or that receive regulatory approval may not achieve expected levels of market acceptance, efficacy or safety; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings on Viatris; any significant breach of data security or data privacy or disruptions to our IT systems; risks associated with international operations; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties regarding future demand, pricing and reimbursement for the Company's products; uncertainties and matters beyond the control of management, including but not limited to general political and economic conditions, potential adverse impacts from future tariffs and trade restrictions, inflation rates and global exchange rates; and the other risks described in Viatris' filings with the Securities and Exchange Commission ("SEC"). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this press release other than as required by law.
Shoals Technologies Group ve 2. čtvrtletí zvýšila tržby o 47,4 % na 163,4 milionu USD a vykázala čistý zisk 12,1 milionu USD. Backlog a získané zakázky dosáhly rekordních 801,4 milionu USD.
– Provides Third Quarter and Reaffirms Full-year Outlook –
PORTLAND, Tenn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a global leader in electrical infrastructure solutions for the energy transition market, today announced results for its second quarter ended June 30, 2026.
“The year is progressing well, with second quarter revenue and Adjusted EBITDA within our expected range. The market remains resilient as evidenced by our record backlog and awarded orders of $801.4 million. We have completed the move into our new facility and are steadily making progress towards improving productivity,” said Brandon Moss, CEO of Shoals.
“At Shoals, we’ve stayed focused on strengthening our core business while strategically expanding into high-growth markets that are shaping the future of energy, and that strategy is yielding results. With our market position, manufacturing footprint, and innovation pipeline, we believe we’re exceptionally well positioned for what lies ahead and we’re excited by the opportunities in front of us,” said Mr. Moss.
________________________
1Non-GAAP financial measures referenced in this release are used by management to assist investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Reconciliations of non-GAAP operating measures to the most directly comparable GAAP financial measures are included in the non-GAAP reconciliation in this release. Non-GAAP measures should not be used as a substitute for the closest comparable GAAP measures.
Second Quarter 2026 Financial Results
Revenue increased 47.4%, to $163.4 million, compared to $110.8 million for the prior-year period, driven by strong underlying demand of products, the impact of market share capture initiatives, and an increase in volume of projects in the current year.
Gross profit was $49.5 million, compared to $41.2 million in the prior-year period. Gross profit as a percentage of revenue was 30.3% compared to 37.2% in the prior-year period. Gross profit as a percentage of revenue declined year over year primarily due to operational inefficiencies associated with the ramp-up and transition into the new manufacturing facility and product mix within the quarter, along with costs incurred to address product quality matters, including rework and corrective actions, as well as material-related inefficiencies and incremental lease accounting amortization.
General and administrative expenses were $28.5 million, compared to $23.1 million during the same period in the prior year. The increase in general and administrative expenses was the result of a $4.4 million increase in cash and share-based incentive compensation expense due to increased headcount in comparison to the prior-year period.
Income from operations was $18.7 million, compared to $16.0 million during the prior-year period.
Net income was $12.1 million compared to $13.9 million during the prior-year period. Earnings per share was $0.07 in the current period and $0.08 in the prior-year period.
Adjusted EBITDA1 was $31.6 million, compared to $24.7 million in the prior-year period.
Adjusted Net Income1 was $19.7 million compared to $17.1 million during the prior-year period. Adjusted Diluted Earnings Per Share1 was $0.12 compared to $0.10 in the prior-year period.
Backlog and Awarded Orders
The Company’s backlog and awarded orders as of June 30, 2026, were $801.4 million, representing a 19.4% increase compared to the prior-year period and a 5.7% sequential increase from March 31, 2026. The increase in backlog and awarded orders as compared to the prior-year period reflects consistent demand for the Company’s innovative products, with growth in emerging battery energy storage markets.
Backlog represents signed purchase orders or contractual minimum purchase commitments with take-or-pay provisions and awarded orders are orders we are in the process of documenting with a contract but for which a contract has not yet been signed.
Third Quarter 2026 Outlook
At this time, the Company is providing an outlook for the third quarter. Based on current business conditions, business trends and other factors, for the quarter ending September 30, 2026, the Company expects:
Revenue in the range of $150 million to $170 million; andAdjusted EBITDA1 in the range of $32 million to $37 million. Full Year 2026 Outlook
Based on current business conditions, business trends and other factors, for the full year 2026, the Company continues to expect:
Revenue in the range of $600 million to $640 million;Adjusted EBITDA1 in the range of $118 million to $132 million;Cash flow from operations in the range of $65 million to $85 million;Capital expenditures in the range of $20 million to $30 million; andInterest expense in the range of $8 million to $12 million. A reconciliation of Adjusted EBITDA1 guidance, which is a forward-looking measure that is a non-GAAP measure, to the most closely comparable GAAP measure is not provided because we are unable to provide such reconciliation without unreasonable effort. The inability to provide a quantitative reconciliation is due to the uncertainty and inherent difficulty in predicting the occurrence, the financial impact and the periods in which the components of the applicable GAAP measures and non-GAAP adjustments may be recognized. The GAAP measure may include the impact of such items as non-cash share-based compensation, amortization of intangible assets and the tax effect of such items, in addition to other items we have historically excluded from Adjusted EBITDA and Adjusted Net Income. We expect to continue to exclude these items in future disclosures of these non-GAAP measures and may also exclude other similar items that may arise in the future.
Webcast and Conference Call Information
Company management will host a webcast and conference call on August 4, 2026, at 8:00 a.m. Eastern Time, to discuss the Company’s financial results.
Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company’s website at https://investors.shoals.com.
About Shoals Technologies Group, Inc.
Shoals Technologies Group is a leading manufacturer of advanced electrical infrastructure solutions for mission-critical applications across utility scale solar, battery storage, and data center power systems. Since its founding in 1996, the Company has designed innovative technologies and systems solutions that allow its customers to substantially increase installation efficiency and safety while improving system performance and reliability at scale. Shoals Technologies Group is a recognized leader in the energy transition industry. For additional information, please visit: https://www.shoals.com.
Investor Relations Contact
Shoals Technologies Group, Inc.
Email: [email protected]
Forward-Looking Statements
This report contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Forward-looking statements include information concerning our possible or assumed future results of operations; expectations regarding the utility-scale solar market; project delays; regulatory environment, including changes or potential changes to such environment; the effects of strategic pricing actions, volume discounts and customer mix in our key markets; pipeline and orders; business strategies, plans and expectations, including sales and marketing goals; technology developments; financing and investment plans; warranty and liability accruals and estimates of loss or gains; estimates of potential loss related to the wire insulation shrinkback matter discussed in our public filings; litigation strategy and expected benefits or results from the current intellectual property and wire insulation shrinkback litigation; potential growth opportunities, including opportunities associated with our entry into new markets; and production and capacity at our plants. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would” or similar expressions and the negatives of those terms.
Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
Some of the key factors and scenarios that could cause actual results to differ from our expectations include, among others, if demand for solar energy projects diminishes, we may not be able to grow, and our financial results, business and prospects could be materially adversely impacted; if we fail to accurately estimate the potential losses related to the wire insulation shrinkback matter, or fail to recover the costs and expenses incurred by us from the supplier, and our profit margins, financial results, business and prospects could be materially adversely impacted; the interruption of the flow of raw materials from international vendors has disrupted our supply chain, including as a result of the imposition of additional duties, tariffs, and other charges on imports and exports; the imposition of trade restrictions, import tariffs, anti-dumping, and countervailing duties; we have modified, and in the future may modify, our business strategy to abandon lines of business or implement new lines of business, and modifying our business strategy could have an adverse effect on our business and financial results; amounts included in our backlog and awarded orders may not result in actual revenue or translate into profits; defects or performance problems in our products or their parts, whether due to manufacturing, installation, or use, including those related to the wire insulation shrinkback matter, have a high consequence of failure and can lead to equipment and systems failure, physical injury or death, and in the past have, and in the future could, result in loss of customers, reputational damage and decreased revenue, and materially adversely impact our business, financial condition and results of operations; we have experienced, and may experience in the future, delays, disruptions, quality control, or reputational problems in our manufacturing operations in part due to our vendor concentration; if we fail to retain our key personnel and attract additional qualified personnel, our business strategy and prospects could suffer; our products are primarily manufactured and shipped from our production facilities in Tennessee, and any damage or disruption at these facilities may harm our business; we may face difficulties integrating and optimizing our consolidated Tennessee-based manufacturing and distribution operations, and may not fully realize the anticipated benefits thereof; safety issues may subject us to penalties, negatively impact customer relationships, result in higher operating costs, and negatively impact employee morale and turnover; the market for our products is competitive, and we face increased competition as new and existing competitors introduce EBOS system solutions and components, which could negatively affect our results of operations and market share; macroeconomic conditions, including high inflation, high interest rates, and geopolitical instability, impact our business and financial results; we are subject to risks associated with the patent infringement complaints that we filed with the U.S. International Trade Commission and District Courts; if we fail to, or incur significant costs in order to obtain, maintain, protect, defend, or enforce our intellectual property portfolio and other proprietary rights, including the patents we are asserting in ongoing patent infringement litigation; acquisitions, joint ventures, and/or investments and the failure to integrate acquired businesses could disrupt our business and negatively impact revenue, results of operations and cash flow; a loss of one or more of our significant customers, their inability to perform under their contracts, or their default in payment could harm our business, financial condition, results of operations and prospects; a significant drop in the price of electricity may harm our business; the unauthorized access to our information technology systems or the disclosure of personal or sensitive data or confidential information, whether through a breach of our computer system or otherwise, could severely disrupt our business; failure of our information technology systems, including those managed by third parties, whether intentional or inadvertent, could lead to delays in our business operations and, if significant or extreme, affect our results of operations; our expansion outside the U.S. could subject us to additional business, financial, regulatory, and competitive risks; our indebtedness could adversely affect our financial flexibility, restrict our current and future operations, and our competitive position; existing electric utility industry, federal, state, and municipal renewable energy and solar energy policies and regulations, including zoning and siting laws, and any subsequent changes, present technical, regulatory, and economic barriers to the purchase and use of solar energy systems that may significantly reduce demand for our products or harm our ability to compete; changes in tax laws or regulations that are applied adversely to us, or our customers could materially adversely affect our business, financial condition, results of operations, and prospects; and the market price of our Class A common stock may decline and may continue to be subject to significant volatility.
These and other important risk factors are described more fully in the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and other documents filed with the Securities and Exchange Commission and could cause actual results to vary from expectations. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date of this report. You should read this report with the understanding that our actual future results may be materially different from what we expect.
Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Non-GAAP Financial Measures
Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted Earnings per Share (“EPS”)
We define Adjusted Gross Profit as gross profit plus plant optimization expenses. We define Adjusted Gross Profit Percentage as Adjusted Gross Profit divided by revenue. We define Adjusted EBITDA as net income plus/(minus) (i) interest expense, (ii) interest income, (iii) income tax expense/(benefit), (iv) depreciation expense, (v) amortization of intangibles, (vi) equity-based compensation, (vii) gain (loss) on sale of asset (viii) wire insulation shrinkback litigation expenses, (ix) plant optimization expenses, (x) shareholder litigation expenses, and (xi) litigation settlement expense, net of insurance recoveries. We define Adjusted Net Income as net income plus (i) amortization of intangibles, (ii) amortization / write-off of deferred financing costs, (iii) equity-based compensation, (iv) gain (loss) on sale of asset (v) wire insulation shrinkback litigation expenses, (vi) plant optimization expenses, (vii) shareholder litigation expenses, and (viii) litigation settlement expenses, net of insurance recoveries, all net of applicable income taxes. We define Adjusted Diluted EPS as Adjusted Net Income divided by the diluted weighted average shares of Class A common stock outstanding for the applicable period.
Beginning with the three months ended March 31, 2026, we revised our definition of Adjusted EBITDA to exclude shareholder litigation costs, which are reflected in General and Administrative expenses on our consolidated statements of operations. Comparative amounts for prior periods have been recast to conform to the current period presentation. Management believes this revised definition provides a more meaningful representation of the Company’s ongoing operating performance as the costs are not reflective of our core operations.
Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS are intended as supplemental measures of performance that are neither required by, nor presented in accordance with, GAAP. We present Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS because we believe they assist investors and analysts in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS: (i) as factors in evaluating management’s performance when determining incentive compensation, as applicable; (ii) to evaluate the effectiveness of our business strategies; and (iii) because our credit agreement uses measures similar to Adjusted EBITDA, Adjusted Net Income and Adjusted Diluted EPS to measure our compliance with certain covenants.
Among other limitations, Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS do not reflect our cash expenditures, or future requirements for capital expenditures or contractual commitments; do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations; and may be calculated by other companies in our industry differently than we do or not at all, which may limit their usefulness as comparative measures.
Because of these limitations, Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted EPS should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP. You should review the reconciliation of gross profit to Adjusted Gross Profit and Adjusted Gross Profit Percentage, net income Adjusted EBITDA, and net income to Adjusted Net Income and Adjusted Diluted EPS below and not rely on any single financial measure to evaluate our business.
Shoals Technologies Group, Inc.
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except shares and par value) June 30,
2026 December 31,
2025Assets Current Assets Cash and cash equivalents$15,724 $7,320 Accounts receivable, net 134,822 128,793 Unbilled receivables 22,526 22,133 Inventory 184,720 89,878 Insurance receivable 191 — Other current assets 11,475 9,762 Total Current Assets 369,458 257,886 Property, plant and equipment, net 63,265 53,302 Goodwill 69,941 69,941 Other intangible assets, net 29,706 33,499 Deferred tax assets 434,758 438,027 Right-of-use operating lease assets 43,946 46,044 Other assets 5,826 5,402 Total Assets$1,016,900 $904,101 Liabilities and Stockholders’ Equity Current Liabilities Accounts payable$65,981 $64,875 Accrued expenses and other 35,270 22,215 Litigation settlement liability 4,499 — Warranty liability—current portion 3,481 3,202 Deferred revenue 55,245 37,031 Total Current Liabilities 164,476 127,323 Revolving line of credit 196,750 136,750 Right-of-use operating lease liabilities 37,061 38,661 Warranty liability, less current portion 403 403 Other long-term liabilities 991 991 Total Liabilities 399,681 304,128 Commitments and Contingencies Stockholders’ Equity Preferred stock, $0.00001 par value - 5,000,000 shares authorized; none issued and outstanding as of June 30, 2026 and December 31, 2025 — — Class A common stock, $0.00001 par value - 1,000,000,000 shares authorized; 172,196,879 and 171,358,711 shares issued; 168,288,492 and 167,450,324 outstanding as of June 30, 2026 and December 31, 2025, respectively 2 2 Additional paid-in capital 498,495 493,090 Treasury stock, at cost, 3,908,387 shares as of June 30, 2026 and December 31, 2025 (25,272) (25,272)Retained earnings 143,994 132,153 Total Stockholders' Equity 617,219 599,973 Total Liabilities and Stockholders’ Equity$1,016,900 $904,101 Shoals Technologies Group, Inc.
Condensed Consolidated Statements of Operations (Unaudited)
(in thousands, except per share amounts)
Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Revenue$163,372 $110,841 $303,929 $191,202 Cost of revenue 113,847 69,639 213,394 121,860 Gross profit 49,525 41,202 90,535 69,342 Operating expenses General and administrative expenses 28,465 23,064 59,479 44,757 Depreciation and amortization 2,338 2,140 4,616 4,275 Total operating expenses 30,803 25,204 64,095 49,032 Income from operations 18,722 15,998 26,440 20,310 Interest expense (3,474) (2,236) (6,377) (4,651)Interest income 268 76 327 194 Litigation settlement expense, net of recoveries — — (5,250) — Gain (loss) on sale of assets — 3,134 (2) 3,134 Foreign currency gain (loss) (20) — (28) — Income before income taxes 15,496 16,972 15,110 18,987 Income tax expense (3,358) (3,117) (3,269) (5,414)Net income$12,138 $13,855 $11,841 $13,573 Earnings per share of Class A common stock: Basic$0.07 $0.08 $0.07 $0.08 Diluted$0.07 $0.08 $0.07 $0.08 Weighted average shares of Class A common stock outstanding: Basic 168,059 167,286 167,808 167,124 Diluted 170,023 167,562 169,893 167,238 Shoals Technologies Group, Inc.
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands) Six Months Ended June 30, 2026 2025 Cash Flows from Operating Activities Net income$11,841 $13,573 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization 8,732 6,622 Amortization/write off of deferred financing costs 311 311 Equity-based compensation 7,698 5,255 Provision for obsolete or slow-moving inventory 2,245 617 Provision for warranty expense 4,369 256 Deferred taxes 3,269 6,592 Other 3,529 (3,134)Changes in assets and liabilities: Accounts receivable (6,029) (25,251)Unbilled receivables (393) 10,973 Inventory (97,087) (1,539)Other assets (2,448) (2,449)Accounts payable 865 6,099 Accrued expenses and other 10,026 3,937 Warranty liability (4,090) (21,463)Litigation receivable and settlement liabilities 4,308 — Deferred revenue 18,214 1,338 Net Cash Provided by (Used in) Operating Activities (34,640) 1,737 Cash Flows from Investing Activities Purchases of property, plant and equipment (14,663) (15,430)Proceeds from sale of property, plant and equipment — 5,088 Net Cash Used in Investing Activities (14,663) (10,342)Cash Flows from Financing Activities Employee withholding taxes related to net settled equity awards (2,293) (279)Proceeds from revolving credit facility 60,000 30,000 Repayments of revolving credit facility — (40,000)Excise taxes on treasury stock transactions — 59 Net Cash Provided by (Used in) Financing Activities 57,707 (10,220)Net Increase (Decrease) in Cash and Cash Equivalents 8,404 (18,825)Cash and Cash Equivalents—Beginning of Period 7,320 23,511 Cash and Cash Equivalents—End of Period$15,724 $4,686 Shoals Technologies Group, Inc.
Adjusted Gross Profit, Adjusted Gross Profit Percentage, Adjusted EBITDA, Adjusted Net Income and
Adjusted Diluted Earnings per Share (“EPS”) (Unaudited) Reconciliation of Gross Profit to Adjusted Gross Profit and Adjusted Gross Profit Percentage (in thousands):
Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Revenue$163,372 $110,841 $303,929 $191,202 Cost of revenue 113,847 69,639 213,394 121,860 Gross profit$49,525 $41,202 $90,535 $69,342 Gross profit percentage 30.3% 37.2% 29.8% 36.3% Plant optimization expense$496 $— $1,117 $— Adjusted gross profit$50,021 $41,202 $91,652 $69,342 Adjusted gross profit percentage 30.6% 37.2% 30.2% 36.3% Reconciliation of Net Income to Adjusted EBITDA (in thousands):
Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Net income$12,138 $13,855 $11,841 $13,573 Interest expense 3,474 2,236 6,377 4,651 Interest income (268) (76) (327) (194)Income tax expense 3,358 3,117 3,269 5,414 Depreciation expense 2,740 1,439 4,939 2,830 Amortization of intangibles 1,891 1,896 3,793 3,792 Equity-based compensation 4,381 2,593 7,698 5,254 (Gain) loss on sale of asset — (3,134) 2 (3,134)Wire insulation shrinkback litigation expenses(a) 2,876 2,546 6,583 5,075 Plant optimization expenses(b) 496 — 1,117 — Shareholder litigation expenses(c) 464 197 2,120 913 Litigation settlement expense(c) — — 5,250 — Adjusted EBITDA$31,550 $24,669 $52,662 $38,174 Reconciliation of Net Income to Adjusted Net Income (in thousands):
Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Net income$12,138 $13,855 $11,841 $13,573 Amortization of intangibles 1,891 1,896 3,793 3,792 Amortization / write-off of deferred financing costs 156 156 311 311 Equity-based compensation 4,381 2,593 7,698 5,254 (Gain) loss on sale of asset — (3,134) 2 (3,134)Wire insulation shrinkback litigation expenses(a) 2,876 2,546 6,583 5,075 Plant optimization expenses(b) 496 — 1,117 — Shareholder litigation expenses(c) 464 197 2,120 913 Litigation settlement expense(c) — — 5,250 — Tax impact of adjustments(d) (2,669) (1,021) (6,987) (2,955)Adjusted Net Income$19,733 $17,087 $31,728 $22,829 (a) For the three and six months ended June 30, 2026, represents $2.9 million and $6.6 million, respectively, of expenses incurred in connection with the lawsuit initiated by the Company against the supplier of the defective wire. For the three and six months ended June 30, 2025, represents $2.5 million and $5.1 million, respectively, of expenses incurred in connection with the lawsuit initiated by the Company against the supplier of the defective wire. We consider this litigation distinct from ordinary course legal matters given the expected magnitude of the expenses, the nature of the allegations in the Company’s complaint, the amount of damages sought, and the impact of the matter underlying the litigation on the Company’s financial results. In the future, we also intend to exclude from our non-GAAP measures the benefit of recovery, if any. We believe excluding expenses from these discrete litigation events provides investors with a better view of the operating performance of our business and allows for comparability through periods.
(b) For the three and six months ended June 30, 2026, represents $0.5 million and $1.1 million of expenses incurred in connection with actions taken to consolidate our operations into a newly constructed facility, including items such as professional fees, relocation, facility set-up and other costs. We believe excluding expenses from these events provides investors with a better view of the operating performance of our business and allows for comparability through periods.
(c) For the three and six months ended June 30, 2026, represents $0.5 million and $2.1 million of expenses incurred in connection with the Company’s defense of certain derivative and class action litigation and for the three months and six months ended June 30, 2026, represents zero and $5.3 million, respectively, in settlement expenses associated with this litigation. For the three and six months ended June 30, 2025, represents $0.2 million and $0.9 million of expenses incurred in connection with the Company’s defense of certain derivative and class action litigation. We consider expenses incurred in connection with these legal matters distinct from normal matters and expenses within the operation of our business.
(d) Shoals Technologies Group, Inc. is subject to U.S. Federal income taxes, in addition to state and local taxes. Represents the estimated tax impact of all Adjusted Net Income add-backs, excluding those which represent permanent differences between book versus tax. The adjustment to the provision for income tax reflects the effective tax rates below.
Three Months Ended June 30, Six Months Ended June 30, 2026
2025
2026
2025
Statutory U.S. Federal income tax rate21.0% 21.0% 21.0% 21.0%Permanent adjustments2.5% 0.6% 2.5% 0.6%State and local taxes (net of federal benefit)2.5% 2.4% 2.5% 2.6%Effective income tax rate for Adjusted Net Income26.0% 24.0% 26.0% 24.2% Calculation of Adjusted Diluted Earnings per Share (in thousands, except per share amounts):
Three Months Ended June 30, Six Months Ended June 30, 2026
2025
2026
2025
Diluted weighted average shares outstanding 170,023 167,562 169,893 167,238 Adjusted Net Income$19,733 $17,087 $31,728 $22,829Adjusted Diluted EPS$0.12 $0.10 $0.19 $0.14
Solana Foundation otevírá seniorní pozice pro AI, stablecoiny a institucionální růst, což signalizuje posun od meme coinů k infrastruktuře. Zvlášť cílí na Greater China a Japonsko.
For a blockchain that spent much of the past two years synonymous with meme coins and retail speculation, the Solana Foundation’s latest hiring push reads like a deliberate turn toward infrastructure. The organization has opened several senior positions including a General Manager of AI Ecosystem, a Head of Stablecoins, a Director of Institutional Growth, and institutional growth leads for Greater China and Japan, according to a report from WuBlockchain. Rather than chasing the next viral token, these roles target the plumbing of a durable layer-one network: on-chain intelligence, dollar-pegged assets, and serious capital.
The listings arrive at a moment when Solana’s network metrics have largely recovered from the congestion crises of 2024, and developer engagement has been climbing. Solana has consistently ranked among the top blockchains by developer activity, but institutional onboarding and deeper stablecoin liquidity have lagged behind Ethereum and even some newer ecosystems. A full-time Head of Stablecoins signals that the Foundation now views this gap as strategic, not incidental.
Not Just Another AI Narrative The GM of AI Ecosystem role is the most revealing. While every chain now claims an AI strategy, few foundations have committed to a dedicated senior executive for it. Solana’s AI ambitions come as the broader market watches decentralized compute networks and on-chain agents evolve from experiments into real products. It also aligns with the growing trend of AI-driven Web3 applications, similar to projects like UXLINK and Origins Network’s partnership, which aims to merge decentralized computing with scalable user experiences.
What matters here is timing. Solana’s high throughput gives it a natural advantage for AI agent interactions that demand sub-second finality. But without a coordinated foundation effort, developer tooling and grant programs for AI on Solana have been fragmented. Hiring a GM suggests the Foundation wants to consolidate these efforts before competitors close the window.
Stablecoins as Institutional Rails The Head of Stablecoins position is equally pragmatic. Stablecoin supply on Solana has grown, but it remains dominated by a few large players. A dedicated lead implies the Foundation wants to diversify issuer relationships, expand regional on-ramps, and potentially explore yield-bearing or compliant alternatives that traditional institutions find palatable. In practice, that means courting fintechs and payment firms in Asia and the US, not just crypto-native issuers.
This is not happening in a vacuum. Across the industry, tokenization of real-world assets and stablecoin-based settlement is accelerating, as seen in recent milestones like the first live tokenized Treasury settlement between Ondo and JPMorgan. For Solana to capture a slice of that institutional flow, it needs a stablecoin stack that meets the compliance and integration demands of traditional finance. The new hire will face the hard problem of making Solana rails feel safe to treasury managers who still equate crypto with chaos.
Asia Takes Center Stage The institutional growth leads for Greater China and Japan confirm that Solana sees Asia as the primary battleground for the next adoption wave. These are not passive outreach roles; they imply dedicated boots on the ground who can navigate regulatory nuance, broker exchange liquidity deals, and onboard local institutions. Both markets have seen a surge in Web3 gaming and social-fi, two verticals where Solana has already gained traction. Yet institutional capital in the region has mostly flowed to Ethereum and, in some cases, to newer L1s that offer staking incentives to traditional firms, as seen when institutional staking drove a SUI price surge earlier this month.
Japan’s evolving regulatory clarity and China’s gray-market innovation demand local knowledge. A San Francisco–led playbook will not work. If filled quickly, these hires could reshape where Solana’s next wave of validators, wallets, and on-ramp partners emerge.
What remains uncertain is how quickly these roles will be filled and whether the Foundation can secure candidates who combine deep crypto expertise with mainstream institutional credibility. Job listings don’t guarantee execution, and Solana has lost senior talent in the past. Still, the positions themselves tell a story about where the network’s stewards believe the puck is moving. For market participants accustomed to chasing memes, it’s a reminder that the foundations underneath are getting more serious.
AUTHOR
Brenda is a writer with three years of experience specializing in cryptocurrency, artificial intelligence and emerging technologies. She graduated from the University of Mombasa with a degree in Psychology. She has worked at Cryptopolitan and Blockchain Reporter.
Backpack v červenci na Solaně překonal xStocksFi v měsíčním objemu tokenizovaných akcií s 1,06 miliardy USD, přestože drží jen asi 5 % nabídky. xStocksFi má zhruba 87 % nabídky.
Backpack just did something that shouldn’t really be possible on paper. The exchange overtook xStocksFi in monthly tokenized equities volume on Solana in July 2026, pulling in $1.06 billion in trading volume. The kicker: Backpack holds roughly 5% of Solana’s total tokenized stock supply, while xStocksFi controls about 87%.
That 73% issuer market share came exactly one month after Backpack launched its tokenized securities offering.
How a 5% supply player captured 73% of volume Backpack’s edge appears to come from its propAMM models, a proprietary automated market maker design built through strategic partnerships that concentrates liquidity more efficiently than traditional order book or AMM approaches.
Advertisement
The platform’s SpaceX token, trading under the ticker SPCX, has been a standout performer. Shortly after its June 2026 listing, SPCX crossed 10,000 onchain holders. Cumulative volume on that single token surpassed $350 million.
Backpack’s tokenized version of SK Hynix, listed as SKHY through a partnership with Sunrise, generated $1.18 million in volume on its very first day of trading on July 10.
Traditional stock markets operate roughly 6.5 hours per day, five days per week. Tokenized equities on Solana trade around the clock.
Solana’s quiet dominance in tokenized equities Solana now accounts for approximately 95% of all global onchain tokenized-equity trading. The category’s cumulative volume has crossed $10 billion, with recent monthly growth of around 180%.
The Backpack-xStocksFi competition reflects a divergence in approach: xStocksFi, developed by Backed Finance and closely integrated with Kraken’s infrastructure, has built its dominant supply position using models that incorporate synthetic elements. Backpack, operating as a regulated brokerage, has leaned into direct redeemability and 1:1 backing with real shares.
What this means for investors The $1.06 billion monthly figure deserves some scrutiny before anyone gets too excited. Trading volume can be inflated by wash trading, bot activity, or incentivized liquidity programs that temporarily juice numbers. The SpaceX token’s organic holder growth suggests at least some of this volume is genuine.
xStocksFi still controls 87% of the tokenized stock supply on Solana. Solana’s 95% market share in tokenized equities creates concentration risk: if the chain experiences downtime, an entire global tokenized equity market effectively pauses.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
Intesa Sanpaolo prudce snížila expozici vůči Bitcoin ETF a zároveň více než ztrojnásobila podíl ve staked Ethereum fondu. Solana téměř zmizela, zatímco XRP zůstalo beze změny.
Intesa Sanpaolo, Italy’s largest banking group, has significantly changed the composition of its crypto exchange-traded fund (ETF) holdings, according to its latest mandatory disclosure to US regulators.
Sharp reduction in Bitcoin ETF exposureAccording to the Form 13F filed with the US Securities and Exchange Commission (SEC) on July 31, the bank’s common shareholding in the iShares Bitcoin Trust fund fell dramatically between March and June. The reported position decreased from 646,809 shares on March 31 to 40,723 by June 30, marking an approximate 94% reduction.
Intesa Sanpaolo also reduced its exposure through call options. The underlying share count tied to these positions fell steeply, from 2,496,500 to 18,000, which reflects a drop of over 99%. Additionally, the June filing introduced a new put option tied to 500,000 underlying shares, a position that did not appear in earlier disclosures.
Asset/PositionMarch 31 HoldingsJune 30 HoldingsChange (%)iShares Bitcoin Trust (Common Shares)646,80940,723-93.7%iShares Bitcoin Trust (Call Options)2,496,50018,000-99.3%iShares Bitcoin Trust (Put Options)0500,000New PositionThe Form 13F report, a quarterly filing required by institutional investment managers with at least $100 million in assets under management, only reveals positions held as of the end of the reporting period. It does not specify strike prices, expiry dates, or whether options were sold short, leaving the bank’s precise strategy and risk exposure open to interpretation.
Intesa Sanpaolo is Italy’s leading financial institution, with operations spanning commercial banking, asset management, and insurance in Europe and beyond.
Ethereum positions surge as Solana holdings all but disappearWhile reducing its Bitcoin ETF exposure, Intesa Sanpaolo increased its stake in the iShares Staked Ethereum Trust fund. The bank tripled its holding, from 116,200 shares on March 31 to 349,600 shares at the end of June.
Meanwhile, its investment in the Bitwise Solana Staking ETF was almost entirely eliminated, dropping from 2,817 shares to just seven between quarters. Holdings of the Grayscale XRP Trust ETF remained steady at 712,319 shares, showing little to no movement after accounting for possible trading activity that left the quarter-end balance unchanged.
ETFMarch 31 SharesJune 30 SharesChangeiShares Staked Ethereum Trust116,200349,600+201%Bitwise Solana Staking ETF2,8177-99.8%Grayscale XRP Trust ETF712,319712,3190% Intesa Sanpaolo reported a sharp reduction in both its Bitcoin ETF and call option positions, while increasing its staked Ethereum fund exposure more than threefold. The bank’s Solana holdings nearly vanished, with XRP balances remaining unaltered over the quarter.
Form 13F filings reveal only a snapshot at the end of each quarter, presenting limited insight into daily trading or rationale behind trades. The filings do not capture written or short option strategies and lack detail concerning strike prices or expiration dates.
Due to these disclosure gaps, outside observers cannot definitively calculate the bank’s net exposure to any crypto asset based only on publicly available records.
Nevertheless, the data show Intesa Sanpaolo’s declared crypto investments now favor staked Ethereum over Bitcoin, with dramatically reduced exposure to Solana and steady XRP holdings.
Mini dictionary: Form 13F, a quarterly report that US institutional investment managers managing at least $100 million in certain securities must file with the SEC, disclosing their equity holdings as of the quarter’s end.
Disclaimer: The information contained in this article does not constitute investment advice. Investors should be aware that cryptocurrencies carry high volatility and therefore risk, and should conduct their own research.
Průzkum Aflac ukázal, že 76 % příslušníků Gen Z a 63 % mileniálů se nejdřív obrací na AI pro zdravotní radu, než navštíví lékaře. Zároveň častěji odkládají preventivní prohlídky.
Aflac Wellness Matters ® survey reveals wellness paradox:
health confidence up, preventive care down
Gen Z (76%) and millennials (63%) use AI for health support
before seeking professional medical care
Younger generations (43% of Gen Z and 39% of millennials) spend
more on self-care and wellness but are less likely to have a primary care doctor
Growing reliance on emergency room and urgent care suggests shift
from preventive to reactive wellness as more than 2 in 5 Americans
primarily use these services for healthcare needs
, /PRNewswire/ -- August is National Wellness Month, a time to emphasize the importance of healthy routines, sustainable health habits and preventive care. Key findings from the fourth annual Wellness Matters survey1 released by Aflac Incorporated, the leading provider of supplemental health insurance in the U.S.2 and a pioneer in cancer insurance for more than seven decades, reveal younger generations — 76% of Gen Z and 63% of millennials — are turning first to artificial intelligence (AI) for health support in lieu of seeking professional medical care. A wellness paradox is emerging as Americans — particularly younger generations — feel more confident and in control of their health than ever before, yet they have never been less likely to see a doctor.
Primary care shift: digital first, doctor second
Young Americans are taking a digital-first approach to healthcare, with three-quarters of Gen Z and more than half of millennials using AI instead of seeking professional medical support and expertise typically provided by a human physician, therapist, dietician, personal trainer, sleep coach and others, compared to 47% of Americans overall. According to the survey, 18% of Gen Z and 14% of millennials admit that they will only schedule a doctor's appointment after exhausting AI or online tools for answers to health questions or when health concerns escalate, compared to 3% of Gen X and 2% of baby boomers. On-demand access to social media, health influencers and online search is helping Gen Z and millennials feel more informed and confident on health matters, but they are equally passive when it comes to making preventive care appointments. Furthermore, the feeling of being healthy, logistics and frustration associated with doctor's appointments are the biggest barriers to proactive healthcare for young Americans. Gen Z (42%) and millennials (47%) worry frequently or always about increasing healthcare costs, in line with 50% of Americans overall. According to the survey:
Nearly two-thirds of Gen Z (65%) and millennials (61%) admit to delaying or skipping routine checkups and screenings, significantly higher than Gen X (47%) and baby boomers (33%). 35% of Gen Z and 29% of millennials don't get checkups or screenings on time because they feel healthy, compared to 1 in 4 (24%) Americans overall. 2 in 5 (41%) Gen Z canceled or decided not to schedule an appointment because the wait time was too long, compared to 34% overall. 51% of Gen Z and 48% of millennials say the biggest hurdle to preventive care appointments is logistics, driven by scheduling difficulties, the time it takes for the appointment and challenges taking off work — compared to 43% overall. Gen Z and millennials trust influencers and social media at much higher rates than other generations (23% of Gen Z and 17% of millennials say they trust influencers for health information, compared to 4% of Gen X and 1% of baby boomers; 28% of Gen Z and 20% of millennials trust social media, compared to 6% of Gen X and 4% of baby boomers). 45% of Gen Z and 54% of millennials are consulting online search, medical websites (38%, 40%) and social media (32%, 34%) to manage their health at much higher rates than they consult doctors, nurses or other health professionals (22%, 31%). "Young Americans are replacing in-person preventive care with the convenience and speed of digital health support," said Aflac Incorporated Chief Human Resources Officer and Chief Administrative Officer Matthew Owenby. "The use of AI and other digital-first healthcare resources isn't inherently negative, as it ultimately depends on how the information is used. What is alarming is the rate that Gen Z is delaying or forgoing preventive care, greatly lessening the opportunity for early detection or a critical health diagnosis from a medical professional."
Self-care surge
While often bypassing traditional care, ironically, Gen Z and millennials are spending more on self-care than any other generation. In fact, Gen Z (43%) and millennials (39%) are far more likely to spend at least $100 per month across categories than Gen X (10%) and baby boomers (6%). Categories include vitamins and supplements, organic foods, salon services, mental health therapy, wellness retreats and more. They are much less likely to have a primary doctor (48% of Gen Z and 58% of millennials, compared to 79% of Gen X and 87% of baby boomers) but more likely to have a mental health therapist (25% Gen Z and 29% millennials, compared to 17% Gen X and 7% baby boomers). Gen Z and millennials actively invest in health and wellness, with 1 in 4 having a network of three or more health and wellness professionals, compared to 11% of Gen X and 7% of baby boomers. U.S. Hispanics and Asians (34%) and African Americans (30%) are more likely than Caucasians (23%) to spend at least $100 per month across several wellness categories, especially organic foods, salon services and meal delivery. Despite this, they are also more likely to be reactive when it comes to professional healthcare.
Use of emergency rooms and urgent care signals a reactive approach to health
Holding consistent year over year, more than 2 in 5 Americans primarily use emergency and urgent care for their healthcare needs. However, use of emergency and urgent care is up this year for Gen Z, U.S. Hispanics, African Americans and Asian Americans, indicating a significant shift from proactive to reactive healthcare. According to the survey, Gen Z (62%, compared to 51% in 2025), U.S. Hispanics (52%, compared to 44% in 2025), African Americans (57%, compared to 47% in 2025) and Asian Americans (55%, compared to 45% in 2025) seek medical attention from an emergency room or urgent care. Men (48%) seek emergency/urgent care more than women (39%).
Cancer blind spots uncovered
Despite feeling confident in their health, many Americans lack knowledge around long-term health risks, particularly those associated with cancer. Understanding cancer risks and screening guidelines is key to preventive care, yet the survey uncovers alarming statistics:
46% of Americans don't know when they are supposed to begin cancer screenings. 51% of Gen Z feel it's unlikely they will be diagnosed with cancer in their lifetime, compared to 36% of millennials and 26% of Gen X. Nearly 90% of Gen Z diagnosed with cancer admit to avoiding a screening. 15% of Gen Z do not get regular checkups and screenings because they prefer research online and 11% prefer to self-diagnose. "As a leading provider of cancer insurance in the United States, Aflac often sees both the positive impact of early detection and the negative consequences of a delayed diagnosis," said Owenby. "Our policies are designed to help encourage proactive wellness visits, which could lead to a diagnosis or a clean bill of health. Fortunately, early detection can push five-year survival rates above 90% for many cancers, according to the American Cancer Society3."
Personal, human connection endures
Although younger generations are relying on technology, AI and social media for healthcare support and management, they trust healthcare professionals most for definitive, credible health information. Personal relationships are critical to healthcare conversations that drive preventive care and positive long-term care outlooks. Parents are top health advocates for younger generations (43% Gen Z, 35% millennials, compared to 28% overall). A family member or loved one's encouragement is cited as one of the top motivators for getting a cancer screening (20% Gen Z, 19% millennial, compared to 15% overall).
"The bottom line is that wellness does, in fact, matter," said Owenby. "Whether it is logistics, costs or other factors that prevent people from prioritizing their health and preventive care, Aflac wants to be part of solutions that can help lead to a healthier outlook for Americans."
Aflac Wellness Matters® survey results are available to American consumers, healthcare providers, families and health-related stakeholders, at no cost, to educate and inspire a healthier population. To learn more and find tips on how to take charge of your own health and encourage others to prioritize theirs, visit Aflac.com/WellnessMatters.
ABOUT THE 2026 AFLAC WELLNESS MATTERS® SURVEY
The 2026 Aflac Wellness Matters® study was conducted among a nationally representative sample of 2,000 employed U.S. adults ages 18-65 in March 2026 by Kantar Profiles on behalf of Aflac. The survey provides insight into healthcare attitudes, behaviors and influences of U.S. adults. It explores important issues such as preventive care, health screenings and how healthcare is prioritized.
ABOUT AFLAC INCORPORATED
Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.2 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force.4 The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 20 consecutive years (2026) and Fortune's World's Most Admired Companies for 25 years (2026). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."
1 "Aflac. "2026 Wellness Matters Survey overview." Published Aug. 2026.
2 LIMRA 2025 U.S. Supplemental Health Insurance Total Market Report.
3 American Cancer Society: "Cancer Facts and Figures 2025."
4 As of March 31, 2025, Aflac estimates based on company data.
Media contact: Jon Sullivan, 706-763-4813 or [email protected]
Analyst and investor contact: David A. Young, 706-596-3264, 800-235-2667 or [email protected]
Aflac | Aflac New York | WWHQ | 1932 Wynnton Road | Columbus, GA 31999
FAQs about the 2026 Aflac Wellness Matters® survey
Why are younger Americans prioritizing AI and digital health tools as their initial sources for health information?
Younger adults are increasingly turning to AI and digital resources because they provide convenient, on-demand access to health information.
According to the 2026 Aflac Wellness Matters® survey, 76% of Gen Z and 63% of millennials use AI before seeking professional medical care, and many report that online resources, health influencers and social media help them feel more informed and confident about health decisions.
What is the "wellness paradox" identified in the 2026 Aflac Wellness Matters® survey?
The "wellness paradox" is the growing disconnect between health confidence and preventive healthcare behaviors.
The 2026 Aflac Wellness Matters® survey found that many Americans, especially Gen Z and millennials, say they feel informed, confident and in control of their health, yet they are also more likely to delay routine checkups, preventive care visits and recommended health screenings.
Why are younger adults using emergency and urgent care more often?
The 2026 Aflac Wellness Matters® survey suggests that younger adults are adopting a more reactive approach to healthcare, often relying on emergency rooms and urgent care centers rather than preventive care and primary care visits. Use of emergency and urgent care increased among Gen Z compared with the previous year (2025), reflecting a broader shift from proactive to reactive healthcare behaviors.
Why are younger Americans delaying preventive care appointments?
Younger Americans are delaying preventive care for several reasons, including:
Feeling healthy Scheduling challenges Long wait times Concerns about healthcare costs According to the 2026 Aflac Wellness Matters® survey, two-thirds of Gen Z (65%) and more than half of millennials (61%) admit to delaying or skipping routine checkups and screenings, with many seeking answers from AI and online resources before consulting a healthcare professional.
Is AI replacing healthcare professionals?
No. The 2026 Aflac Wellness Matters® survey found that while many younger Americans use AI and digital tools as a first step when seeking health information, healthcare professionals remain the most trusted source for definitive, credible health information. The survey suggests that AI is often used before professional care, rather than as a replacement for it.
Personal relationships also continue to influence care decisions, with parents, family members and loved ones playing an important role in encouraging preventive care and recommended screenings.
Why is cancer screening awareness a concern for younger Americans?
Cancer screening awareness remains a concern because many younger adults underestimate their potential cancer risk and are less likely to prioritize preventive screenings.
The 2026 Aflac Wellness Matters® survey found that 51% of Gen Z believe a cancer diagnosis is unlikely in their lifetime, while nearly half of Americans (46%) do not know when they should begin cancer screenings. Understanding cancer risks and screening guidelines is a key part of preventive care and early detection.
TransDigm ve 3. čtvrtletí zvýšil tržby o 23 % na 2,741 miliardy USD a čistý zisk o 10 % na 540 milionů USD. Zároveň zvedl celoroční výhled pro fiskální rok 2026.
, /PRNewswire/ -- TransDigm Group Incorporated (NYSE: TDG), a leading global designer, producer and supplier of highly engineered aircraft components, today reported results for the third quarter ended June 27, 2026.
Third quarter highlights include:
Net sales of $2,741 million, up 23% from $2,237 million in the prior year's quarter; Net income of $540 million, up 10% from the prior year's quarter; Earnings per share of $9.39, up 11% from the prior year's quarter; EBITDA As Defined of $1,447 million, up 19% from $1,217 million in the prior year's quarter; EBITDA As Defined margin of 52.8%; Adjusted earnings per share of $10.87, up 13% from $9.60 in the prior year's quarter; and Upward revision to fiscal 2026 financial guidance. Quarter-to-Date Results
Net sales for the quarter increased 23%, or $504 million, to $2,741 million from $2,237 million in the comparable quarter a year ago. Organic sales growth as a percentage of net sales was 13%.
Net income for the quarter increased $47 million, or 10%, to $540 million from $493 million in the comparable quarter a year ago. The increase in net income primarily reflects the increase in net sales described above and the application of our value-driven operating strategy. The increase was partially offset by higher selling and administration expense and higher interest expense.
Adjusted net income for the quarter increased 12% to $624 million, or $10.87 per share, from $558 million, or $9.60 per share, in the comparable quarter a year ago.
EBITDA for the quarter increased 20% to $1,345 million from $1,123 million for the comparable quarter a year ago. EBITDA As Defined for the quarter increased 19% to $1,447 million compared with $1,217 million in the comparable quarter a year ago. EBITDA As Defined as a percentage of net sales for the quarter was 52.8% compared with 54.4% in the comparable quarter a year ago.
"Our team executed another strong quarter, and we are very pleased with our results," stated Mike Lisman, TransDigm Group's CEO. "All three of our major market channels again delivered double-digit growth compared to the prior year's third quarter. Commercial aftermarket growth of 17% remained strong this quarter. Commercial OEM grew nicely as well as the aircraft OEMs continue to increase build rates. Meanwhile, Defense saw another quarter of consistent growth and also built sizable backlog. Our reported EBITDA As Defined margin for the quarter was 52.8%. Adjusting for acquisition dilution, our base businesses continued to expand EBITDA margins on a year-over-year basis as the team executes on our value drivers.
After the quarter ended, we announced the acquisition of Prince & Izant for approximately $1.07 billion. Prince & Izant's highly engineered, proprietary products are sold primarily into the aerospace and defense, aeroderivative turbine, and transportation end markets, and we believe the business will be an excellent fit within TransDigm.
Additionally, during the third quarter, we returned capital of approximately $1.0 billion to our shareholders through share repurchases bringing our year-to-date repurchases of our common stock to over $1.8 billion. As we look ahead to the remainder of fiscal 2026, we have significant liquidity and financial flexibility to address any likely range of capital requirements and remain highly focused on our capital allocation.
As always, we remain committed to our operating strategy and the TransDigm value drivers. We look forward to the opportunity to continue creating value for our shareholders as we finish our fiscal 2026."
Acquisition Activity
As previously announced on April 7, 2026, TransDigm completed the acquisition of Jet Parts Engineering and Victor Sierra for approximately $2.2 billion in cash. Jet Parts Engineering is a leading independent designer and manufacturer of aerospace aftermarket solutions, primarily proprietary OEM-alternative parts and repairs. Victor Sierra is a leading designer, manufacturer, and distributor of proprietary PMA and other aftermarket parts serving the commercial aerospace end market — primarily the general aviation and business aviation sectors.
Subsequent to the quarter-end and as previously announced on July 27, 2026, TransDigm entered into a definitive agreement to acquire Prince & Izant ("P&I") from Industrial Growth Partners for approximately $1.07 billion in cash, including certain tax benefits. P&I is a global designer and manufacturer of highly engineered brazing alloys and specialty metal components used across a range of advanced performance and high cost-of-failure applications. P&I primarily supports the aerospace and defense, aeroderivative turbine, and transportation end markets. Additionally, but to a lesser degree, P&I serves the medical and general industrial end markets.
Financing Activity
During the quarter, on April 17, 2026, TransDigm completed an incremental debt offering of $1.5 billion of new debt consisting of an additional $0.5 billion of 6.125% Senior Subordinated Notes maturing July 31, 2034 and $1.0 billion of additional Tranche N term loans maturing February 13, 2033.
Share Repurchase Activity
During the third quarter of fiscal 2026, TransDigm repurchased 809,101 shares of its common stock at an average price per share of $1,208 for a total amount of $1.0 billion. For the thirty-nine week period ended June 27, 2026, TransDigm repurchased 1,496,383 shares of its common stock at an average price per share of $1,207 for a total amount of $1.8 billion.
Year-to-Date Results
Net sales for the thirty-nine week period ended June 27, 2026 increased 18%, or $1,175 million, to $7,569 million from $6,394 million in the comparable period a year ago. Organic sales growth as a percentage of net sales for fiscal 2026 was 10%.
Net income for the thirty-nine week period ended June 27, 2026 increased $56 million, or 4%, to $1,521 million from $1,465 million in the comparable period a year ago. The increase in net income primarily reflects the increase in net sales described above and the application of our value-driven operating strategy. The increase was offset by higher selling and administrative expenses and higher interest expense.
GAAP earnings per share were reduced for the thirty-nine week periods ended June 27, 2026 and June 28, 2025 by $1.02 per share and $0.83 per share, respectively, as a result of dividend equivalent payments made during each year. As a reminder, GAAP earnings per share are reduced when TransDigm makes dividend equivalent payments pursuant to its stock option plans. These dividend equivalent payments are made during TransDigm's first fiscal quarter each year and also upon payment of any special dividends.
Adjusted net income for the thirty-nine week period ended June 27, 2026 increased 9% to $1,677 million, or $28.94 per share, from $1,543 million, or $26.53 per share, in the comparable period a year ago.
EBITDA for the thirty-nine week period ended June 27, 2026 increased 15% to $3,781 million from $3,299 million for the comparable period a year ago. EBITDA As Defined for the period increased 16% to $3,981 million compared with $3,441 million in the comparable period a year ago. EBITDA As Defined as a percentage of net sales for the period was 52.6% compared with 53.8% in the comparable period a year ago.
Please see the attached tables for a reconciliation of net income to EBITDA, EBITDA As Defined, and adjusted net income; a reconciliation of net cash provided by operating activities to EBITDA and EBITDA As Defined; and a reconciliation of earnings per share to adjusted earnings per share for the periods discussed in this press release.
Fiscal 2026 Outlook
Mr. Lisman stated, "Our strong third quarter performance is enabling us to increase our guidance for the full year. Bookings have exceeded expectations, and we see the current momentum continuing. At the mid-point, we are increasing guidance for sales by $150 million, EBITDA As Defined by $100 million, and adjusted EPS by $1.52.
Additionally, we are shifting our market channel guidance upward to reflect our latest market growth expectations." The guidance excludes any contribution from the pending acquisition of P&I.
TransDigm now expects fiscal 2026 financial guidance to be as follows:
Net sales are anticipated to be in the range of $10,470 million to $10,550 million compared with $8,831 million in fiscal 2025, an increase of 19% at the midpoint (an increase of $150 million at the midpoint from prior guidance); Net income is anticipated to be in the range of $2,102 million to $2,150 million compared with $2,074 million in fiscal 2025, an increase of 3% at the midpoint (an increase of $60 million at the midpoint from prior guidance); Earnings per share is expected to be in the range of $35.38 to $36.21 per share based upon weighted average shares outstanding of 57.7 million shares, compared with $32.08 per share in fiscal 2025, which is an increase of 12% at the midpoint (an increase of $1.20 per share at the midpoint from prior guidance); EBITDA As Defined is anticipated to be in the range of $5,490 million to $5,550 million compared with $4,760 million in fiscal 2025, an increase of 16% at the midpoint (an increase of $100 million at the midpoint from prior guidance and corresponding to an EBITDA As Defined margin guide of approximately 52.5% for fiscal 2026); Adjusted earnings per share is expected to be in the range of $40.62 to $41.46 per share compared with $37.33 per share in fiscal 2025, an increase of 10% at the midpoint compared to prior year (and an increase of $1.52 per share at the midpoint from prior guidance); and Fiscal 2026 outlook is based on the following market growth assumptions: Commercial OEM revenue growth in the mid-teens percentage range; Commercial aftermarket revenue growth in the low double-digit percentage range; and Defense revenue growth in the high single-digit to low double-digit percentage range. Please see the attached Table 6 for a reconciliation of EBITDA, EBITDA As Defined to net income and reported earnings per share to adjusted earnings per share guidance midpoint estimated for the fiscal year ending September 30, 2026. Additionally, please see attached Table 7 for comparison of the current fiscal year 2026 guidance versus the previously issued fiscal year 2026 guidance.
Earnings Conference Call
TransDigm Group will host a conference call for investors and security analysts on August 4, 2026, beginning at 11:00 a.m., Eastern Time. To join the call telephonically, please register for the call at https://register-conf.media-server.com/register/BI7977bf81590d469998b139f1d3e8ff9a. Once registered, participants will receive the dial-in information and a unique pin to access the call. The dial-in information and unique pin will be sent to the email used to register for the call. The unique pin is exclusive to the registrant and can only be used by one person at a time. A live audio webcast of the call can also be accessed online at https://www.transdigm.com. A slide presentation will also be available for reference during the conference call; go to the investor relations page of our website and click on "Presentations."
The call will be archived on the website and available for replay at approximately 2:00 p.m., Eastern Time.
About TransDigm Group
TransDigm Group, through its wholly-owned subsidiaries, is a leading global designer, producer and supplier of highly engineered aircraft components for use on nearly all commercial and military aircraft in service today. Major product offerings, substantially all of which are ultimately provided to end-users in the aerospace industry, include mechanical/electro-mechanical actuators and controls, ignition systems and engine technology, specialized pumps and valves, power conditioning devices, specialized AC/DC electric motors and generators, batteries and chargers, engineered latching and locking devices, engineered rods, engineered connectors and elastomer sealing solutions, databus and power controls, cockpit security components and systems, specialized and advanced cockpit displays, engineered audio, radio and antenna systems, specialized lavatory components, seat belts and safety restraints, engineered and customized interior surfaces and related components, advanced sensor products, switches and relay panels, thermal protection and insulation, lighting and control technology, parachutes, high performance hoists, winches and lifting devices, and cargo loading, handling and delivery systems, specialized flight, wind tunnel and jet engine testing services and equipment, electronic components used in the generation, amplification, transmission and reception of microwave signals, and complex testing and instrumentation solutions.
Non-GAAP Supplemental Information
EBITDA, EBITDA As Defined, EBITDA As Defined margin, adjusted net income and adjusted earnings per share are non-GAAP financial measures presented in this press release as supplemental disclosures to net income and reported results. TransDigm Group defines EBITDA as earnings before interest, taxes, depreciation and amortization and defines EBITDA As Defined as EBITDA plus certain non-operating items recorded as corporate expenses, including non-cash compensation charges incurred in connection with TransDigm Group's stock option or deferred compensation plans, foreign currency gains and losses, acquisition-integration costs, acquisition transaction-related expenses, and refinancing costs. Acquisition transaction and integration-related expenses represent costs incurred to integrate acquired businesses into our operations; facility relocation costs and other acquisition-related costs; transaction and valuation-related costs for acquisitions comprising deal fees, legal, financial and tax due diligence expenses; and amortization expense of inventory step-up recorded in connection with the purchase accounting of acquired businesses. TransDigm Group defines adjusted net income as net income plus purchase accounting backlog amortization expense, effects from the sale on businesses, non-cash compensation charges incurred in connection with TransDigm Group's stock option or deferred compensation plans, foreign currency gains and losses, acquisition-integration costs, acquisition transaction-related expenses, and refinancing costs. EBITDA As Defined margin represents EBITDA As Defined as a percentage of net sales. TransDigm Group defines adjusted diluted earnings per share as adjusted net income divided by the total outstanding shares for basic and diluted earnings per share. For more information regarding the computation of EBITDA, EBITDA As Defined, adjusted net income and adjusted earnings per share, please see the attached financial tables.
TransDigm Group presents these non-GAAP financial measures because it believes that they are useful indicators of its operating performance. TransDigm Group believes that EBITDA is useful to investors because it is frequently used by securities analysts, investors and other interested parties to measure operating performance among companies with different capital structures, effective tax rates and tax attributes, capitalized asset values and employee compensation structures, all of which can vary substantially from company to company. In addition, analysts, rating agencies and others use EBITDA to evaluate a company's ability to incur and service debt. EBITDA As Defined is used to measure TransDigm Inc.'s compliance with the financial covenant contained in its credit facility. TransDigm Group's management also uses EBITDA As Defined to review and assess its operating performance, to prepare its annual budget and financial projections and to review and evaluate its management team in connection with employee incentive programs. Moreover, TransDigm Group's management uses EBITDA As Defined to evaluate acquisitions and as a liquidity measure. In addition, TransDigm Group's management uses adjusted net income as a measure of comparable operating performance between time periods and among companies as it is reflective of changes in pricing decisions, cost controls and other factors that affect operating performance.
None of EBITDA, EBITDA As Defined, EBITDA As Defined margin, adjusted net income or adjusted earnings per share is a measurement of financial performance under U.S. GAAP and such financial measures should not be considered as an alternative to net income, operating income, earnings per share, cash flows from operating activities or other measures of performance determined in accordance with U.S. GAAP. In addition, TransDigm Group's calculation of these non-GAAP financial measures may not be comparable to the calculation of similarly titled measures reported by other companies.
Although we use EBITDA and EBITDA As Defined as measures to assess the performance of our business and for the other purposes set forth above, the use of these non-GAAP financial measures as analytical tools has limitations, and you should not consider any of them in isolation, or as a substitute for analysis of our results of operations as reported in accordance with U.S. GAAP. Some of these limitations are:
neither EBITDA nor EBITDA As Defined reflects the significant interest expense, or the cash requirements, necessary to service interest payments on our indebtedness; although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and neither EBITDA nor EBITDA As Defined reflects any cash requirements for such replacements; the omission of the substantial amortization expense associated with our intangible assets further limits the usefulness of EBITDA and EBITDA As Defined; neither EBITDA nor EBITDA As Defined includes the payment of taxes, which is a necessary element of our operations; and EBITDA As Defined excludes the cash expense we have incurred to integrate acquired businesses into our operations, which is a necessary element of certain of our acquisitions. Forward-Looking Statements
Statements in this press release that are not historical facts, including statements under the heading "Fiscal 2026 Outlook," are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "may," "will," "should," "expect," "intend," "plan," "predict," "anticipate," "estimate," or "continue" and other words and terms of similar meaning may identify forward-looking statements.
All forward-looking statements involve risks and uncertainties that could cause TransDigm Group's actual results to differ materially from those expressed or implied in any forward-looking statements made by, or on behalf of, TransDigm Group. These risks and uncertainties include but are not limited to: the sensitivity of our business to the number of flight hours that our customers' planes spend aloft and our customers' profitability, both of which are affected by general economic conditions; supply chain constraints; increases in raw material costs, taxes and labor costs that cannot be recovered in product pricing; failure to complete or successfully integrate acquisitions; our indebtedness; current and future geopolitical or other worldwide events, including, without limitation, wars or conflicts and public health crises; cybersecurity threats; risks related to the transition or physical impacts of climate change and other natural disasters or meeting regulatory requirements; our reliance on certain customers; the United States ("U.S.") defense budget and risks associated with being a government supplier including government audits and investigations; failure to maintain government or industry approvals; risks related to changes in laws and regulations, including increases in compliance costs and potential changes in trade policies and tariffs; potential environmental liabilities; liabilities arising in connection with litigation; risks and costs associated with our international sales and operations; and other factors. Further information regarding the important factors that could cause actual results to differ materially from projected results can be found in TransDigm Group's most recent Annual Report on Form 10-K and other reports that TransDigm Group or its subsidiaries have filed with the Securities and Exchange Commission. Except as required by law, TransDigm Group undertakes no obligation to revise or update the forward-looking statements contained in this press release.
Contact:
Investor Relations
216-706-2945
[email protected]
TRANSDIGM GROUP INCORPORATED
CONSOLIDATED STATEMENTS OF INCOME
FOR THE THIRTEEN AND THIRTY-NINE WEEK PERIODS ENDED
Table 1
JUNE 27, 2026 AND JUNE 28, 2025
(Amounts in millions, except per share amounts)
(Unaudited)
Thirteen Week Periods Ended
Thirty-Nine Week Periods Ended
June 27, 2026
June 28, 2025
June 27, 2026
June 28, 2025
NET SALES
$ 2,741
$ 2,237
$ 7,569
$ 6,394
COST OF SALES
1,113
905
3,078
2,553
GROSS PROFIT
1,628
1,332
4,491
3,841
SELLING AND ADMINISTRATIVE EXPENSES
332
242
859
689
AMORTIZATION OF INTANGIBLE ASSETS
69
51
185
148
INCOME FROM OPERATIONS
1,227
1,039
3,447
3,004
INTEREST EXPENSE—NET
514
397
1,472
1,152
OTHER EXPENSE (INCOME)
—
7
(10)
(24)
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES
713
635
1,985
1,876
INCOME TAX PROVISION
173
142
464
411
NET INCOME
540
493
1,521
1,465
LESS: NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS
(1)
(1)
(2)
(1)
NET INCOME ATTRIBUTABLE TO TD GROUP
$ 539
$ 492
$ 1,519
$ 1,464
NET INCOME APPLICABLE TO TD GROUP COMMON STOCKHOLDERS
$ 539
$ 492
$ 1,460
$ 1,415
Earnings per share attributable to TD Group common stockholders:
Earnings per share—Basic and diluted
$ 9.39
$ 8.47
$ 25.20
$ 24.31
Weighted-average shares outstanding:
Basic and diluted
57.4
58.1
57.9
58.2
TRANSDIGM GROUP INCORPORATED
SUPPLEMENTAL INFORMATION - RECONCILIATION OF
EBITDA, EBITDA AS DEFINED TO NET INCOME
FOR THE THIRTEEN AND THIRTY-NINE WEEK PERIODS ENDED
Table 2
JUNE 27, 2026 AND JUNE 28, 2025
(Amounts in millions, except per share amounts)
(Unaudited)
Thirteen Week Periods Ended
Thirty-Nine Week Periods Ended
June 27, 2026
June 28, 2025
June 27, 2026
June 28, 2025
Net Income
$ 540
$ 493
$ 1,521
$ 1,465
Adjustments:
Depreciation and amortization expense
118
91
324
271
Interest expense-net
514
397
1,472
1,152
Income tax provision
173
142
464
411
EBITDA
1,345
$ 1,123
3,781
3,299
Adjustments:
Acquisition transaction and integration-related expenses (1)
35
9
66
32
Non-cash stock and deferred compensation expense (2)
65
51
118
124
Other, net (3)
2
34
16
(14)
Gross Adjustments to EBITDA
102
94
200
142
EBITDA As Defined
$ 1,447
$ 1,217
$ 3,981
$ 3,441
EBITDA As Defined Margin (4)
52.8 %
54.4 %
52.6 %
53.8 %
(1)
Represents costs incurred to integrate acquired businesses into our operations; facility relocation costs and other acquisition-related costs; transaction and valuation-related costs for acquisitions comprising deal fees, legal, financial and tax due diligence expenses; and amortization expense of inventory step-up recorded in connection with the purchase accounting of acquired businesses.
(2)
Represents the compensation expense recognized under our stock option plans and deferred compensation plans.
(3)
Primarily represents foreign currency transaction gains or losses, costs expensed related to debt financing activities, including new issuances, extinguishments, refinancings and amendments to existing agreements, payroll withholding taxes related to dividend equivalent payments and stock option exercises, non-service related pension costs, deferred compensation payments and other miscellaneous income or expense, such as gain on sale of business.
(4)
The EBITDA As Defined Margin represents the amount of EBITDA As Defined as a percentage of net sales.
TRANSDIGM GROUP INCORPORATED
SUPPLEMENTAL INFORMATION - RECONCILIATION OF REPORTED
EARNINGS PER SHARE TO ADJUSTED EARNINGS PER SHARE
FOR THE THIRTEEN AND THIRTY-NINE WEEK PERIODS ENDED
Table 3
JUNE 27, 2026 AND JUNE 28, 2025
(Amounts in millions, except per share amounts)
(Unaudited)
Thirteen Week Periods Ended
Thirty-Nine Week Periods Ended
June 27, 2026
June 28, 2025
June 27, 2026
June 28, 2025
Reported Earnings Per Share
Net income
$ 540
$ 493
$ 1,521
$ 1,465
Less: Net income attributable to noncontrolling interests
(1)
(1)
(2)
(1)
Net income attributable to TD Group
539
492
1,519
1,464
Less: Dividends paid on participating securities
—
—
(59)
(49)
Net income applicable to TD Group common stockholders—basic and diluted
$ 539
$ 492
$ 1,460
$ 1,415
Weighted-average shares outstanding under the two-class method
Weighted-average common shares outstanding
55.7
56.2
56.1
56.2
Vested options deemed participating securities
1.7
1.9
1.8
2.0
Total shares for basic and diluted earnings per share
57.4
58.1
57.9
58.2
Earnings per share—basic and diluted
$ 9.39
$ 8.47
$ 25.20
$ 24.31
Adjusted Earnings Per Share
Net income
$ 540
$ 493
$ 1,521
$ 1,465
Gross Adjustments to EBITDA
102
94
200
142
Purchase Accounting Backlog Amortization
7
6
23
14
Tax adjustment (1)
(25)
(35)
(67)
(78)
Adjusted net income
$ 624
$ 558
$ 1,677
$ 1,543
Adjusted diluted earnings per share under the two-class method
$ 10.87
$ 9.60
$ 28.94
$ 26.53
Diluted Earnings Per Share to Adjusted Earnings Per Share
Diluted earnings per share from net income attributable to TD Group
$ 9.39
$ 8.47
$ 25.20
$ 24.31
Adjustments to diluted earnings per share:
Inclusion of the dividend equivalent payments
—
—
1.02
0.83
Acquisition transaction and integration-related expenses
0.54
0.20
1.16
0.60
Non-cash stock and deferred compensation expense
0.87
0.67
1.55
1.62
Tax adjustment on income from continuing operations before taxes (1)
0.04
(0.19)
(0.20)
(0.67)
Other, net
0.03
0.45
0.21
(0.16)
Adjusted earnings per share
$ 10.87
$ 9.60
$ 28.94
$ 26.53
(1)
For the thirteen and thirty-nine week periods ended June 27, 2026 and June 28, 2025, the Tax adjustment represents the tax effect of the adjustments at the applicable effective tax rate, as well as the impact on the effective tax rate when excluding the excess tax benefits on stock option exercises. Stock compensation expense is excluded from adjusted net income and therefore we have excluded the impact that the excess tax benefits on stock option exercises have on the effective tax rate for determining adjusted net income.
TRANSDIGM GROUP INCORPORATED
SUPPLEMENTAL INFORMATION - RECONCILIATION OF NET CASH
PROVIDED BY OPERATING ACTIVITIES TO EBITDA, EBITDA AS DEFINED
FOR THE THIRTY-NINE WEEK PERIODS ENDED
Table 4
JUNE 27, 2026 AND JUNE 28, 2025
(Amounts in millions)
(Unaudited)
Thirty-Nine Week Periods Ended
June 27, 2026
June 28, 2025
Net cash provided by operating activities
$ 1,691
$ 1,531
Adjustments:
Changes in assets and liabilities, net of effects from acquisitions and sales of businesses
305
337
Interest expense-net (1)
1,437
1,124
Income tax provision-current
466
414
Gain on sale of businesses, net
—
17
Non-cash stock and deferred compensation expense (2)
(118)
(124)
EBITDA
3,781
3,299
Adjustments:
Acquisition transaction and integration-related expenses (3)
66
32
Non-cash stock and deferred compensation expense (2)
118
124
Other, net (4)
16
(14)
EBITDA As Defined
$ 3,981
$ 3,441
(1)
Represents interest expense, net of interest income, excluding the amortization of debt issuance costs and premium and discount on debt.
(2)
Represents the compensation expense recognized under our stock option plans and deferred compensation plans.
(3)
Represents costs incurred to integrate acquired businesses into our operations; facility relocation costs and other acquisition-related costs; transaction and valuation-related costs for acquisitions comprising deal fees, legal, financial and tax due diligence expenses; and amortization expense of inventory step-up recorded in connection with the purchase accounting of acquired businesses.
(4)
Primarily represents foreign currency transaction gains or losses, costs expensed related to debt financing activities, including new issuances, extinguishments, refinancings and amendments to existing agreements, payroll withholding taxes related to dividend equivalent payments and stock option exercises, non-service related pension costs, deferred compensation payments and other miscellaneous income or expense, such as gain on sale of business.
Wix.com (WIX - Free Report) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to earnings of $2.28 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +23.01%. A quarter ago, it was expected that this cloud-based web development company would post earnings of $1.21 per share when it actually produced earnings of $0.68, delivering a surprise of -43.8%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.
Wix.com, which belongs to the Zacks Computers - IT Services industry, posted revenues of $563.06 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 1.56%. This compares to year-ago revenues of $489.93 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Wix.com shares have lost about 45.3% since the beginning of the year versus the S&P 500's gain of 11%.
What's Next for Wix.com?While Wix.com has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Wix.com was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.31 on $567.76 million in revenues for the coming quarter and $4.55 on $2.25 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computers - IT Services is currently in the bottom 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Taboola.com Ltd. (TBLA - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026. The results are expected to be released on August 5.
This company is expected to post quarterly earnings of $0.13 per share in its upcoming report, which represents a year-over-year change of +30%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Taboola.com Ltd.'s revenues are expected to be $500.4 million, up 7.5% from the year-ago quarter.
McDonald's ve druhém čtvrtletí zvýšil čistý zisk o pět procent a pokračoval v růstu celkových tržeb, výsledky však zastínilo zpomalení na klíčovém americkém trhu. Tržby restaurací otevřených déle než rok v USA rostly podstatně pomaleji než před rokem a zaostaly za očekáváním analytiků. Slabší výkon podle firmy odráží opatrnější chování spotřebitelů, kteří kvůli ekonomické nejistotě a vyšším nákladům omezují výdaje za stravování mimo domov.
Americký řetězec restaurací rychlého občerstvení McDonald's ve druhém čtvrtletí zvýšil čistý zisk meziročně o pět procent na 2,36 miliardy dolarů (téměř 50 miliard Kč). Oznámila to dnes firma. Představila rovněž změnu ve vedení aktivit ve Spojených státech, kde zaznamenala zpomalení růstu tržeb.
Konsolidované tržby společnosti ve druhém čtvrtletí vzrostly o zhruba čtyři procenta na 7,1 miliardy dolarů z 6,8 miliardy před rokem. Tržby restaurací v USA otevřených nejméně rok se zvýšily pouze o 0,8 procenta. Jejich růst tak výrazně zpomalil z 2,5 procenta před rokem a zaostal za očekáváním analytiků.
Firma dnes oznámila, že novou šéfkou aktivit v USA se stane Skye Andersonová, která tak nahradí Joea Erlingera. Spojené státy jsou největším trhem společnosti. Američtí zákazníci se však v poslední době kvůli obavám ohledně vývoje ekonomiky snaží omezovat výdaje na stravování v restauracích, napsala agentura Reuters.
Společnost McDonald's již v květnu varovala, že vyšší ceny benzinu na čerpacích stanicích a obavy spotřebitelů související s konfliktem mezi USA a Íránem by mohly mít negativní dopad na její tržby.
Řetězec McDonald's působí rovněž v České republice, kde provozuje více než 140 restauraci. Předloni do restaurací McDonalds's v Česku zavítalo 53,5 milionu zákazníků.
Tagy: McDonald´s, výsledky, akcie, potravinářství
Reklama
Na tomto místě můžete zahájit diskusi. Zatím nebyl zadán žádný názor. Do diskuse mohou přispívat pouze přihlášení uživatelé (Přihlásit). Pokud nemáte účet, na který byste se mohli přihlásit, registrujte se zde.
Aktuální komentáře
04.08.2026 14:34McDonald's zvýšil zisk, Američané ale ztrácejí chuť utrácet 13:52Palantir zasadil medvědům těžkou ránu. Své tržby meziročně téměř zdvojnásobil 12:35Lufthansa zhoršila výhled a akcie prudce padají. Náklady na palivo začínají tvrdě dopadat na aerolinky 11:46Techy fungují, ropa moc nezlobí a výsledky trhům svědčí 10:50Evropské akcie těží z nečekaně silných výsledků. A je tu prostor pro ještě další růst 10:35CSG posiluje výrobu munice. V Německu investuje miliardy do strategických surovin pro evropskou obranu 9:10Rozbřesk: Komunikační revoluce Fedu začíná být nebezpečnou hrou s ohněm 8:53Palantir září díky AI, Lufthansa doplácí na drahá paliva a Evropu mezitím ochromuje historické sucho 6:01Zitron: Celé odvětví datových center je těžce závislé na OpenAI a ta zase na externím přísunu kapitálu 03.08.2026 22:00Americké trhy se vrací do optimistické nálady 17:13Od SSSR přes Brazílii, Japonsko po Čínu. Nebo i USA? 15:54PODCAST Týdenní výhled: V centru pozornosti AMD a Palantir 15:18Korejský výprodej slábne. Investoři AI akciím věří dál, problémem byla hlavně finanční páka 14:28TotalEnergies kupuje od Shellu evropské portfolio a navazuje na partnerství s EPH 12:09Warshovo „ticho“. Je ještě brzy říkat, že se trhům stýská po Powellovi? 11:02Český průmysl dál roste, tempo oživení však v létě zpomalilo 10:31Rozvíjející se trhy čelí zkoušce. AI, drahá ropa a vyšší sazby vytvářejí nebezpečnou kombinaci 9:29Šéf Fedu zvažuje revoluci v měnové politice. Počet zasedání by mohl klesnout 8:50Rozbřesk: Nabitý týden v Česku. Makro data v čele s inflací a zasedání ČNB 8:49ČEZ zahajuje výplatu dividend, trhy sázejí na uklidnění situace s Íránem a Fed zvažuje změnu fungování
Reklama
Pentagon v dubnu 2026 požádal o rozpočet ve výši 1,5 bilionu USD, z toho asi 75 miliard USD má jít na drony, protidronové technologie a související systémy. To je největší investice do dronové války v historii USA.
Investors have faded drone stocks in 2026. But many companies in this sector continue to deliver strong results. So why the disconnect with stock prices? In a word, valuation. The drone industry has a long runway for growth, and stock prices have gotten well ahead of that story.
Each of the stocks presented here shares a common theme. Each has climbed in the last five years. However, they are all down sharply from all-time highs made in early 2026. That doesn’t mean investors have lost faith in these companies. It just means that investors have taken profits on stocks that have a bright future but an overvalued present.
Get AeroVironment alerts:
The Pentagon Has Plans to Dramatically Increase Spending on Drone TechnologyOne of the drone industry’s largest customers is the U.S. military. Unmanned, autonomous vehicles will play a key role in the future of warfare. That commitment is outlined in the Pentagon's $1.5 trillion budget request in April 2026.
That request earmarks $53.6 billion for autonomous drone platforms and contested logistics. Another $21 billion is reserved for munitions, counter-drone technologies, and advanced systems like the Collaborative Combat Aircraft and MQ-25. That means approximately $75 billion out of $1.5 trillion is dedicated to this sector. This would represent the largest investment in drone warfare and counter-drone technology in U.S. history.
To put that number in perspective, the three stocks in this article delivered a combined trailing 12-month (TTM) revenue of around $3.4 billion. It’s true that these aren’t the only names in this space, but it does show investors the size of the opportunity.
AeroVironment: A Pure-Play Bet With Room to RecoverAeroVironment NASDAQ: AVAV is probably one of the best pure-play names in the drone sector. AVAV is up more than 50% in the last five years, but it’s down 40% in the last 12 months.
AeroVironment Today
$159.18 +9.81 (+6.57%)
As of 08/3/2026 04:00 PM Eastern
52-Week Range$135.20▼
$417.86Price Target$266.68
The concern isn’t about revenue growth. It's more about how much the company will have to invest to fulfill that growth. Adjusted earnings per share (EPS) growth year-over-year (YOY) in the company’s fiscal year 2027 (FY2027) is projected in a range between $3.02 and $3.34. At the high end of that range, it would be roughly flat YOY.
In addition to a falling stock price, analysts’ price targets have also declined since the company’s fourth-quarter earnings report for FY2026.
However, this seems to be the case of investors setting a lower ceiling, and the consensus price target of $266.68 still leaves an impressive 71% upside.
Kratos: A Direct Line Into the Pentagon's Drone BuildoutLike AeroVironment, Kratos Defense & Security Solutions NASDAQ: KTOS has seen its price targets lowered by analysts since the company’s Q1 2026 earnings report. However, also like AVAV, analysts are still forecasting significant upside. In this case, analysts give KTOS a consensus price target of $101.29, which is over 100% higher than the stock’s price as of this writing.
Kratos Defense & Security Solutions Today
KTOS
Kratos Defense & Security Solutions
$49.21 +2.61 (+5.60%)
As of 08/3/2026 04:00 PM Eastern
52-Week Range$43.09▼
$134.00P/E Ratio289.47
Price Target$101.29
Kratos delivered Q1 2026 revenue of $371 million, up 22.6% year-over-year, alongside a record $2 billion backlog and an opportunity pipeline exceeding $14 billion. Much of that momentum ties directly to the Pentagon's spending priorities outlined above.
Kratos is viewed as a key beneficiary of the Pentagon's $1.1 billion Drone Dominance Program, thanks to its AI-enabled XQ-58A Valkyrie drone and existing defense backlog. The company also successfully completed flight testing of its Firejet target drone, powered by a domestically produced J85 engine, reinforcing its vertically integrated drone-and-propulsion strategy while easing supply-chain risk.
Kratos reports Q2 2026 earnings on Aug. 4, with analysts expecting EPS of 13 cents (up 18.18% YOY) and revenue of $411.7 million (up 17.1% YOY). The company has beaten earnings estimates in each of the last four quarters. Investors should note KTOS trades at a steep premium, so execution on this backlog matters more than headline growth alone.
Red Cat: Small-Cap Exposure to Outsized Revenue GrowthRed Cat Holdings NASDAQ: RCAT is the small-cap name among these three stocks with a market cap of around $990 million as of this writing. It’s also the only name on this list that’s not delivering positive EPS.
Red Cat Today
$8.26 +0.73 (+9.69%)
As of 08/3/2026 04:00 PM Eastern
52-Week Range$5.77▼
$18.78Price Target$21.40
But that’s where the asymmetric opportunity may lie.
The U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security is starting to take off.
In Q1 2026, Red Cat delivered YOY revenue growth of 849% with a gross margin that grew 199% from the prior quarter. That means that the company should have sufficient revenue to prevent the shareholder dilution that has weighed on earnings.
That could shift the risk-reward of RCAT into investors’ favor. Analysts have a consensus price target on RCAT of $21.40, which would be a gain of over 160% from is price as of this writing.
Should You Invest $1,000 in AeroVironment Right Now?Before you consider AeroVironment, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AeroVironment wasn't on the list.
While AeroVironment currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Warren Buffett stepped down as CEO of Berkshire Hathaway (NYSE:BRK-B | BRK-B Price Prediction) on December 31, 2025, after six decades leading the conglomerate he transformed from a struggling textile mill into a $1 trillion empire. The “Oracle of Omaha” left his successor, Greg Abel, with a very concentrated portfolio: almost 70% of Berkshire’s $381 billion portfolio is invested in just six stocks. Abel, who has served as vice chair overseeing non-insurance operations, officially took over as CEO on January 1, 2026. At 95 years old, Buffett isn’t fully retiring—he remains chair of the board and plans to continue coming to the Omaha headquarters as much as before. However, he has stated he will be “going quiet” and leaving all decision-making to Abel.
While Berkshire Hathaway has erased much of its 2026 underperformance against the S&P 500, it still boils down to a few compounding and frustrating headwinds: a $397 billion cash pile earning T-bill yields while the market rallied hard, a deliberate retreat from equities at exactly the wrong time, and a leadership transition that shook investor confidence. Its sheer size makes transformative acquisitions nearly impossible, and its “old economy” tilt toward railroads, insurance, and energy meant it sat out the AI-driven tech surge that powered index returns. Remember, the only reason the S&P 500 and the Nasdaq are up this year is the technology sector’s outperformance. In short, Berkshire got penalized for being cautious and boring, though for patient, long-term investors, that may ultimately prove to be a feature, not a bug.
Here are the five reasons why Berkshire Hathaway is my favorite stock for the rest of 2026 and beyond.
1. Gigantic Pile of Cash Berkshire Hathaway sits on the largest cash pile in its history: $397.4 billion at the end of Q2 2026, equal to roughly 59% of its investable assets. In fact, it’s enough cash to buy 476 of the S&P 500. That massive reserve acts as a powerful safety net in the event of a recession or market downturn, while giving Abel tremendous flexibility to pursue attractive acquisitions or make bold capital investments in businesses Berkshire already owns. When the right deal finally appears—and it always does—this kind of financial firepower is truly exceptional.
2. Earnings Are Strong Berkshire’s operating earnings rose 18% to $11.35 billion in Q1 2026, boosted by a robust 28.5% jump in insurance underwriting profit to $1.72 billion. Net income more than doubled to $10.1 billion. This isn’t accounting noise; it’s a clear reflection of genuine operational strength across Berkshire’s massive portfolio of businesses. Second-quarter earnings are due next week, and Wall Street expects them to come in solidly.
3. Portfolio Built to Withstand Disruption Over the past 60 years, Berkshire has assembled a portfolio of operating businesses and investments that are remarkably resilient to disruption from AI and emerging technologies. Railroads, insurance, energy, and consumer staples form the core. These are classic businesses protected by wide, durable competitive moats that are unlikely to be upended overnight.
_________________________________
What's Your Number...?Here's a question most people 5y from retirement can't answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset's free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)
__________________________________________
4. Buybacks Have Started Berkshire ended its 21-month buyback moratorium because its shares finally became attractive enough to repurchase. The price-to-book ratio fell to 1.4 in March, well below the 60% to 80% premium range that had kept buybacks on hold for nearly two years. Consistent with Berkshire’s long-standing policy, the company repurchases shares only when management believes the stock is trading below its intrinsic value. The resumption of buybacks is therefore a clear signal that management views the current price as undervalued—and if they do, investors likely will too. Plus, financial analyses, including estimates from Barron’s, indicate that Berkshire repurchased between $5 billion and $11 billion of its stock in the second quarter.
5. Greg Abel Is the Right One to Lead the Way Abel personally purchased $15 million of Berkshire shares. That amount is roughly equal to his entire after-tax annual salary. In addition, he has committed to repeating the buy each year going forward. Given his decades-long tenure at the company, Abel is unlikely to make abrupt changes to Berkshire’s direction. However, his more active management approach could still unlock meaningful growth in the years ahead. Skin in the game and strong cultural continuity send a powerful positive signal. A signal that will likely continue to resonate with investors for decades to come.
A List of Berkshire Hathaway’s Wholly Owned Private Companies When you own the shares, you own a lot more than the 26 companies in the stock portfolio.
Insurance
GEICO (auto insurance) General Re (reinsurance) Berkshire Hathaway Reinsurance Group Alleghany Corporation Kansas Bankers Surety Transportation and Logistics
BNSF Railway (one of the largest freight railroads in North America) FlightSafety International (pilot training) NetJets (fractional aircraft ownership) Energy and Utilities
Berkshire Hathaway Energy (parent of MidAmerican Energy, PacifiCorp, NV Energy, Northern Powergrid) Manufacturing and Industrial
Marmon Holdings (100+ industrial businesses) Precision Castparts (aerospace/industrial components) IMC International Metalworking Companies Acme Brick Company OxyChem (acquired in January 2026 for $9.7 billion—the most recent major addition) Retail and Consumer
Dairy Queen See’s Candies Ben Bridge Jeweler Borsheims Fine Jewelry Nebraska Furniture Mart Building and Home
Benjamin Moore & Co. (paints) Clayton Homes (manufactured housing) Shaw Industries (flooring) Johns Manville (insulation/building products) Taylor Morrison (acquisition recently completed) Finance and Services
Berkshire Hathaway HomeServices (real estate brokerage) CORT Business Services (furniture rental) Berkadia (mortgage financing, 50% JV) Berkshire has a staggering 800 subsidiaries worldwide, but these are the flagship names that drive the bulk of operating earnings.
The Berkshire Hathaway shares are trading roughly 5% off their all-time high, sitting on a record cash pile, with buybacks just resuming and a new CEO who’s eating his own cooking. For long-term investors, that’s a rare combination. That said, always do your own due diligence before investing. With the stock market overbought and the AI/data center trade still driving investor groupthink, this may be the best opportunity to own a legendary company.
If You’ve Been Thinking About Retirement, Pay Attention (sponsor) Retirement planning doesn’t have to feel overwhelming. The key is finding expert guidance, and SmartAsset’s simple quiz makes it easier than ever for you to connect with a vetted financial advisor. Here’s how:
Answer a Few Simple Questions.
Get Matched with Vetted Advisors
Choose Your Fit
Why wait? Start building the retirement you’ve always dreamed of. Get started today! (sponsor)
Aehr Test Systems získala navazující výrobní objednávku od klíčového zákazníka pro křemíkovou fotoniku na plně automatizovaný systém FOX-XP. Dodávka se očekává v první polovině kalendářního roku 2027.
FREMONT, CA / ACCESS Newswire / August 4, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced it has received a follow-on production order from its lead silicon photonics wafer-level burn-in (WLBI) customer for a fully automated FOX-XP® multi-wafer production burn-in system to support the continued expansion of the customer's manufacturing capacity for next-generation silicon photonic integrated circuits.
The AI industry is rapidly transitioning from moving electrons to moving photons, driving a significant expansion in silicon photonics as hyperscale data centers seek higher bandwidth, lower latency, improved power efficiency, and greater scalability. As silicon photonic integrated circuits become increasingly critical to next-generation AI networking, optical switching, co-packaged optics, linear pluggable optics, and chip-to-chip optical I/O architectures, manufacturers are placing greater emphasis on production-scale reliability screening and WLBI to ensure long-term performance while improving manufacturing yields and reducing production costs.
The ordered system is configured with nine independent WaferPak® test blades, each capable of delivering up to 3,500 watts of power for production burn-in and reliability screening of high-performance silicon photonic integrated circuits used in optical transceivers and emerging chip-to-chip optical I/O applications. The system also includes Aehr's fully integrated automated wafer-level handling solution, consisting of the FOX-XP multi-wafer production burn-in system, integrated WaferPak Auto Aligner™, robotic wafer handling, and automated wafer loading and unloading, providing a complete high-volume automated WLBI solution.
The system is expected to ship during the first half of calendar 2027.
Gayn Erickson, President and Chief Executive Officer of Aehr Test Systems, commented:
"This production order is another indication that silicon photonics is moving from technology adoption into manufacturing scale-up, and we believe that transition represents a significant long-term growth opportunity for Aehr. The order reflects our lead silicon photonics customer's continued expansion of manufacturing capacity and represents another important milestone in the industry's transition toward high-volume production of silicon photonic integrated circuits.
"As AI clusters continue to grow in size and performance, silicon photonics is emerging as a key enabling technology for delivering the bandwidth, power efficiency, and scalability required by next-generation AI infrastructure. What began with optical transceivers is now expanding into optical switching, co-packaged optics, linear pluggable optics, and chip-to-chip optical I/O.
"At the same time, the industry is moving toward more highly-integrated optical architectures that integrate or closely co-package laser sources with silicon photonic integrated circuits. These advances improve performance, reduce system cost, simplify manufacturing, and make device reliability even more critical.
"As silicon photonic devices continue to increase in complexity, power density, and production volumes, we believe WLBI is becoming a foundational manufacturing step for many of these next-generation devices. Identifying latent defects and stabilization of the integrated lasers before packaging improves manufacturing yields, lowers overall production costs, and enables the long-term reliability demanded by hyperscale AI infrastructure.
"Over the past year, we've seen a meaningful increase in engagement from silicon photonics companies around the world spanning engineering qualification systems, production capacity planning, and next-generation device roadmaps. These discussions reinforce our belief that the market is approaching an important inflection point.
"As production requirements evolve toward higher power, fully-automated wafer-level manufacturing, and larger production volumes, we believe our FOX-XP platform and integrated automated wafer-level handling solution position Aehr to become the production standard for wafer-level reliability screening of silicon photonic integrated circuits."
Industry analysts project strong growth for silicon photonics through the remainder of the decade as hyperscale AI infrastructure, cloud computing, high-performance computing, and advanced optical networking continue driving demand for higher bandwidth and lower power interconnect technologies. Emerging applications including co-packaged optics, optical switching, linear pluggable optics, and chip-to-chip optical I/O are expected to further expand the adoption of silicon photonics throughout AI infrastructure. Industry research also points to increasing adoption of integrated and co-packaged laser architectures that improve optical performance, manufacturing scalability, and system efficiency while further increasing the importance of production reliability screening.
Aehr's FOX-XP multi-wafer production burn-In system performs full WLBI, stability testing, and production screening of semiconductor devices while enabling customers to test multiple wafers simultaneously in a highly automated manufacturing environment. The FOX-XP platform supports silicon photonics, silicon carbide power semiconductors, AI processors, optical devices, and other semiconductor products requiring production burn-in and reliability screening.
About Aehr Test Systems
Headquartered in Fremont, California, Aehr Test Systems is a leading provider of test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer-level, singulated die, and package-level form, and has installed thousands of systems worldwide. Increasing quality, reliability, safety, and security needs of semiconductors used across multiple applications, including advanced artificial intelligence (AI) processors, silicon photonics, data and telecommunications infrastructure, electric vehicles, electric vehicle charging infrastructure, solar and wind power, computing, and solid-state memory and storage are driving additional test requirements, incremental capacity needs, and new opportunities for Aehr's products and solutions. Aehr has developed and introduced several innovative products including the FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX WaferPak Contactor, FOX DiePak® Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full-wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize a wide range of devices such as leading-edge silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets, and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices. The FOX-CP system is a low-cost single-wafer compact test solution for logic, memory and photonic devices and the newest addition to the FOX-P product family. The FOX WaferPak Contactor contains a unique full-wafer contactor capable of testing wafers up to 300mm that enables IC manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. The FOX DiePak Carrier allows testing, burning in, and stabilization of singulated bare die and modules up to 1024 devices in parallel per DiePak on the FOX-NP and FOX-XP systems up to nine DiePaks at a time. Acquired through its acquisition of Incal Technology, Inc., Aehr's new line of high-power package-level reliability/burn-in test solutions for AI semiconductor manufacturers, including its ultra-high-power Sonoma family of test solutions for AI accelerators, GPUs, and high-performance computing (HPC) processors, position Aehr within the rapidly growing AI market as a turnkey provider of reliability and testing that span from engineering to high volume production. For more information, please visit Aehr Test Systems' website at www.aehr.com.
Safe Harbor Statement
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally relate to future events or Aehr's future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as "may," "will," "should," "expects," "plans," "anticipates," "going to," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of these words or other similar terms or expressions that concern Aehr's expectations, strategy, priorities, plans, or intentions. Forward-looking statements in this press release include, but are not limited to, future requirements and orders of Aehr's new and existing customers; Aehr's ability to receive orders and generate revenue in the future, as well as Aehr's beliefs regarding the factors impacting the foregoing, including the growth of the markets referred to herein; Aehr's ability to integrate Incal efficiently; and the timing and extent to which the acquisition is accretive. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in Aehr's recent Form 10-K, 10-Q and other reports filed from time to time with the Securities and Exchange Commission. Aehr disclaims any obligation to update information contained in any forward-looking statement to reflect events or circumstances occurring after the date of this press release.
KeyCorp dokončila akvizici společnosti Clearwater Corporate Finance LLP, britské poradenské firmy zaměřené na střední trh. Tím posílí svou globální poradenskou platformu.
, /PRNewswire/ -- KeyCorp (NYSE: KEY) announced today that it has completed its previously-announced acquisition of Clearwater Corporate Finance LLP ("Clearwater UK"), a leading UK-based middle market investment banking advisory firm.
"Completing this acquisition marks an important step in expanding our global advisory platform," said Randy Paine, President of Key Institutional Bank. "Clearwater UK's strong middle-market expertise and sector depth will help us better serve clients with more comprehensive, cross-border advice and execution."
About Clearwater UK
Clearwater UK focuses on providing corporate finance advice for mid-market transactions including M&A, private equity and debt advisory. Across its ten sectors covering automotive, business services, consumer, energy and utilities, financial services, food and beverage, healthcare, industrials and chemicals, real estate, and tech, as well as its debt advisory and private equity specialists, the team provides in-depth knowledge and industry experience to every project. The UK business has offices in Birmingham, London, Leeds and Manchester.
About KeyCorp
KeyCorp's roots trace back more than 200 years to Albany, New York. Headquartered in Cleveland, Ohio, Key is one of the nation's largest bank-based financial services companies, with assets of approximately $191 billion at June 30, 2026.
Key provides deposit, lending, cash management, and investment services to individuals and businesses in 15 states under the name KeyBank National Association through a network of approximately 950 branches and approximately 1,100 ATMs. Key also provides a broad range of sophisticated corporate and investment banking products, such as merger and acquisition advice, public and private debt and equity, syndications and derivatives to middle market companies in selected industries throughout the United States under the KeyBanc Capital Markets trade name. For more information, visit https://www.key.com/. KeyBank Member FDIC.
Sabre Insurance Group uvedla, že za první pololetí 2026 zvýšila hrubé předepsané pojistné o 15,7 % na 160 milionů GBP a čeká, že celoroční zisk překoná výsledek z roku 2025.
Sabre Insurance Group LON: SBRE reported higher first-half premium income and said it remains confident that full-year profit will exceed the 2025 result, despite a temporary decline in its underwriting margin as new business written during the period has yet to fully earn through.
Gross written premium rose 15.7% year-over-year to £160 million in the first half of 2026, while profit before tax was £23.9 million, slightly below the comparable prior-year period. Chief Financial Officer Adam Westwood said the profit outcome was in line with expectations, reflecting the timing difference between writing insurance policies and recognizing the associated revenue over their duration.
Get Sabre Insurance Group alerts:
The insurer said its net insurance margin was 15.7% in the first half, compared with 19.2% in 2025. Sabre expects the measure to return to its 18%-22% target range by year-end as higher 2026 premium volumes earn through and its expense ratio declines.
Margin pressure tied to earned-premium timing Sabre’s net loss ratio was 55.7%, compared with 54.1% for 2025, while its expense ratio rose to 29.9%. Westwood said the higher expense ratio reflected lower earned premium from reduced volumes written during 2025, alongside continued investments in personnel, systems and technology under its Ambition 2030 strategy.
“Because our growth returned strongly in the first half of this year, there’s a natural timing mismatch between writing the business and earning the associated revenue,” Westwood said.
The current-year loss ratio was 66.5%, although the group said this remained within normal volatility and included substantial explicit margins for recently reported claims. Favorable prior-year development contributed a 10.8% prior-year loss ratio, reflecting releases of margins held against older reserves as claims matured.
Chief Actuary Matt Wright said Sabre expects the overall loss ratio to improve in the second half. He said large claims were more prominent in the first quarter than the second, while the company expects the current-year loss ratio to move closer to its target range as business written at target margins earns through.
Motor growth and motorcycle expansion Motor vehicle remained Sabre’s main source of profitability, delivering a 52% net loss ratio. Policy count in the division increased 16.5% year-over-year, while management said the company had maintained underwriting discipline and continued to write new business within its target margins.
Motorcycle premium increased by more than 50% from the first half of 2025, driven largely by the rollout of Sabre Direct Motorcycle. The business had an elevated first-half loss ratio due to individually large claims, seasonal factors and the relatively small size of the portfolio.
Wright noted that motorcycle claims tend to be weighted toward the peak riding season and said the product had shown similar half-year volatility in 2025. He said the loss ratio was above 100% at the 2025 half-year point before improving to roughly 70% by the end of that year.
Taxi underwriting also improved, with its loss ratio falling to 48.2%. However, Sabre said it has deliberately limited volume in parts of the taxi market where pricing does not provide adequate returns.
The company said it expects further growth in the second half, even if the wider market does not experience a significant pricing turn. It added that its core motor mix was broadly in line with expectations, although the increasing contribution from motorcycle and the gradual rollout of Ambition 2030 initiatives could reduce average premiums over time.
Market pricing and claims inflation Management described the motor insurance pricing environment as stabilized but still insufficient to fully cover expected claims inflation across the market. Sabre said it sees forward-looking claims inflation of 6% to 7% from its current rating base and believes its pricing already reflects that outlook.
The company said other market participants may need to raise prices by 10% to 15% over the next two years to remain profitable. Management said Sabre could potentially increase prices by less than the market because of its existing price adequacy.
Claims Director Trevor Webb said claims frequency had recently begun to edge higher after a period of improvement, while personal-injury frequency had remained broadly flat. He said the group was not seeing offsetting improvements in frequency or severity that would lessen the need to account for mid-single-digit claims inflation.
Sabre said it was monitoring potential cost pressures in care claims and had not yet seen clear evidence that current geopolitical conflicts were affecting claims costs through the supply chain.
Capital returns and technology plans The board declared an interim dividend of 4.1 pence per share, up 20% from 3.4 pence a year earlier and in line with its stated dividend policy. Sabre’s £5 million share buyback program is nearing completion.
Its solvency coverage ratio stood at 161.4% after accounting for the interim dividend and buyback, slightly above the group’s preferred 140%-160% operating range. Westwood said the position provides flexibility to support growth and investment while maintaining shareholder returns.
Sabre also outlined plans to use artificial intelligence to support software development, fraud detection, pricing and customer interactions. Management said it did not intend to reduce headcount through the technology program, instead describing AI as a tool to enhance employees’ work as the business grows.
Webb said the insurer is alert to the potential use of AI-generated images and other material in fraudulent claims, but it has not seen large volumes so far. The company continues to use physical vehicle inspections, accident-scene investigations and other established fraud-control measures.
Looking ahead, Sabre reiterated that it expects strong growth, full-year profit above 2025 levels and a return of net insurance margin to its target range by the end of 2026. Management said Ambition 2030 remains on track, with early evidence of progress coming from motorcycle growth and further motor pricing initiatives.
About Sabre Insurance Group (LON:SBRE)Sabre Insurance Group plc, through its subsidiaries, engages in the writing of general insurance for motor vehicles in the United Kingdom. It offers taxi, private car, and motorcycle insurance through a network of insurance brokers, as well as through its Go Girl and Insure 2 Drive brands. The company was founded in 1982 and is based in Dorking, the United Kingdom.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Sabre Insurance Group Right Now?Before you consider Sabre Insurance Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabre Insurance Group wasn't on the list.
While Sabre Insurance Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Main Street Capital oznámila čtvrtletní běžné měsíční dividendy ve výši 0,265 USD na akcii za říjen, listopad a prosinec 2026. V září 2026 vyplatí také mimořádnou dividendu 0,30 USD na akcii.
Regular Monthly Dividends of $0.265 Per Share for each of October, November and December 2026
Supplemental Dividend of $0.30 Per Share Payable in September 2026
, /PRNewswire/ -- Main Street Capital Corporation (NYSE: MAIN) ("Main Street") is pleased to announce that its Board of Directors declared regular monthly cash dividends of $0.265 per share for each of October, November and December 2026. These monthly dividends, which will be payable pursuant to the table below, total $0.795 per share for the fourth quarter of 2026 and are consistent with the regular monthly dividends declared for the third quarter of 2026 and represent a 3.9% increase from the regular monthly dividends paid in the fourth quarter of 2025. Since its October 2007 initial public offering, Main Street has periodically increased the amount of its regular monthly dividends paid per share and has never reduced its regular monthly dividend amount per share.
Summary of Fourth Quarter 2026 Regular Monthly Dividends
Declared
Ex-Dividend Date
Record Date
Payment Date
Amount Per Share
8/3/2026
10/8/2026
10/8/2026
10/15/2026
$0.265
8/3/2026
11/6/2026
11/6/2026
11/13/2026
$0.265
8/3/2026
12/8/2026
12/8/2026
12/15/2026
$0.265
Total for Fourth Quarter 2026:
$0.795
In addition to the regular monthly dividends for the fourth quarter of 2026, the Board of Directors declared a supplemental cash dividend of $0.30 per share payable in September 2026. This supplemental cash dividend, which will be payable as set forth in the table below, will be paid out of Main Street's undistributed taxable income (taxable income in excess of dividends paid) as of June 30, 2026.
Supplemental Cash Dividend Payable in September 2026
Declared
Ex-Dividend Date
Record Date
Payment Date
Amount Per Share
8/3/2026
9/21/2026
9/21/2026
9/28/2026
$0.30
Including all dividends declared to date, including the fourth quarter 2026 regular monthly dividends and the September 2026 supplemental dividend, Main Street will have paid $51.205 per share in cumulative cash dividends since its October 2007 initial public offering at $15.00 per share. Including the fourth quarter 2026 regular monthly dividends and the September 2026 supplemental dividend, these most recent dividend declarations represent total dividends to Main Street shareholders of $1.095 per share, representing an annualized current yield of 7.9% based on the closing price of $55.75 per share on August 3, 2026.
The final determination of the tax attributes for dividends each year are made after the close of the tax year. The final tax attributes for 2026 dividends are currently expected to include a combination of ordinary taxable income and qualified dividends and may include capital gains and return of capital.
Main Street maintains a dividend reinvestment and direct stock purchase plan (the "Plan"). The dividend reinvestment feature of the Plan (the "DRIP") provides for the reinvestment of dividends on behalf of Main Street's registered stockholders who hold their shares with Main Street's transfer agent and registrar, Equiniti Trust Company, LLC, or certain brokerage firms that have elected to participate in the DRIP. Under the DRIP, if Main Street declares a dividend, registered stockholders who have not "opted out" of the DRIP by the dividend record date will have their dividend automatically reinvested into additional shares of Main Street common stock. The direct stock purchase feature of the Plan (the "DSPP") provides investors with a convenient and economical method to purchase shares of Main Street common stock. More information about the Plan (including the DSPP prospectus) can be found on the Main Street website (https://ir.mainstcapital.com/dividend-reinvestment-and-direct-stock-purchase-plan).
ABOUT MAIN STREET CAPITAL CORPORATION
Main Street (www.mainstcapital.com) is a principal investment firm that primarily provides customized long-term debt and equity capital solutions to lower middle market companies and debt capital to private companies owned by or in the process of being acquired by a private equity fund. Main Street's portfolio investments are typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. Main Street seeks to partner with entrepreneurs, business owners and management teams and generally provides customized "one-stop" debt and equity financing solutions within its lower middle market investment strategy. Main Street seeks to partner with private equity fund sponsors and primarily invests in secured debt investments in its private loan investment strategy. Main Street's lower middle market portfolio companies generally have annual revenues between $10 million and $150 million. Main Street's private loan portfolio companies generally have annual revenues between $25 million and $500 million.
Main Street, through its wholly-owned portfolio company MSC Adviser I, LLC ("MSC Adviser"), also maintains an asset management business through which it manages investments for external parties. MSC Adviser is registered as an investment adviser under the Investment Advisers Act of 1940, as amended.
FORWARD-LOOKING STATEMENTS
This press release contains certain forward-looking statements, including but not limited to the continued payment and growth of future dividends and the potential tax attributes for 2026 dividends, which are based upon Main Street management's current expectations and are inherently uncertain. Any such statements other than statements of historical fact are likely to be affected by other unknowable future events and conditions, including elements of the future that are or are not under Main Street's control, and that Main Street may or may not have considered; accordingly, such statements cannot be guarantees or assurances of any aspect of future performance. Actual performance, events and results could vary materially from these estimates and projections of the future as a result of a number of factors, including those described from time to time in Main Street's filings with the U.S. Securities and Exchange Commission. Such statements speak only as of the time when made and are based on information available to Main Street as of the date hereof and are qualified in their entirety by this cautionary statement. Main Street assumes no obligation to revise or update any such statement now or in the future.
dYdX uvedl, že dYdX Chain od spuštění zobchodoval objem obchodů 406 mld. USD a kumulativní poplatky protokolu činí 66,3 mil. USD. Program Buyback už přeměnil 75 % čistých poplatků na 22,3 mil. DYDX.
The dYdX Foundation is pleased to release the dYdX Ecosystem Report - H1 2026, a structured overview of protocol and ecosystem performance across trading activity, token dynamics, governance participation, and infrastructure development.
In the first half of 2026, the dYdX Chain continued to mature under community governance, marked by steady participation, expanding programs like Surge and Buyback, and deepening transparency — with the protocol remaining community-owned, governed, and secured throughout.
📄 Full report
Key Highlights:Trading volume: $406B since the launch of the dYdX Chain, bringing dYdX to $1.58T+ cumulative volumeProtocol fees: $66.3M in cumulative protocol fees since v4DYDX Buybacks: expanded Buyback Program converted 75% of net protocol fees into cumulative 22.3M DYDXTrader participation: unique traders totalled 6,268 in Q1 2026 and 4,210 in Q2Token distribution: DYDX token holders increased to 98.5K (+44% YoY)Staking rewards: ~$48.1M in cumulative staking rewards distributedCampaigns: dYdX Surge seasons 10-15, Affiliate Booster Program, Voltrade Trading Competition and BONK partnershipLooking ahead: following the launch of Arcus, the dYdX Foundation reaffirmed that dYdX Chain is unaffected and continues to operate as it always has - governed by its token holders, secured by its validators, and owned by its community.
Treasury and Operations SubDAOs continue to operate under their existing mandates and funds managed only by community decision aiming to continue dYdX’s role as a scalable alternative to centralized platforms.
📄 Full report
About the dYdX Foundation
Legitimacy and Disclaimer
Crypto-assets can be highly volatile and trading crypto-assets involves risk of loss, particularly when using leverage. Investment into crypto-assets may not be regulated and may not be adequate for retail investors. Do your own research and due diligence before engaging in any activity involving crypto-assets.dYdX is a decentralised, disintermediated and permissionless protocol, and is not available in the U.S. or to U.S. persons as well as in other restricted jurisdictions. The dYdX Foundation does not operate or participate in the operation of any component of the dYdX Chain's infrastructure.
The dYdX Foundation’s purpose is to support the current implementation and any future implementations of the dYdX protocol and to foster community-driven growth in the dYdX ecosystem.
The dYdX Chain software (including dYdX Unlimited) is open-source software to be used or implemented by any party in accordance with the applicable license. At no time should the dYdX Chain and/or its software or related components (including dYdX Unlimited) be deemed to be a product or service provided or made available in any way by the dYdX Foundation. Interactions with the dYdX Chain software (including dYdX Unlimited) or any implementation thereof are permissionless and disintermediated, subject to the terms of the applicable licenses and code. Users who interact with the dYdX Chain software, i ncluding dYdX Unlimited (or any implementations thereof) will not be interacting with the dYdX Foundation in any way whatsoever. The dYdX Foundation does not make any representations, warranties or covenants in connection with the dYdX Chain software (or any implementations and/or components thereof, including dYdX Unlimited), including (without limitation) with regard to their technical properties or performance, as well as their actual or potential usefulness or suitability for any particular purpose, and users agree to rely on the dYdX Chain software (or any implementations and/or components thereof, including dYdX Unlimited) “AS IS, WHERE IS”.
Nothing in this post should be used or considered as legal, financial, tax, or any other advice, nor as an instruction or invitation to act by anyone. Users should conduct their own research and due diligence before making any decisions. The dYdX Foundation may alter or update any information in this post in the future at its sole discretion and assumes no obligation to publicly disclose any such change. This post is solely based on the information available to the dYdX Foundation at the time it was published and should only be read and taken into consideration at the time it was published and on the basis of the circumstances that surrounded it. The dYdX Foundation makes no guarantees of future performance and is under no obligation to undertake any of the activities contemplated herein.
Depositing into the MegaVault carries risks. Do your own research and make sure to understand the risks before depositing funds. MegaVault returns are not guaranteed and may fluctuate over time depending on multiple factors. MegaVault returns may be negative and you may lose your entire investment.The dYdX Foundation does not operate or has control over the MegaVault and has not been involved in the development, deployment and operation of any component of the dYdX Unlimited software (including the MegaVault).
Insulet čelí žalobě kvůli cenným papírům kvůli údajnému zkreslování bezpečnosti produktů Omnipod po výrobních vadách. Akcie $PODD po oznámení 12. března klesly o 6,88 %.
A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet's Omnipod products.
, /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Insulet Corporation (NASDAQ: PODD) and certain of the Company's senior executives for securities fraud after its significant stock drop resulting from potential violations of the federal securities laws.
If you invested in Insulet, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/insulet-class-action-lawsuit.
Key Details of the Insulet ($PODD) Class Action:
Lead Plaintiff Deadline: August 31, 2026 Alleged Misconduct: Securities fraud relating to the safety of Insulet's Omnipod products Largest Alleged Stock Drop: March 12, 2026 – 6.88% Stock Drop Court: U.S. District Court for the District of Massachusetts Take Action: Contact BFA Law to discuss your rights Insulet investors have until August 31, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Insulet securities. The class action is pending in the U.S. District Court for the District of Massachusetts. It is captioned Hu v. Insulet Corporation et al., No. 26-cv-13062.
Why is Insulet Being Sued for Securities Fraud?
Insulet is primarily engaged in the development, manufacture, and sale of insulin delivery systems for people with insulin-dependent diabetes through its Omnipod platform. The Omnipod platform includes: the Omnipod® 5 Automated Insulin Delivery System ("Omnipod 5"), the Omnipod DASH® Insulin Management System ("Omnipod DASH"), and the Omnipod Insulin Management System ("Omnipod Eros").
Throughout the relevant period, Insulet misrepresented the safety of its Omnipod products as well as its ability to efficiently produce "medical grade quality at consumer electronic scale." In reality, certain of Insulet's products suffered from undisclosed manufacturing defects that put patient safety at risk.
Why did Insulet's Stock Drop?
On March 12, 2026, Insulet disclosed that a manufacturing issue with its Omnipod® 5 Pods caused a "tear in the internal tubing that delivers insulin" resulting in insulin being released inside the Pod "instead of being fully infused into the body as intended." Accordingly, Insulet "initiated a voluntary Medical Device Correction for specific lots of Omnipod® 5 Pods."
This news caused the price of Insulet stock to drop $16.23 per share, or 6.88%, from a closing price of $236.07 per share on March 12, 2026, to $219.84 per share on March 13, 2026.
On May 26, 2026, Insulet announced another voluntary Medical Device Correction due to a manufacturing issue, this time to its Omnipod 5, Omnipod DASH, and Omnipod Eros systems. It again indicated that the manufacturing issue resulted in a tear in the tubing which "could result in insulin under-delivery."
This news caused the price of Insulet stock to drop $7.79 per share, or 5.07%, from a closing price of $218.11 per share on May 26, 2026, to $146.01 per share on May 27, 2026.
Click here for more information: https://www.bfalaw.com/cases/insulet-class-action-lawsuit.
What Can You Do?
If you invested in Insulet, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named "Elite Trial Lawyers" by the National Law Journal, "Litigation Stars" by Benchmark Litigation, among the top "500 Leading Plaintiff Financial Lawyers" by Lawdragon, "Titans of the Plaintiffs' Bar" by Law360 and "SuperLawyers" by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff's securities litigation law firm, with clients noting: "[t]here is no better service provider in the practice area," "[t]he interest of the client is always front and center," and "[t]here isn't a better firm in this space." One testimonial described the firm as "nimble and entrepreneurial," with a "relentless focus on adding value for clients."
Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Eve Holding ve 2. čtvrtletí 2026 snížila čistou ztrátu na 34,2 mil. USD z 64,7 mil. USD díky nižším nákladům na výzkum a vývoj. Hotovostní odtok klesl na 49,4 mil. USD.
, /PRNewswire/ -- Eve Holding, Inc. ("Eve") (NYSE: EVEX and EVEXW / B3: EVEB31) reports its second quarter 2026 earnings results.
Financial Highlights
Eve Air Mobility is an aerospace company dedicated to developing an eVTOL (electric Vertical Takeoff and Landing) aircraft and the Urban Air Mobility (UAM) ecosystem. This includes aircraft development, Services & Support solutions like Eve TechCare® and Eve Vector®, an Urban Air Traffic Management system. Eve is pre-operational. We do not expect meaningful revenue, if any, during the aircraft development phase. Financial results during this period are expected to be driven mostly by program development costs.
Eve reported a net loss of $34.2 million in 2Q26 versus $64.7 million in 2Q25. The reduction in net loss in 2Q26 was mainly due to lower Research & Development expenses. These costs and activities are necessary to advance our suite of UAM products and services, including the Master Service Agreement (MSA) with Embraer. R&D expenses were $28.9 million in 2Q26 compared to $45.7 million in 2Q25 and reflect better than expected supplier contract negotiations and program development updates. The decrease came despite continuous supplier engagement and R&D activity – including eVTOL development and allocation of Embraer engineering resources to our project. R&D continues to demand additional program development activities and testing infrastructure. The MSA primarily drives our R&D costs with Embraer, which performs several critical activities for Eve.
Selling, General & Administrative (SG&A) was relatively flat yoy, at $8.3 million in 2Q26 ($8.2 million in 2Q25). The number of direct Eve employees remained unchanged yoy at 185 contributors, and despite the c.8% appreciation of the Brazilian Real versus the US Dollar, personnel and outsourced expenses decreased by about 5% yoy – Eve is already capturing some of the additional cost savings and synergies identified with Embraer. This decrease was offset by higher depreciation charges, reflecting the growth of Eve's fixed-asset base.
Eve's total cash consumption in 2Q26 was $49.4 million – vs. $56.9 million in 2Q25, despite continuous design & development activities, with some MSA-related payments deferred to the beginning of the third quarter. Including this payment, Eve's full year 2026 cashflow consumption is expected to reach the mid-range of our guidance at $250 million as we start to capture additional synergies with Embraer. Eve's Cash, Cash Equivalents, and Financial Investments totaled $403.3 million at the end of 2Q26. Total liquidity – including undrawn credit lines with the Brazil's National Development Bank (BNDES) and a grant, reached a $531.3 million. We believe this funding is sufficient to support our operations and program investments through 2028.
For additional information, please access the full 2Q26 Earnings release, available at the Investor Relations website ir.eveairmobility.com
Webcast details
Management will discuss the results on a conference call on Tuesday, August 04, 2026, at 8:00 AM (Eastern Time). The webcast will be publicly available in the Upcoming Events section of the company website: www.eveairmobility.com
To listen by phone, please dial 1-877-407-0752 or 1-201-389-0912. A replay of the call will be available until August 18, 2026, by dialing 1-844-512-2921 or 1-412-317-6671 and entering passcode 13761886.
Webcast access here
About Eve Holding, Inc.
Eve is dedicated to accelerating the Urban Air Mobility ecosystem. Benefitting from a start-up mindset, backed by Embraer S.A.'s more than 50-year history of aerospace expertise, and with a singular focus, Eve is taking a holistic approach to progressing the UAM ecosystem, with an advanced eVTOL project, comprehensive global services and support network and a unique air traffic management solution. Since May 10, 2022, Eve has been listed on the New York Stock Exchange, where its shares of common stock and public warrants trade under the tickers "EVEX" and "EVEXW". In December 2025, the Company was listed on the B3, Brazilian Stock Exchange, under the ticker EVEB31. The information on, or accessible through, any website referenced herein is not incorporated by reference into, and is not a part of, this release. For more information, please visit www.eveairmobility.com
Forward Looking Statements
Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by words such as "may," "will," "expect," "intend," "anticipate," "believe," "estimate," "plan," "project," "could," "should," "would," "continue," "seek," "target," "guidance," "outlook," "if current trends continue," "optimistic," "forecast" and other similar words or expressions. All statements, other than statements of historical facts, are forward-looking statements, including, but not limited to, statements about the company's plans, objectives, expectations, outlooks, projections, intentions, estimates, and other statements of future events or conditions, including with respect to all companies or entities named within. These forward-looking statements are based on the company's current objectives, beliefs and expectations, and they are subject to significant risks and uncertainties that may cause actual results and financial position and timing of certain events to differ materially from the information in the forward-looking statements. These risks and uncertainties include, but are not limited to, those set forth herein as well as in Part I, Item 1A. Risk Factors and Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations of the company's most recent Annual Report on Form 10-K, Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors of the company's most recent Quarterly Report on Form 10-Q, and other risks and uncertainties listed from time to time in the company's other filings with the Securities and Exchange Commission. Additionally, there may be other factors which the company is not currently aware of that may affect matters discussed in the forward-looking statements and may also cause actual results to differ materially from those discussed. The company does not assume any obligation to publicly update or supplement any forward-looking statement to reflect actual results, changes in assumptions or changes in other factors affecting these forward-looking statements, other than as required by law. Any forward-looking statements speak only as of the date hereof or as of the dates indicated in the statement.
HOUSTON--(BUSINESS WIRE)--NRG Energy, Inc. (NYSE: NRG) today announced financial results for the second quarter ended June 30, 2026, and reports GAAP Net Income of $506 million, GAAP Earnings per Share (EPS) — basic of $2.32, and GAAP Cash Provided by Operating Activities of $1,117 million. The Company's non-GAAP metrics are Adjusted Net Income of $315 million, Adjusted EPS of $1.49, Adjusted EBITDA of $1,217 million, and Free Cash Flow before Growth Investments (FCFbG) of $1,025 million for the second quarter of 2026.
“Today we provided a progress update on our Bring Your Own Power data center strategy,” said Robert Gaudette, President & CEO. “This is the model for how large load growth should work. The customer supports the investment, with reliability and affordability protected for all. We also delivered a solid second quarter and are reaffirming our 2026 guidance. I am confident in the discipline and execution that continue to drive NRG forward.”
Consolidated Financial Results
Table 1:
Three Months Ended
Six Months Ended
(In millions, except per share amounts)
6/30/2026
6/30/2025
6/30/2026
6/30/2025
GAAP Net Income/(Loss)
$
506
$
(104
)
$
631
$
646
Adjusted Net Incomea b
$
315
$
339
$
623
$
870
GAAP EPS — basicc
$
2.32
$
(0.62
)
$
2.86
$
3.11
Adjusted EPSa d
$
1.49
$
1.73
$
2.98
$
4.42
Adjusted EBITDAa
$
1,217
$
909
$
2,297
$
2,035
GAAP Cash Provided by Operating Activities
$
1,117
$
451
$
948
$
1,306
Free Cash Flow Before Growth Investments (FCFbG)a
$
1,025
$
914
$
959
$
1,207
a Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, and FCFbG are non-GAAP financial measures; see Appendix tables A-1 through A-6 for GAAP reconciliations. Adjusted EPS, Adjusted Net Income, and Adjusted EBITDA exclude fair value adjustments related to derivatives
b Adjusted Net Income as shown here is 'Adjusted Net Income available for common stockholders'; see Appendix tables A-1 through A-4
c GAAP Net Income/(Loss) per Weighted Average Common Share - Basic
d Adjusted EPS calculated based on Adjusted Net Income divided by weighted average number of common shares outstanding - basic
NRG reported GAAP Net Income of $506 million for the second quarter of 2026, an increase of $610 million from the prior year. The improvement was due to the addition of the portfolio of assets acquired from LS Power and higher realized capacity prices in the East, partially offset by milder weather and higher supply costs. Results also benefited from unrealized, non-cash gains on economic hedges, primarily in the East, compared to losses in the prior year. These hedge positions are adjusted to market value each period, while the related customer contracts are not. As a result, the accounting treatment can result in temporary unrealized gains or losses that may differ from expected results when the contracts settle.
Adjusted Net Income for the second quarter 2026 is $315 million, $24 million lower than prior year, primarily driven by higher interest expense and depreciation and amortization related to the acquisition of the portfolio of assets acquired from LS Power, partially offset by a $308 million increase in Adjusted EBITDA, the impacts of which are described in the segment results below. Adjusted EPS is $1.49 for the second quarter 2026, $0.24 lower than prior year. The second quarter 2026 Adjusted EPS results include the financial impacts from Adjusted Net Income and impacts of shares issued as part of the completed acquisition of generation assets and CPower from LS Power.
Reaffirming 2026 Guidance
NRG is reaffirming its guidance for 2026 as set forth below.
Table 2: Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, and FCFbG Guidance for 2026a
2026
(In millions, except per share amounts)
Guidance
Adjusted Net Income
$1,685 - $2,115
Adjusted EPS
$7.90 - $9.90
Adjusted EBITDA
$5,325 - $5,825
FCFbG
$2,800 - $3,300
a Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, and FCFbG are non-GAAP financial measures; see Appendix tables A-8 and A-9 for GAAP reconciliations. Adjusted Net Income, Adjusted EPS, and Adjusted EBITDA exclude fair value adjustments related to derivatives. The Company does not guide to GAAP Net Income due to the impact of such fair value adjustments related to derivatives in a given year.
2026 Capital Allocation
The Company plans to return $1.0 billion to shareholders through share repurchases and approximately $407 million through common stock dividends in 2026, as part of its previously announced 2026 capital allocation plan. Through July 31, 2026, the Company completed $932 million in share repurchases and distributed $202 million in common stock dividends.
On July 22, 2026, NRG declared a quarterly dividend of $0.475 per common share, or $1.90 per share on an annualized basis. The dividend is payable on August 17, 2026 to common stockholders of record as of August 3, 2026.
NRG's share repurchase program and common stock dividend are subject to maintaining satisfactory credit metrics, available capital, market conditions, and compliance with associated laws and regulations. The timing and amount of any shares of common stock repurchased under the share repurchase authorization will be determined by NRG’s management based on market conditions and other factors. NRG will only repurchase shares when management believes it would not jeopardize the Company’s ability to maintain satisfactory credit ratings.
NRG Strategic Developments
Advanced BYOP Data Center Strategy
NRG advanced its Bring Your Own Power (BYOP) strategy with a leading global cloud and AI hyperscaler. The parties are aligned on principal commercial terms for the development of a 1.2 GW combined cycle natural gas generation facility in Texas and remains subject to final documentation and approvals. This update highlights NRG's BYOP strategy of meeting large load growth through customer-backed generation investment to support grid reliability, energy affordability, and local communities.
Texas Energy Fund (TEF)
On May 26, 2026, NRG achieved commercial operations at its first project, the 415 MW T.H. Wharton facility. The project satisfied the eligibility requirements for the completion bonus grant program, and on June 17, 2026, the Company entered into a completion bonus grant agreement with the PUCT for T.H. Wharton for up to $54.72 million, to be paid in ten annual installments, subject to performance of the facility, beginning after the initial test period ends on May 31, 2027. NRG's two additional TEF projects remain on time and on budget. Through the program, NRG plans to bring online a total of 1.5 GW of new, reliable, affordable power generation by mid-2028 to support the increasing energy demands of Texas consumers.
Segment Results
Table 3: Adjusted EBITDAa
(In millions)
Three Months Ended
Six Months Ended
Segment
6/30/2026
6/30/2025
6/30/2026
6/30/2025
Texas
$
381
$
512
$
597
$
811
East
469
99
933
573
West/Otherb
66
39
172
112
Vivint Smart Home
301
259
595
539
Adjusted EBITDA
$
1,217
$
909
$
2,297
$
2,035
a Adjusted EBITDA is a non-GAAP financial measure; see Appendix tables A-1 through A-4 for GAAP reconciliation of Adjusted EBITDA (by operating segment) to GAAP Net Income (by operating segment). Adjusted EBITDA excludes fair value adjustments related to derivatives
b Includes Corporate activities
Texas: Second quarter 2026 Adjusted EBITDA was $381 million, $131 million lower than the prior year. For the first six months of 2026, Adjusted EBITDA was $597 million, $214 million lower than prior year. Results were primarily driven by higher supply costs, mild winter weather, including a ~30% decrease in heating degree days as compared to prior year leading to lower retail load, and additional operating expenses for the new generation assets.
East: Second quarter 2026 Adjusted EBITDA was $469 million, $370 million higher than the prior year. For the first six months of 2026, Adjusted EBITDA was $933 million, $360 million higher than prior year. Results were primarily driven by contribution of the new generation assets and CPower and higher capacity prices for owned generation, partially offset by higher power supply costs during Winter Storm Fern and lower natural gas margins.
West/Other: Second quarter 2026 Adjusted EBITDA was $66 million, $27 million higher than the prior year. For the first six months of 2026, Adjusted EBITDA was $172 million, $60 million higher than prior year. The increase was primarily driven by lower operating expenses associated with a lease expiration in May 2025.
Vivint Smart Home: Second quarter 2026 Adjusted EBITDA was $301 million, $42 million higher than the prior year. For the first six months of 2026, Adjusted EBITDA was $595 million, $56 million higher than prior year. The increase for both the quarter and the first six months of 2026 is attributable to higher new customer adds and an increase in monthly recurring service margin per customer.
Liquidity and Capital Resources
Table 4: Corporate Liquidity
(In millions)
6/30/26
12/31/25
Cash and Cash Equivalents
$
162
$
4,708
Restricted Cash
50
30
Total
$
212
$
4,738
Total availability under revolving credit facility and collective collateral facilitiesa
5,068
4,890
Total liquidity, excluding funds deposited by counterparties
$
5,280
$
9,628
a Total capacity of the revolving credit facility and collective collateral facilities was $9.0 billion and $7.7 billion as of June 30, 2026 and December 31, 2025, respectively
As of June 30, 2026, NRG's unrestricted cash was approximately $0.2 billion, and $5.1 billion was available under the Company’s credit facilities. Total liquidity was $5.3 billion, which was $4.3 billion lower than December 31, 2025, primarily driven by funding of the acquisition of generation assets and CPower from LS Power.
Earnings Conference Call
On August 4, 2026, NRG will host a conference call at 9:00 a.m. Eastern (8:00 a.m. Central) to discuss these results. Investors, the news media and others may access the live webcast of the conference call and accompanying presentation materials through the investor relations website under “presentations and webcasts” on investors.nrg.com. The webcast will be archived on the site for those unable to listen in real-time.
About NRG
NRG is a leading provider of electricity, natural gas, and smart home solutions to eight million customers across North America. The company operates a customer-first platform supported by a diversified supply strategy and the safe, reliable operation of approximately 25 GW of power generation. NRG plays a meaningful role in competitive energy markets and our innovative team is creating the flexible and affordable solutions that households and large businesses need today and in the future.
Forward-Looking Statements
In addition to historical information, the information presented in this press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements involve estimates, expectations, projections, goals, assumptions, known and unknown risks and uncertainties and can typically be identified by terminology such as “may,” “should,” “could,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “expect,” “intend,” “seek,” “plan,” “think,” “anticipate,” “estimate,” “predict,” “target,” “potential” or “continue” or the negative of these terms or other comparable terminology. Such forward-looking statements include, but are not limited to, statements about NRG's future revenues, income, indebtedness, capital structure, plans, expectations, objectives, projected financial performance and/or business results and other future events, and views of economic and market conditions.
Although NRG believes that its expectations are reasonable, it can give no assurance that these expectations will prove to be correct, and actual results may vary materially. Factors that could cause actual results to differ materially from those contemplated herein include, among others, general economic conditions, the imposition of tariffs, the escalation of international trade disputes, and the occurrence or re-escalation of geopolitical conflicts (including the hostilities with Iran and the conflicts in the Middle East) and inflationary impacts resulting therefrom, risks associated with the integration of the portfolio of assets acquired from LS Power, including potential disruption to ongoing operations and other transition difficulties, the inability of the combined company to realize expected synergies and benefits of integration (or that it takes longer than expected) which may result in the combined company not operating as effectively as expected, the emergence of hazards customary in the power industry, weather conditions and extreme weather events, competition in wholesale power, gas and smart home markets, the volatility of energy and fuel prices, the volatility in demand for power and gas, customer affordability concerns that may constrain the pricing of NRG's products and services and limit its ability to recover costs, the failure of customers or counterparties to perform under contracts, changes in the wholesale power and gas markets, the failure of NRG’s expectations regarding load growth to materialize, changes in government or market regulations, the condition of capital markets generally and NRG’s ability to access capital markets, NRG’s ability to execute its supply strategy, risks related to data privacy, cyberterrorism and inadequate cybersecurity, the loss of data, unanticipated outages at NRG’s generation facilities, operational and reputational risks related to the use of artificial intelligence and the adherence to developing laws and regulations related to the use thereof, NRG’s ability to achieve its net debt targets, adverse results in current and future litigation, complaints, product liability claims and/or adverse publicity, failure to identify, execute or successfully implement acquisitions or asset sales, risks of the smart home and security industry, including risks of and publicity surrounding the sales, customer origination and retention process, the impact of changes in consumer spending patterns, consumer preferences, geopolitical tensions, demographic trends, supply chain disruptions, NRG’s ability to implement value enhancing improvements to plant operations and company wide processes, NRG’s ability to achieve or maintain investment grade credit metrics, NRG’s ability to execute definitive agreements for, and proceed with or complete, proposed projects (including the data center project) on the contemplated terms, timeline and budget, the inability to maintain or create successful partnering relationships, NRG’s ability to operate its business efficiently, NRG’s ability to retain customers, the ability to successfully integrate businesses of acquired assets or companies (including the portfolio acquisition from LS Power), NRG’s ability to realize anticipated benefits of transactions (including expected cost savings and other synergies) or the risk that anticipated benefits may take longer to realize than expected, NRG’s ability to execute its capital allocation plan, and the other risks and uncertainties discussed in this release and in our Forms 10-K, 10-Q, and 8-K filed with or furnished to the Securities and Exchange Commission (the "SEC"). Achieving investment grade credit metrics is not an indication of or guarantee that NRG will receive investment grade credit ratings. Debt and share repurchases may be made from time to time subject to market conditions and other factors, including as permitted by United States securities laws. Furthermore, any common stock dividend is subject to available capital and market conditions.
NRG undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. The Adjusted EBITDA, adjusted cash provided by operating activities, Free Cash Flow before Growth Investments, Adjusted Net Income, and Adjusted EPS guidance are estimates as of August 4, 2026. These estimates are based on assumptions NRG believed to be reasonable as of that date. NRG disclaims any current intention to update such guidance, except as required by law. The foregoing review of factors that could cause NRG’s actual results to differ materially from those contemplated in the forward-looking statements included in this press release should be considered in connection with information regarding risks and uncertainties that may affect NRG's future results included in NRG's filings with the SEC at www.sec.gov. For a more detailed discussion of these factors, see the information under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in NRG’s most recent Annual Report on Form 10-K, and in subsequent SEC filings. NRG’s forward-looking statements speak only as of the date of this communication or as of the date they are made.
NRG ENERGY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three months ended June 30,
Six months ended June 30,
(In millions, except per share amounts)
2026
2025
2026
2025
Revenue
Revenue
$
7,481
$
6,740
$
17,737
$
15,325
Operating Costs and Expenses
Cost of operations (excluding depreciation and amortization shown below)
5,470
5,629
14,328
12,190
Depreciation and amortization
494
344
926
670
Selling, general and administrative costs (excluding amortization of customer acquisition costs of $93, $68, $180, and $133 respectively, which are included in depreciation and amortization shown separately above)
562
724
1,155
1,273
Acquisition-related transaction and integration costs
16
43
61
51
Total operating costs and expenses
6,542
6,740
16,470
14,184
Gain/(Loss) on sale of assets
37
—
37
(7
)
Operating Income
976
—
1,304
1,134
Other Income/(Expense)
Other income, net
6
5
46
19
Loss on debt extinguishment
(9
)
(10
)
(9
)
(10
)
Interest expense
(310
)
(148
)
(595
)
(311
)
Total other expense
(313
)
(153
)
(558
)
(302
)
Income/(Loss) Before Income Taxes
663
(153
)
746
832
Income tax expense/(benefit)
157
(49
)
115
186
Net Income/(Loss)
$
506
$
(104
)
$
631
$
646
Less: Cumulative dividends attributable to Series A Preferred Stock
17
17
34
34
Net Income/(Loss) Available for Common Stockholders
$
489
$
(121
)
$
597
$
612
Income/(Loss) per Share
Weighted average number of common shares outstanding — basic
211
196
209
197
Income/(Loss) per Weighted Average Common Share — Basic
$
2.32
$
(0.62
)
$
2.86
$
3.11
Weighted average number of common shares outstanding — diluted
212
196
210
203
Income/(Loss) per Weighted Average Common Share — Diluted
$
2.31
$
(0.62
)
$
2.84
$
3.01
NRG ENERGY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)
(Unaudited)
Three months ended June 30,
Six months ended June 30,
(In millions)
2026
2025
2026
2025
Net Income/(Loss)
$
506
$
(104
)
$
631
$
646
Other Comprehensive (Loss)/Income
Foreign currency translation adjustments
(3
)
13
(4
)
15
Defined benefit plans
—
1
(2
)
1
Other comprehensive (loss)/income
(3
)
14
(6
)
16
Comprehensive Income/(Loss)
$
503
$
(90
)
$
625
$
662
NRG ENERGY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
June 30, 2026
December 31, 2025
(In millions, except share data)
(Unaudited)
(Audited)
ASSETS
Current Assets
Cash and cash equivalents
$
162
$
4,708
Funds deposited by counterparties
167
260
Restricted cash
50
30
Accounts receivable, net
3,534
4,065
Inventory
793
461
Derivative instruments
3,188
2,189
Cash collateral paid in support of energy risk management activities
441
365
Prepayments and other current assets
1,318
1,069
Total current assets
9,653
13,147
Property, plant and equipment, net
14,076
3,632
Other Assets
Operating lease right-of-use assets, net
142
130
Goodwill
8,815
5,017
Customer relationships, net
1,177
1,203
Other intangible assets, net
963
1,106
Derivative instruments
1,617
1,568
Deferred income taxes
1,725
1,843
Other non-current assets
1,772
1,494
Total other assets
16,211
12,361
Total Assets
$
39,940
$
29,140
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities
Current portion of long-term debt and finance leases
$
1,512
$
31
Current portion of operating lease liabilities
41
35
Accounts payable
2,579
2,834
Derivative instruments
3,120
2,257
Cash collateral received in support of energy risk management activities
167
260
Deferred revenue current
837
748
Accrued expenses and other current liabilities
1,719
1,864
Total current liabilities
9,975
8,029
Other Liabilities
Long-term debt and finance leases
21,744
16,412
Non-current operating lease liabilities
170
144
Derivative instruments
1,327
1,103
Deferred income taxes
15
15
Deferred revenue non-current
984
895
Other non-current liabilities
870
861
Total other liabilities
25,110
19,430
Total Liabilities
35,085
27,459
Commitments and Contingencies
Stockholders’ Equity
Preferred stock; 10,000,000 shares authorized; 650,000 Series A shares issued and outstanding at June 30, 2026 and December 31, 2025, aggregate liquidation preference of $650; at June 30, 2026 and December 31, 2025
650
650
Common stock; $0.01 par value; 500,000,000 shares authorized; 225,198,900 and 199,828,615 shares issued and 210,307,902 and 190,376,607 shares outstanding at June 30, 2026 and December 31, 2025, respectively
2
2
Additional paid-in-capital
3,880
215
Retained earnings
2,374
1,982
Treasury stock, at cost; 14,890,998 shares and 9,452,008 shares at June 30, 2026, and December 31, 2025, respectively
(1,964
)
(1,087
)
Accumulated other comprehensive loss
(87
)
(81
)
Total Stockholders’ Equity
4,855
1,681
Total Liabilities and Stockholders’ Equity
$
39,940
$
29,140
NRG ENERGY, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Six months ended June 30,
(In millions)
2026
2025
Cash Flows from Operating Activities
Net income
$
631
$
646
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation of property, plant and equipment and amortization of customer relationships and other intangible assets
602
444
Amortization of capitalized contract costs
324
226
Accretion of asset retirement obligations
17
20
Provision for credit losses
104
113
Amortization of financing costs and debt discounts/premiums
10
13
Loss on debt extinguishment
9
10
Amortization of in-the-money contracts and emissions allowances
47
51
Amortization of unearned equity compensation
72
62
Net (gain)/loss on sale of assets and disposal of assets
(38
)
10
Gain on proceeds from insurance recoveries for Property, plant and equipment, net
—
(100
)
Changes in derivative instruments
(61
)
18
Changes in current and deferred income taxes and liability for uncertain tax benefits
(33
)
126
Changes in collateral deposits in support of risk management activities
14
197
Changes in other working capital:
Accounts receivable, net
910
(17
)
Inventory
(156
)
16
Prepayments and other current assets
(441
)
(368
)
Accounts payable
(780
)
(39
)
Accrued expenses and other current liabilities
(164
)
(120
)
Other assets and liabilities
(119
)
(2
)
Cash provided by operating activities
$
948
$
1,306
Cash Flows from Investing Activities
Payments for acquisitions of businesses and assets, net of cash acquired
$
(7,101
)
$
(586
)
Capital expenditures
(655
)
(595
)
Proceeds from sales of assets, net
44
6
Purchases of emissions allowances
(41
)
(10
)
Sales of emissions allowances
44
3
Proceeds from insurance recoveries for Property, plant and equipment, net
—
100
Cash used in investing activities
$
(7,709
)
$
(1,082
)
Cash Flows from Financing Activities
Equivalent shares purchased in lieu of tax withholdings
$
(99
)
$
(77
)
Payments for share repurchase activity and excise tax
(931
)
(603
)
Payments of dividends to preferred and common stockholders
(235
)
(207
)
Proceeds from issuance of long-term debt
3,652
—
Repayments of long-term debt and finance leases
(1,619
)
(10
)
Payments for debt extinguishment costs
(9
)
—
Payments of deferred financing costs
(84
)
(31
)
Net receipts from settlement of acquired derivatives that include financing elements
16
38
Proceeds from credit facilities
8,675
865
Repayments to credit facilities
(7,226
)
(730
)
Cash provided by/(used in) financing activities
$
2,140
$
(755
)
Effect of exchange rate changes on cash and cash equivalents
2
1
Net Decrease in Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash
(4,619
)
(530
)
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at Beginning of Period
4,998
1,173
Cash and Cash Equivalents, Funds Deposited by Counterparties and Restricted Cash at End of Period
$
379
$
643
Appendix Table A-1: Second Quarter 2026 Adjusted EBITDA and Adjusted Net Income Reconciliation by Operating Segment and Consolidated Adjusted EPS Reconciliation
The following table summarizes the calculation of Adjusted EBITDA, Adjusted Net Income and Adjusted EPS and provides a reconciliation from Net Income/(Loss) Available for Common Stockholders:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Earnings
Per
Share,
Basic 6, 7
Earnings
Per
Share,
Diluted 6, 7
Net Income/(Loss) Available for Common Stockholders
$
289
$
506
$
155
$
71
$
(532
)
$
489
$
2.32
$
2.31
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
17
17
0.08
0.08
Net Income/(Loss)
$
289
$
506
$
155
$
71
$
(515
)
$
506
$
2.40
$
2.39
Plus:
Interest expense, net
—
—
—
—
305
305
1.45
1.44
Income tax expense
—
—
—
—
157
157
0.74
0.74
Loss on debt extinguishment
—
—
—
—
9
9
0.04
0.04
Depreciation and amortization
123
134
7
216
14
494
2.34
2.33
ARO expense
6
4
—
—
—
10
0.05
0.05
Contract and emission credit amortization, net
1
(10
)
1
—
—
(8
)
(0.04
)
(0.04
)
Stock-based compensation1
12
7
1
8
—
28
0.13
0.13
Acquisition and divestiture integration and transaction costs
—
—
—
—
16
16
0.08
0.08
Cost to achieve1
3
—
—
5
12
20
0.09
0.09
Deactivation costs
1
2
—
—
—
3
0.01
0.01
Loss/(gain) on sale of assets
—
6
(43
)
—
—
(37
)
(0.18
)
(0.17
)
Other and non-recurring charges
2
—
1
1
(1
)
3
0.01
0.01
Mark to market (MtM) (gain) on economic hedges2
(56
)
(180
)
(53
)
—
—
(289
)
(1.37
)
(1.36
)
Adjusted EBITDA
$
381
$
469
$
69
$
301
$
(3
)
$
1,217
$
5.77
$
5.74
Adjusted interest expense, net3
—
—
—
—
(313
)
(313
)
(1.48
)
(1.48
)
Depreciation and amortization
(123
)
(134
)
(7
)
(216
)
(14
)
(494
)
(2.34
)
(2.33
)
Adjusted Income before income taxes
258
335
62
85
(330
)
410
1.94
1.93
Adjusted income tax expense4
—
—
—
—
(78
)
(78
)
(0.37
)
(0.37
)
Adjusted Net Income before Preferred Stock dividends
258
335
62
85
(408
)
332
1.57
1.57
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(17
)
(17
)
(0.08
)
(0.08
)
Adjusted Net Income5
$
258
$
335
$
62
$
85
$
(425
)
$
315
$
1.49
$
1.49
1 Stock-based compensation of $1 million is reflected in cost to achieve. Stock-based compensation includes employee stock purchase plan expense
2 Gain of $(289) million was primarily driven by the reversal of previously recognized unrealized losses on contracts that settled during the period as well as an increase in the value of open positions in East as a result of increases in RGGI prices
3 Excludes mark-to-market gain on interest hedges of $8 million
4 Income tax calculated using Adjusted effective tax rate (ETR) on Adjusted Income before income taxes. Adjusted ETR includes impact of NRG’s tax credits as well as non-recurring tax items, using CAMT rate to accrue tax. Other adjustments are shown on pre-tax basis
5 Adjusted Net Income as shown here is 'Adjusted Net Income available for common stockholders'
6 Items may not sum due to rounding
7 Earnings per share amounts are based on weighted average number of common shares outstanding - basic of 211 million and on weighted average number of common shares outstanding - diluted of 212 million for the three months ended June 30, 2026
Second Quarter 2026 condensed financial information by Operating Segment:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Revenue1
$
2,747
$
3,484
$
644
$
587
$
(13
)
$
7,449
Cost of fuel, purchased power and other cost of sales2
1,886
2,682
538
60
(6
)
5,160
Economic gross margin
861
802
106
527
(7
)
2,289
Operations & maintenance and other cost of operations3
294
180
11
75
(1
)
559
Selling, marketing, general and administrative4
187
152
27
151
(2
)
515
Other
(1
)
1
(1
)
—
(1
)
(2
)
Adjusted EBITDA
$
381
$
469
$
69
$
301
$
(3
)
$
1,217
Adjusted interest expense, net5
—
—
—
—
(313
)
(313
)
Depreciation and amortization
(123
)
(134
)
(7
)
(216
)
(14
)
(494
)
Adjusted Income before income taxes
258
335
62
85
(330
)
410
Adjusted income tax expense5
—
—
—
—
(78
)
(78
)
Adjusted Net Income before Preferred Stock dividends
258
335
62
85
(408
)
332
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(17
)
(17
)
Adjusted Net Income5
$
258
$
335
$
62
$
85
$
(425
)
$
315
Weighted average number of common shares outstanding - basic
211
Adjusted EPS
$
1.49
1 Excludes MtM gain of $(18) million and contract amortization of $(14) million
2 Includes TDSP expense, capacity and emission credits
3 Excludes ARO expense of $10 million, deactivation costs of $3 million, stock-based compensation of $2 million and other and non-recurring charges of $1 million
4 Excludes stock-based compensation of $26 million, cost to achieve of $20 million and other and non-recurring charges of $1 million
5 See previous table for details
Appendix Table A-2: Second Quarter 2025 Adjusted EBITDA and Adjusted Net Income Reconciliation by Operating Segment and Consolidated Adjusted EPS Reconciliation
The following table summarizes the calculation of Adjusted EBITDA, Adjusted Net Income and Adjusted EPS and provides a reconciliation from Net Income/(Loss) Available for Common Stockholders:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Earnings
Per
Share,
Basic 8, 9
Earnings
Per
Share,
Diluted 8, 9
Net Income/(Loss) Available for Common Stockholders
$
381
$
(346
)
$
142
$
(115
)
$
(183
)
$
(121
)
$
(0.62
)
$
(0.62
)
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
17
17
0.09
0.09
Net Income/(Loss)
$
381
$
(346
)
$
142
$
(115
)
$
(166
)
$
(104
)
$
(0.53
)
$
(0.53
)
Plus:
Interest expense, net
—
—
—
—
141
141
0.72
0.70
Income tax (benefit)
—
—
—
—
(49
)
(49
)
(0.25
)
(0.24
)
Loss on debt extinguishment
—
—
—
—
10
10
0.05
0.05
Depreciation and amortization
93
36
9
195
11
344
1.76
1.70
ARO expense
14
16
—
—
—
30
0.15
0.15
Contract and emission credit amortization, net
3
(2
)
2
—
—
3
0.02
0.01
Stock-based compensation1
9
3
1
15
—
28
0.14
0.14
Acquisition and divestiture integration and transaction costs1
—
—
—
—
40
40
0.20
0.20
Cost to achieve
—
—
—
—
4
4
0.02
0.02
Deactivation costs
5
5
—
—
—
10
0.05
0.05
Other and non-recurring charges2
1
(1
)
3
164
2
169
0.86
0.84
Mark to market (MtM) loss/(gain) on economic hedges3
6
388
(111
)
—
—
283
1.44
1.40
Dilutive impact adjustment on Net (Loss) Available for Common Stockholders4
0.02
Adjusted EBITDA
$
512
$
99
$
46
$
259
$
(7
)
$
909
$
4.64
$
4.50
Adjusted interest expense, net5
—
—
—
—
(136
)
(136
)
(0.69
)
(0.67
)
Depreciation and amortization
(93
)
(36
)
(9
)
(195
)
(11
)
(344
)
(1.76
)
(1.70
)
Adjusted Income before income taxes
419
63
37
64
(154
)
429
2.19
2.12
Adjusted income tax expense6
—
—
—
—
(73
)
(73
)
(0.37
)
(0.36
)
Adjusted Net Income before Preferred Stock dividends
419
63
37
64
(227
)
356
1.82
1.76
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(17
)
(17
)
(0.09
)
(0.08
)
Adjusted Net Income7
$
419
$
63
$
37
$
64
$
(244
)
$
339
$
1.73
$
1.68
1 Stock-based compensation of $5 million is reflected in acquisition and divestiture integration and transaction costs. Stock-based compensation includes employee stock purchase plan expense
2 Includes $163 million of reserves for legal matters
3 Loss of $283 million was primarily driven by unrealized non-cash mark-to-market loss on economic hedges due to declines in forward natural gas and northeast power prices
4 Includes the potential dilutive impacts of the Convertible Senior Notes of 4 million shares and equity compensation of 2 million shares for the three months ended June 30, 2025. Under GAAP when there is a net loss, dilutive securities are not included in the diluted share count as they are anti-dilutive. As Adjusted Net Income is in an income position and not a loss position, this line item reflects the impact of the anti-dilutive securities as if they were dilutive
5 Excludes mark-to-market loss on interest hedges of $5 million
6 Income tax calculated using Adjusted ETR on Adjusted Income before income taxes. Adjusted ETR includes impact of NRG’s tax credits as well as non-recurring tax items, using CAMT rate to accrue tax. Other adjustments are shown on pre-tax basis
7 Adjusted Net Income as shown here is 'Adjusted Net Income available for common stockholders'
8 Items may not sum due to rounding
9 Earnings per share amounts are based on weighted average number of common shares outstanding - basic of 196 million and on weighted average number of common shares outstanding - diluted of 202 million as if they were dilutive for the three months ended June 30, 2025
Second Quarter 2025 condensed financial information by Operating Segment:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Revenue1
$
2,846
$
2,735
$
646
$
522
$
(8
)
$
6,741
Cost of fuel, purchased power and other cost of sales2
1,846
2,367
526
55
(2
)
4,792
Economic gross margin
1,000
368
120
467
(6
)
1,949
Operations & maintenance and other cost of operations3
284
121
42
61
2
510
Selling, marketing, general & administrative4
204
149
34
147
(1
)
533
Other
—
(1
)
(2
)
—
—
(3
)
Adjusted EBITDA
$
512
$
99
$
46
$
259
$
(7
)
$
909
Adjusted interest expense, net5
—
—
—
—
(136
)
(136
)
Depreciation and amortization
(93
)
(36
)
(9
)
(195
)
(11
)
(344
)
Adjusted Income before income taxes
419
63
37
64
(154
)
429
Adjusted income tax expense5
—
—
—
—
(73
)
(73
)
Adjusted Net Income before Preferred Stock dividends
419
63
37
64
(227
)
356
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(17
)
(17
)
Adjusted Net Income5
$
419
$
63
$
37
$
64
$
(244
)
$
339
Weighted average number of common shares outstanding - basic
196
Adjusted EPS
$
1.73
1 Excludes MtM loss of $1 million
2 Includes TDSP expense, capacity and emission credits
3 Excludes ARO expense of $30 million, deactivation costs of $10 million and stock-based compensation of $2 million
4 Excludes other and non-recurring charges of $164 million, stock-based compensation of $26 million, cost to achieve of $4 million and acquisition and divestiture integration and transaction costs of $(3) million
5 See previous table for details
Appendix Table A-3: YTD Second Quarter 2026 Adjusted EBITDA and Adjusted Net Income Reconciliation by Operating Segment and Consolidated Adjusted EPS Reconciliation
The following table summarizes the calculation of Adjusted EBITDA, Adjusted Net Income and Adjusted EPS and provides a reconciliation from Net Income/(Loss) Available for Common Stockholders:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Earnings
Per
Share,
Basic 6,7
Earnings
Per
Share,
Diluted 6,7
Net Income/(Loss) Available for common stockholders
$
318
$
744
$
200
$
146
$
(811
)
$
597
$
2.86
$
2.84
Cumulative Dividends attributable to Series A Preferred Stock
—
—
—
—
34
34
0.16
0.16
Net Income/(Loss)
$
318
$
744
$
200
$
146
$
(777
)
$
631
$
3.02
$
3.00
Plus:
Interest expense, net
—
—
—
—
546
546
2.61
2.60
Income tax expense
—
—
—
—
115
115
0.55
0.55
Loss on debt extinguishment
—
—
—
—
9
9
0.04
0.04
Depreciation and amortization
231
236
15
416
28
926
4.43
4.41
ARO expense
9
8
—
—
—
17
0.08
0.08
Contract and emission credit amortization, net
3
(2
)
2
—
—
3
0.01
0.01
Stock-based compensation1
33
18
2
18
—
71
0.34
0.34
Acquisition and divestiture integration and transaction costs
—
—
—
—
61
61
0.29
0.29
Cost to achieve1
5
—
—
11
13
29
0.14
0.14
Deactivation costs
1
3
—
—
—
4
0.02
0.02
Loss/(gain) on sale of assets
—
6
(43
)
—
—
(37
)
(0.18
)
(0.18
)
Other and non-recurring charges
2
—
—
4
—
6
0.03
0.03
Mark to market (MtM) (gain)/loss on economic hedges2
(5
)
(80
)
1
—
—
(84
)
(0.40
)
(0.40
)
Adjusted EBITDA
$
597
$
933
$
177
$
595
$
(5
)
$
2,297
$
10.99
$
10.94
Adjusted Interest expense, net3
—
—
—
—
(560
)
(560
)
(2.68
)
(2.67
)
Depreciation and amortization
(231
)
(236
)
(15
)
(416
)
(28
)
(926
)
(4.43
)
(4.41
)
Adjusted Income before income taxes
366
697
162
179
(593
)
811
3.88
3.86
Adjusted income tax expense4
—
—
—
—
(154
)
(154
)
(0.74
)
(0.73
)
Adjusted Net Income before Preferred Stock dividends
366
697
162
179
(747
)
657
3.14
3.13
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(34
)
(34
)
(0.16
)
(0.16
)
Adjusted Net Income5
$
366
$
697
$
162
$
179
$
(781
)
$
623
$
2.98
$
2.97
1 Stock-based compensation of $1 million is reflected in cost to achieve. Stock-based compensation includes employee stock purchase plan expense
2 Gain of $(84) million was primarily driven by the reversal of previously recognized unrealized losses on contracts that settled during the period as well as an increase in the value of open positions in East as a result of increases in RGGI prices, partially offset by a decrease in the value of open positions in West/Other as a result of decreases in natural gas price and CAISO and Alberta power prices
3 Excludes mark-to-market gain on interest hedges of $14 million
4 Income tax calculated using Adjusted ETR on Adjusted Income before income taxes. Adjusted ETR includes impact of NRG’s tax credits as well as non-recurring tax items, using CAMT rate to accrue tax. Other adjustments are shown on pre-tax basis
5Adjusted Net Income as shown here is 'Adjusted Net Income available for common stockholders'
6 Items may not sum due to rounding
7 Earnings per share amounts are based on weighted average number of common shares outstanding - basic of 209 million and on weighted average number of common shares outstanding - diluted of 210 million for the six months ended June 30, 2026
YTD Second Quarter 2026 condensed financial information by Operating Segment:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Revenue1
$
5,140
$
9,954
$
1,508
$
1,165
$
(26
)
$
17,741
Cost of fuel, purchased power and other cost of sales2
3,594
8,353
1,249
112
(7
)
13,301
Economic gross margin
1,546
1,601
259
1,053
(19
)
4,440
Operations & maintenance and other cost of operations3
564
349
25
146
(1
)
1,083
Selling, general and administrative costs4
385
319
56
312
(11
)
1,061
Other
—
—
1
—
(2
)
(1
)
Adjusted EBITDA
$
597
$
933
$
177
$
595
$
(5
)
$
2,297
Adjusted interest expense, net5
—
—
—
—
(560
)
(560
)
Depreciation and amortization
(231
)
(236
)
(15
)
(416
)
(28
)
(926
)
Adjusted Income before income taxes
366
697
162
179
(593
)
811
Adjusted income tax expense5
—
—
—
—
(154
)
(154
)
Adjusted Net Income before Preferred Stock dividends
366
697
162
179
(747
)
657
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(34
)
(34
)
Adjusted Net Income5
$
366
$
697
$
162
$
179
$
(781
)
$
623
Weighted average number of common shares outstanding - basic
209
Adjusted EPS
$
2.98
1 Excludes MtM loss of $24 million and contract amortization of $(20) million
2 Includes TDSP expense, capacity and emission credits
3 Excludes ARO expense of $17 million, stock-based compensation of $7 million, deactivation costs of $4 million and other and non-recurring charges of $1 million
4 Excludes stock-based compensation of $64 million, cost to achieve of $29 million and other and non-recurring charges of $1 million
5 See previous table for details
Appendix Table A-4: YTD Second Quarter 2025 Adjusted EBITDA and Adjusted Net Income Reconciliation by Operating Segment and Consolidated Adjusted EPS Reconciliation
The following table summarizes the calculation of Adjusted EBITDA, Adjusted Net Income and Adjusted EPS and provides a reconciliation from Net Income/(Loss) Available for Common Stockholders:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Earnings
Per
Share,
Basic 7, 8
Earnings
Per
Share,
Diluted 7, 8
Net Income/(Loss) Available for Common Stockholders
$
718
$
359
$
208
$
(61
)
$
(612
)
$
612
$
3.11
$
3.01
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
34
34
0.17
0.17
Net Income/(Loss)
$
718
$
359
$
208
$
(61
)
$
(578
)
$
646
$
3.28
$
3.18
Plus:
Interest expense, net
—
—
—
—
290
290
1.47
1.43
Income tax expense
—
—
—
—
186
186
0.94
0.92
Loss on debt extinguishment
—
—
—
—
10
10
0.05
0.05
Depreciation and amortization
176
73
18
381
22
670
3.40
3.30
ARO expense
18
2
—
—
—
20
0.10
0.10
Contract and emission credit amortization, net
4
27
2
—
—
33
0.17
0.16
Stock-based compensation1
18
7
2
28
—
55
0.28
0.27
Acquisition and divestiture integration and transaction costs1
—
—
—
1
50
51
0.26
0.25
Cost to achieve1
—
—
—
—
7
7
0.04
0.03
Deactivation costs
8
7
—
—
—
15
0.08
0.07
Loss on sale of assets
—
—
7
—
—
7
0.04
0.03
Other and non-recurring charges2
(99
)
(1
)
4
190
(1
)
93
0.47
0.46
Mark to market (MtM) (gain)/loss on economic hedges3
(32
)
99
(115
)
—
—
(48
)
(0.24
)
(0.24
)
Adjusted EBITDA
$
811
$
573
$
126
$
539
$
(14
)
$
2,035
$
10.33
$
10.02
Adjusted interest expense, net4
—
—
—
—
(276
)
(276
)
(1.40
)
(1.36
)
Depreciation and amortization
(176
)
(73
)
(18
)
(381
)
(22
)
(670
)
(3.40
)
(3.30
)
Adjusted Income before income taxes
635
500
108
158
(312
)
1,089
5.53
5.36
Adjusted income tax expense5
—
—
—
—
(185
)
(185
)
(0.94
)
(0.91
)
Adjusted Net Income before Preferred Stock dividends
635
500
108
158
(497
)
904
4.59
4.45
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(34
)
(34
)
(0.17
)
(0.17
)
Adjusted Net Income6
$
635
$
500
$
108
$
158
$
(531
)
$
870
$
4.42
$
4.29
1 Stock-based compensation of $6 million is reflected in acquisition and divestiture integration and transaction costs and $1 million is reflected in cost to achieve. Stock-based compensation includes employee stock purchase plan expense
2 Includes $(100) million of property insurance proceeds and $180 million of reserves for legal matters
3 Gain of $(48) million was primarily driven by unrealized non-cash mark-to-market gains on economic hedges in Texas due to increases in ERCOT power prices
4 Excludes mark-to-market loss on interest hedges of $14 million
5 Income tax calculated using Adjusted ETR on Adjusted Income before income taxes. Adjusted ETR includes impact of NRG’s tax credits as well as non-recurring tax items, using CAMT rate to accrue tax. Other adjustments are shown on pre-tax basis
6 Adjusted Net Income as shown here is 'Adjusted Net Income available for common stockholders'
7 Items may not sum due to rounding
8 Earnings per share amounts are based on weighted average number of common shares outstanding - basic of 197 million and on weighted average number of common shares outstanding - diluted of 203 million for the six months ended June 30, 2025
YTD Second Quarter 2025 condensed financial information by Operating Segment:
(In millions, except per share amounts)
Texas
East
West/
Other
Vivint
Smart
Home
Corp/
Elim
Total
Revenue1
$
5,281
$
7,336
$
1,714
$
1,033
$
(18
)
$
15,346
Cost of fuel, purchased power and other cost of sales2
3,544
6,227
1,451
91
(5
)
11,308
Economic gross margin
1,737
1,109
263
942
(13
)
4,038
Operations & maintenance and other cost of operations3
526
252
76
123
1
978
Selling, marketing, general & administrative4
400
288
67
280
—
1,035
Other
—
(4
)
(6
)
—
—
(10
)
Adjusted EBITDA
$
811
$
573
$
126
$
539
$
(14
)
$
2,035
Adjusted interest expense, net5
—
—
—
—
(276
)
(276
)
Depreciation and amortization
(176
)
(73
)
(18
)
(381
)
(22
)
(670
)
Adjusted Income before income taxes
635
500
108
158
(312
)
1,089
Adjusted income tax expense5
—
—
—
—
(185
)
(185
)
Adjusted Net Income before Preferred Stock dividends
635
500
108
158
(497
)
904
Cumulative dividends attributable to Series A Preferred Stock
—
—
—
—
(34
)
(34
)
Adjusted Net Income5
$
635
$
500
$
108
$
158
$
(531
)
$
870
Weighted average number of common shares outstanding - basic
197
Adjusted EPS
$
4.42
1 Excludes MtM loss of $16 million and contract amortization of $5 million
2 Includes TDSP expense, capacity and emission credits
3 Excludes ARO expense of $20 million, deactivation costs of $15 million, stock-based compensation of $4 million and other and non-recurring charges of $(99) million
4 Excludes other and non-recurring charges of $180 million, stock-based compensation of $51 million and cost to achieve of $7 million
5 See previous table for details
Appendix Table A-5: Three Months Ended June 30, 2026 and 2025 Free Cash Flow before Growth Investments (FCFbG)
The following table summarizes the calculation of FCFbG providing a reconciliation from Adjusted EBITDA and Cash provided by operating activities:
Three Months Ended
(In millions)
6/30/2026
6/30/2025
Adjusted EBITDA
$
1,217
$
909
Interest payments, net
(221
)
(103
)
Income tax payments
(44
)
(53
)
Gross capitalized contract costs
(387
)
(311
)
Collateral/working capital/other assets and liabilities
552
9
Cash provided by operating activities
1,117
451
Net (payments)/receipts from settlement of acquired derivatives that include financing elements
(3
)
13
Acquisition and divestiture integration and transaction costs1
38
29
Adjustment for change in collateral
(156
)
426
Other2
34
1
Adjusted cash provided by operating activities
1,030
920
Maintenance capital expenditures, net
(79
)
(67
)
Environmental capital expenditures
(8
)
(14
)
Cost of acquisition
82
75
Free Cash Flow before Growth Investments (FCFbG)
$
1,025
$
914
1 Three months ended 6/30/26 includes $16 million from acquisition and divestiture integration and transaction costs and $20 million cost to achieve payments (see Appendix table A-1), plus $2 million cash payments accrued in prior quarter; three months ended 6/30/25 includes $40 million from acquisition and divestiture integration and transaction costs and $4 million cost to achieve payments (see Appendix table A-2), less $15 million non-cash acquisition costs and non-cash stock-based compensation
2 Three months ended 6/30/26 includes a $15 million payment for a legal matter
Appendix Table A-6: Six Months Ended June 30, 2026 and 2025 Free Cash Flow before Growth Investments (FCFbG)
The following table summarizes the calculation of FCFbG providing a reconciliation from Adjusted EBITDA and Cash provided by operating activities:
Six Months Ended
(In millions)
6/30/2026
6/30/2025
Adjusted EBITDA
$
2,297
$
2,035
Interest payments, net
(403
)
(241
)
Income tax payments
(73
)
(60
)
Gross capitalized contract costs
(587
)
(486
)
Collateral/working capital/other assets and liabilities
(286
)
58
Cash provided by operating activities
948
1,306
Net receipts from settlement of acquired derivatives that include financing elements
16
38
Acquisition and divestiture integration and transaction costs1
90
41
Adjustment for change in collateral
(14
)
(197
)
Other2
13
4
Adjusted cash provided by operating activities
1,053
1,192
Maintenance capital expenditures, net3
(173
)
(52
)
Environmental capital expenditures
(13
)
(19
)
Cost of acquisition
92
86
Free Cash Flow before Growth Investments (FCFbG)
$
959
$
1,207
1 Six months ended 6/30/26 includes from Table A-3 $61 million acquisition and divestiture integration and transaction costs, $29 million cost to achieve payments; Six months ended 6/30/25 includes from Table A-4 $51 million acquisition and divestiture integration and transaction costs, $7 million cost to achieve payments, excludes $17 million non-cash acquisition costs and non-cash stock-based compensation
2 Six months ended 6/30/26 includes a $15 million payment for a legal matter
3 Six months ended 6/30/25 is presented net of W.A. Parish Unit 8 insurance recoveries related to property, plant and equipment of $100 million
Appendix Table A-7: Six Months Ended June 30, 2026 Sources and Uses of Liquidity
The following table summarizes the sources and uses of liquidity for the six months ended June 30, 2026:
(In millions)
Six months ended June 30, 2026
Sources:
Adjusted cash provided by operating activities
$
1,053
Proceeds from credit facilities
8,675
Proceeds from issuance of long-term debt
3,652
Change in availability under revolving credit facility and collective collateral facilities
178
Cash collateral paid in support of energy risk management activities
108
Proceeds from sales of assets, net
44
Sales of emissions allowances
44
Uses:
Repayments to credit facilities
(7,226
)
Payments for acquisitions of businesses and assets, net of cash acquired
(7,101
)
Repayments of long-term debt and finance leases
(1,619
)
Payments for share repurchase activity and excise tax
(931
)
Investments and integration capital expenditures
(469
)
Payments of dividends to preferred and common stockholders
(235
)
Maintenance and environmental capital expenditures
(186
)
Equivalent shares purchased in lieu of tax withholdings
(99
)
Acquisition and divestiture integration and transaction costs1
(90
)
Payments of deferred financing costs
(84
)
Purchases of emissions allowances
(41
)
Payments for debt extinguishment costs
(9
)
Other
(12
)
Change in Total Liquidity
(4,348
)
1 Six months ended 6/30/26 includes from Table A-3 $61 million acquisition and divestiture integration and transaction costs, $29 million cost to achieve payments
Appendix Table A-8: 2026 Guidance Reconciliation
The following table summarizes the 2026 Guidance calculations of Adjusted EBITDA, Adjusted Net Income and Adjusted EPS and provides a reconciliation from Net Income:
2026
(In millions, except per share amounts)
Guidance8,9
Net Income1
$1,325 - $1,755
Interest expense, net
1,195
Income tax expense2
490 - 560
Depreciation and amortization3
1,955
ARO expense
30
Stock-based compensation
120
Acquisition and divestiture integration and transaction costs
110
Other4
100
Adjusted EBITDA
$5,325 - $5,825
Adjusted interest expense, net5
(1,195)
Depreciation and amortization3
(1,955)
Adjusted Income before income taxes
$2,175 - $2,675
Adjusted income tax expense6
(423) - (493)
Adjusted Net Income before Preferred Stock dividends
$1,752 - $2,182
Cumulative dividends attributable to Series A Preferred Stock
(67)
Adjusted Net Income7
$1,685 - $2,115
Weighted average number of common shares outstanding - basic
214
Adjusted EPS
$7.90 - $9.90
1 The Company does not guide to Net Income due to the impact of fair value adjustments related to derivatives in a given year. For purposes of guidance, fair value adjustments related to derivatives are assumed to be zero
2 Represents anticipated GAAP income tax
3 Estimates for the acquired LS Power assets are provisional and subject to revisions until evaluations are completed to assess the fair value of long-lived assets
4 Includes adjustments for sale of assets, deactivation costs, and other and non-recurring charges
5 Excludes mark-to-market gains/losses on interest hedges
6 Income tax calculated using Adjusted ETR on Adjusted Income before income taxes. Adjusted ETR includes impact of NRG’s tax credits as well as non-recurring tax items, using CAMT rate to accrue tax. Other adjustments are shown on pre-tax basis
7 Adjusted Net Income as shown here is 'Adjusted Net Income available for common stockholders'
8 Items may not sum due to rounding
9 Includes 11 months of ownership of the portfolio acquired from LS Power
Appendix Table A-9: 2026 Guidance Reconciliation
The following table summarizes the calculation of FCFbG providing a reconciliation from Adjusted EBITDA and Cash provided by operating activities:
2026
(In millions)
Guidance4,5
Adjusted EBITDA
$5,325 - $5,825
Interest payments, net1
(1,100)
Income tax payments
(70) - (90)
Gross capitalized contract costs
(1,020)
Working capital/other assets and liabilities2
(135)
Cash provided by operating activities3
$3,000 - $3,480
Acquisition and other costs2
110
Adjusted cash provided by operating activities
$3,110 - $3,590
Maintenance capital expenditures
(450) - (480)
Environmental capital expenditures
(10) - (20)
Cost of acquisition
180
Free Cash Flow before Growth Investments (FCFbG)
$2,800 - $3,300
1 Interest payments, net represents Interest expense, net of $(1,195) million on Appendix table A-8 plus $95 million accrued interest expense not yet paid
2 Working capital/other assets and liabilities includes payments for Acquisition and divestiture integration and transaction costs, which is adjusted in Acquisition and other costs, and includes net deferred revenues
3 Excludes fair value adjustments related to derivatives and changes in collateral deposits in support of risk management activities
4 Items may not sum due to rounding
5 Includes 11 months of ownership of the portfolio acquired from LS Power
Non-GAAP Financial Measures
NRG reports its financial results in accordance with the accounting principles generally accepted in the United States (GAAP) and supplements with certain non-GAAP financial measures. These measures are not recognized in accordance with GAAP and should not be viewed in isolation or as an alternative to GAAP measures of performance. In addition, other companies may calculate non-GAAP financial measures differently than NRG does, limiting their usefulness as a comparative measure.
NRG uses the following non-GAAP measures to provide additional insight into financial performance:
Adjusted EBITDA: Defined as EBITDA (earnings before interest, taxes, depreciation, and amortization, impact of asset retirement obligation expenses and contract amortization consisting of amortization of power and fuel contracts and amortization of emission allowances) with further adjustments for stock-based compensation, impairment losses, deactivation costs, gains or losses on sales, dispositions or retirements of assets, any mark-to-market gains or losses from forward position of economic hedges, gains or losses on the repurchase, modification or extinguishment of debt, restructuring costs, and other non-recurring items plus adjustments to reflect the Adjusted EBITDA from our unconsolidated investments or non-controlling interests. Adjusted EBITDA is intended to facilitate period-to-period comparisons and is widely used by investors for performance assessment. Adjusted Net Income: Defined as net income available to common shareholders excluding the impact of asset retirement obligation expenses, contract amortization consisting of amortization of power and fuel contracts and amortization of emission allowances, stock-based compensation, impairment losses, deactivation costs, gains or losses on sales, dispositions or retirements of assets, any mark-to-market gains or losses from forward position of economic hedges, gains or losses on the repurchase, modification or extinguishment of debt, the impact of restructuring and any extraordinary, unusual or non-recurring items plus adjustments to reflect the Adjusted EBITDA from our unconsolidated investments and non-controlling interests. Adjusted Earnings per Share (EPS): Defined as Adjusted Net Income, divided by the average basic common shares outstanding. Adjusted Cash Provided/(Used) by Operating Activities: Defined as cash provided/(used) by operating activities with the reclassification of net payments of derivative contracts acquired in business combinations from financing to operating cash flow, as well as the add back of merger, integration, related restructuring costs, adjustment for change in collateral, and the impact of extraordinary, unusual or non-recurring items. Free Cash Flow before Growth Investments: Defined as Adjusted Cash provided/(used) by operating activities less maintenance and environmental capital expenditures, net of funding and insurance recoveries related to property, plant and equipment, and adjustments to exclude cost of acquisition related to growth. Management believes these non-GAAP financial measures are useful to investors and other users of NRG's financial statements in evaluating the Company’s operating performance and growth, as well as the impact of the Company’s capital allocation program. They provide an additional tool to compare business performance across periods and adjust for items that management does not consider indicative of NRG’s future operating performance. Management uses these non-GAAP financial measures to assist in comparing financial performance from period to period on a consistent basis and to readily view operating trends, as a measure for planning and forecasting overall expectations, and for evaluating actual results against such expectations, and in communications with NRG's Board of Directors, shareholders, creditors, analysts and investors concerning its financial performance.
Energizer Holdings vykázala ve 3. fiskálním čtvrtletí tržby ve výši 734,1 mil. USD, meziročně o 1,2 % více, a upravený zisk na akcii 0,75 USD. Zároveň snížila celoroční výhled upraveného EPS i Adjusted EBITDA na spodní hranici původního rozpětí.
Net sales of $734.1 million, +1.2% to prior year and +2.7% organic increase(1) Gross Margin of 38.2% and 39.2% on an adjusted basis(1) Earnings per share of $0.58 & Adjusted Earnings per share of $0.75(1) Updating fiscal year outlook for Adjusted Earnings per share and Adjusted EBITDA to the low end of the originally provided ranges(1) , /PRNewswire/ -- Energizer Holdings, Inc. (NYSE: ENR) today announced results for the third fiscal quarter ended June 30, 2026.
"We delivered a solid third quarter in an operating environment that remains dynamic, with organic Net sales growth across both segments and continued progress against the strategic priorities we outlined at the beginning of the year," said Mark LaVigne, Chief Executive Officer. "The actions we have taken to strengthen the business are improving our execution, enhancing the quality of our portfolio, and reinforcing our competitive position."
"At the core of our investment thesis is a resilient business capable of generating strong free cash flow across a range of operating environments. We believe that durable cash generation, combined with disciplined capital allocation, provides a compelling path to long-term shareholder value creation."
Top-Line Performance
For the quarter, we had Net sales of $734.1 million compared to $725.3 million in the prior year period.
Third Quarter
% Chg
Net sales - FY'25
$ 725.3
Organic
19.7
2.7 %
Acquisition impact
(17.2)
(2.4) %
Change in highly inflationary markets
(0.9)
(0.1) %
Impact of currency
7.2
1.0 %
Net sales - FY'26
$ 734.1
1.2 %
_______________
1) See Press Release attachments and supplemental schedules for additional information, including the GAAP and Non-GAAP reconciliations.
Organic Net sales increased 2.7% primarily due to the following items:
Global distribution gains and new product development in Batteries & Lights drove volume increases of 1.9%; and Auto care, primarily driven by higher refrigerant distribution in North America, contributed volume growth of 2.2%. Partially offsetting the volume improvement were pricing declines of 1.4% driven by increased promotional investments in the Batteries & Lights segment. Acquisition impact decreased net sales 2.4%. The Company completed the Advanced Power Solutions (APS) acquisition on May 2, 2025 and sold batteries under an acquired brand license from the acquisition date through December 31, 2025. The expiration of the acquired license resulted in a decline of net sales under the licensed brands of $17.2 million with ongoing revenue generated from the transition to legacy brands reported as a component of organic revenue.
Gross Margin
Gross margin percentage on a reported basis was 38.2% versus 55.1% in the prior year. During the prior year quarter, the Company recorded an estimated $112.4 million of production credits related to battery production in our U.S. facilities. The amount related to FY25 production was $33.9 million and an additional $78.5 million was recorded for production retroactive to the start of the production credit period of January 1, 2023.
Excluding the estimated FY23 & FY24 production credits of $78.5 million recorded in the prior year quarter, restructuring and related costs in the current and prior year of $7.5 million and $2.9 million, respectively, and the prior year network transition costs of $0.9 million, Adjusted Gross margin was 39.2% compared to 44.8% in the prior year, a decrease of 560 basis points.(1)
Third Quarter
Gross margin - FY25 Reported
55.1 %
Prior year impact of restructuring and related costs, network transition costs and FY23 & FY24 production credits
(10.3) %
Gross margin - FY25 Adjusted(1)
44.8 %
Production credit impact for Q1 and Q2 FY25 recorded in Q3 FY25
(3.6) %
Product mix
(1.4) %
Pricing
(0.8) %
All other, including currency impacts
0.2 %
Gross margin - FY26 Adjusted(1)
39.2 %
Current year impact of restructuring and related costs
(1.0) %
Gross margin - FY26 Reported
38.2 %
The third quarter prior year Adjusted Gross margin included the first three quarters of FY25 production credit of $33.9 million, which included $7.2 million for the third quarter FY25 production and an additional $26.7 million of production credit from prior quarters production. The current year adjusted gross margin was further impacted by unfavorable product mix and increased promotional investment in the quarter compared to the prior year. (1)
Selling, General and Administrative Expense (SG&A)
SG&A, excluding restructuring and acquisition costs, was 16.6% of Net sales for the third quarter, or $122.1 million, compared to 17.0%, or $123.6 million in the prior year. The year-over-year dollar decrease was primarily driven by Project Momentum savings of approximately $8 million and lower stock compensation expense in the current quarter. The decrease was partially offset by increased legal fees.(1)
Advertising and Promotion Expense (A&P)
A&P expense decreased $1.7 million for the third fiscal quarter to 5.7% of Net sales, compared to 6.0% in the prior year.
Earnings Per Share and Adjusted EBITDA
Third Quarter
(In millions, except per share data)
2026
2025
Net earnings
$ 39.9
$ 153.5
Diluted net earnings per common share
$ 0.58
$ 2.13
Adjusted Net earnings(1)
$ 51.6
$ 81.5
Adjusted Diluted net earnings per common share(1)
$ 0.75
$ 1.13
Adjusted Diluted net earnings per common share excluding out of period production credits(1)
$ 0.75
$ 0.85
Adjusted EBITDA(1)
$ 138.7
$ 171.4
Adjusted EBITDA excluding out of period production credits(1)
$ 138.7
$ 151.8
Currency neutral Adjusted Diluted net earnings per common share(1)
$ 0.73
Currency neutral Adjusted EBITDA(1)
$ 136.7
Net earnings, Earnings per share, Adjusted Earnings per share and Adjusted EBITDA were impacted by unfavorable product mix and increased promotional investment which resulted in lower Gross margin in the current period. These impacts were partially offset by the decline in SG&A and lower A&P and R&D spending the current period.
Free cash flow and Capital allocation
Operating cash flow for the nine months ended June 30, 2026 was $156.0 million, and Free cash flow was $105.0 million, or 4.9% of Net sales. Dividend payments in the quarter were $20.6 million, or $0.30 per common share. Financial Outlook and Assumptions for Fiscal Year 2026(1)
Our outlook for fourth quarter earnings growth remains strong. Although we expect fourth quarter organic Net sales to be flat to down low single digits year-over-year, we expect Adjusted Earnings per share of $1.25 to $1.35, representing approximately 25% growth versus the prior year at the midpoint. This improvement reflects the cumulative impact of our productivity initiatives, supply chain optimization, and the actions we have taken to strengthen the profitability of the business over the course of the year.
For the full fiscal year, we now expect organic Net sales to be down low single digits resulting in Adjusted Earnings per share for the full year at the low end of the originally provided range of $3.30 to $3.60 and Adjusted EBITDA at the low end of the originally provided range of $580 to $610 million.
Webcast Information
In conjunction with this announcement, the Company will post prepared comments under the Investor/Events & Presentations section of the Company website around 7:00 a.m. Eastern Time today and will hold an investor conference call beginning at 10:00 a.m. Eastern Time today. The call will focus on third fiscal quarter earnings and recent trends in the business. All interested parties may access a live webcast of this conference call at www.energizerholdings.com, under "Investors" and "Events and Presentations" tabs or by using the following link:
https://app.webinar.net/m4QadBZde3B
For those unable to participate during the live webcast, a replay will be available on www.energizerholdings.com, under "Investors," "Events and Presentations," and "Past Events" tabs.
This document contains both historical and forward-looking statements. Forward-looking statements are not based on historical facts but instead reflect our expectations, estimates or projections concerning future results or events, including, without limitation, the future sales, gross margins, costs, earnings, cash flows, tax rates and performance of the Company. These statements generally can be identified by the use of forward-looking words or phrases such as "believe," "expect," "expectation," "anticipate," "may," "could," "will," "intend," "belief," "estimate," "plan," "target," "predict," "likely," "should," "forecast," "outlook," or other similar words or phrases. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause our actual results to differ materially from those indicated by those statements. We cannot assure you that any of our expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document and we disclaim any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Numerous factors could cause our actual results and events to differ materially from those expressed or implied by forward-looking statements, including, without limitation:
Global economic and financial market conditions beyond our control might materially and negatively impact us. Competition in our product categories might hinder our ability to execute our business strategy, achieve profitability, or maintain relationships with existing customers. Changes in the retail environment and consumer preferences could adversely affect our business, financial condition and results of operations. Loss or impairment of the reputation of our Company or our leading brands or failure of our marketing plans could have an adverse effect on our business. Loss of any of our principal customers could significantly decrease our sales and profitability. Our ability to meet our growth targets depends on successful product, marketing and operations innovation and successful responses to competitive innovation and changing consumer habits. We are subject to risks related to our international operations, including tariff and currency fluctuations, which could adversely affect our results of operations. We must successfully manage the demand, supply, and operational challenges brought on by any disease outbreak, including epidemics, pandemics, or similar widespread public health concerns. If we fail to protect our intellectual property rights, competitors may manufacture and market similar products, which could adversely affect our market share and results of operations. Changes in production costs, including raw material prices and transportation costs, from tariffs, inflation or otherwise, have adversely affected, and in the future could erode, our profit margins and negatively impact operating results. Our reliance on certain significant suppliers subjects us to numerous risks, including possible interruptions in supply, which could adversely affect our business. Our business is vulnerable to the availability of raw materials, as well as our ability to forecast customer demand and manage production capacity. The manufacturing facilities, supply channels or other business operations of the Company and our suppliers may be subject to disruption from events beyond our control. Our future results may be affected by our operational execution, including our ability to achieve cost savings as a result of any current or future restructuring efforts. If our goodwill and indefinite-lived intangible assets become impaired, we will be required to record impairment charges, which may be significant. Sales of certain of our products are seasonal and adverse weather conditions during our peak selling seasons for certain auto care products could have a material adverse effect. We may use artificial intelligence in our business, which could result in reputational harm, competitive harm, and legal liability, and adversely affect our operations. A failure of a key information technology system could adversely impact our ability to conduct business. We rely significantly on information technology and any inadequacy, interruption, theft or loss of data, malicious attack, integration failure, failure to maintain the security, confidentiality or privacy of sensitive data residing on our systems or other security failure of that technology could harm our ability to effectively operate our business and damage the reputation of our brands. We may not be able to attract, retain and develop key employees, as well as effectively manage human capital resources. We have significant debt obligations that could adversely affect our business. Our credit ratings are important to our cost of capital. We may experience losses or be subject to increased funding and expenses related to our pension plans. The estimates and assumptions on which our financial projections are based may prove to be inaccurate, which may cause our actual results to materially differ from our projections, which may adversely affect our future profitability, cash flows and stock price. If we pursue strategic acquisitions, divestitures or joint ventures, we might experience operating difficulties, dilution, and other consequences that may harm our business, financial condition, and operating results, and we may not be able to successfully consummate favorable transactions or successfully integrate acquired businesses. Our business involves the potential for product liability claims, labeling claims, commercial claims and other legal claims against us, which could affect our results of operations and financial condition and result in product recalls or withdrawals. Our business is subject to increasing government regulations in both the U.S. and abroad that could impose material costs. Section 45X of the Internal Revenue Code contains production tax credits for certain battery components. Our ability to benefit from Section 45X production tax credits is not guaranteed and is dependent upon the federal government's ongoing implementation, guidance, regulations, or rulemakings. Increased focus by governmental and non-governmental organizations, customers, consumers and shareholders on sustainability issues, including those related to climate change, may have an adverse effect on our business, financial condition and results of operations and damage our reputation. We are subject to environmental laws and regulations that may expose us to significant liabilities and have a material adverse effect on our results of operations and financial condition. We are subject to uncertainties regarding the IEEPA tariff refunds, including the timing of these refunds. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of any such forward-looking statements. The list of factors above is illustrative, but by no means exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Additional risks and uncertainties include those detailed from time to time in our publicly filed documents, including those described under the heading "Risk Factors" in our Form 10-K filed with the Securities and Exchange Commission on November 18, 2025 and Part II, Item 1A. "Risk Factors" of our subsequent Form 10-Q filings.
ENERGIZER HOLDINGS, INC.
CONSOLIDATED STATEMENT OF EARNINGS
(Condensed)
(In millions, except per share data - Unaudited)
For the Quarters Ended
June 30,
For the Nine Months Ended
June 30,
2026
2025
2026
2025
Net sales
$ 734.1
$ 725.3
$ 2,156.3
$ 2,119.9
Cost of products sold (1) (2) (3)
453.5
325.6
1,360.3
1,191.6
Gross profit
280.6
399.7
796.0
928.3
Selling, general and administrative expense (1)
129.3
128.3
411.7
395.6
Advertising and sales promotion expense
41.7
43.4
109.9
117.6
Research and development expense
7.4
8.2
22.8
24.3
Amortization of intangible assets
12.5
14.7
39.0
44.1
Interest expense
39.7
39.0
118.1
114.0
Loss on extinguishment/modification of debt
—
—
0.9
5.3
Other items, net (4)
0.2
1.9
26.9
(3.3)
Earnings before income taxes
49.8
164.2
66.7
230.7
Income tax provision
9.9
10.7
20.1
26.6
Net earnings
$ 39.9
$ 153.5
$ 46.6
$ 204.1
Basic net earnings per common share
$ 0.58
$ 2.16
$ 0.68
$ 2.84
Diluted net earnings per common share
$ 0.58
$ 2.13
$ 0.67
$ 2.80
Weighted average shares of common stock - Basic
68.5
71.2
68.5
71.8
Weighted average shares of common stock - Diluted
69.2
72.1
69.2
72.9
(1)
See the attached Supplemental Schedules - Non-GAAP Reconciliations, which break out the Restructuring and related costs, FY23 and FY24 production credits, Network transition costs, Acquisition and integration costs and a litigation matter included within these lines.
(2)
During the quarter and nine months ended June 30, 2026, the Company recorded a benefit to cost of goods sold of $16.5 and $64.1, respectively, for the estimated refund of the tariffs previously paid under IEEPA associated with sold inventory.
(3)
During the quarter ended June 30, 2025, the Company obtained reasonable assurance on the qualification of certain battery cell and manufacturing component production credits (production credits) eligibility under Section 45X of the Internal Revenue Code. Cost of products sold includes the estimated production credits recognized of $112.4 in the quarter and nine months ended June 30, 2025. This included $33.9 for the credits related to fiscal 2025 production and sales and an additional $78.5 retroactive adjustment to the beginning of the effective date of January 1, 2023. The Company recorded production credits of $15.1 and $36.5 in the quarter and nine months ended June 30, 2026, respectively.
(4)
During the three and nine months ended June 30, 2026, the Company recorded a non-cash settlement loss on the termination of the U.K. Pension plan of $0.2 and $26.3, respectively, within Other items, net.
ENERGIZER HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(Condensed)
(In millions - Unaudited)
Assets
June 30,
2026
September 30,
2025
Current assets
Cash and cash equivalents
$ 173.4
$ 236.2
Trade receivables
366.9
404.2
Inventories
747.8
781.2
Other current assets
311.7
257.5
Total current assets
$ 1,599.8
$ 1,679.1
Property, plant and equipment, net
384.6
403.0
Operating lease assets
89.9
93.2
Goodwill
1,048.5
1,051.2
Other intangible assets, net
966.7
1,005.5
Deferred tax assets
166.7
166.6
Other assets
209.8
158.1
Total assets
$ 4,466.0
$ 4,556.7
Liabilities and Shareholders' Equity
Current liabilities
Current maturities of long-term debt
$ 8.6
$ 8.6
Current portion of finance leases
1.6
1.5
Notes payable
30.5
13.7
Accounts payable
404.2
402.2
Current operating lease liabilities
12.6
16.2
Other current liabilities
314.7
352.8
Total current liabilities
$ 772.2
$ 795.0
Long-term debt
3,294.9
3,407.9
Operating lease liabilities
82.8
84.8
Deferred tax liabilities
11.5
6.1
Other liabilities
101.4
93.0
Total liabilities
$ 4,262.8
$ 4,386.8
Shareholders' equity
Common stock
0.8
0.8
Additional paid-in capital
598.4
603.5
Retained earnings
66.5
87.0
Treasury stock
(279.8)
(295.8)
Accumulated other comprehensive loss
(182.7)
(225.6)
Total shareholders' equity
$ 203.2
$ 169.9
Total liabilities and shareholders' equity
$ 4,466.0
$ 4,556.7
ENERGIZER HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Condensed)
(In millions - Unaudited)
For the Nine Months Ended
June 30,
2026
2025
Cash Flow from Operating Activities
Net earnings
$ 46.6
$ 204.1
Non-cash integration and restructuring charges
26.0
6.3
Depreciation and amortization
92.6
94.6
Production credits
7.8
(112.4)
IEEPA tariff refund receivable
(67.1)
—
Deferred income taxes
4.4
1.3
Share-based compensation expense
20.4
19.7
Settlement loss on U.K. pension plan termination
26.3
—
Loss on extinguishment of debt
0.9
1.1
Exchange loss/(gain) included in income
4.3
(1.4)
Non-cash items included in income, net
10.8
10.0
Other, net
(14.8)
(4.2)
Changes in current assets and liabilities used in operations
(2.2)
(133.5)
Net cash from operating activities
$ 156.0
$ 85.6
Cash Flow from Investing Activities
Capital expenditures
(52.1)
(69.1)
Proceeds from sale of assets
1.1
—
Acquisitions, net of cash acquired
—
(12.8)
Net cash used by investing activities
$ (51.0)
$ (81.9)
Cash Flow from Financing Activities
Cash proceeds from issuance of debt with original maturities greater than 90 days (1)
—
198.2
Payments on debt with maturities greater than 90 days (1)
(97.5)
(221.0)
Net increase in debt with original maturities of 90 days or less
15.5
118.4
Debt issuance costs
(1.5)
(8.0)
Payment of acquisition earn-out and indemnification hold back
(6.0)
(0.5)
Common stock purchased (inclusive of excise tax of $0.9)
(5.4)
(62.6)
Dividends paid on common stock
(64.5)
(66.6)
Taxes paid for withheld share-based payments
(8.1)
(7.7)
Net cash used by financing activities
$ (167.5)
$ (49.8)
Effect of exchange rate changes on cash
$ (0.3)
$ 0.3
Net decrease in cash, cash equivalents, and restricted cash
$ (62.8)
$ (45.8)
Cash, cash equivalents, and restricted cash, beginning of period
236.2
216.9
Cash, cash equivalents, and restricted cash, end of period
$ 173.4
$ 171.1
(1)
Represents cash inflows and outflows due to changes in term loan lender composition in the nine months ended June 30, 2025.
ENERGIZER HOLDINGS, INC.
Reconciliation of GAAP and Non-GAAP Measures
For the Quarter and Nine months ended June 30, 2026
The Company reports its financial results in accordance with accounting principles generally accepted in the U.S. ("GAAP"). However, management believes that certain non-GAAP financial measures provide users with additional meaningful comparisons to the corresponding historical or future period, and are used for management incentive compensation. These non-GAAP financial measures exclude items that are not reflective of the Company's on-going operating performance, such as restructuring and related costs, network transition costs, FY23 & FY24 production credits, acquisition and integration costs, a litigation matter, impairment of intangible assets, the settlement loss on the U.K. pension plan termination and the loss on extinguishment/modification of debt. In addition, these measures help investors to analyze year over year comparability when excluding currency fluctuations as well as other Company initiatives that are not on-going. We believe these non-GAAP financial measures are an enhancement to assist investors in understanding our business and in performing analysis consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or superior to, the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in methods and in the items being adjusted.
We provide the following non-GAAP measures and calculations, as well as the corresponding reconciliation to the closest GAAP measure in the following supplemental schedules:
Segment Profit. This amount represents the operations of our two reportable segments including allocations for shared support functions. General corporate and other expenses, amortization expense, interest expense, loss on extinguishment/modification of debt, other items, net, restructuring and related costs, network transition costs, FY23 & FY24 production credits, acquisition and integration costs and a litigation matter have all been excluded from segment profit.
Adjusted Net Earnings and Adjusted Diluted Net Earnings per Common Share (EPS). These measures exclude the impact of restructuring and related costs, network transition costs, FY23 & FY24 production credits, costs related to acquisition and integration, a litigation matter, the settlement loss on the U.K. pension plan termination and the loss on extinguishment/modification of debt.
Non-GAAP Tax Rate. This is the tax rate when excluding the pre-tax impact of restructuring and related costs, network transition costs, FY23 & FY24 production credits, costs related to acquisition and integration, a litigation matter, the settlement loss on the U.K. pension plan termination and the loss on extinguishment/modification of debt, as well as the related tax impact for these items, calculated utilizing the statutory rate for the jurisdictions where the impact was incurred.
Organic. This is the non-GAAP financial measurement of the change in Net sales or Segment profit that excludes or otherwise adjusts for the Acquisition impact, the Change in highly inflationary markets and impact of currency from the changes in foreign currency exchange rates as defined below:
Acquisition Impact. The Company completed the APS acquisition on May 2, 2025. These adjustments include the impact of the operations associated with the acquired branded battery business, as well as exiting the branded license. The Company sold batteries under an acquired brand license from the acquisition date through December 31, 2025, and then transitioned from the branded businesses to legacy brands. This does not include the impact of acquisition and integration costs associated with this acquisition.
Change in highly inflationary markets. The Company is presenting separately all changes in sales and segment profit from our Egypt and Argentina affiliates due to the designation of the economies as highly inflationary as of October 1, 2024 and July 1, 2018, respectively.
Impact of currency. The Company evaluates the operating performance of our Company on a currency neutral basis. The Impact of Currency is the change in foreign currency exchange rates year-over-year on reported results, which is calculated by comparing the value of current year foreign operations at the current period USD exchange rate versus the value of current year foreign operations at the prior period USD exchange rate. The impact of currency also includes (gains)/losses of currency hedging programs, and it excludes highly inflationary markets.
Adjusted Comparisons. Detail for Adjusted Gross profit, Adjusted Gross margin, adjusted SG&A, adjusted SG&A as percent of Net sales and Adjusted Other Items, net are also supplemental non-GAAP measure disclosures. These measures exclude the impact of restructuring and related costs, network transition costs, FY23 & FY24 production credits, acquisition and integration costs, a litigation matter and the settlement loss on the U.K. pension plan termination.
EBITDA and Adjusted EBITDA. EBITDA is defined as (loss)/earnings before Income tax provision, Interest expense, the Loss on extinguishment/modification of debt, and depreciation and amortization. Adjusted EBITDA further excludes the impact of the costs related to restructuring, network transition costs, acquisition and integration costs, the settlement loss on the U.K. pension plan termination, a litigation matter, FY23 & FY24 production credits, impairment of intangible assets, and share based payments.
Free Cash Flow. Free Cash Flow is defined as net cash provided by operating activities reduced by capital expenditures, net of the proceeds from asset sales.
Net Debt. Net Debt is defined as total Company debt, less Cash and cash equivalents.
Currency-neutral. Currency-neutral excludes the Impact of currency as defined above on key measures. Highly inflationary markets are excluded from this calculation.
ENERGIZER HOLDINGS, INC.
Reconciliation of GAAP and Non-GAAP Measures
For the Quarter and Nine months ended June 30, 2026
Operations for Energizer are managed via two product segments: Batteries & Lights and Auto Care. Energizer's operating model includes a combination of standalone and shared business functions between the product segments, varying by country and region of the world. Shared functions include the sales and marketing functions, as well as human resources, IT and finance shared service costs. Energizer applies a fully allocated cost basis, in which shared business functions are allocated between segments. Such allocations are estimates, and may not represent the costs of such services if performed on a standalone basis. Segment sales, significant expenses and profitability for the quarters and nine months ended June 30, 2026 and 2025 are presented below:
Quarters Ended June 30,
Batteries & Lights
Auto Care
Total
2026
2025
2026
2025
2026
2025
Segment Net sales
$ 524.2
$ 535.1
$ 209.9
$ 190.2
$ 734.1
$ 725.3
Segment Cost of products sold
301.6
279.3
144.4
121.0
446.0
400.3
Segment Advertising and promotion expense
24.3
23.4
17.4
20.0
41.7
43.4
Other segment items
70.4
73.6
27.4
25.1
97.8
98.7
Segment profit
$ 127.9
$ 158.8
$ 20.7
$ 24.1
$ 148.6
$ 182.9
Segment Depreciation and amortization
$ 13.5
$ 13.7
$ 3.9
$ 3.5
$ 17.4
$ 17.2
Nine Months Ended June 30,
Batteries & Lights
Auto Care
Total
2026
2025
2026
2025
2026
2025
Segment Net sales
$ 1,682.6
$ 1,655.5
$ 473.7
$ 464.4
$ 2,156.3
$ 2,119.9
Segment Cost of products sold
991.5
943.8
318.9
287.7
1310.4
1231.5
Segment Advertising and promotion expense
80.1
85.1
29.8
32.5
109.9
117.6
Other segment items
243.7
236.2
66.6
64.4
310.3
300.6
Segment profit
$ 367.3
$ 390.4
$ 58.4
$ 79.8
$ 425.7
$ 470.2
Segment Depreciation and amortization
$ 43.2
$ 40.6
$ 10.4
$ 9.9
$ 53.6
$ 50.5
Reconciliation of total Segment profit to Earnings before income taxes:
Quarters Ended June 30,
Nine Months Ended June 30,
2026
2025
2026
2025
Total segment profit
$ 148.6
$ 182.9
$ 425.7
$ 470.2
General corporate & other expenses (1)
(31.7)
(33.1)
(94.9)
(91.0)
Restructuring and related costs (2)
(14.4)
(8.0)
(76.8)
(45.9)
Network transition costs (3)
—
(0.9)
—
(17.6)
FY23 & FY24 production credits (4)
—
78.5
—
78.5
Acquisition and integration costs (2)
(0.3)
(1.3)
(2.4)
(4.8)
Litigation matter (5)
—
1.7
—
1.7
Amortization of intangible assets
(12.5)
(14.7)
(39.0)
(44.1)
Interest expense
(39.7)
(39.0)
(118.1)
(114.0)
Loss on extinguishment/modification of debt
—
—
(0.9)
(5.3)
Settlement loss on U.K. pension plan termination (6)
(0.2)
—
(26.3)
—
Other items, net - Adjusted (7)
—
(1.9)
(0.6)
3.0
Total earnings before income taxes
$ 49.8
$ 164.2
$ 66.7
$ 230.7
(1)
Recorded in SG&A on the Consolidated (Condensed) Statement of Earnings.
(2)
See the Supplemental Schedules - Non-GAAP Reconciliations for the line items where these charges are recorded in the Consolidated (Condensed) Statement of Earnings.
(3)
This represents incremental network transition costs, primarily related to freight and third-party packaging support, to maintain business continuity and service our customers as the Company decommissions certain facilities and relocates production and packaging lines as part of Project Momentum. These costs were recorded in Cost of products sold on the Consolidated (Condensed) Statement of Earnings.
(4)
This represents the estimated production credits retroactive to the start of the credit period through fiscal year 2024 and recorded in the prior fiscal year. These credits were recorded in Cost of products sold on the Consolidated (Condensed) Statement of Earnings
(5)
Litigation matter relates to an accrual adjustment recorded in SG&A on the Consolidated (Condensed) Statement of Earnings.
(6)
During the nine months ended June 30, 2026, the Company terminated the U.K. pension plan and recorded a non-cash settlement loss on the termination of the plan within Other items, Net.
(7)
See the Supplemental Non-GAAP reconciliation for the Other items, net reconciliation between the reported and adjusted balances.
Energizer Holdings, Inc.
Supplemental Schedules - GAAP EPS to Adjusted EPS Reconciliation
For the Quarter and Nine months ended June 30, 2026
(In millions, except per share data - Unaudited)
For the Quarters Ended
June 30,
For the Nine Months Ended
June 30,
2026
2025
2026
2025
Net earnings
$ 39.9
$ 153.5
$ 46.6
$ 204.1
Pre-tax adjustments
Restructuring and related costs (1)
14.4
8.0
76.8
45.9
Network transition costs (1)
—
0.9
—
17.6
Acquisition and integration (1)
0.3
1.3
2.4
4.8
FY23 & FY24 production credits (1)
—
(78.5)
—
(78.5)
Litigation matter (1)
—
(1.7)
—
(1.7)
Loss on extinguishment/modification of debt
—
—
0.9
5.3
Settlement loss on U. K. pension plan termination (1)
0.2
—
26.3
—
Total adjustments, pre-tax
$ 14.9
$ (70.0)
$ 106.4
$ (6.6)
Total adjustments, after tax (2)
$ 11.7
$ (72.0)
$ 91.4
$ (23.8)
Adjusted Net earnings (2)
$ 51.6
$ 81.5
$ 138.0
$ 180.3
Diluted net earnings per common share
$ 0.58
$ 2.13
$ 0.67
$ 2.80
Adjustments (per common share)
Restructuring and related costs
0.17
0.08
0.90
0.48
Network transition costs
—
0.01
—
0.19
Acquisition and integration
—
0.01
0.03
0.05
FY23 & FY24 production credits
—
(1.08)
—
(1.08)
Litigation matter
—
(0.02)
—
(0.02)
Loss on extinguishment/modification of debt
—
—
0.01
0.05
Settlement loss on U. K. pension plan termination
—
—
0.38
—
Adjusted Diluted net earnings per diluted common share
$ 0.75
$ 1.13
$ 1.99
$ 2.47
Weighted average shares of common stock - Diluted
69.2
72.1
69.2
72.9
Q1 and Q2 FY25 production credits, net (3)
—
(0.28)
Adjusted EPS excluding out of period production credits
$ 0.75
$ 0.85
(1)
See Supplemental Schedules - Non-GAAP Reconciliations for the line items where these costs are recorded on the Consolidated (Condensed) Statement of Earnings.
(2)
The effective tax rate for the Adjusted Net earnings and Adjusted Diluted EPS for the quarters ended June 30, 2026 and 2025 was 20.2% and 13.5%, respectively, and for the nine months ended June 30, 2026 and 2025 was 20.3% and 19.5%, respectively, as calculated utilizing the statutory rate for where the costs were incurred.
(3)
This measure further excludes the benefit of the Q1 and Q2 FY25 production credits, net of related compensation costs and tax impacts, recorded during Q3 FY25.
For the Quarter Ended
Prior
Quarter
Ended
June 30, 2026
% Change
% Change
As
Reported
Impact of
Currency(1)
Currency
Neutral
June 30,
2025
As
Reported
Basis
Currency
Neutral
Basis
As Reported under GAAP
Diluted net earnings per common share
$ 0.58
$ 0.02
$ 0.56
$ 2.13
(72.8) %
(73.7) %
Net earnings
$ 39.9
$ 1.6
$ 38.3
$ 153.5
(74.0) %
(75.0) %
As Adjusted (non-GAAP)(2)
Adjusted diluted net earnings per common share
$ 0.75
$ 0.02
$ 0.73
$ 1.13
(33.6) %
(35.4) %
Adjusted EBITDA
$ 138.7
$ 2.0
$ 136.7
$ 171.4
(19.1) %
(20.2) %
For the Nine Months Ended
Prior Nine
Months
Ended
June 30, 2026
% Change
% Change
As
Reported
Impact of
Currency(1)
Currency
Neutral
June 30,
2025
As
Reported
Basis
Currency
Neutral
Basis
As Reported under GAAP
Diluted net earnings per common share
$ 0.67
$ 0.12
$ 0.55
$ 2.80
(76.1) %
(80.4) %
Net earnings
$ 46.6
$ 8.3
$ 38.3
$ 204.1
(77.2) %
(81.2) %
As Adjusted (non-GAAP)(2)
Adjusted diluted net earnings per common share
$ 1.99
$ 0.12
$ 1.87
$ 2.47
(19.4) %
(24.3) %
Adjusted EBITDA
$ 404.2
$ 10.4
$ 393.8
$ 452.4
(10.7) %
(13.0) %
(1)
The Impact of Currency is the change in foreign currency exchange rates year-over-year on reported results, which is calculated by comparing the value of current year foreign operations at the current period USD exchange rate versus the value of current year foreign operations at the prior period USD exchange rate. The impact of currency also includes gains/(losses) of currency hedging programs, and it excludes highly inflationary markets.
(2)
See supplemental schedules - Non-GAAP Reconciliations for full reconciliations of the Company's non-GAAP adjusted amounts.
Energizer Holdings, Inc.
Supplemental Schedules - Segment Sales and Profit
For the Quarter and Nine Months Ended June 30, 2026
(In millions - Unaudited)
Net sales
Q1'26
% Chg
Q2'26
% Chg
Q3'26
% Chg
Nine
Months
'26
% Chg
Batteries & Lights
Net sales - prior year
$ 632.4
$ 488.0
$ 535.1
$ 1,655.5
Organic
(24.3)
(3.8) %
(28.8)
(5.9) %
1.6
0.3 %
$ (51.5)
(3.1) %
Acquisition impact
64.6
10.2 %
2.1
0.4 %
(17.2)
(3.2) %
$ 49.5
3.0 %
Change in highly inflationary markets
0.2
— %
(1.0)
(0.2) %
(0.9)
(0.2) %
$ (1.7)
(0.1) %
Impact of currency
12.3
1.9 %
12.9
2.7 %
5.6
1.1 %
$ 30.8
1.8 %
Net sales - current year
$ 685.2
8.3 %
$ 473.2
(3.0) %
$ 524.2
(2.0) %
$ 1,682.6
1.6 %
Auto Care
Net sales - prior year
$ 99.3
$ 174.9
$ 190.2
$ 464.4
Organic
(6.9)
(6.9) %
(7.8)
(4.5) %
18.1
9.5 %
$ 3.4
0.7 %
Change in highly inflationary markets
(0.1)
(0.1) %
(0.1)
(0.1) %
—
— %
$ (0.2)
— %
Impact of currency
1.4
1.4 %
3.1
1.9 %
1.6
0.9 %
$ 6.1
1.3 %
Net sales - current year
$ 93.7
(5.6) %
$ 170.1
(2.7) %
$ 209.9
10.4 %
$ 473.7
2.0 %
Total Net Sales
Net sales - prior year
$ 731.7
$ 662.9
$ 725.3
$ 2,119.9
Organic
(31.2)
(4.3) %
(36.6)
(5.5) %
19.7
2.7 %
(48.1)
(2.3) %
Acquisition impact
64.6
8.8 %
2.1
0.3 %
(17.2)
(2.4) %
49.5
2.3 %
Change in highly inflationary markets
0.1
— %
(1.1)
(0.2) %
(0.9)
(0.1) %
(1.9)
(0.1) %
Impact of currency
13.7
2.0 %
16.0
2.4 %
7.2
1.0 %
36.9
1.8 %
Net sales - current year
$ 778.9
6.5 %
$ 643.3
(3.0) %
$ 734.1
1.2 %
$ 2,156.3
1.7 %
Energizer Holdings, Inc.
Supplemental Schedules - Segment Sales and Profit
For the Quarter and Nine Months Ended June 30, 2026
(In millions - Unaudited)
Segment profit
Q1'26
% Chg
Q2'26
% Chg
Q3'26
% Chg
Nine
Months
'26
% Chg
Batteries & Lights
Segment profit - prior year
$ 119.3
$ 112.3
$ 158.8
$ 390.4
Organic
(23.0)
(19.3) %
21.7
19.3 %
(25.6)
(16.1) %
(26.9)
(6.9) %
Acquisition impact
5.3
4.4 %
(2.1)
(1.9) %
(5.1)
(3.2) %
(1.9)
(0.5) %
Change in highly inflationary markets
(0.1)
(0.1) %
—
— %
(1.5)
(0.9) %
(1.6)
(0.4) %
Impact of currency
4.2
3.6 %
1.8
1.7 %
1.3
0.7 %
7.3
1.9 %
Segment profit - current year
$ 105.7
(11.4) %
$ 133.7
19.1 %
$ 127.9
(19.5) %
$ 367.3
(5.9) %
Auto Care
Segment profit - prior year
$ 20.5
$ 35.2
$ 24.1
$ 79.8
Organic
(12.1)
(59.0) %
(8.1)
(23.0) %
(4.4)
(18.3) %
(24.6)
(30.8) %
Change in highly inflationary markets
(0.1)
(0.5) %
—
— %
—
— %
(0.1)
(0.1) %
Impact of currency
0.8
3.9 %
1.5
4.2 %
1.0
4.2 %
3.3
4.1 %
Segment profit - current year
$ 9.1
(55.6) %
$ 28.6
(18.8) %
$ 20.7
(14.1) %
$ 58.4
(26.8) %
Total Segment Profit
Segment profit - prior year
$ 139.8
$ 147.5
$ 182.9
$ 470.2
Organic
(35.1)
(25.1) %
13.6
9.2 %
(30.0)
(16.4) %
(51.5)
(11.0) %
Acquisition impact
5.3
3.8 %
(2.1)
(1.4) %
(5.1)
(2.8) %
(1.9)
(0.4) %
Change in highly inflationary markets
(0.2)
(0.1) %
—
— %
(1.5)
(0.8) %
(1.7)
(0.4) %
Impact of currency
5.0
3.5 %
3.3
2.2 %
2.3
1.2 %
10.6
2.3 %
Segment profit - current year
$ 114.8
(17.9) %
$ 162.3
10.0 %
$ 148.6
(18.8) %
$ 425.7
(9.5) %
Energizer Holdings, Inc.
Supplemental Schedules - Non-GAAP Reconciliations
For the Quarter and Nine Months Ended June 30, 2026
(In millions - Unaudited)
Gross profit
Q1'26
Q2'26
Q3'26
Q1'25
Q2'25
Q3'25
Q3'26
YTD
Q3'25
YTD
Net sales
$ 778.9
$ 643.3
$ 734.1
$ 731.7
$ 662.9
$ 725.3
$ 2,156.3
$ 2,119.9
Reported Cost of products sold
522.3
384.5
453.5
462.1
403.9
325.6
1,360.3
1,191.6
Gross profit
$ 256.6
$ 258.8
$ 280.6
$ 269.6
$ 259.0
$ 399.7
$ 796.0
$ 928.3
Gross margin
32.9 %
40.2 %
38.2 %
36.8 %
39.1 %
55.1 %
36.9 %
43.8 %
Adjustments
Restructuring and related costs
15.3
27.1
7.5
9.4
8.7
2.9
49.9
21.0
Network transition costs
—
—
—
14.0
2.7
0.9
—
17.6
FY23 & FY24 production credits
—
—
—
—
—
(78.5)
—
(78.5)
Cost of products sold - adjusted
507.0
357.4
446.0
438.7
392.5
400.3
1,310.4
1,231.5
Adjusted Gross profit
$ 271.9
$ 285.9
$ 288.1
$ 293.0
$ 270.4
$ 325.0
$ 845.9
$ 888.4
Adjusted Gross margin
34.9 %
44.4 %
39.2 %
40.0 %
40.8 %
44.8 %
39.2 %
41.9 %
SG&A
Q1'26
Q2'26
Q3'26
Q1'25
Q2'25
Q3'25
Q3'26
YTD
Q3'25
YTD
Reported SG&A
$ 149.3
$ 133.1
$ 129.3
$ 131.3
$ 136.0
$ 128.3
$ 411.7
$ 395.6
Reported SG&A % of Net sales
19.2 %
20.7 %
17.6 %
17.9 %
20.5 %
17.7 %
19.1 %
18.7 %
Adjustments
Restructuring and related costs
15.6
4.4
6.9
10.9
9.2
5.1
26.9
25.2
Acquisition and integration costs
0.5
1.6
0.3
1.2
2.3
1.3
2.4
4.8
Litigation matter
—
—
—
—
—
(1.7)
—
(1.7)
SG&A Adjusted - subtotal
$ 133.2
$ 127.1
$ 122.1
$ 119.2
$ 124.5
$ 123.6
$ 382.4
$ 367.3
SG&A Adjusted % of Net sales
17.1 %
19.8 %
16.6 %
16.3 %
18.8 %
17.0 %
17.7 %
17.3 %
Other items, net
Q1'26
Q2'26
Q3'26
Q1'25
Q2'25
Q3'25
Q3'26
YTD
Q3'25
YTD
Interest income
$ (0.7)
$ (2.5)
$ (1.1)
$ (1.2)
$ (0.6)
$ (0.2)
$ (4.3)
$ (2.0)
Foreign currency exchange loss/(gain)
1.3
1.8
1.2
(3.8)
0.4
2.0
4.3
(1.4)
Pension cost other than service costs and settlement loss
0.5
0.2
0.1
—
—
—
0.8
—
Other
—
—
(0.2)
—
0.3
0.1
(0.2)
0.4
Other items, net - Adjusted
$ 1.1
$ (0.5)
$ —
$ (5.0)
$ 0.1
$ 1.9
$ 0.6
$ (3.0)
Settlement loss on U.K. Pension plan termination
—
26.1
0.2
—
—
—
26.3
—
Restructuring and related costs
—
—
—
—
(0.3)
—
—
(0.3)
Total Other items, net
$ 1.1
$ 25.6
$ 0.2
$ (5.0)
$ (0.2)
$ 1.9
$ 26.9
$ (3.3)
Restructuring and related costs
Q1'26
Q2'26
Q3'26
Q1'25
Q2'25
Q3'25
Q3'26
YTD
Q3'25
YTD
Cost of products sold - Restructuring
$ 9.2
$ 22.1
$ 3.7
$ 9.4
$ 8.7
$ 2.9
$ 35.0
$ 21.0
Cost of products sold - U.S. operating efficiency project
6.1
5.0
3.8
—
—
—
14.9
—
SG&A - Restructuring costs
15.6
4.4
6.9
4.8
3.8
3.4
26.9
12.0
SG&A - IT Enablement
—
—
—
6.1
5.4
1.7
—
13.2
Other items, net
—
—
—
—
(0.3)
—
—
(0.3)
Total Restructuring and related costs
$ 30.9
$ 31.5
$ 14.4
$ 20.3
$ 17.6
$ 8.0
$ 76.8
$ 45.9
Acquisition and integration
Q1'26
Q2'26
Q3'26
Q1'25
Q2'25
Q3'25
Q3'26
YTD
Q3'25
YTD
SG&A
$ 0.5
$ 1.6
$ 0.3
$ 1.2
$ 2.3
$ 1.3
$ 2.4
$ 4.8
Total Acquisition and integration related items
$ 0.5
$ 1.6
$ 0.3
$ 1.2
$ 2.3
$ 1.3
$ 2.4
$ 4.8
Energizer Holdings, Inc.
Supplemental Schedules - Non-GAAP Reconciliations cont.
For the Quarter and Nine Months Ended June 30, 2026
(In millions - Unaudited)
Q3'26
Q2'26
Q1'26
Q4'25
LTM
6/30/26 (1)
Q3'25
Net earnings/(loss)
$ 39.9
$ 10.1
$ (3.4)
$ 34.9
$ 81.5
$ 153.5
Income tax provision/(benefit)
9.9
11.6
(1.4)
18.5
38.6
10.7
Earnings/(loss) before income taxes
49.8
21.7
(4.8)
53.4
120.1
164.2
Interest expense
39.7
39.3
39.1
40.3
158.4
39.0
Loss on extinguishment/modification of debt
—
—
0.9
6.8
7.7
—
Depreciation & Amortization
29.9
31.1
31.6
32.1
124.7
31.9
EBITDA
$ 119.4
$ 92.1
$ 66.8
$ 132.6
$ 410.9
$ 235.1
Adjustments:
Restructuring and related costs
14.4
31.5
30.9
22.8
99.6
8.0
Network transition costs
—
—
—
2.1
2.1
0.9
Acquisition and integration costs
0.3
1.6
0.5
1.4
3.8
1.3
Settlement loss on the U.K. pension plan termination
0.2
26.1
—
—
26.3
—
FY23 & FY24 production credits
—
—
—
0.5
0.5
(78.5)
Litigation matter
—
—
—
—
—
(1.7)
Impairment of intangible assets
—
—
—
5.9
5.9
—
Share-based payments
4.4
7.3
8.7
5.9
26.3
6.3
Adjusted EBITDA
$ 138.7
$ 158.6
$ 106.9
$ 171.2
$ 575.4
$ 171.4
Q1 & Q2 FY25 production credits, net (2)
—
—
—
—
—
(19.6)
Adjusted EBITDA excluding out of period production credits
$ 138.7
$ 158.6
$ 106.9
$ 171.2
$ 575.4
$ 151.8
(1)
LTM defined as the latest 12 months for the period ending June 30, 2026.
(2)
This measure further excludes the benefit of the Q1 and Q2 FY25 production credits, net of related compensation costs, recorded during Q3 FY25.
For the Nine Months Ended June 30,
Free cash flow
2026
2025
Net cash from operating activities
$ 156.0
$ 85.6
Capital expenditures
(52.1)
(69.1)
Proceeds from sale of assets
1.1
—
Free cash flow
$ 105.0
$ 16.5
Net debt
6/30/2026
9/30/2025
Current maturities of long-term debt
$ 8.6
$ 8.6
Current portion of finance leases
1.6
1.5
Notes payable
30.5
13.7
Long-term debt
3,294.9
3,407.9
Total debt per the balance sheet
$ 3,335.6
$ 3,431.7
Cash and cash equivalents
173.4
236.2
Net debt
$ 3,162.2
$ 3,195.5
Energizer Holdings, Inc.
Supplemental Schedules - Non-GAAP Reconciliations cont.
FY 2026 Outlook
(In millions - Unaudited)
Fiscal 2026 Outlook Reconciliation - Adjusted earnings and Adjusted net earnings per common share (EPS)
Fiscal Q4 2026 Outlook
Fiscal Year 2026 Outlook
(in millions, except per share data)
Adjusted net
earnings
Adjusted EPS
Adjusted net
earnings
Adjusted EPS
Fiscal 2026 - GAAP Outlook
$73
to
$91
$1.05
to
$1.31
$128
to
$164
$1.83
to
$2.33
Impacts:
Restructuring and related costs
14
2
0.20
0.04
73
61
1.04
0.87
Acquisition and integration costs
—
—
—
—
2
2
0.03
0.02
Loss on extinguishment/modification of debt
—
—
—
—
2
1
0.03
0.01
Settlement loss on pension plan termination
—
—
—
—
26
26
0.37
0.37
Fiscal 2026 - Adjusted Outlook
$87
to
$93
$1.25
to
$1.35
$231
to
$254
$3.30
to
$3.60
Fiscal 2026 Outlook Reconciliation - Adjusted EBITDA
LGI Homes ve 2. čtvrtletí zvýšila dodávky domů o 8,8 % na 1 440 a tržby dosáhly 516,0 milionu USD. Zároveň zvedla celoroční výhled průměrné prodejní ceny na 360 000 až 370 000 USD.
THE WOODLANDS, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) today announced financial results for the second quarter and the six months ended June 30, 2026.
“We delivered strong results during the second quarter, exceeding expectations across key metrics while navigating a dynamic operating environment,” said Eric Lipar, Chairman and Chief Executive Officer of LGI Homes.
“During the quarter, we delivered 1,440 homes, an 8.8% increase year-over-year, generating total revenues of $516.0 million and homebuilding revenues of $501.5 million.
“We ended the quarter with 151 active communities, achieving the low end of our full year guidance just six months into the year, and representing an increase of 3.4% compared to the same time last year.
“Homebuilding gross margin of 19.8% and adjusted homebuilding gross margin of 23.2% both exceeded the midpoint of our previously increased guidance range, reflecting our disciplined approach to pricing, incentives, and inventory management and the continued benefits of our self-development platform.
“We made significant progress strengthening our balance sheet during the quarter, reducing debt by $128.6 million and ending the period with a debt-to-capital ratio of 42.6%, a 220 basis point improvement year-over-year.
“On the strength of our outperformance in the first half of the year, we are raising our full-year gross margin guidance for the second consecutive quarter. We now expect our homebuilding gross margin will range between 19.0% and 21.0% and adjusted homebuilding gross margin between 22.5% and 24.5%. We are also raising the guidance for our full-year average sales price per home closed to between $360,000 and $370,000.”
Mr. Lipar concluded, “With strong visibility into the second half of the year, we are confident in achieving all of our objectives for 2026 and remain focused on balancing sales pace, profitability, and inventory management as we create long-term value for our shareholders.”
Second Quarter 2026 Highlights and Comparisons to Second Quarter 2025
Homebuilding revenues of $501.5 million, an increase of 3.7%Total home closings of 1,440, including 75 currently and previously leased homes, an increase of 8.8%Home closings of 1,365, an increase of 3.2%Average sales price per home closed of $367,407, an increase of 0.5%Homebuilding gross margin as a percentage of homebuilding revenues of 19.8%Adjusted homebuilding gross margin* as a percentage of homebuilding revenues of 23.2%Net income before income taxes of $36.6 millionNet income of $27.0 million or $1.16 basic EPS and $1.16 diluted EPS Six Months Ended June 30, 2026 Highlights and Comparisons to Six Months Ended June 30, 2025
Homebuilding revenues of $821.2 million, a decrease of 1.6%Total home closings of 2,356, including 110 currently and previously leased homes, an increase of 1.6%Home closings of 2,246, a decrease of 3.1%Average sales price per home closed of $365,649, an increase of 1.6%Homebuilding gross margin as a percentage of homebuilding revenues of 19.4%Homebuilding gross margin excluding inventory impairment* as a percentage of homebuilding revenues of 20.0%Adjusted homebuilding gross margin* as a percentage of homebuilding revenues of 23.3%Net income before income taxes of $40.9 millionNet income of $29.1 million or $1.26 basic EPS and $1.25 diluted EPSAdjusted net income* of $32.6 million, or $1.41 adjusted basic EPS* and $1.40 adjusted diluted EPS* *Please see “Non-GAAP Measures” for a reconciliation of Homebuilding Gross Margin Excluding Inventory Impairment (a non-GAAP measure) and Adjusted Homebuilding Gross Margin (a non-GAAP measure) to Homebuilding Gross Margin, and Adjusted Net Income (a non-GAAP measure) to Net Income, the most directly comparable GAAP measures, and for calculations of adjusted basic EPS and adjusted diluted EPS.
Balance Sheet Highlights
Total liquidity of $468.0 million at June 30, 2026, including cash and cash equivalents of $61.1 million and $406.9 million of availability under the Company’s revolving credit facilityNet debt to capital ratio* of 41.6% at June 30, 2026 *Please see “Non-GAAP Measures” for a reconciliation of net debt to capital ratio (a non-GAAP measure) to debt to capital ratio, the most directly comparable GAAP measure.
Full Year 2026 Outlook
Subject to the caveats in the Forward-Looking Statements section of this press release and the assumptions noted below, the Company is updating its average sales price per home closed, homebuilding gross margin, and adjusted homebuilding gross margin as a percentage of homebuilding revenues outlook for the full year 2026 and reiterating its other outlook items for the full year 2026. Currently, the Company expects for full year 2026:
Home closings between 4,600 and 5,400Active selling communities at the end of 2026 between 150 and 160Average sales price per home closed between $360,000 and $370,000Homebuilding gross margin as a percentage of homebuilding revenues between 19.0% and 21.0%, adjusted for estimated capitalized interest and estimated purchase accounting of approximately 3.5%, which results in adjusted homebuilding gross margin (non-GAAP) as a percentage of homebuilding revenues between 22.5% and 24.5%SG&A as a percentage of total revenues between 15.0% and 16.0%Effective tax rate of approximately 26.5% This outlook assumes that general economic conditions, including input costs, materials, product and labor availability, interest rates and mortgage availability, in the remainder of 2026 are similar to those experienced to date in 2026 and that construction costs, availability of land and land development costs for the remainder of 2026 are consistent with the Company’s recent experience. In addition, this outlook assumes that governmental regulations relating to land development and home construction are similar to those currently in place and does not take into account any additional changes to U.S. trade policies, including the imposition of tariffs and duties on homebuilding products.
Earnings Conference Call
The Company will host a conference call via live webcast for investors and other interested parties beginning at 12:30 p.m. Eastern Time on Tuesday, August 4, 2026 (the “Earnings Call”).
Participants may access the live webcast by visiting the Investor Relations section of the Company’s website at https://investor.lgihomes.com.
An archive of the Earnings Call webcast will be available for replay on the Company’s website for one year from the date of the Earnings Call.
About LGI Homes, Inc.
Headquartered in The Woodlands, Texas, LGI Homes, Inc. is a pioneer in the homebuilding industry, successfully applying an innovative and systematic approach to the design, construction and sale of homes across 36 markets in 21 states. LGI Homes has closed over 80,000 homes since its founding in 2003 and has delivered profitable financial results every year. Nationally recognized for its quality construction and exceptional customer service, LGI Homes was named to Newsweek’s list of the World’s Most Trustworthy Companies. LGI Homes’ commitment to excellence extends to its employees, earning the Company numerous workplace awards at the local, state, and national level, including the Top Workplaces USA 2026 Award. For more information about LGI Homes and its unique operating model focused on making the dream of homeownership a reality for families across the nation, please visit the Company’s website at www.lgihomes.com.
Forward-Looking Statements
Any statements made in this press release or on the Earnings Call that are not statements of historical fact, including statements about the Company’s beliefs, outlook and expectations, are forward-looking statements within the meaning of the federal securities laws, and should be evaluated as such. Forward-looking statements include information concerning expected 2026 home closings, active selling communities, average sales price per home closed, homebuilding gross margin as a percentage of homebuilding revenues, adjusted homebuilding gross margin as a percentage of homebuilding revenues, SG&A as a percentage of total revenues and effective tax rate, as well as market conditions and possible or assumed future results of operations, including descriptions of the Company’s business plan and strategies. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “objective,” “plan,” “potential,” “predict,” “projection,” “should,” “will” or, in each case, their negative, or other variations or comparable terminology. For more information concerning factors that could cause actual results to differ materially from those contained in the forward-looking statements please refer to the “Risk Factors” section in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, including the “Cautionary Statement about Forward-Looking Statements” subsection within the “Risk Factors” section, and subsequent filings by the Company with the U.S. Securities and Exchange Commission (the “SEC”), including the “Risk Factors” and “Cautionary Statement about Forward-Looking Statements” sections in the Company’s Quarterly Report on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026 (when it is filed with the SEC). The Company bases these forward-looking statements or outlook on its current expectations, plans and assumptions that it has made in light of its experience in the industry, as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances and at such time. As you read and consider this press release or listen to the Earnings Call, you should understand that these statements are not guarantees of future performance or results. The forward-looking statements, including the Company’s 2026 outlook, are subject to and involve risks, uncertainties and assumptions and you should not place undue reliance on these forward-looking statements or outlook. Although the Company believes that these forward-looking statements and outlook are based on reasonable assumptions at the time they are made, you should be aware that many factors could affect the Company’s actual results to differ materially from those expressed in the forward-looking statements and outlook. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. If the Company does update one or more forward-looking statements, there should be no inference that it will make additional updates with respect to those or other forward-looking statements.
LGI HOMES, INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except share data) June 30, December 31, 2026 2025 ASSETS Cash and cash equivalents $61,081 $61,247 Accounts receivable 33,850 32,467 Real estate inventory 3,512,613 3,555,602 Pre-acquisition costs and deposits 19,248 28,950 Property and equipment, net 149,579 107,145 Other assets 119,812 119,909 Deferred tax assets, net 10,392 9,904 Goodwill 12,018 12,018 Total assets $3,918,593 $3,927,242 LIABILITIES AND EQUITY Accounts payable $58,750 $16,179 Accrued expenses and other liabilities 146,280 157,971 Notes payable, net 1,580,907 1,656,803 Total liabilities 1,785,937 1,830,953 COMMITMENTS AND CONTINGENCIES EQUITY Common stock, par value $0.01, 250,000,000 shares authorized, 27,904,864 shares issued and 23,248,272 shares outstanding as of June 30, 2026 and 27,789,678 shares issued and 23,133,086 shares outstanding as of December 31, 2025 279 277 Additional paid-in capital 354,476 347,308 Retained earnings 2,187,483 2,158,339 Treasury stock, at cost, 4,656,592 shares as of June 30, 2026 and December 31, 2025 (409,582) (409,635)Total equity 2,132,656 2,096,289 Total liabilities and equity $3,918,593 $3,927,242 LGI HOMES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except share and per share data) Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Revenues Homebuilding revenues $501,511 $483,485 $821,247 $834,905 Land and other revenues 14,537 4,757 27,677 36,725 Total revenues 516,048 488,242 848,924 871,630 Cost of sales Homebuilding costs 402,117 372,877 661,924 650,584 Land and other costs 12,235 5,725 24,175 32,729 Total cost of sales 414,352 378,602 686,099 683,313 Selling expenses 44,149 41,599 76,799 83,941 General and administrative 28,571 29,401 56,432 60,603 Other income, net (7,615) (3,400) (11,316) (3,991)Net income before income taxes 36,591 42,040 40,910 47,764 Income tax provision 9,607 10,507 11,766 12,237 Net income $26,984 $31,533 $29,144 $35,527 Earnings per share: Basic $1.16 $1.36 $1.26 $1.52 Diluted $1.16 $1.36 $1.25 $1.52 Weighted average shares outstanding: Basic 23,201,571 23,221,565 23,191,411 23,308,534 Diluted 23,279,553 23,265,062 23,248,046 23,364,957 Homebuilding Revenues, Home Closings, Average Sales Price Per Home Closed (ASP), Average Community Count, Average Monthly Absorption Rate, and Ending Community Count by Reportable Segment
(Revenues in thousands, unaudited)
Three Months Ended June 30, 2026 As of June 30,
2026Reportable Segment Homebuilding
Revenues Home
Closings ASP Average
Community
Count Average
Monthly
Absorption
Rate Community
Count at End
of PeriodCentral $127,777 419 $304,957 50.0 2.8 50Southeast 108,145 323 334,814 29.7 3.6 30Northwest 59,605 121 492,603 17.0 2.4 17West 134,609 299 450,197 28.7 3.5 29Florida 71,375 203 351,601 24.3 2.8 25Total $501,511 1,365 $367,407 149.7 3.0 151 Three Months Ended June 30, 2025 As of June 30,
2025Reportable Segment Homebuilding
Revenues Home
Closings ASP Average
Community
Count Average
Monthly
Absorption
Rate Community
Count at End
of PeriodCentral $112,986 360 $313,850 47.3 2.5 46Southeast 150,110 456 329,189 33.7 4.5 35Northwest 53,487 100 534,870 16.0 2.1 16West 100,339 230 436,257 24.7 3.1 25Florida 66,563 177 376,062 24.3 2.4 24Total $483,485 1,323 $365,446 146.0 3.0 146 Homebuilding Revenues, Home Closings, Average Sales Price Per Home Closed (ASP), Average Community Count, and Average Monthly Absorption Rate by Reportable Segment
(Revenues in thousands, unaudited)
Six Months Ended June 30, 2026 As of June 30,
2026Reportable Segment Homebuilding
Revenues Home
Closings ASP Average
Community
Count Average
Monthly
Absorption
Rate Community
Count at End
of PeriodCentral $ 216,937 715 $ 303,408 48.5 2.5 50 Southeast 180,468 542 332,967 29.7 3.0 30 Northwest 96,611 187 516,636 15.7 2.0 17 West 210,459 471 446,834 27.7 2.8 29 Florida 116,772 331 352,785 23.6 2.3 25 Total $ 821,247 2,246 $ 365,649 145.2 2.6 151 Six Months Ended June 30, 2025 As of June 30,
2025Reportable Segment Homebuilding
Revenues Home
Closings ASP Average
Community
Count Average
Monthly
Absorption
Rate Community
Count at End
of PeriodCentral $214,132 690 $310,336 49.2 2.3 46Southeast 251,792 768 327,854 31.5 4.1 35Northwest 87,724 165 531,661 16.3 1.7 16West 167,295 389 430,064 25.2 2.6 25Florida 113,962 307 371,212 24.8 2.1 24Total $834,905 2,319 $360,028 147.0 2.6 146 Owned and Controlled Lots
The table below shows (i) home closings by reportable segment for the six months ended June 30, 2026 and (ii) the Company’s owned or controlled lots by reportable segment as of June 30, 2026.
Six Months Ended
June 30, 2026 As of June 30, 2026Reportable Segment Home Closings Owned(1) Controlled TotalCentral 715 18,272 256 18,528Southeast 542 12,868 1,212 14,080Northwest 187 5,795 1,142 6,937West 471 8,621 3,145 11,766Florida 331 4,966 1,129 6,095Total 2,246 50,522 6,884 57,406 (1) Of the 50,522 owned lots as of June 30, 2026, 33,775 were raw/under development lots and 16,747 were finished lots. Finished lots included 1,858 completed homes, including information centers, and 1,899 homes in progress.
Backlog Data
As of the dates set forth below, the Company’s net orders, cancellation rate and ending backlog homes and value were as follows (dollars in thousands, unaudited):
Six Months Ended June 30,Backlog Data 2026(4) 2025(5)Net orders (1) 2,260 2,528 Cancellation rate (2) 47.4% 24.2%Ending backlog – homes (3) 1,298 808 Ending backlog – value (3) $525,549 $322,466 (1) Net orders are new (gross) orders for the purchase of homes during the period, less cancellations of existing purchase contracts during the period.
(2) Cancellation rate for a period is the total number of purchase contracts cancelled during the period divided by the total new (gross) orders for the purchase of homes during the period.
(3) Ending backlog consists of retail homes at the end of the period that are under a purchase contract that has been signed by homebuyers who have met preliminary financing criteria but have not yet closed and wholesale contracts with varying terms. Ending backlog is valued at the contract amount.
(4) As of June 30, 2026, the Company had 269 units related to bulk sales agreements associated with its wholesale business.
(5) As of June 30, 2025, the Company had 91 units related to bulk sales agreements associated with its wholesale business.
Non-GAAP Measures
In addition to the results reported in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company has provided information in this press release relating to adjusted net income, adjusted basic earnings per share, adjusted diluted earnings per share, homebuilding gross margin excluding inventory impairment, adjusted homebuilding gross margin, and net debt to capital ratio.
Adjusted Net Income, Adjusted Basic Earnings per Share, and Adjusted Diluted Earnings per Share
Adjusted net income, adjusted basic earnings per share, and adjusted diluted earnings per share are non-GAAP financial measures used by management as supplemental measures in evaluating operating performance. The Company defines adjusted net income as net income less inventory impairment charges. The Company defines adjusted basic earnings per share as adjusted net income divided by weighted average basic shares outstanding. The Company defines adjusted diluted earnings per share as adjusted net income divided by weighted average diluted shares outstanding. Management believes that the presentation of adjusted net income, adjusted basic earnings per share, and adjusted diluted earnings per share provides useful information to investors because such measures isolate the impact that inventory impairment charges have on net income and earnings per share. However, because adjusted net income, adjusted basic earnings per share, and adjusted diluted earnings per share exclude the inventory impairment charge, which has real economic effects and could impact the Company’s results, the utility of adjusted net income, adjusted basic earnings per share, and adjusted diluted earnings per share as measures of the Company’s operating performance may be limited. In addition, other companies may not calculate adjusted net income, adjusted basic earnings per share, and adjusted diluted earnings per share in the same manner that the Company does. Accordingly, adjusted net income, adjusted basic earnings per share, and adjusted diluted earnings per share should be considered only as supplements to net income, basic earnings per share, and diluted earnings per share, respectively, as measures of the Company’s performance.
The following table reconciles adjusted net income to net income, which is the GAAP financial measure that management believes to be most directly comparable, and adjusted basic earnings per share and adjusted diluted earnings per share are calculated by dividing adjusted net income by basic or diluted weighted average shares outstanding, respectively (dollars in thousands, except earnings per share, unaudited):
Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025Net income$26,984 $31,533 $29,144 $35,527Basic weighted average number of shares outstanding 23,201,571 23,221,565 23,191,411 23,308,534Basic earnings per share$1.16 $1.36 $1.26 $1.52Diluted weighted average number of shares outstanding 23,279,553 23,265,062 23,248,046 23,364,957Diluted earnings per share$1.16 $1.36 $1.25 $1.52 Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025Net income$26,984 $31,533 $29,144 $35,527Inventory impairment — — 4,681 —Tax impact due to above reconciling item — — (1,225) —Adjusted net income$26,984 $31,533 $32,600 $35,527 Basic weighted average number of shares outstanding 23,201,571 23,221,565 23,191,411 23,308,534Adjusted basic earnings per share$1.16 $1.36 $1.41 $1.52Diluted weighted average number of shares outstanding 23,279,553 23,265,062 23,248,046 23,364,957Adjusted diluted earnings per share$1.16 $1.36 $1.40 $1.52 Homebuilding Gross Margin Excluding Inventory Impairment and Adjusted Homebuilding Gross Margin
Homebuilding gross margin excluding inventory impairment and adjusted homebuilding gross margin are non-GAAP financial measures used by management as supplemental measures in evaluating operating performance. The Company defines homebuilding gross margin excluding inventory impairment as homebuilding gross margin less inventory impairment charges. The Company defines adjusted homebuilding gross margin as homebuilding gross margin excluding inventory impairment, less capitalized interest and adjustments resulting from the application of purchase accounting included in the cost of sales. Management believes homebuilding gross margin excluding inventory impairment and adjusted homebuilding gross margin are useful because they isolate the impact that capitalized interest, purchase accounting adjustments, and inventory impairment (as applicable) have on homebuilding gross margin. However, because homebuilding gross margin excluding inventory impairment and adjusted homebuilding gross margin exclude capitalized interest, purchase accounting adjustments, and inventory impairment (as applicable), which have real economic effects and could impact the Company’s results, the utility of homebuilding gross margin excluding inventory impairment and adjusted homebuilding gross margin as measures of the Company’s operating performance may be limited. In addition, other companies may not calculate homebuilding gross margin excluding inventory impairment and adjusted homebuilding gross margin in the same manner that the Company does. Accordingly, homebuilding gross margin excluding inventory impairment and adjusted homebuilding gross margin should be considered only as supplements to homebuilding gross margin as a measure of the Company’s performance.
The following table reconciles homebuilding gross margin excluding inventory impairment and adjusted homebuilding gross margin to homebuilding gross margin (homebuilding revenues less homebuilding costs), which is the GAAP financial measure that management believes to be most directly comparable (dollars in thousands, unaudited):
Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Homebuilding revenues $501,511 $483,485 $821,247 $834,905 Homebuilding costs 402,117 372,877 661,924 650,584 Homebuilding gross margin $99,394 $110,608 $159,323 $184,321 Inventory impairment — — 4,681 — Homebuilding gross margin excluding inventory impairment $99,394 $110,608 $164,004 $184,321 Capitalized interest charged to cost of sales 16,472 11,836 26,448 20,103 Purchase accounting adjustments (1) 544 1,042 933 1,851 Adjusted homebuilding gross margin $116,410 $123,486 $191,385 $206,275 Homebuilding gross margin % (2) 19.8% 22.9% 19.4% 22.1%Homebuilding gross margin % excluding inventory impairment (2) 19.8% 22.9% 20.0% 22.1%Adjusted homebuilding gross margin % (2) 23.2% 25.5% 23.3% 24.7% (1) Adjustments result from the application of purchase accounting for acquisitions and represent the amount of the fair value step-up adjustments included in cost of sales for real estate inventory sold after the acquisition dates.
(2) Calculated as a percentage of homebuilding revenues.
Net Debt to Capital Ratio
Net debt to capital ratio is a non-GAAP financial measure used by management as a supplemental measure in understanding the leverage employed in the Company’s operations and as an indicator of its ability to obtain financing. The Company defines net debt to capital ratio as net debt (which is total debt minus cash and cash equivalents) divided by net debt plus total equity. Management believes that the presentation of net debt to capital ratio provides useful information to investors regarding the Company’s financial leverage and its ability to meet long-term obligations. By excluding cash and cash equivalents from total debt, the ratio offers a clearer view of the Company’s capital structure and financial flexibility. Management uses this metric to monitor the Company’s capital efficiency and to evaluate the effectiveness of its capital management strategies over time. Other companies may define this measure differently and, as a result, the Company’s measure of net debt to capital ratio may not be directly comparable to the measures of other companies.
The following table reconciles net debt to capital ratio (a non-GAAP financial measure) to debt to capital ratio, which is the GAAP financial measure that management believes to be most directly comparable (dollars in thousands, unaudited):
June 30, 2026 December 31, 2025Total debt (Notes payable) $1,580,907 $1,656,803 Total equity 2,132,656 2,096,289 Total capital $3,713,563 $3,753,092 Debt to capital ratio 42.6% 44.1% Total debt (Notes payable) $1,580,907 $1,656,803 Less: Cash and cash equivalents 61,081 61,247 Net debt $1,519,826 $1,595,556 Total equity 2,132,656 2,096,289 Total net capital $3,652,482 $3,691,845 Net debt to capital ratio (1) 41.6% 43.2% (1) Net debt to capital ratio is calculated as net debt (which is total debt minus cash and cash equivalents) divided by net debt plus total equity.
CONTACT:
Joshua D. Fattor
Executive Vice President of Finance and Capital Markets
(281) 210-2586 [email protected]
Leidos ve 2. čtvrtletí zvýšil tržby o 7 % na 4,56 miliardy USD a zvýšil celoroční výhled tržeb, EPS i provozního cash flow. Získal také zakázky za 4,9 miliardy USD.
Revenues of $4.6 billion, up 7% year-over-year Net income of $356 million or $2.81 per diluted share Adjusted EBITDA (non-GAAP) of $631 million and Adjusted EBITDA margin (non-GAAP) of 13.8% Non-GAAP Diluted Earnings per Share of $3.26, up 2% year-over-year Cash Flows from Operations of $793 million; Non-GAAP Free Cash Flow of $761 million , /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS) today reported financial results for the second quarter of fiscal year 2026, highlighted by robust revenue growth and free cash flow generation.
"I'm pleased to report another strong quarter for Leidos," said Chief Executive Officer Tom Bell. "In addition to achieving milestones for revenue and cash, we booked $5 billion of contract awards. We're seeing meaningful growth emerge across our Defense Tech, Energy Infrastructure, and Cyber growth pillars. And we have greater visibility into the long-term role of our Managed Healthcare pillar. The strength of our balanced portfolio allows us to enhance our 2026 guidance for revenues, earnings, and cash."
SUMMARY OPERATING RESULTS
Three Months Ended
(in millions, except margin and per share data)
July 3, 2026
July 4, 2025
Revenues
$ 4,558
$ 4,253
Net income
$ 356
$ 393
Net income margin
7.8 %
9.2 %
Diluted earnings per share (EPS)
$ 2.81
$ 3.01
Non-GAAP Measures*:
Adjusted EBITDA
$ 631
$ 647
Adjusted EBITDA margin
13.8 %
15.2 %
Non-GAAP diluted EPS
$ 3.26
$ 3.21
* Non-GAAP financial measures should be considered in addition to, but not as a substitute for, the information provided in accordance with GAAP. Management believes that these non-GAAP measures provide another representation of Leidos' results of operations and financial condition, including its ability to comply with financial covenants. See Non-GAAP Financial Measures at the end of this press release for more information and a reconciliation of our selected reported results to these non-GAAP measures.
Revenues for the quarter were $4.56 billion, up 7% compared to the second quarter of 2025, including 4% organically. Revenues grew year-over-year due to increased customer demand for defense tech products, energy and air traffic management solutions, and intelligence mission support.
For the second quarter, net income was $356 million, or $2.81 per diluted share. Net income and diluted EPS were both down 9% and 7%, respectively, year-over-year; net income margin was 7.8% compared to 9.2% in the second quarter of 2025. Net income and diluted EPS for the quarter reflect $29 million in costs associated with the acquisition of ENTRUST Solutions Group ("Entrust") and the pending joint venture with Analogic Corporation, as well as restructuring costs associated with the NorthStar 2030 re-alignment. Adjusting for these and certain other items, non-GAAP net income decreased 1% year-over-year, to $413 million for the second quarter, and non-GAAP diluted EPS increased 2% to $3.26.
In addition, adjusted EBITDA was $631 million for the second quarter, down 2% year-over-year. Adjusted EBITDA margin of 13.8% decreased from 15.2% in the second quarter of 2025. Profitability in the current quarter reflected excellent program execution and disciplined cost management across the portfolio; profitability in the year-ago quarter benefited from several one-time, non-operational gains, including a $25 million insurance reimbursement for legal costs.
CASH FLOW SUMMARY
Net cash provided by operating activities for the quarter was $793 million for an operating cash flow conversion ratio of 224%. After adjusting for property, equipment, and software payments, quarterly free cash was $761 million for a free cash flow conversion ratio of 185%.
For the quarter, Leidos used $38 million in investing activities, including $32 million in property, equipment and software payments. Leidos used $423 million in financing activities, consisting primarily of $300 million in debt paydown and $127 million returned to shareholders, including $72 million in share repurchases and $55 million as part of a regular quarterly cash dividend program. As of July 3, 2026, Leidos had $748 million in cash and cash equivalents and $6.0 billion of debt.
NEW BUSINESS AWARDS
Net bookings totaled $4.9 billion in the quarter, representing a book-to-bill ratio of 1.1. As a result, backlog at the end of the quarter was $48.7 billion, of which $10.2 billion was funded. Trailing-twelve-month book-to-bill of 1.1 resulted in year-over-year growth in total and funded backlog of 5% and 44%, respectively. Quarterly bookings included several key awards:
Avionics Intermediate Shop (AIS) Production Support Integration (PIS). The U.S. Air Force Sustainment Center awarded Leidos a $475 million follow-on AIS PIS contract to manage the computerized diagnostic system that fixes the F-16 fighter jets. The company will deliver independent systems engineering, resolve complex component shortages, and manage original equipment manufacturer subcontracts. This work ensures sustained mission readiness of F-16 fleets for the U.S. Air Force, European, and foreign partners. General Services Administration (GSA) Military OneSource. Leidos secured a $456 million contract from the GSA to manage the Military OneSource program over the next four years. Under this agreement, Leidos will deliver comprehensive 24/7 well-being services, including confidential counseling, tax support, and relocation tools to more than 4.7 million service members and their families worldwide. This strategic win further cements Leidos as a leading provider of global military health and managed health services. U.S. Air Force Electronic Warfare Mission Support. Leidos received a $350 million contract modification to provide additional high-end technical support for the U.S. Air Force Material Command. The company will supply additional units of its advanced low-band surveillance radar infrastructure alongside specialized signal-processing software. These mission-critical capabilities are engineered to defeat adversary low-observable assets and mitigate heavy electronic countermeasures, providing defense networks with the definitive, high-fidelity threat intelligence required for modern multi-domain operations. Defense Health Agency (DHA) Reserve Health Readiness Program (RHRP) 3.1. Leidos will maintain uninterrupted medical and dental exams for U.S. military reservists under a potential 30-month, $325 million contract modification while the DHA finalizes its long-term transition strategy for RHRP. Customs Border Patrol (CBP) Medium Energy Mobile (MEM) Systems. Leidos secured a five-year, $270 million single-award indefinite delivery, indefinite quantity (IDIQ) contract from CBP to deliver up to 100 MEM Systems. These flexible, non-intrusive inspection units scan vehicles and cargo for contraband, drugs, and weapons and will be deployed at various points of entry across the U.S. This award will align to the Leidos Security Enterprise Solutions and Analogic Corporation joint venture upon its formation. Naval Surface Warfare Center (NSWC) Multi-Service Advanced Capability Hypersonics Test Bed (MACH-TB) 2.0. The NSWC awarded Leidos an $88 million other transaction authority (OTA) contract to develop experimental hypersonic glide vehicles to serve as real-world testbeds for advancing high-speed flight technologies. FORWARD GUIDANCE
Leidos is raising its fiscal year 2026 guidance as follows:
FY26 Guidance
Measure
Current
Prior
Revenues (B)
$18.20 - $18.40
$18.00 - $18.40
Adjusted EBITDA Margin
Mid 13%
Mid 13%
Non-GAAP Diluted EPS
$12.20 - $12.50
$12.10 - $12.50
Cash Flows Provided by Operating Activities (B)
Approximately $1.85
Approximately $1.80
For information regarding adjusted EBITDA margin and non-GAAP diluted EPS, see the related explanations and reconciliations to GAAP measures included elsewhere in this release.
Leidos does not provide a reconciliation of forward-looking adjusted EBITDA margins or non-GAAP diluted EPS to net income margin or diluted EPS due to the inherent difficulty in forecasting and quantifying certain amounts that are necessary for such reconciliation. Because certain deductions for non-GAAP exclusions used to calculate projected net income margin or diluted EPS may vary significantly based on actual events, Leidos is not able to forecast on a GAAP basis with reasonable certainty all deductions needed in order to provide a GAAP calculation of projected net income at this time. The amounts of these deductions may be material and, therefore, could result in projected net income margin and diluted EPS being materially less than what may be implied by projected adjusted EBITDA margins and non-GAAP diluted EPS.
CONFERENCE CALL INFORMATION
Leidos management will discuss operations and financial results in an earnings conference call beginning at 8 A.M. eastern time on August 4, 2026. A live audio broadcast of the conference call along with a supplemental presentation will be available to the public through links on the Leidos Investor Relations website (http://ir.leidos.com). An archived version of the webcast will be available on the Leidos Investor Relations website until August 4, 2027.
ABOUT LEIDOS
Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. Headquartered in Reston, Virginia, with 50,000 global employees, Leidos reported annual revenues of approximately $17.2 billion for the fiscal year ended January 2, 2026. For more information, visit www.leidos.com.
FORWARD-LOOKING STATEMENTS
Certain statements in this release contain or are based on "forward-looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of our future growth, strategy and financial and operating performance, including future revenues, adjusted EBITDA margins, diluted EPS (including on a non-GAAP basis) and cash flows provided by operating activities, as well as statements about our business contingency plans, government budgets and spending, uncertainties in tax due to new tax legislation or other regulatory developments, strategy, planned investments including the pending joint venture, sustainability goals and our future dividends, share repurchases, capital expenditures, debt repayments, acquisitions, dispositions and cash flow conversion. These statements reflect our belief and assumptions as to future events that may not prove to be accurate.
Actual performance and results may differ materially from those results anticipated by our guidance and other forward-looking statements made in this release depending on a variety of factors, including, but not limited to: developments in the U.S. government defense and non-defense budgets, including budget reductions, sequestration, implementation of spending limits or changes in budgetary priorities, potential future U.S. government shutdown and other or future delays in the U.S. government budget process, or the U.S. government's failure to raise the debt ceiling, which increases the possibility of a default by the U.S. government on its debt obligations, related credit-rating downgrades, or an economic recession; uncertainties in tax due to new tax legislation or other regulatory developments; deterioration of economic conditions or weakening in credit or capital markets; uncertainty in the consequences of current and future geopolitical events; inflationary pressures and fluctuations in interest rates; delays in the U.S. government contract procurement process or the award of contracts and delays or loss of contracts as a result of competitor protests; changes in U.S. government procurement rules, regulations and practices; our compliance with various U.S. government and other government procurement rules and regulations; governmental reviews, audits and investigations of our company; our ability to effectively compete and win contracts with the U.S. government and other customers; our ability to respond rapidly to emerging technology trends, including the use of artificial intelligence; our reliance on information technology spending by hospitals/healthcare organizations; our reliance on infrastructure investments by industrial and natural resources organizations; energy efficiency and alternative energy sourcing investments; investments by U.S. government and commercial organizations in environmental impact and remediation projects; the effects of an epidemic, pandemic or similar outbreak may have on our business, financial position, results of operations and/or cash flows; our ability to attract, train and retain skilled employees, including our management team, and to obtain security clearances for our employees; our ability to accurately estimate costs, including cost increases due to inflation, associated with our firm-fixed-price contracts and other contracts; resolution of legal and other disputes with our customers and others or legal or regulatory compliance issues; cybersecurity, data security or other security threats, system failures or other disruptions of our business; our compliance with international, federal, state and local laws and regulations regarding privacy, data security, protection, storage, retention, transfer, disposal and other processing, technology protection and personal information; the damage and disruption to our business resulting from natural disasters and the effects of climate change; our ability to effectively acquire businesses and make investments; our ability to maintain relationships with prime contractors, subcontractors and joint venture partners; our ability to manage performance and other risks related to customer contracts; the failure of our inspection or detection systems to detect threats; the adequacy of our insurance programs, customer indemnifications or other liability protections designed to protect us from significant product or other liability claims, including cybersecurity attacks; our ability to manage risks associated with our international business; our ability to comply with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010 and similar worldwide anti-corruption and anti-bribery laws and regulations; our ability to protect our intellectual property and other proprietary rights by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to prevail in litigation brought by third parties of infringement, misappropriation or other violations by us of their intellectual property rights; our ability to declare or increase future dividends based on our earnings, financial condition, capital requirements and other factors, including compliance with applicable law and our agreements; our ability to grow our commercial health and infrastructure businesses, which could be negatively affected by budgetary constraints faced by hospitals and by developers of energy and infrastructure projects; our ability to successfully integrate acquired businesses; and our ability to execute our business plan and long-term management initiatives effectively and to overcome these and other known and unknown risks that we face.
These are only some of the factors that may affect the forward-looking statements contained in this release. For further information concerning risks and uncertainties associated with our business, please refer to the filings we make from time to time with the U.S. Securities and Exchange Commission (SEC), including the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Legal Proceedings" sections of our latest Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, all of which may be viewed or obtained through the Investor Relations section of our website at www.leidos.com.
All information in this release is as of August 4, 2026. Leidos expressly disclaims any duty to update the guidance or any other forward-looking statement provided in this release to reflect subsequent events, actual results or changes in Leidos' expectations. Leidos also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.
CONTACTS:
Investor Relations:
Media Relations:
Stuart Davis
Brandon Ver Velde
571.526.6124
571.526.6257
[email protected]
[email protected]
LEIDOS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
Six Months Ended
(in millions, except per share data)
July 3,
2026
July 4,
2025
July 3,
2026
July 4,
2025
Revenues
$ 4,558
$ 4,253
$ 8,958
$ 8,498
Cost of revenues
3,741
3,471
7,380
6,959
Selling, general and administrative expenses
283
217
506
447
Acquisition, integration and restructuring costs
27
2
62
6
Equity earnings of non-consolidated subsidiaries
(7)
(8)
(12)
(15)
Operating income
514
571
1,022
1,101
Non-operating expense:
Interest expense, net
(69)
(55)
(124)
(104)
Other income (expense), net
6
2
(18)
(1)
Income before income taxes
451
518
880
996
Income tax expense
(95)
(125)
(189)
(238)
Net income
356
393
691
758
Less: net income attributable to non-controlling interest
2
2
9
4
Net income attributable to Leidos common stockholders
$ 354
$ 391
$ 682
$ 754
Earnings per share:
Basic
$ 2.81
$ 3.03
$ 5.41
$ 5.84
Diluted
2.81
3.01
5.37
5.80
Weighted average number of common shares outstanding:
Basic
126
129
126
129
Diluted
126
130
127
130
Cash dividends declared per share
$ 0.43
$ 0.40
$ 0.86
$ 0.80
LEIDOS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except share and per share data)
July 3,
2026
January 2,
2026
Assets:
Cash and cash equivalents
$ 748
$ 1,108
Receivables, net
2,968
2,708
Inventory, net
94
342
Other current assets
493
656
Assets held for sale
943
—
Total current assets
5,246
4,814
Property, plant and equipment, net
900
961
Intangible assets, net
943
458
Goodwill
7,663
6,342
Operating lease right-of-use assets, net
491
526
Other long-term assets
389
392
Total assets
$ 15,632
$ 13,493
Liabilities:
Accounts payable and accrued liabilities
$ 2,180
$ 1,988
Accrued payroll and employee benefits
855
819
Current portion of long-term debt
22
20
Liabilities held for sale
163
—
Total current liabilities
3,220
2,827
Long-term debt, net of current portion
6,009
4,628
Operating lease liabilities
547
587
Other long-term liabilities
520
489
Total liabilities
10,296
8,531
Stockholders' equity:
Common stock, $0.0001 par value, 500,000,000 shares authorized, 125,492,013 and 126,380,657 shares issued and outstanding at July 3, 2026, and January 2, 2026, respectively
—
—
Additional paid-in capital
88
319
Retained earnings
5,219
4,647
Accumulated other comprehensive loss
(23)
(50)
Total Leidos stockholders' equity
5,284
4,916
Non-controlling interest
52
46
Total stockholders' equity
5,336
4,962
Total liabilities and stockholders' equity
$ 15,632
$ 13,493
LEIDOS HOLDINGS, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended
Six Months Ended
(in millions)
July 3,
2026
July 4,
2025
July 3,
2026
July 4,
2025
Cash flows from operations:
Net income
$ 356
$ 393
$ 691
$ 758
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization
81
72
153
141
Stock-based compensation
26
25
51
46
Deferred income taxes
6
224
(2)
200
Net (gain) loss on pension plan settlement
(3)
—
20
—
Other
4
1
14
—
Change in assets and liabilities, net of effects of acquisitions and dispositions:
Receivables
(33)
10
(193)
(236)
Other current assets and other long-term assets
35
(7)
38
(34)
Accounts payable and accrued liabilities and other long-term liabilities
43
(188)
97
(260)
Accrued payroll and employee benefits
188
155
34
7
Income taxes receivable/payable
90
(199)
191
(78)
Net cash provided by operating activities
793
486
1,094
544
Cash flows from investing activities:
Acquisition of a business, net of cash acquired
—
(285)
(2,338)
(285)
Payments for property, equipment and software
(32)
(29)
(63)
(51)
Divestiture of a business
—
—
4
—
Net proceeds from sale of assets
4
—
4
—
Other
(10)
—
(4)
—
Net cash used in investing activities
(38)
(314)
(2,397)
(336)
Cash flows from financing activities:
Proceeds from debt issuance
—
—
1,397
997
Repayments from commercial paper
(300)
—
—
—
Repayments of borrowings
(5)
(30)
(10)
(559)
Payments for debt issuance costs
—
—
(15)
(7)
Dividend payments
(55)
(52)
(110)
(105)
Repurchases of stock and other
(72)
(9)
(315)
(537)
Proceeds from issuances of stock
17
16
33
31
Net capital distributions to non-controlling interests
(1)
(2)
(3)
(7)
Other
(7)
(6)
(7)
(6)
Net cash (used in) provided by financing activities
(423)
(83)
970
(193)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
1
7
—
14
Net increase (decrease) in cash, cash equivalents and restricted cash, including cash classified in current assets held for sale
333
96
(333)
29
Less: change in cash balances classified as assets held for sale
41
—
41
—
Net increase (decrease) in cash, cash equivalents and restricted cash
292
96
(374)
29
Cash, cash equivalents and restricted cash at beginning of period
538
924
1,204
991
Cash, cash equivalents and restricted cash at end of period
830
1,020
830
1,020
Less: restricted cash at end of period
82
90
82
90
Cash and cash equivalents at end of period
$ 748
$ 930
$ 748
$ 930
LEIDOS HOLDINGS, INC.
UNAUDITED SEGMENT OPERATING RESULTS
Three Months Ended
Six Months Ended
(in millions)
July 3,
2026
July 4,
2025
July 3,
2026
July 4,
2025
Revenues:
Intelligence & Digital
$ 1,499
$ 1,408
$ 3,012
$ 2,816
Health
1,086
1,175
2,274
2,363
Homeland
1,018
771
1,834
1,541
Defense
955
899
1,838
1,778
Total
$ 4,558
$ 4,253
$ 8,958
$ 8,498
Operating income (loss):
Intelligence & Digital
$ 142
$ 135
$ 288
$ 267
Health
254
303
538
591
Homeland
92
64
125
125
Defense
84
78
146
152
Corporate
(58)
(9)
(75)
(34)
Total
$ 514
$ 571
$ 1,022
$ 1,101
Operating income margin:
Intelligence & Digital
9.5 %
9.6 %
9.6 %
9.5 %
Health
23.4 %
25.8 %
23.7 %
25.0 %
Homeland
9.0 %
8.3 %
6.8 %
8.1 %
Defense
8.8 %
8.7 %
7.9 %
8.5 %
Total
11.3 %
13.4 %
11.4 %
13.0 %
Beginning fiscal 2026, we completed a realignment of our reporting structure, which resulted in the identification of four reportable segments: Intelligence & Digital, Health, Homeland and Defense. Additionally, we separately present the unallocable costs associated with corporate functions as Corporate. We commenced operating and reporting under the new organizational structure effective the first day of fiscal 2026. As a result of this change, prior year segment results have been recast to reflect the current reportable segment structure.
Intelligence & Digital
Intelligence & Digital revenues grew 6% year-over-year to $1.50 billion driven by recent contract awards and increased volumes for Intelligence Community mission support, as well as $9 million from Kudu Dynamics through May 23, 2026 (12 months from the close of the acquisition). Operating income margin was 9.5% compared to 9.6% in the prior year quarter, and non-GAAP operating income margin was 10.1%, unchanged from the prior year quarter.
Health
Health revenues of $1.09 billion decreased by 8% compared to the prior year quarter. Health operating income margin for the quarter was 23.4%, compared to 25.8% in the prior year quarter, and non-GAAP operating income margin was 23.8%, compared to 26.3% in the prior year quarter. The declines in revenues and margins were primarily driven by lower medical disability exam volumes.
Homeland
Homeland revenues of $1.02 billion increased by 32% compared to the prior year quarter. Revenue growth was driven by continued strong demand in the Air Traffic and Energy businesses, and included $141 million from the acquisition of ENTRUST Solutions. Operating income margin for the quarter was 9.0%, compared to 8.3% in the prior year quarter, and non-GAAP operating margin increased to 12.1% from 9.3% in the prior year quarter. Profitability enhancements were driven by a better mix of security products, as well as improved program performance and lower indirect expenses across the portfolio.
Defense
Defense revenues of $955 million were up 6% compared to the prior year quarter led by increased demand for several defense tech product lines. Defense operating income margin for the quarter was 8.8%, compared to 8.7% in the prior year quarter, and non-GAAP operating margin was 9.9%, compared to 10.0% in the prior year quarter.
LEIDOS HOLDINGS, INC.
UNAUDITED BACKLOG BY REPORTABLE SEGMENT
Backlog represents the revenues we expect to recognize under negotiated contracts and unissued task orders on sole source IDIQ contracts, to the extent we believe their execution and funding to be probable. Backlog does not include potential task orders expected to be awarded under multiple award IDIQ contracts.
Backlog value is based on management's estimates about volume of services, availability of customer funding and other factors, and excludes contracts that are under protest. Estimated backlog comprises both funded and negotiated unfunded backlog. Backlog estimates are subject to change and may be affected by several factors, including modifications of contracts, non-exercise of options and foreign currency movements.
Funded backlog for contracts with the U.S. government represents the value on contracts for which funding is appropriated less revenues previously recognized on these contracts. Funded backlog for contracts with non-U.S. government entities and commercial customers represents the estimated value on contracts, which may cover multiple future years, under which Leidos is obligated to perform, less revenue previously recognized on the contracts. Unfunded backlog represents all remaining value on task orders that is not funded, including options, that we expect to recognize as well as expected future task orders under sole source IDIQ contracts.
The estimated value of backlog as of the dates presented was as follows:
July 3, 2026
July 4, 2025
(in millions)
Funded
Unfunded
Total
Funded
Unfunded
Total
Intelligence & Digital
$ 1,922
$ 16,492
$ 18,414
$ 1,667
$ 16,081
$ 17,748
Health
1,242
5,369
6,611
504
7,522
8,026
Homeland
3,669
6,261
9,930
2,918
6,920
9,838
Defense
3,390
10,366
13,756
2,033
8,565
10,598
Total
$ 10,223
$ 38,488
$ 48,711
$ 7,122
$ 39,088
$ 46,210
Backlog at July 3, 2026, includes amounts acquired as part of the Entrust transaction. As of March 27, 2026, the acquisition date, Entrust had $371 million of backlog that was included within the Homeland reportable segment.
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES
Leidos uses and refers to non-GAAP operating income, non-GAAP operating margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP diluted EPS, non-GAAP free cash flow and non-GAAP free cash flow conversion, which are not measures of financial performance under generally accepted accounting principles in the U.S. and, accordingly, these measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be read in conjunction with Leidos's consolidated financial statements prepared in accordance with GAAP.
Management believes that these non-GAAP measures provide another representation of the results of operations and financial condition, including its ability to comply with financial covenants. These non-GAAP measures are frequently used by financial analysts covering Leidos and its peers. The computation of non-GAAP measures may not be comparable to similarly titled measures reported by other companies, thus limiting their use for comparability.
Organic revenues capture the revenue that is inherent in the underlying business excluding the impact of acquisitions and divestitures made within the prior year; it is computed as current revenues excluding revenues from acquisitions within the last 12 months and divestitures within the current and year-ago periods.
Non-GAAP operating income is computed by excluding the following discrete items from operating income:
Acquisition, integration and restructuring costs – Represents acquisition, integration, lease termination, severance and retention costs and asset markdowns related to acquisitions and restructuring activities. Amortization of acquired intangible assets – Represents the amortization of the fair value of the acquired intangible assets. We do not exclude the revenue associated with these acquired intangible assets from non-GAAP operating income. Asset impairment charges – Represents impairments of long-lived intangible assets and other assets. Non-GAAP non operating income is computed by excluding the discrete items from operating income and the following discrete items from non operating income.
Settlement loss on pension plan buy-out – Represents the settlement loss in connection with the buy-out of our UK defined benefit pension plan. Acquisition related financing costs – Represents the cost associated with the termination of the bridge loan facility in connection with the acquisition of Entrust. Non-GAAP operating margin is computed by dividing non-GAAP operating income by revenues.
Adjusted EBITDA is computed by excluding the following items from income before income taxes: (i) discrete items as identified above; (ii) interest expense; (iii) interest income; (iv) depreciation expense; and (v) amortization of internally developed intangible assets.
Adjusted EBITDA margin is computed by dividing adjusted EBITDA by revenues.
Non-GAAP net income is computed by excluding the discrete items listed under non-GAAP operating income and non-GAAP non operating income and their related tax impacts.
Non-GAAP diluted EPS is computed by dividing net income attributable to Leidos common stockholders, adjusted for the discrete items as identified above and the related tax impacts, by the diluted weighted average number of common shares outstanding.
Non-GAAP free cash flow is computed by deducting expenditures for property, equipment and software from net cash provided by (used in) operating activities.
Non-GAAP free cash flow conversion is computed by dividing non-GAAP free cash flow by non-GAAP net income attributable to Leidos common stockholders; operating cash flow conversion is computed by dividing net cash provided by operating activities by net income attributable to Leidos common stockholders.
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except growth percentages)
The following table presents the reconciliation of revenues to organic revenues by reportable segment and total operations:
Three Months Ended
July 3, 2026
July 4, 2025
Percent Change
Intelligence & Digital
Revenues, as reported
$ 1,499
$ 1,408
6.5 %
Acquisition revenues(1)
9
—
Organic revenues
1,490
1,408
5.8 %
Health
Revenues, as reported
1,086
1,175
(7.6) %
Homeland
Revenues, as reported
1,018
771
32.0 %
Acquisition and divestiture revenues(1)(2)
141
9
Organic revenues
877
762
15.1 %
Defense
Revenues, as reported
955
899
6.2 %
Total Operations
Revenues, as reported
4,558
4,253
7.2 %
Acquisition and divestiture revenues(1)(2)
150
9
Organic revenues
$ 4,408
$ 4,244
3.9 %
(1)
Current period acquisition revenues reflects revenues in the current as reported figures for 12 months from closing of each acquisition. Acquisition revenues for the three months ended July 3, 2026, for the Intelligence & Digital and Homeland segments includes Kudu Dynamics (acquired May 23, 2025) and Entrust (acquired March 27, 2026).
(2)
Prior period divestiture revenues reflect revenues from assets subsequently divested. Divestiture revenues for the three months ended July 4, 2025, for the Homeland segment include an immaterial business not aligned to the Company's long term strategy (divested October 31, 2025).
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)
The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the three months ended July 3, 2026:
Three Months Ended July 3, 2026
As reported
Acquisition,
integration
and
restructuring
costs (1)
Amortization
of acquired
intangibles
Asset
impairment
charges
Non-GAAP
results
Operating income
$ 514
$ 29
$ 40
$ 1
$ 584
Non-operating expense, net
(63)
—
—
—
(63)
Income before income taxes
451
29
40
1
521
Income tax expense(2)
(95)
(3)
(10)
—
(108)
Net income
356
26
30
1
413
Less: net income attributable to non-controlling interest
2
—
—
—
2
Net income attributable to Leidos common stockholders
$ 354
$ 26
$ 30
$ 1
$ 411
Diluted EPS attributable to Leidos common stockholders(3)
$ 2.81
$ 0.21
$ 0.24
$ 0.01
$ 3.26
Diluted shares
126
126
126
126
126
Three Months Ended July 3, 2026
As reported
Acquisition,
integration
and
restructuring
costs (1)
Amortization
of acquired
intangibles
Asset
impairment
charges
Non-GAAP
results
Net income
$ 356
$ 26
$ 30
$ 1
$ 413
Income tax expense(2)
95
3
10
—
108
Income before income taxes
451
29
40
1
521
Depreciation expense
41
—
—
—
41
Amortization of intangibles
40
—
(40)
—
—
Interest expense, net
69
—
—
—
69
Adjusted EBITDA
$ 601
$ 29
$ —
$ 1
$ 631
Adjusted EBITDA margin
13.2 %
13.8 %
(1)
Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.
(2)
Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(3)
Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)
The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the three months ended July 4, 2025:
Three Months Ended July 4, 2025
As reported
Acquisition,
integration
and
restructuring
costs
Amortization
of acquired
intangibles
Non-GAAP
results
Operating income
$ 571
$ 2
$ 32
$ 605
Non-operating expense, net
(53)
—
—
(53)
Income before income taxes
518
2
32
552
Income tax expense(1)
(125)
(1)
(7)
(133)
Net income
393
1
25
419
Less: net income attributable to non-controlling interest
2
—
—
2
Net income attributable to Leidos common stockholders
$ 391
$ 1
$ 25
$ 417
Diluted EPS attributable to Leidos common stockholders(2)
$ 3.01
$ 0.01
$ 0.19
$ 3.21
Diluted shares
130
130
130
130
Three Months Ended July 4, 2025
As reported
Acquisition,
integration
and
restructuring
costs
Amortization
of acquired
intangibles
Non-GAAP
results
Net income
$ 393
$ 1
$ 25
$ 419
Income tax expense(1)
125
1
7
133
Income before income taxes
518
2
32
552
Depreciation expense
40
—
—
40
Amortization of intangibles
32
—
(32)
—
Interest expense, net
55
—
—
55
Adjusted EBITDA
$ 645
$ 2
$ —
$ 647
Adjusted EBITDA margin
15.2 %
15.2 %
(1)
Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(2)
Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)
The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the six months ended July 3, 2026:
Six Months Ended July 3, 2026
As reported
Acquisition,
integration
and
restructuring
costs(1)
Amortization
of acquired
intangibles
Asset
impairment
charges
Settlement
loss on
pension plan
buy-out
Acquisition
related
financing
costs
Non-GAAP
results
Operating income
$ 1,022
$ 64
$ 70
$ 1
$ —
$ —
$ 1,157
Non-operating expense, net
(142)
—
—
—
23
5
(114)
Income before income taxes
880
64
70
1
23
5
1,043
Income tax expense(2)
(189)
(9)
(17)
—
(6)
(1)
(222)
Net income
691
55
53
$ 1
$ 17
$ 4
821
Less: net income attributable to non-controlling interest
9
—
—
—
—
—
9
Net income attributable to Leidos common stockholders
$ 682
$ 55
$ 53
$ 1
$ 17
$ 4
$ 812
Diluted EPS attributable to Leidos common stockholders(3)
$ 5.37
$ 0.43
$ 0.42
$ 0.01
$ 0.13
$ 0.03
$ 6.39
Diluted shares
127
127
127
127
127
127
127
Six Months Ended July 3, 2026
As reported
Acquisition,
integration
and
restructuring
costs(1)
Amortization
of acquired
intangibles
Asset
impairment
charges
Settlement
loss on
pension plan
buy-out
Acquisition
related
financing
costs
Non-GAAP
results
Net income
$ 691
$ 55
$ 53
$ 1
$ 17
$ 4
$ 821
Income tax expense(2)
189
9
17
—
6
1
222
Income before income taxes
880
64
70
1
23
5
1,043
Depreciation expense
83
—
—
—
—
—
83
Amortization of intangibles
70
—
(70)
—
—
—
—
Interest expense, net
124
—
—
—
—
(5)
119
Adjusted EBITDA
$ 1,157
$ 64
$ —
$ 1
$ 23
$ —
$ 1,245
Adjusted EBITDA margin
12.9 %
13.9 %
(1)
Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.
(2)
Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(3)
Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except per share data and margin percentages)
The following tables present the reconciliation of non-GAAP operating income, net income, diluted EPS, adjusted EBITDA, and adjusted EBITDA margin to the most directly comparable GAAP measures for the six months ended July 4, 2025:
Six Months Ended July 4, 2025
As reported
Acquisition,
integration
and
restructuring
costs(1)
Amortization
of acquired
intangibles
Non-GAAP
results
Operating income
$ 1,101
$ 7
$ 62
$ 1,170
Non-operating expense, net
(105)
—
—
(105)
Income before income taxes
996
7
62
1,065
Income tax expense(2)
(238)
(2)
(15)
(255)
Net income
758
5
47
810
Less: net loss attributable to non-controlling interest
4
—
—
4
Net income attributable to Leidos common stockholders
$ 754
$ 5
$ 47
$ 806
Diluted EPS attributable to Leidos common stockholders(3)
$ 5.80
$ 0.04
$ 0.36
$ 6.20
Diluted shares
130
130
130
130
Six Months Ended July 4, 2025
As reported
Acquisition,
integration
and
restructuring
costs(1)
Amortization
of acquired
intangibles
Non-GAAP
results
Net income
$ 758
$ 5
$ 47
$ 810
Income tax expense(2)
238
2
15
255
Income before income taxes
996
7
62
1,065
Depreciation expense
79
—
—
79
Amortization of intangibles
62
—
(62)
—
Interest expense, net
104
—
—
104
Adjusted EBITDA
$ 1,241
$ 7
$ —
$ 1,248
Adjusted EBITDA margin
14.6 %
14.7 %
(1)
Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.
(2)
Calculation uses an estimated statutory tax rate on non-GAAP adjustments.
(3)
Earnings per share is computed independently for each of the non-GAAP adjustment presented and therefore may not sum to the total non-GAAP earnings per share due to rounding.
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except margin percentages)
The following tables present the reconciliation of non-GAAP operating income by reportable segment and Corporate to operating income:
Three Months Ended July 3, 2026
Operating
income
(loss)
Acquisition,
integration
and
restructuring
costs(1)
Amortization
of acquired
intangibles
Asset
impairment
charges
Non-GAAP
operating
income
(loss)
Non-GAAP
operating
margin
Intelligence & Digital
$ 142
$ 1
$ 7
$ 1
$ 151
10.1 %
Health
254
2
3
—
259
23.8 %
Homeland
92
12
19
—
123
12.1 %
Defense
84
—
11
—
95
9.9 %
Corporate
(58)
14
—
—
(44)
NM
Total
$ 514
$ 29
$ 40
$ 1
$ 584
12.8 %
NM - Not Meaningful
(1) Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations
Three Months Ended July 4, 2025
Operating
income
(loss)
Acquisition,
integration
and
restructuring
costs
Amortization
of acquired
intangibles
Non-GAAP
operating
income
(loss)
Non-GAAP
operating
margin
Intelligence & Digital
$ 135
$ —
$ 7
$ 142
10.1 %
Health
303
—
6
309
26.3 %
Homeland
64
1
7
72
9.3 %
Defense
78
—
12
90
10.0 %
Corporate
(9)
1
—
(8)
NM
Total
$ 571
$ 2
$ 32
$ 605
14.2 %
Six Months Ended July 3, 2026
Operating
income
(loss)
Acquisition,
integration
and
restructuring
costs(1)
Amortization
of acquired
intangibles
Asset
impairment
charges
Non-GAAP
operating
income
(loss)
Non-GAAP
operating
margin
Intelligence & Digital
$ 288
$ 2
$ 15
$ 1
$ 306
10.2 %
Health
538
2
7
—
547
24.1 %
Homeland
125
41
26
—
192
10.5 %
Defense
146
—
22
—
168
9.1 %
Corporate
(75)
19
—
—
(56)
NM
Total
$ 1,022
$ 64
$ 70
$ 1
$ 1,157
12.9 %
NM - Not Meaningful
(1) Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except margin percentages)
The following tables present the reconciliation of non-GAAP operating income by reportable segment and Corporate to operating income:
Six Months Ended July 4, 2025
Operating
income
(loss)
Acquisition,
integration
and
restructuring
costs(1)
Amortization
of acquired
intangibles
Non-GAAP
operating
income
(loss)
Non-GAAP
operating
margin
Intelligence & Digital
$ 267
$ —
$ 12
$ 279
9.9 %
Health
591
—
12
603
25.5 %
Homeland
125
5
14
144
9.3 %
Defense
152
—
24
176
9.9 %
Corporate
(34)
2
—
(32)
NM
Total
$ 1,101
$ 7
$ 62
$ 1,170
13.8 %
NM - Not Meaningful
(1) Asset markdowns associated with restructuring activities were recorded to "Cost of revenues" in the condensed consolidated statements of operations.
LEIDOS HOLDINGS, INC.
UNAUDITED NON-GAAP FINANCIAL MEASURES [CONTINUED]
(in millions, except percentages)
The following table presents the reconciliation of free cash flow to net cash provided by operating activities as well as the calculation of operating cash flow and free cash flow conversion ratios:
Three Months Ended
July 3, 2026
July 4, 2025
Net cash provided by operating activities
$ 793
$ 486
Payments for property, equipment and software
(32)
(29)
Non-GAAP free cash flow
$ 761
$ 457
Net income attributable to Leidos common stockholders
$ 354
$ 391
Acquisition, integration and restructuring costs(1)(2)
26
1
Amortization of acquired intangibles(1)
30
25
Asset impairment charges(1)
1
—
Non-GAAP net income attributable to Leidos common stockholders
$ 411
$ 417
Operating cash flow conversion ratio
224 %
124 %
Non-GAAP free cash flow conversion ratio
185 %
110 %
(1)
After-tax expenses excluded from non-GAAP net income.
(2)
Asset markdowns associated with restructuring activities for the three months ended July 3, 2026, were recorded to "Cost of revenues" in the condensed consolidated statements of operations.
IDEXX Laboratories ve 2. čtvrtletí zvýšila výnosy o 10 % na 1,217 miliardy USD a upravené EPS o 18 % na 4,27 USD. Zároveň zvedla celoroční výhled výnosů i EPS.
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results.
Second Quarter Results
The Company reports revenues of $1,217 million for the second quarter of 2026, an increase of 10% as reported and 9% organic, driven by Companion Animal Group ("CAG") growth of 9% as reported and organic, Water revenue growth of 15% as reported and 13% organic, and LPD revenue growth of 11% as reported and 9% organic.
Second quarter earnings per diluted share (“EPS”) were $4.27, an increase of 18% as reported and 15% on a comparable basis. Second quarter EPS included $0.14 per share in tax benefits from share-based compensation and $0.06 per share benefit from year-over-year currency changes.
“Our second quarter results reflect the strength of our Technology for Life strategy, with continued innovation across our Catalyst, Fecal Dx, and IDEXX inVue Dx platforms supporting deeper customer adoption and higher diagnostic utilization,” said Mike Erickson, President and Chief Executive Officer. “This is the kind of durable, compounding growth we're building for the long term, helping veterinarians see more and do more for their patients while creating lasting value for our shareholders.”
Second Quarter Performance Highlights
Companion Animal Group (“CAG”)
CAG revenue growth was led by CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic, including 14% reported and 12% organic gains in International regions, and 10% reported and organic growth in the U.S., outpacing sector growth levels.
Additional U.S. companion animal practice key metrics are available in the Q2 2026 Earnings Snapshot accessible on the IDEXX website, www.idexx.com/investors.
Exceptional commercial execution - including strong volume gains, net customer expansion, benefits from IDEXX innovation, and growth of the premium instrument installed base - drove double-digit CAG Diagnostics recurring revenue growth.
IDEXX VetLab™ consumables generated 15% reported and 14% organic revenue growth, supported by testing utilization gains, including benefits from recent product launches and net new customer growth with 11% expansion of the IDEXX global premium instrument installed base and net price gains. Reference laboratory diagnostic and consulting services generated 11% reported and 10% organic revenue growth, driven by higher testing volumes and net new customer gains. Rapid assay products revenues increased 1% as reported and on an organic basis, driven by net price benefits and an easing of the volume impacts from adoption of the Catalyst™ Pancreatic Lipase Test, which has shifted some testing across modalities. CAG Diagnostics capital instrument revenues decreased 19% as reported and 20% on an organic basis, lapping the Q2 2025 broad availability of IDEXX inVue Dx, with current-year period revenue benefiting from over 1,600 IDEXX inVue Dx placements.
Veterinary software, services and diagnostic imaging systems revenues grew 12% on a reported and organic basis for the quarter, with benefits from cloud-native software growth and installed base expansion. Diagnostic imaging systems delivered another record quarter of installations, led by ImageVue™ DR50 Plus.
Water
Water revenues grew 15% as reported and 13% organic for the quarter, reflecting solid organic growth in the U.S. and Europe.
Livestock, Poultry and Dairy (“LPD”)
LPD revenues increased 11% as reported and 9% organic for the quarter, led by strong growth in the Americas.
Gross Profit and Operating Profit
Gross profit increased 12% as reported and 11% on a comparable basis. Gross margin of 64.0% increased 140 basis points as reported and 120 basis points on a comparable basis, supported by strong recurring revenue volume gains, operational productivity initiatives, and net price realization.
Operating margin was 35.0% for the quarter, higher than the prior year period by 140 basis points as reported and by 110 basis points on a comparable basis. Operating margin results reflect a 10% operating expense increase as reported and 9% growth on a comparable basis. Operating expense growth supported expansion of commercial capabilities, advancement of the Company's innovation agenda, and enabling information technology investments.
2026 Growth and Financial Performance Outlook
The Company is updating its full year revenue growth guidance range to $4,700 million - $4,745 million, or reported growth of 9.1% - 10.3%, an increase of $5 million at midpoint, net of a $15 million reduction to projected revenues from a stronger U.S. dollar. The Company is increasing its outlook for organic revenue growth to 8.5% - 9.7%, an increase of 0.4% at midpoint, reflecting operational performance.
The Company increased its full year reported operating margin outlook to 32.3% - 32.5%, bringing the projected full year operating profit margin expansion to 70 - 90 basis points as reported and on a comparable basis. This outlook benefits from strong second quarter operating performance, while advancing strategic investment priorities.
The Company updated its EPS outlook range to $14.69 - $14.94, reflecting increased reported growth of 12% - 14% and 13% - 15% comparable growth. At midpoint this reflects benefits of $0.14 per share from operational performance; $0.05 from higher share-based compensation benefits and a $0.05 headwind from updated estimates for foreign exchange impacts.
The following table provides the Company's updated outlook for annual key financial metrics in 2026 with a comparison to the prior outlook:
Amounts in millions except per share data and percentages
2026 Growth and Financial Performance Outlook
Updated
Prior
Revenue
$4,700
-
$4,745
$4,675
-
$4,760
Reported growth
9.1%
-
10.3%
8.6%
-
10.6%
Organic growth
8.5%
-
9.7%
7.7%
-
9.7%
CAG Diagnostics Recurring Revenue Growth
Reported growth
10.1%
-
11.3%
9.6%
-
11.6%
Organic growth
9.5%
-
10.7%
8.7%
-
10.7%
Operating Margin
32.3%
-
32.5%
32.1%
-
32.5%
Operating margin expansion
70 bps
-
90 bps
50 bps
-
90 bps
Comparable margin expansion
70 bps
-
90 bps
50 bps
-
90 bps
EPS
$14.69
-
$14.94
$14.45
-
$14.90
Reported growth
12%
-
14%
11%
-
14%
Comparable growth
13%
-
15%
11%
-
15%
Other Key Metrics
Net interest expense
~ $35
~ $34
Share-based compensation tax benefit
~ $19
~ $15
Share-based compensation tax rate benefit
~ 1.3%
~ 1.0%
Effective tax rate
~ 21.1%
~ 21.4%
Share-based compensation EPS impact
~ $0.24
~ $0.19
Reduction in average shares outstanding
1.5%
-
2%
1%
-
2%
Operating Cash Flow (% of Net Income)
110%
-
120%
105%
-
115%
Free Cash Flow (% of Net Income)
90%
-
100%
85%
-
95%
Capital Expenditures
~ $180
~ $180
The following table outlines estimates of foreign currency exchange rate impacts, net of foreign currency hedging transactions, and foreign currency exchange rate assumptions reflected in the above financial performance outlook for 2026.
IDEXX Laboratories, Inc. will host a conference call today at 8:30 a.m. (ET) to discuss its second quarter 2026 results and management’s outlook. Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. (ET) via the same link and will remain available for one year. The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-330-6730 or 1-213-279-1575 and reference passcode 922025.
2026 Investor Day
IDEXX Laboratories, Inc. will host its 2026 Investor Day on Thursday, August 13, 2026 from 8:00 am to approximately 12:00 pm (ET). A live webcast and accompanying slide presentations will be available at www.idexx.com/investors. An archived webcast replay of the event will be available approximately one hour following the event at www.idexx.com/investors. For additional information, contact [email protected].
About IDEXX Laboratories, Inc.
IDEXX is a global leader in pet healthcare innovation. Our diagnostic and software products and services create clarity in the complex, constantly evolving world of veterinary medicine. We support longer, fuller lives for pets by delivering insights and solutions that help the veterinary community around the world make confident decisions—to advance medical care, improve efficiency, and build thriving practices. Our innovations also help measure the safety of milk and water across the world and maintain the health and well-being of people and livestock. IDEXX Laboratories, Inc. is a member of the S&P 500™ Index. Headquartered in Maine, IDEXX employs approximately 11,000 people and offers solutions and products to customers in more than 175 countries and territories. For more information about IDEXX, visit www.idexx.com.
Note Regarding Forward-Looking Statements
This earnings release and the statements to be made in the accompanying earnings conference call contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including statements about the Company’s business prospects and estimates of the Company’s financial results for future periods. Forward-looking statements are included above under "2026 Growth and Financial Performance Outlook" and elsewhere and can be identified by the use of words such as "expects", "may", "anticipates", "intends", "would", "will", "plans", "believes", "estimates", "projected", "should", and similar words and expressions. Our forward-looking statements include statements relating to our expectations regarding financial performance; revenue growth and EPS outlooks; operating and free cash flow forecast; projected impact of foreign currency exchange rates and interest rates; projected operating margins and expenses and capital expenditures, including anticipated investments in global commercial capabilities and innovation; projected tax, tax rate and EPS benefits from share-based compensation arrangements; projected effective tax rates, reduction of average shares outstanding and net interest expense; trends and other factors impacting the pet healthcare industry, including pet population demographics and U.S. clinical visits, and their anticipated effects on the Company; IDEXX inVue Dx analyzer placements; IDEXX Cancer Dx testing panel expansion; rollout of Fine Needle Aspiration to the IDEXX inVue Dx analyzer; and future commercial expansions. These statements are intended to provide management's expectations or forecasts of future events as of the date of this earnings release; are based on management's estimates, projections, beliefs, and assumptions as of the date of this earnings release; and are not guarantees of future performance. These forward-looking statements involve known and unknown risks and uncertainties that may cause the Company's actual results, levels of activity, performance or achievements to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, among other things, the adverse impact, and the duration, of macroeconomic events, conditions, and uncertainties, such as geopolitical instability (including wars, terrorist attacks, and armed conflicts), general economic uncertainty, changes in U.S. and other countries’ tariff and trade policies, severe weather and other natural conditions, and supply chain challenges on our business, results of operations, liquidity, financial condition, and stock price, as well as the matters described under the headings "Business," "Risk Factors," "Legal Proceedings," "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Quantitative and Qualitative Disclosures About Market Risk" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and in the corresponding sections of the Company's Quarterly Report on Form 10-Q for the quarters ended March 31, 2026 and June 30, 2026, as well as those described from time to time in the Company’s other filings with the U.S. Securities and Exchange Commission available at www.sec.gov. The Company specifically disclaims any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.
Statement Regarding Non-GAAP Financial Measures
The following defines terms and conventions and provides reconciliations regarding certain measures used in this earnings release and/or the accompanying earnings conference call that are not required by, or presented in accordance with, generally accepted accounting principles in the United States of America ("GAAP"), otherwise referred to as non-GAAP financial measures. To supplement the Company’s consolidated results presented in accordance with GAAP, the Company has disclosed non-GAAP financial measures that exclude or adjust certain items. Management believes these non-GAAP financial measures provide useful supplemental information for its and investors’ evaluation of the Company’s business performance and liquidity and are useful for period-over-period comparisons of the performance of the Company’s business and its liquidity and to the performance and liquidity of our peers. While management believes that these non-GAAP financial measures are useful in evaluating the Company’s business, this information should be considered as supplemental in nature and should not be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similarly titled measures reported by other companies.
Constant currency - Constant currency references are non-GAAP financial measures which exclude the impact of changes in foreign currency exchange rates and are consistent with how management evaluates our performance and comparisons with prior and future periods. We estimate the net impacts of currency on our revenue, gross profit, operating profit, and EPS results by restating results to the average exchange rates or exchange rate assumptions for the comparative period, which includes adjusting for the estimated impacts of foreign currency hedging transactions and certain impacts on our effective tax rates. These estimated currency changes impacted second quarter 2026 results as follows: increased gross profit growth by 1.1%, increased gross margin expansion 20 basis points, increased operating expense growth by 0.5%, increased operating profit growth by 1.6%, increased operating profit margin growth by 30 basis points, and increased EPS growth by 1.7%. Constant currency revenue growth represents the percentage change in revenue during the applicable period, as compared to the prior year period, excluding the impact of changes in foreign currency exchange rates. See the supplementary analysis of results below for revenue percentage change from currency for the three and six months ended June 30, 2026 and refer to the 2026 Growth and Financial Performance Outlook section of this earnings release for estimated foreign currency exchange rate impacts on 2026 projections and estimates.
Growth and organic revenue growth - All references to growth and organic growth refer to growth compared to the equivalent prior year period unless specifically noted. Organic revenue growth is a non-GAAP financial measure that represents the percentage change in revenue, as compared to the same period for the prior year, net of the effect of changes in foreign currency exchange rates, certain business acquisitions, and divestitures. Management believes that reporting organic revenue growth provides useful information to investors by facilitating easier comparisons of our revenue performance with prior and future periods and to the performance of our peers. Organic revenue growth should be considered in addition to, and not as a replacement of or a superior measure to, revenue growth reported in accordance with GAAP. See the supplementary analysis of results below for a reconciliation of reported revenue growth to organic revenue growth for the three and six months ended June 30, 2026. Please refer to the constant currency note above for a summary of foreign currency exchange rate impacts. Please refer to the 2026 Growth and Financial Performance Outlook section of this earnings release for estimated full year 2026 organic revenue growth for the Company and CAG Diagnostics recurring revenue growth. The percentage change in revenue resulting from acquisitions represents revenues during the current year period, limited to the initial 12 months from the date of the acquisition, that are directly attributable to business acquisitions. Revenue from acquisitions is expected to have an immaterial impact on projected full year 2026 revenue growth and no impact on CAG Diagnostics recurring revenue growth.
We exclude from organic revenue growth the effect of changes in foreign currency exchange rates because changes in foreign currency exchange rates are not under management’s control, are subject to volatility, and can obscure underlying business trends. We calculate the impact on revenue resulting from changes in foreign currency exchange rates by applying the difference between the weighted average exchange rates during the current year period and the comparable prior year period to foreign currency denominated revenues for the prior year period.
We also exclude from organic revenue growth the effect of certain business acquisitions and divestitures because the nature, size, and number of these transactions can vary dramatically from period to period, and because they either require or generate cash as an inherent consequence of the transaction, and therefore can also obscure underlying business and operating trends. We consider acquisitions to be a business when all three elements of inputs, processes, and outputs are present, consistent with ASU 2017-01, “Business Combinations: (Topic 805) Clarifying the Definition of a Business.” We do not consider acquired assets to be a business if substantially all the fair value of the assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. A typical acquisition that we do not consider a business is a customer relationship asset acquisition, which does not have all elements necessary to operate a business, such as employees or infrastructure. Revenue from these customers acquired is included in organic revenue growth because we believe the efforts required to convert and retain these acquired customers are similar in nature to our efforts to obtain and retain our existing customer base.
Comparable growth metrics - Comparable gross profit growth, comparable gross margin gain (or growth), comparable operating expense growth, comparable operating profit growth and comparable operating margin gain (or growth) are non-GAAP financial measures and exclude the impact of changes in foreign currency exchange rates and non-recurring or unusual items (if any). Please refer to the constant currency note above for a summary of foreign currency exchange rate impacts. Management believes that reporting comparable gross profit growth, comparable gross margin gain (or growth), comparable operating expense growth, comparable operating profit growth and comparable operating margin gain (or growth) provides useful information to investors because it enables better period-over-period comparisons of the fundamental financial results by excluding items that vary independent of performance and provides greater transparency to investors regarding key metrics used by management. Comparable gross profit growth, comparable gross margin gain (or growth), comparable operating expense growth, comparable operating profit growth and comparable operating margin gain (or growth) should be considered in addition to, and not as replacements of or superior measures to, gross profit growth, gross margin gain, operating expense growth, operating profit growth and operating margin gain reported in accordance with GAAP.
The reconciliation of these non-GAAP financial measures is as follows:
Three Months Ended
Year-over-Year
Six Months Ended
Year-over-Year
June 30,
June 30,
Change
June 30,
June 30,
Change
Dollar amounts in thousands
2026
2025
2026
2025
Gross profit and growth (as reported)
$
779,087
$
694,732
12
%
$
1,501,826
$
1,318,111
14
%
Gross margin and margin gain
64.0
%
62.6
%
140 bps
63.7
%
62.5
%
120 bps
Less: comparability adjustments
Change from currency
7,511
—
27,982
—
Comparable gross profit and growth
$
771,576
$
694,732
11
%
$
1,473,844
$
1,318,111
12
%
Comparable gross margin and margin gain
63.9
%
62.6
%
120 bps
63.6
%
62.5
%
110 bps
Operating expenses and growth (as reported)
$
353,521
$
321,686
10
%
$
713,674
$
628,531
14
%
Less: comparability adjustments
Change from currency
1,458
—
7,728
—
Loss on equity investment
—
—
5,000
—
Now-concluded litigation matter —
—
—
(8,600)
Comparable operating expense and growth
$
352,063
$
321,686
9
%
$
700,946
$
637,131
10
%
Operating profit and growth (as reported)
$
425,566
$
373,046
14
%
$
788,152
$
689,580
14
%
Operating margin and margin gain
35.0
%
33.6
%
140 bps
33.4
%
32.7
%
70 bps
Less: comparability adjustments
Change from currency
6,053
—
20,254
—
Loss on equity investment
—
—
(5,000
)
—
Now-concluded litigation matter
—
—
—
8,600
Comparable operating profit and growth
$
419,513
$
373,046
12
%
$
772,898
$
680,980
13
%
Comparable operating margin and margin gain
34.7
%
33.6
%
110 bps
33.3
%
32.3
%
100 bps
Amounts presented may not recalculate due to rounding.
Projected 2026 comparable operating margin expansion outlined in the 2026 Growth and Financial Performance Outlook section of this earnings release reflects the following adjustments: (i) full year 2026 reported operating margin adjusted for a $5 million unfavorable impact of loss on an equity investment; (ii) adjustment to projected 2026 operating margin for a positive impact from year-over-year foreign currency exchange rate changes at noted exchange rates; and (iii) adjustment to 2025 operating margin for the positive impact of the approximately $9 million discrete litigation expense accrual adjustment in the second quarter of 2025.
These impacts described above reconcile reported gross profit growth, gross margin gain, operating expense growth, operating profit growth and operating margin gain (including projected 2026) to comparable gross profit growth, comparable gross margin gain, comparable operating expense growth, comparable operating profit growth and comparable operating margin gain for the Company.
Comparable EPS growth - Comparable EPS growth is a non-GAAP financial measure that represents the percentage change in earnings per share (diluted) ("EPS") for a measurement period, as compared to the prior base period, net of the impact of changes in foreign currency exchange rates from the prior base period and excluding the tax benefits of share-based compensation activity under ASU 2016-09, "Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting," and non-recurring or unusual items (if any). Management believes comparable EPS growth is a more useful way to measure the Company’s business performance than EPS growth because it enables better period-over-period comparisons of the fundamental financial results by excluding items that vary independent of performance and provides greater transparency to investors regarding a key metric used by management. Comparable EPS growth should be considered in addition to, and not as a replacement of or a superior measure to, EPS growth reported in accordance with GAAP. Please refer to the constant currency note above for a summary of foreign currency exchange rate impacts.
The reconciliation of this non-GAAP financial measure is as follows:
Three Months Ended
Year-over-Year
Six Months Ended
Year-over-Year
June 30,
June 30,
Growth
June 30,
June 30,
Growth
2026
2025
2026
2025
Earnings per share (diluted) and growth
$
4.27
$
3.63
18
%
$
7.74
$
6.59
17
%
Less: comparability adjustments
Share-based compensation activity
0.14
0.10
0.23
0.11
Loss on equity investment
—
—
(0.05
)
—
Now-concluded litigation matter
—
—
—
0.08
Change from currency
0.06
—
0.20
—
Comparable EPS and growth
$
4.07
$
3.53
15
%
$
7.36
$
6.40
15
%
Amounts presented may not recalculate due to rounding.
Projected 2026 comparable EPS growth outlined in the 2026 Growth and Financial Performance Outlook section of this earnings release reflects the following adjustments: (i) adjustment to projected full year 2026 reported EPS for estimated positive year-over-year foreign currency exchange rate change impact of $0.22 at noted exchange rates; (ii) adjustment to projected full year 2026 reported EPS for estimated positive impact of share-based compensation activity of $0.24; (iii) adjustment to projected full year 2026 EPS of $0.05 for unfavorable impact of a loss on an equity investment; (iv) adjustment to full year 2025 reported EPS for a positive $0.08 impact from the discrete litigation expense accrual adjustment in the second quarter of 2025; and (v) adjustment to full year 2025 reported EPS for positive impact of share-based compensation activity of $0.35.
These impacts and those described in the constant currency note above reconcile reported EPS growth (including projected 2026 reported EPS growth) to comparable EPS growth for the Company.
Segment and Other Income from Operations - We report segment income from operations in our Segment Information table below. Segment income from operations is a non-GAAP financial measure that adjusts for the impact of foreign currency transaction gains and losses and should be considered in addition to, and not as a replacement for, or superior measure to, income from operations. We exclude foreign currency transaction gains and losses for each reportable segment (CAG, Water, and LPD) from segment income from operations and report the full amount of foreign currency transaction gains and losses in Other. We believe that reporting segment income from operations provides supplemental analysis to help investors further evaluate each reportable segment’s business performance by excluding foreign currency transaction gains and losses, which are centrally managed by our corporate treasury function and which we do not consider relevant for assessing the results of each reportable segment’s operations. In addition, we believe that reporting segment income from operations provides information to investors regarding key metrics that are used by management, including our chief operating decision-maker, in evaluating the performance of each reportable segment.
The reconciliation of this non-GAAP financial measure is as follows for the three and six months ended June 30, 2026 and 2025:
Amounts in thousands
Three Months Ended June 30,
2026
2025
Income from Operations
Impact from Foreign Currency
Segment and Other Income from Operations
Income from Operations
Impact from Foreign Currency
Segment and Other Income from Operations
CAG
$
393,069
$
214
$
393,283
$
347,983
$
494
$
348,477
Water
30,258
16
30,274
24,606
36
24,642
LPD
2,395
16
2,411
(543
)
38
(505
)
Other
(156
)
(246
)
(402
)
1,000
(568
)
432
Total
$
425,566
$
—
$
425,566
$
373,046
$
—
$
373,046
Amounts in thousands
Six Months Ended June 30,
2026
2025
Income from Operations
Impact from Foreign Currency
Segment and Other Income from Operations
Income from Operations
Impact from Foreign Currency
Segment and Other Income from Operations
CAG
$
730,234
$
604
$
730,838
$
642,554
$
1,078
$
643,632
Water
53,901
42
53,943
45,380
79
45,459
LPD
3,657
44
3,701
(462
)
82
(380
)
Other
360
(690
)
(330
)
2,108
(1,239
)
869
Total
$
788,152
$
—
$
788,152
$
689,580
$
—
$
689,580
Free cash flow - Free cash flow is a non-GAAP financial measure and means, with respect to a measurement period, the cash generated from operations during that period, reduced by the Company’s investments in property and equipment. Management believes free cash flow is a useful measure because it indicates the cash the operations of the business are generating after appropriate reinvestment for recurring investments in property and equipment that are required to operate the business. Free cash flow should be considered in addition to, and not as a replacement of or a superior measure to, net cash provided by operating activities. See the supplementary analysis of results below for our calculation of free cash flow for the three and six months ended June 30, 2026 and 2025. To estimate projected 2026 free cash flow, we have deducted projected purchases of property and equipment (also referred to as capital expenditures) of approximately $180 million. Free cash flow conversion, or the net income to free cash flow ratio, is a non-GAAP financial measure that is defined as free cash flow, with respect to a measurement period, divided by net income for the same period. To calculate trailing twelve-month net income to free cash flow ratio for the twelve months ended June 30, 2026, we have deducted purchases of property and equipment of approximately $117 million from net cash provided from operating activities of approximately $1,372 million, divided by net income of approximately $1,140 million.
Debt to Adjusted EBITDA (Leverage Ratios) - Adjusted EBITDA, gross debt, and net debt are non-GAAP financial measures. Adjusted EBITDA is a non-GAAP financial measure of earnings before interest, taxes, depreciation, amortization, non-recurring transaction expenses incurred in connection with acquisitions, share-based compensation expense, and certain other non-cash losses and charges. Management believes that reporting Adjusted EBITDA, gross debt, and net debt in the Debt to Adjusted EBITDA ratios provides supplemental analysis to help investors further evaluate the Company's business performance and available borrowing capacity under the Company's credit facility. Adjusted EBITDA, gross debt, and net debt should be considered in addition to, and not as replacements of or superior measures to, net income or total debt reported in accordance with GAAP. For further information on how Adjusted EBITDA and the Debt to Adjusted EBITDA Ratios are calculated, see the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
Notes and Definitions
Discrete litigation expense accrual - During the first quarter of 2025, the Company reduced its previously established $89.0 million accrual related to a concluded litigation matter by approximately $9 million, which represented our best estimate at that time of the amount of the loss.
Concluded litigation matter - The Company was a defendant in a litigation matter involving an alleged breach of contract for underpayment of royalty payments made from 2004 through 2017 under an expired patent license agreement, and the trial court ruled in favor of the plaintiff in 2020. Following appeals and in light of the appellate court's April 3, 2025 decision, on April 17, 2025, the Company paid the judgment of approximately $80 million, and the plaintiff executed a satisfaction and release of judgment, which was filed with the trial court on the same date, concluding this matter. For further information, see the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
IDEXX Laboratories, Inc. and Subsidiaries
Condensed Consolidated Statement of Operations
Amounts in thousands except per share data (Unaudited)
Three Months Ended
Six Months Ended
June 30,
June 30,
June 30,
June 30,
2026
2025
2026
2025
Revenue:
Revenue
$
1,216,585
$
1,109,457
$
2,357,405
$
2,107,884
Expenses and Income:
Cost of revenue
437,498
414,725
855,579
789,773
Gross profit
779,087
694,732
1,501,826
1,318,111
Sales and marketing
171,277
161,107
346,527
317,330
General and administrative
116,815
98,681
235,930
190,242
Research and development
65,429
61,898
131,217
120,959
Total operating expense
353,521
321,686
713,674
628,531
Income from operations
425,566
373,046
788,152
689,580
Non-operating income (expense), net
(8,342
)
(10,694
)
(15,486
)
(17,144
)
Income before provision for income taxes
417,224
362,352
772,666
672,436
Provision for income taxes
78,812
68,363
155,808
135,770
Net Income:
Net income attributable to stockholders
$
338,412
$
293,989
$
616,858
$
536,666
Earnings per share: Basic
$
4.29
$
3.66
$
7.78
$
6.64
Earnings per share: Diluted
$
4.27
$
3.63
$
7.74
$
6.59
Shares outstanding: Basic
78,954
80,413
79,299
80,864
Shares outstanding: Diluted
79,312
80,994
79,742
81,465
IDEXX Laboratories, Inc. and Subsidiaries
Selected Operating Information (Unaudited)
Three Months Ended
Six Months Ended
June 30,
June 30,
June 30,
June 30,
2026
2025
2026
2025
Operating Ratios
Gross profit
64.0
%
62.6
%
63.7
%
62.5
%
(as a percentage of revenue):
Sales, marketing, general and administrative expense
23.7
%
23.4
%
24.7
%
24.1
%
Research and development expense
5.4
%
5.6
%
5.6
%
5.7
%
Income from operations1
35.0
%
33.6
%
33.4
%
32.7
%
1Amounts presented may not recalculate due to rounding.
IDEXX Laboratories, Inc. and Subsidiaries
Segment and Other Information
Amounts in thousands (Unaudited)
Three Months Ended
June 30, 2026
Percent of Revenue
June 30, 2025
Percent of Revenue
Revenue:
CAG
$
1,118,236
$
1,022,443
Water
58,564
51,001
LPD
35,181
31,762
Other
4,604
4,251
Total
$
1,216,585
$
1,109,457
Gross Profit:
CAG
$
715,787
64.0
%
$
642,102
62.8
%
Water
43,598
74.4
%
35,511
69.6
%
LPD
18,651
53.0
%
14,929
47.0
%
Other
1,051
22.8
%
2,190
51.5
%
Total
$
779,087
64.0
%
$
694,732
62.6
%
Income from Operations:
CAG
$
393,283
35.2
%
$
348,477
34.1
%
Water
30,274
51.7
%
24,642
48.3
%
LPD
2,411
6.9
%
(505
)
(1.6
%)
Other
(402
)
(8.7
%)
432
10.2
%
Total
$
425,566
35.0
%
$
373,046
33.6
%
Six Months Ended
June 30, 2026
Percent of Revenue
June 30, 2025
Percent of Revenue
Revenue:
CAG
$
2,172,288
$
1,942,279
Water
108,829
96,322
LPD
67,664
60,358
Other
8,624
8,925
Total
$
2,357,405
$
2,107,884
Gross Profit:
CAG
$
1,383,296
63.7
%
$
1,216,925
62.7
%
Water
80,135
73.6
%
67,584
70.2
%
LPD
35,561
52.6
%
29,294
48.5
%
Other
2,834
32.9
%
4,308
48.3
%
Total
$
1,501,826
63.7
%
$
1,318,111
62.5
%
Income from Operations:
CAG
$
730,838
33.6
%
$
643,632
33.1
%
Water
53,943
49.6
%
45,459
47.2
%
LPD
3,701
5.5
%
(380
)
(0.6
%)
Other
(330
)
(3.8
%)
869
9.7
%
Total
$
788,152
33.4
%
$
689,580
32.7
%
IDEXX Laboratories, Inc. and Subsidiaries
Revenues and Revenue Growth Analysis by Product and Service Categories and by Domestic and International Markets
Amounts in thousands (Unaudited)
Three Months Ended
June 30, 2026
June 30, 2025
Dollar Change
Reported Revenue Growth1
Percentage Change from
Currency
Percentage Change from Acquisitions
Organic Revenue Growth1
Net Revenue
CAG
$
1,118,236
$
1,022,443
$
95,793
9.4
%
0.6
%
—
8.7
%
United States
734,892
684,497
50,395
7.4
%
—
—
7.4
%
International
383,344
337,946
45,398
13.4
%
1.9
%
—
11.5
%
Water
$
58,564
$
51,001
$
7,563
14.8
%
1.9
%
—
13.0
%
United States
29,621
26,090
3,531
13.5
%
—
—
13.5
%
International
28,943
24,911
4,032
16.2
%
3.8
%
—
12.4
%
LPD
$
35,181
$
31,762
$
3,419
10.8
%
1.8
%
—
9.0
%
United States
6,608
5,767
841
14.6
%
—
—
14.6
%
International
28,573
25,995
2,578
9.9
%
2.1
%
—
7.8
%
Other
$
4,604
$
4,251
$
353
8.3
%
—
—
8.3
%
Total Company
$
1,216,585
$
1,109,457
$
107,128
9.7
%
0.7
%
—
9.0
%
United States
772,968
717,869
55,099
7.7
%
—
—
7.7
%
International
443,617
391,588
52,029
13.3
%
2.0
%
—
11.2
%
Three Months Ended
June 30, 2026
June 30, 2025
Dollar Change
Reported Revenue Growth1
Percentage Change from
Currency
Percentage Change from Acquisitions
Organic Revenue Growth1
Net CAG Revenue
CAG Diagnostics recurring revenue:
$
974,713
$
877,995
$
96,718
11.0
%
0.7
%
—
10.3
%
IDEXX VetLab consumables
430,337
375,112
55,225
14.7
%
1.1
%
—
13.6
%
Rapid assay products
101,575
100,240
1,335
1.3
%
0.3
%
—
1.1
%
Reference laboratory diagnostic and consulting services
406,729
367,694
39,035
10.6
%
0.3
%
—
10.3
%
CAG Diagnostics services and accessories
36,072
34,949
1,123
3.2
%
1.1
%
—
2.1
%
CAG Diagnostics capital – instruments
$
47,174
$
58,600
($
11,426
)
(19.5
%)
0.1
%
—
(19.6
%)
Veterinary software, services and diagnostic imaging systems:
$
96,349
$
85,848
$
10,501
12.2
%
0.4
%
—
11.8
%
Recurring revenue
76,343
68,954
7,389
10.7
%
0.5
%
—
10.2
%
Systems and hardware
20,006
16,894
3,112
18.4
%
0.2
%
—
18.2
%
Net CAG revenue
$
1,118,236
$
1,022,443
$
95,793
9.4
%
0.6
%
—
8.7
%
Three Months Ended
June 30, 2026
June 30, 2025
Dollar Change
Reported Revenue Growth1
Percentage Change from
Currency
Percentage Change from Acquisitions
Organic Revenue Growth1
CAG Diagnostics recurring revenue:
$
974,713
$
877,995
$
96,718
11.0
%
0.7
%
—
10.3
%
United States
630,504
575,009
55,495
9.7
%
—
—
9.7
%
International
344,209
302,986
41,223
13.6
%
2.0
%
—
11.6
%
1See Statements Regarding Non-GAAP Financial Measures, above. Amounts presented may not recalculate due to rounding.
IDEXX Laboratories, Inc. and Subsidiaries
Revenues and Revenue Growth Analysis by Product and Service Categories and by Domestic and International Markets
Amounts in thousands (Unaudited)
Six Months Ended
June 30, 2026
June 30, 2025
Dollar Change
Reported Revenue Growth1
Percentage Change from
Currency
Percentage Change from Acquisitions
Organic Revenue Growth1
Net Revenue
CAG
$
2,172,288
$
1,942,279
$
230,009
11.8
%
1.7
%
—
10.1
%
United States
1,425,792
1,308,386
117,406
9.0
%
—
—
9.0
%
International
746,496
633,893
112,603
17.8
%
5.4
%
—
12.4
%
Water
$
108,829
$
96,322
$
12,507
13.0
%
2.8
%
—
10.2
%
United States
56,014
49,593
6,421
12.9
%
—
—
12.9
%
International
52,815
46,729
6,086
13.0
%
5.6
%
—
7.4
%
LPD
$
67,664
$
60,358
$
7,306
12.1
%
4.0
%
—
8.2
%
United States
12,992
11,555
1,437
12.4
%
—
—
12.4
%
International
54,672
48,803
5,869
12.0
%
4.8
%
—
7.2
%
Other
$
8,624
$
8,925
($
301
)
(3.4
%)
—
—
(3.4
%)
Total Company
$
2,357,405
$
2,107,884
$
249,521
11.8
%
1.8
%
—
10.0
%
United States
1,498,200
1,372,730
125,470
9.1
%
—
—
9.1
%
International
859,205
735,154
124,051
16.9
%
5.3
%
—
11.6
%
Six Months Ended
June 30, 2026
June 30, 2025
Dollar Change
Reported Revenue Growth1
Percentage Change from
Currency
Percentage Change from Acquisitions
Organic Revenue Growth1
Net CAG Revenue
CAG Diagnostics recurring revenue:
$
1,895,026
$
1,684,262
$
210,764
12.5
%
1.8
%
—
10.7
%
IDEXX VetLab consumables
842,919
719,891
123,028
17.1
%
2.6
%
—
14.5
%
Rapid assay products
186,513
184,274
2,239
1.2
%
0.7
%
—
0.5
%
Reference laboratory diagnostic and consulting services
792,908
712,100
80,808
11.3
%
1.4
%
—
10.0
%
CAG Diagnostics services and accessories
72,686
67,997
4,689
6.9
%
2.3
%
—
4.6
%
CAG Diagnostics capital – instruments
$
89,623
$
90,594
($
971
)
(1.1
%)
1.4
%
—
(2.5
%)
Veterinary software, services and diagnostic imaging systems:
$
187,639
$
167,423
$
20,216
12.1
%
0.7
%
—
11.4
%
Recurring revenue
149,879
134,747
15,132
11.2
%
0.8
%
—
10.5
%
Systems and hardware
37,760
32,676
5,084
15.6
%
0.3
%
—
15.2
%
Net CAG revenue
$
2,172,288
$
1,942,279
$
230,009
11.8
%
1.7
%
—
10.1
%
Six Months Ended
June 30, 2026
June 30, 2025
Dollar Change
Reported Revenue Growth1
Percentage Change from
Currency
Percentage Change from Acquisitions
Organic Revenue Growth1
CAG Diagnostics recurring revenue:
$
1,895,026
$
1,684,262
$
210,764
12.5
%
1.8
%
—
10.7
%
United States
1,224,987
1,111,986
113,002
10.2
%
—
—
10.2
%
International
670,039
572,276
97,762
17.1
%
5.4
%
—
11.6
%
1See Statements Regarding Non-GAAP Financial Measures, above. Amounts presented may not recalculate due to rounding.
IDEXX Laboratories, Inc. and Subsidiaries
Condensed Consolidated Balance Sheet
Amounts in thousands (Unaudited)
June 30, 2026
December 31, 2025
Assets:
Current Assets:
Cash and cash equivalents
$
196,933
$
180,070
Accounts receivable, net
627,083
552,378
Inventories
391,579
377,756
Other current assets
293,894
303,623
Total current assets
1,509,489
1,413,827
Property and equipment, net
733,238
747,380
Other long-term assets, net
1,199,608
1,189,552
Total assets
$
3,442,335
$
3,350,759
Liabilities and Stockholders'
Equity:
Current Liabilities:
Accounts payable
$
129,097
$
110,408
Accrued liabilities
453,169
530,147
Line of credit
519,000
398,000
Current portion of long-term debt
149,999
74,995
Deferred revenue
36,400
35,264
Total current liabilities
1,287,665
1,148,814
Long-term debt, net of current portion
299,865
374,842
Other long-term liabilities, net
242,230
221,720
Total long-term liabilities
542,095
596,562
Total stockholders' equity
1,612,575
1,605,383
Total liabilities and stockholders' equity
$
3,442,335
$
3,350,759
IDEXX Laboratories, Inc. and Subsidiaries
Selected Balance Sheet Information (Unaudited)
June 30,
2026
March 31,
2026
December 31,
2025
September 30,
2025
June 30,
2025
Selected Balance Sheet Information:
Days sales outstanding1
46.2
46.2
46.8
46.5
44.7
Inventory turns2
1.4
1.4
1.6
1.5
1.5
1Days sales outstanding represents the average of the accounts receivable balances at the beginning and end of each quarter divided by revenue for that quarter, the result of which is then multiplied by 91.25 days.
2Inventory turns are calculated as the ratio of our inventory-related cost of revenue for the quarter multiplied by four, divided by the average inventory balances at the beginning and end of each quarter.
IDEXX Laboratories, Inc. and Subsidiaries
Condensed Consolidated Statement of Cash Flows
Amounts in thousands (Unaudited)
Six Months Ended
June 30, 2026
June 30, 2025
Operating:
Cash Flows from Operating Activities:
Net income
$
616,858
$
536,666
Non-cash adjustments to net income
143,240
111,582
Changes in assets and liabilities
(146,688
)
(224,543
)
Net cash provided by operating activities
613,410
423,705
Investing:
Cash Flows from Investing Activities:
Purchases of property and equipment
(56,630
)
(64,128
)
Acquisitions
(4,491
)
—
Proceeds from net investment hedges
2,081
890
Net cash used by investing activities
(59,040
)
(63,238
)
Financing:
Cash Flows from Financing Activities:
Borrowings under credit facility, net
121,000
329,000
Payments of senior notes
—
(103,386
)
Repurchases of common stock
(697,840
)
(738,995
)
Proceeds from exercises of stock options and employee stock purchase plans
51,074
24,523
Shares withheld for statutory tax withholding payments on restricted stock
(10,853
)
(7,094
)
Net cash used by financing activities
(536,619
)
(495,952
)
Net effect of changes in exchange rates on cash
(888
)
11,813
Net increase (decrease) in cash and cash equivalents
16,863
(123,672
)
Cash and cash equivalents, beginning of period
180,070
288,266
Cash and cash equivalents, end of period
$
196,933
$
164,594
IDEXX Laboratories, Inc. and Subsidiaries
Free Cash Flow
Amounts in thousands (Unaudited)
Three Months Ended
Six Months Ended
June 30, 2026
June 30, 2025
June 30, 2026
June 30, 2025
Free Cash Flow:
Net cash provided by operating activities
$
347,162
$
185,743
$
613,410
$
423,705
Investing cash flows attributable to purchases of property and equipment
Contract Value, FX Neutral: $5.3 billion, +0.3% Sequentially, +1.7% YoY
SECOND QUARTER 2026 HIGHLIGHTS
Revenues: $1.7 billion, -0.6% as reported; -1.6% FX neutral. Adjusted Revenues: $1.7 billion, +2.8% as reported; +1.8% FX neutral. Net income: $275 million, +14.4% as reported; Adjusted EBITDA excluding divested operation: $466 million, +6.4% as reported, +4.4% FX neutral. Operating cash flow: $398 million, +3.8%; free cash flow: $378 million, +8.9%. Repurchased 3.6 million common shares for $547 million. Board of Directors increased the share repurchase authorization by $500 million in July 2026. STAMFORD, Conn.--(BUSINESS WIRE)--Gartner, Inc. (NYSE: IT) today reported results for the second quarter of 2026 and updated its financial outlook for the full year 2026. Additional information regarding the Company’s results as well as the updated 2026 financial outlook is provided in an earnings supplement available on the Company’s Investor Relations website at https://investor.gartner.com.
Gene Hall, Gartner’s Chairman and Chief Executive Officer, commented, "Contract Value growth accelerated again. Revenues, Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow were ahead of expectations. We repurchased $547 million of stock in the quarter, as our capital allocation continues to create value for our shareholders. In addition, we increased our full year Adjusted EBITDA excluding divested operation, Adjusted EPS, and free cash flow guidance even with the stronger dollar."
CONFERENCE CALL INFORMATION
The Company will host a webcast call at 8:00 a.m. Eastern time on Tuesday, August 4, 2026 to discuss the Company’s financial results. Listeners can access the webcast live at https://edge.media-server.com/mmc/p/siaqzruh. To participate actively in the live call via dial-in, please register at https://register-conf.media-server.com/register/BI60b3b327155d48c99835471ca69f3102. Once registered, participants will receive a dial-in number and a unique PIN to access the call. A replay of the webcast will be available on the Company’s website for approximately 30 days following the call.
CONSOLIDATED RESULTS HIGHLIGHTS
(Unaudited; $ in millions, except per share amounts)
Three Months Ended
June 30,
Inc/(Dec)
2026
2025
Inc/(Dec)
FX Neutral
GAAP Metrics:
Revenues
$
1,676
$
1,686
(0.6
)%
(1.6
)%
Net income
275
241
14.4
%
na
Diluted EPS
4.14
3.11
33.1
%
na
Operating cash flow
398
384
3.8
%
na
Non-GAAP Metrics:
Adjusted revenues
$
1,676
$
1,631
2.8
%
1.8
%
Adjusted EBITDA excluding divested operation
466
438
6.4
%
4.4
%
Adjusted EPS
4.37
3.53
23.8
%
na
Free cash flow
378
347
8.9
%
na
na=not available.
CONTRACT VALUE HIGHLIGHTS
Global Technology Sales Contract Value FX Neutral (GTS CV): $4.0 billion, ~flat Sequentially, +1.1% YoY Global Business Sales Contract Value FX Neutral (GBS CV): $1.3 billion, +1.2% Sequentially, +3.3% YoY SEGMENT RESULTS HIGHLIGHTS
Our segment results for the three months ended June 30, 2026 were as follows:
(Unaudited; $ in millions)
Insights
Conferences
Consulting
Revenues
$
1,290
$
244
$
142
Inc/(Dec)
2.1
%
15.5
%
(8.8
)%
Inc/(Dec) - FX neutral
1.0
%
14.2
%
(8.8
)%
Gross contribution
$
999
$
145
$
54
Inc/(Dec)
4.0
%
19.6
%
(12.6
)%
Contribution margin
77.5
%
59.5
%
37.9
%
Additional details regarding our segment results can be obtained from the earnings supplement, our quarterly report on Form 10–Q filed with the SEC on August 4, 2026 and our webcast.
Certain financial metrics contained in this Press Release are considered non-GAAP financial measures. Definitions of these non-GAAP financial measures are included in this Press Release under “Non-GAAP Financial Measures” and the related reconciliations are under “Supplemental Information — Non-GAAP Reconciliations.” In this Press Release, some totals may not add due to rounding. The percentage changes are based on the unrounded whole number and recalculation based on millions may yield a different result.
ABOUT GARTNER
Gartner, Inc. (NYSE: IT) delivers actionable, objective business and technology insights that drive smarter decisions and stronger performance on an organization’s mission-critical priorities.
FORWARD-LOOKING STATEMENTS
Statements contained in this press release regarding the Company’s growth and prospects, projected financial results, long-term objectives, and all other statements in this release other than recitation of historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, estimates, uncertainties and other factors that may cause actual results to be materially different. Such factors include, but are not limited to, the following: our ability to maintain and expand our products and services; our ability to keep pace with technological and industry developments in artificial intelligence (“AI”) and comply with evolving AI regulations; our ability to achieve continued customer renewals and achieve new contract value, backlog and deferred revenue growth in light of competitive pressures; our ability to grow or sustain revenue from individual customers; our ability to expand or retain our customer base; our ability to carry out our strategic initiatives and manage associated costs; the timing of conferences and meetings, in particular our Gartner Symposium/Xpo series; our ability to achieve and effectively manage growth, including our ability to integrate our acquisitions and consummate and integrate future acquisitions; our ability to attract and retain a professional staff of analysts and consultants as well as experienced sales personnel upon whom we are dependent, especially in light of labor competition; our ability to successfully compete with existing competitors and potential new competitors; our ability to enforce and protect our intellectual property rights; the impact of cybersecurity incidents or other disruptions to our information systems; our ability to pay our debt obligations; the impact of global economic and geopolitical conditions, including inflation (and related monetary policy by governments in response to inflation) and recession; uncertain effects, both direct and indirect, of changes and volatility in tariffs and trade policies; risks associated with the creditworthiness, budget cuts, priorities and shutdown of governments and agencies; additional risks associated with international operations, including foreign currency fluctuations; the impact on our business resulting from changes in international conditions, including those resulting from tensions in the Middle East, the war in Ukraine and current and future sanctions imposed by governments or other authorities; the impact of restructuring and other charges on our businesses and operations; our ability to meet sustainability commitments and comply with applicable regulatory requirements, as well as potential reactions by customers to these commitments; the impact of changes in tax policy (including global minimum tax legislation) and heightened scrutiny from various taxing authorities globally; changes to laws and regulations; and other risks and uncertainties described under “Risk Factors” in our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, which can be found on Gartner’s website at https://investor.gartner.com and the SEC’s website at www.sec.gov. Forward-looking statements included herein speak only as of the date hereof and Gartner disclaims any obligation to revise or update such statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events or circumstances, except as required by applicable law.
NON-GAAP FINANCIAL MEASURES
Certain financial measures used in this Press Release are not defined by U.S. generally accepted accounting principles (“GAAP”) and as such are considered non-GAAP financial measures. We provide these measures to enhance the user’s overall understanding of the Company’s current financial performance and the Company’s prospects for the future. Investors are cautioned that these non-GAAP financial measures may not be defined in the same manner by other companies and, as a result, may not be comparable to other similarly titled measures used by other companies. Also, these non-GAAP financial measures should not be construed as alternatives, or superior, to other measures determined in accordance with GAAP. The non-GAAP financial measures used in this Press Release are defined below.
Adjusted Revenues: Represents GAAP revenues less revenues from our Digital Markets divested operation. We believe Adjusted Revenues is an important measure of our recurring operations as it provides a more accurate period-over period comparison of trends in revenues.
Adjusted EBITDA and Adjusted EBITDA Margin: Represents GAAP net income (loss) adjusted for: (i) interest expense, net; (ii) tax provision (benefit); (iii) gain on event cancellation insurance claims, as applicable; (iv) other (income) expense, net; (v) stock-based compensation expense; (vi) depreciation, amortization, and accretion; (vii) goodwill impairment and other asset impairments, as applicable, (viii) workforce reduction expenses and certain other non-recurring items and (ix) gain/loss on divestitures, as applicable. Adjusted EBITDA Margin represents Adjusted EBITDA divided by GAAP Revenue. We believe Adjusted EBITDA and Adjusted EBITDA Margin are important measures of our recurring operations as they exclude items not representative of our core operating results.
Adjusted EBITDA Excluding Divested Operation and Adjusted EBITDA Margin Excluding Divested Operation: Represents Adjusted EBITDA as defined above less EBITDA from our Digital Markets divested operation. Adjusted EBITDA Margin Excluding Divested Operation represents Adjusted EBITDA Excluding Divested Operation divided by Adjusted Revenue. We believe Adjusted EBITDA Excluding Divested Operation and Adjusted EBITDA Margin Excluding Divested Operation are important measures of our recurring operations as it provides a more accurate and consistent period-over period comparison of our results.
Adjusted Net Income and Adjusted EPS: Represents GAAP net income (loss) and diluted net income (loss) per share adjusted for the impact of certain items directly related to acquisitions and other non-recurring items. These adjustments include (on a per share basis, in the case of Adjusted EPS): (i) the amortization of acquired intangibles*; (ii) workforce reduction expenses and other non-recurring items; (iii) gain on event cancellation insurance claims, as applicable; (iv) the non-cash (gain) loss on de-designated interest rate swaps, as applicable; (v) goodwill impairment and other asset impairments, as applicable, (vi) gain/loss on divestitures, as applicable. and (vii) the related tax impact. We believe Adjusted Net Income and Adjusted EPS are important measures of our recurring operations as they exclude items that may not be indicative of our core operating results.
* The Company excludes amortization of acquired intangibles because it is generally a fixed non-cash expense that can be significantly impacted by the timing and/or size of acquisitions and management does not use it to evaluate core operating results. Although the Company excludes the amortization of acquired intangibles from Adjusted Net Income and Adjusted EPS, management believes that it is important for investors to understand that such intangible assets were recorded as part of acquisition accounting and contribute to revenue generation.
Free Cash Flow: Represents cash provided by operating activities determined in accordance with GAAP less payments for capital expenditures. We believe Free Cash Flow is an important measure of the recurring cash generated by the Company’s core operations that may be available to be used to repay debt obligations, repurchase our stock, invest in future growth through new business development activities, or make acquisitions.
Foreign Currency Neutral (FX Neutral): We provide foreign currency neutral dollar amounts and percentages for our contract values, revenues, certain expenses, and other metrics. These foreign currency neutral dollar amounts and percentages eliminate the effects of exchange rate fluctuations and thus provide a more accurate and meaningful trend in the underlying data being measured. We calculate foreign currency neutral dollar amounts by converting the underlying amounts in local currency for different periods into U.S. dollars by applying the same foreign exchange rates to all periods presented.
SUPPLEMENTAL INFORMATION - NON-GAAP RECONCILIATIONS
The tables below provide reconciliations of certain Non-GAAP financial measures used in this Press Release with the most directly comparable GAAP measure. See “Non-GAAP Financial Measures” above for definitions of these measures.
Reconciliation - GAAP Revenues to Adjusted Revenues
(Unaudited; $ in millions)
Three Months Ended June 30,
2026
2025
Total revenues
$
1,676
$
1,686
Less: Divested operation revenues
—
(56
)
Adjusted revenues
$
1,676
$
1,631
Reconciliation - GAAP Net Income to Adjusted EBITDA Excluding Divested Operation
(Unaudited; $ in millions)
Three Months Ended June 30,
2026
2025
GAAP net income
$
275
$
241
Interest expense, net
22
12
Other expense (income), net
2
(2
)
Tax provision
79
77
Operating income
379
327
Adjustments:
Stock-based compensation expense (a)
41
43
Depreciation, amortization and accretion (b)
45
51
Loss on impairment of lease related assets (c)
—
1
Workforce reduction expenses and other non-recurring items (d)
—
22
Gain from sale of divested operation (e)
1
—
Adjusted EBITDA
$
466
$
443
Less: Divested operation adjusted EBITDA (f)
—
(6
)
Adjusted EBITDA excluding divested operation
$
466
$
438
(a)
Consists of costs for stock-based compensation awards.
(b)
Includes depreciation expense, amortization of intangibles and accretion on asset retirement obligations.
(c)
Includes impairment loss for lease related assets.
(d)
Consists of workforce reduction expenses, direct and incremental expenses related to acquisitions and divestitures, facility-related exit costs and other non-recurring items, if applicable.
(e)
Consists of an adjustment to the gain from the February 2026 sale of our divested operation.
(f)
Divested operation adjusted EBITDA is calculated as divested operation contribution minus certain direct Selling, General, and Administrative expenses. It excludes allocations for corporate support services and other indirect costs that benefited the business.
Reconciliation - GAAP Net Income and GAAP Net Income per Diluted Share to Adjusted Net Income and Adjusted EPS
(Unaudited; $ in millions, except per share amounts)
Three Months Ended June 30,
2026
2025
Amount
Per Share
Amount
Per Share
GAAP net income and GAAP net income per diluted share
$
275
$
4.14
$
241
$
3.11
Acquisition and other adjustments:
Amortization of acquired intangibles (a)
20
0.30
20
0.26
Workforce reduction expenses and other non-recurring items (b), (c)
1
0.02
23
0.29
Gain from sale of divested operation (d)
1
0.01
—
—
Loss on impairment of lease related assets (e)
—
—
1
0.01
Tax impact of adjustments (f)
(6
)
(0.10
)
(11
)
(0.14
)
Adjusted net income and Adjusted EPS (g)
$
291
$
4.37
$
273
$
3.53
(a)
Consists of non-cash amortization from acquired intangibles.
(b)
Consists of workforce reduction expenses, direct and incremental expenses related to acquisitions and divestitures, facility-related exit costs and other non-recurring items, if applicable.
(c)
Includes the amortization of deferred financing fees, which are recorded in Interest expense, net in the Company’s accompanying Condensed Consolidated Statements of Operations.
(d)
Consists of an adjustment to the gain from the February 2026 sale of our divested operation.
(e)
Includes impairment loss for lease related assets.
(f)
The blended effective tax rates on the adjustments were approximately 29.1% and 25.5% for the three months ended June 30, 2026 and 2025, respectively.
(g)
Adjusted EPS was calculated based on 66.6 million and 77.4 million diluted shares for the three months ended June 30, 2026 and 2025, respectively.
Reconciliation - GAAP Cash Provided by Operating Activities to Free Cash Flow
Knife River ve 2. čtvrtletí zvýšila tržby o 13 % na 938,6 mil. USD, ale čistý zisk klesl o 13 % na 43,9 mil. USD. Firma potvrdila celoroční výhled tržeb 3,4 až 3,6 mld. USD.
BISMARCK, N.D.--(BUSINESS WIRE)--Knife River Corporation (NYSE: KNF), an aggregates-based, vertically integrated construction materials and contracting services company, today announced financial results for the second quarter ended June 30, 2026.
PERFORMANCE SUMMARY
Three Months Ended June 30,
(In millions, except per share)
2026
2025
% Change
Revenue
$
938.6
$
833.8
13
%
Net income
$
43.9
$
50.6
(13
)%
Net income margin
4.7
%
6.1
%
Adjusted EBITDA
$
139.7
$
140.8
(1
)%
Adjusted EBITDA margin
14.9
%
16.9
%
Net income per share
$
0.77
$
0.89
(13
)%
Note: Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP financial measures. For more information on all non-GAAP measures and a reconciliation to the nearest GAAP measure, see the section entitled "Non-GAAP Financial Measures."
"During the quarter, we delivered 13% year-over-year revenue growth, including 20% revenue growth in contracting services," said Knife River President and CEO Brian Gray. "That pull-through demand, combined with contributions from acquisitions, helped us generate double-digit volume and gross profit growth across our material product lines. Aggregate pricing also improved by 8% on a product mix-adjusted basis. The fundamentals of our business are strong. During the quarter, headwinds related to energy costs, delayed impact projects, and the type and timing of contracting services impacted Adjusted EBITDA and margins. Last year, we also benefited in the second quarter from $10.3 million in gains on asset sales, compared to just $650,000 this quarter. Despite these factors, we delivered strong operational results year-over-year.
"With the majority of the construction season still ahead of us, we have opportunities to execute on our $1.2 billion contracting services backlog, driving volume and gross profit improvement in all of our product lines," Gray said. "Additionally, we continue to implement our self-help initiatives to improve margins — including price optimization and operational efficiencies.
"The acquisitions we have completed over the last two years also continue to perform as expected, and we have several targets in our pipeline that align with our growth strategy," Gray said. "In addition, we have multiple organic growth projects underway across our footprint, including aggregates reserve expansions designed to strengthen our position, support future earnings growth and create long-term shareholder value."
Knife River expects its full-year 2026 financial results to be in the ranges noted in the following table.
2026 Financial Guidance
Low
High
(In millions)
Revenue
$
3,400.0
$
3,600.0
Adjusted EBITDA
$
520.0
$
560.0
The company further expects:
Aggregates volumes to increase high-single digits and pricing to increase mid-single digits. Ready-mix volumes to increase mid-teens. Asphalt volumes to increase high-single digits. Depreciation, depletion and amortization to increase mid-teens. The guidance ranges are based on normal weather, economic and operating conditions, and do not include the expected impact of future acquisitions.
REPORTING SEGMENT PERFORMANCE
West
Alaska, California, Hawaii, Oregon, Washington
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
% Change
2026
2025
% Change
(In millions)
Revenue
$
290.4
$
317.4
(9
)%
$
502.2
$
525.7
(4
)%
EBITDA
$
49.2
$
60.7
(19
)%
$
71.4
$
85.7
(17
)%
EBITDA margin
17.0
%
19.1
%
14.2
%
16.3
%
Second quarter revenue decreased 9% year-over-year, primarily due to less available public-agency work in Oregon, as well as delays in Hawaii and Alaska related to project phasing and weather. EBITDA decreased 19% compared to the prior year, reflecting decreased activity and lower-margin contracting services work, partially offset by higher aggregate and ready-mix pricing across the region.
Mountain
Idaho, Montana, Utah, Wyoming
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
% Change
2026
2025
% Change
(In millions)
Revenue
$
236.5
$
176.1
34
%
$
317.7
$
242.1
31
%
EBITDA
$
31.0
$
30.9
—
%
$
22.8
$
14.6
56
%
EBITDA margin
13.1
%
17.6
%
7.2
%
6.0
%
Second quarter revenue increased 34% from the prior year, largely driven by an increase in contracting services as well as acquisitions completed in the first quarter. EBITDA was flat, as the revenue growth was primarily offset by the timing of project performance gains and lower-margin contracting services work.
Central
Iowa, Minnesota, North Dakota, South Dakota, Texas
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
% Change
2026
2025
% Change
(In millions)
Revenue
$
325.6
$
255.2
28
%
$
426.8
$
323.1
32
%
EBITDA
$
53.6
$
44.4
21
%
$
26.8
$
20.1
33
%
EBITDA margin
16.5
%
17.4
%
6.3
%
6.2
%
Second quarter revenue increased 28% from the prior year, primarily driven by increased volumes across all product lines as well as contributions from the Texcrete acquisition. EBITDA improved 21%, with a majority of the increase being attributed to aggregate sales, as well as higher margins on contracting services work. However, EBITDA margin declined as the prior-year period benefited from $7.9 million of gains on asset sales that did not recur this quarter.
Energy Services
California, Iowa, Nebraska, Oregon, South Dakota, Texas, Washington, Wyoming
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
% Change
2026
2025
% Change
(In millions)
Revenue
$
103.0
$
97.4
6
%
$
123.5
$
111.3
11
%
EBITDA
$
19.8
$
17.1
16
%
$
15.2
$
9.3
64
%
EBITDA margin
19.2
%
17.5
%
12.3
%
8.3
%
Second quarter revenue increased 6% from the prior year, driven by increased volumes due to improved market opportunities in California. EBITDA improved 16%, largely because of the increased sales volumes in California, as well as lower railcar maintenance expenses compared to prior year.
The company is committed to disciplined capital allocation, including reinvesting to maintain fixed assets, strengthening operations and growing the business.
The company currently estimates total 2026 capital expenditures for maintenance and improvement to be between 5% and 7% of revenue. For the six months ending June 30, 2026, the company spent $90.1 million, largely on the replacement of construction equipment and plant improvements.
Additionally, for the six months ended June 30, 2026, the company spent $244.5 million on growth initiatives, which was comprised of $184.4 million on acquisitions and $60.1 million on aggregate expansions and greenfield projects. For the remainder of 2026, the company expects to spend $76.4 million on organic growth projects. Capital expenditures for future acquisitions and new growth opportunities would be incremental to the outlined capital program. It is anticipated that capital expenditures for the remainder of 2026 will be funded by various sources, including cash from operations and debt.
On May 15, 2026, the company issued an incremental $400 million Term Loan B facility which was used to finance recent acquisitions and growth initiatives previously discussed, repay borrowings under the Revolving Credit Facility, and for working capital and general corporate purposes.
As of June 30, 2026, Knife River had $40.7 million of unrestricted cash and cash equivalents, $1.6 billion of gross debt and $387.2 million of available capacity under its revolving credit facility, net of outstanding letters of credit. Net leverage, defined as the ratio of net debt to trailing-twelve-month Adjusted EBITDA, was 3.2x at June 30, 2026.
Knife River will host a conference call at 11 a.m. EDT today to discuss second quarter results and conduct a question-and-answer session. The event will be webcast at investors.kniferiver.com.
To participate in the live call:
Domestic: 1-585-542-9983 International: 1-833-461-5787 Conference ID: 137711168 After the conclusion of the call, an on-demand replay of the webcast will be made available.
Knife River Corporation, a member of the S&P MidCap 400 index, mines aggregates and markets crushed stone, sand, gravel and related construction materials, including ready-mix concrete, asphalt and other value-added products. Knife River also performs vertically integrated contracting services, specializing in publicly funded DOT projects and private projects across the industrial, commercial and residential space. For more information about the company, visit www.kniferiver.com.
Knife River Corporation
Consolidated Statements of Operations
(Unaudited)
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
2026
2025
(In millions, except per share amounts)
Revenue:
Construction materials
$
532.1
$
493.6
$
794.4
$
707.0
Contracting services
406.5
340.2
554.3
480.2
Total revenue
938.6
833.8
1,348.7
1,187.2
Cost of revenue:
Construction materials
400.2
377.1
673.2
610.9
Contracting services
375.6
299.4
515.5
428.7
Total cost of revenue
775.8
676.5
1,188.7
1,039.6
Gross profit
162.8
157.3
160.0
147.6
Selling, general and administrative expenses
81.7
69.2
165.1
142.2
Operating income (loss)
81.1
88.1
(5.1
)
5.4
Interest expense
24.5
22.3
45.3
37.6
Other income
3.3
2.2
2.6
6.8
Income (loss) before income taxes
59.9
68.0
(47.8
)
(25.4
)
Income tax expense (benefit)
16.0
17.4
(12.5
)
(7.3
)
Net income (loss)
$
43.9
$
50.6
$
(35.3
)
$
(18.1
)
Net income (loss) per share:
Basic
$
0.77
$
0.89
$
(0.62
)
$
(0.32
)
Diluted
$
0.77
$
0.89
$
(0.62
)
$
(0.32
)
Weighted average common shares outstanding:
Basic
56.8
56.7
56.7
56.6
Diluted
56.9
56.9
56.7
56.6
Knife River Corporation
Consolidated Balance Sheets
(Unaudited)
June 30, 2026
June 30, 2025
December 31, 2025
(In millions, except shares and per share amounts)
Assets
Current assets:
Cash, cash equivalents and restricted cash
$
102.0
$
77.7
$
123.4
Receivables, net
468.4
428.1
278.1
Contract assets
121.9
64.0
77.5
Inventories
507.3
479.5
435.7
Prepayments and other current assets
72.0
54.0
46.2
Total current assets
1,271.6
1,103.3
960.9
Noncurrent assets:
Net property, plant and equipment
2,176.7
1,924.3
2,028.9
Goodwill
584.0
464.1
519.7
Other intangible assets, net
33.7
38.1
32.7
Operating lease right-of-use assets
51.4
49.1
52.6
Investments and other
60.4
52.6
55.3
Total noncurrent assets
2,906.2
2,528.2
2,689.2
Total assets
$
4,177.8
$
3,631.5
$
3,650.1
Liabilities and Stockholders' Equity
Current liabilities:
Long-term debt - current portion
$
17.2
$
11.8
$
11.7
Accounts payable
228.0
172.1
145.6
Contract liabilities
26.6
36.3
33.8
Accrued compensation
38.4
31.4
44.3
Current operating lease liabilities
16.5
14.3
15.9
Other taxes payable
18.8
18.0
11.3
Accrued interest
11.8
7.7
7.3
Other accrued liabilities
119.9
105.6
108.1
Total current liabilities
477.2
397.2
378.0
Noncurrent liabilities:
Long-term debt
1,600.1
1,341.2
1,153.8
Deferred income taxes
296.5
257.5
287.9
Noncurrent operating lease liabilities
34.8
34.8
36.7
Other
163.3
139.7
152.8
Total liabilities
2,571.9
2,170.4
2,009.2
Commitments and contingencies
Stockholders' equity:
Common stock, 300,000,000 shares authorized, $0.01 par value, 57,194,556 shares issued and 56,763,420 shares outstanding at June 30, 2026; 57,095,301 shares issued and 56,664,165 shares outstanding at June 30, 2025; 57,095,301 shares issued and 56,664,165 shares outstanding at December 31, 2025
0.6
0.6
0.6
Other paid-in capital
629.6
623.9
629.6
Retained earnings
989.3
849.4
1,024.6
Treasury stock held at cost - 431,136 shares
(3.6
)
(3.6
)
(3.6
)
Accumulated other comprehensive loss
(10.0
)
(9.2
)
(10.3
)
Total stockholders' equity
1,605.9
1,461.1
1,640.9
Total liabilities and stockholders' equity
$
4,177.8
$
3,631.5
$
3,650.1
Knife River Corporation
Consolidated Statements of Cash Flows
(Unaudited)
Six Months Ended
June 30,
2026
2025
(In millions)
Operating activities:
Net loss
$
(35.3
)
$
(18.1
)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation, depletion and amortization
108.5
89.0
Deferred income taxes
0.3
(0.1
)
Provision for credit losses
0.7
0.4
Amortization of debt issuance costs
2.0
1.8
Employee stock-based compensation costs
5.4
5.7
Pension and postretirement benefit plan net periodic benefit cost
0.9
0.7
Unrealized gains on investments
(2.3
)
(1.1
)
Gains on sales of assets
(2.6
)
(12.7
)
Gains on bargain purchases
(0.2
)
(3.6
)
Equity in earnings of unconsolidated affiliates
(0.7
)
(0.2
)
Changes in current assets and liabilities, net of acquisitions:
Receivables
(233.2
)
(177.4
)
Inventories
(66.2
)
(59.9
)
Other current assets
(22.5
)
(18.1
)
Accounts payable
87.6
36.2
Other current liabilities
16.7
(15.6
)
Pension and postretirement benefit plan contributions
(0.3
)
(0.3
)
Other noncurrent changes
7.6
5.5
Net cash used in operating activities
(133.6
)
(167.8
)
Investing activities:
Capital expenditures
(150.2
)
(228.6
)
Acquisitions, net of cash acquired
(184.4
)
(501.9
)
Net proceeds from sale or disposition of property and other
4.8
31.4
Investments
(2.8
)
(2.8
)
Net cash used in investing activities
(332.6
)
(701.9
)
Financing activities:
Issuance of long-term debt
461.0
683.0
Repayment of long-term debt
(6.9
)
(3.0
)
Debt issuance costs
(3.9
)
(11.1
)
Tax withholding on stock-based compensation
(5.4
)
(2.6
)
Net cash provided by financing activities
444.8
666.3
Decrease in cash, cash equivalents and restricted cash
(21.4
)
(203.4
)
Cash, cash equivalents and restricted cash -- beginning of year
123.4
281.1
Cash, cash equivalents and restricted cash -- end of period
$
102.0
$
77.7
Segment Financial Data and Highlights (Unaudited)
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
2026
2025
Dollars
Margin
Dollars
Margin
Dollars
Margin
Dollars
Margin
(Dollars in millions)
Revenues by segment:
West
$
290.4
$
317.4
$
502.2
$
525.7
Mountain
236.5
176.1
317.7
242.1
Central
325.6
255.2
426.8
323.1
Energy Services
103.0
97.4
123.5
111.3
Total segment revenues
955.5
846.1
1,370.2
1,202.2
Corporate Services and Eliminations
(16.9
)
(12.3
)
(21.5
)
(15.0
)
Consolidated revenues
$
938.6
$
833.8
$
1,348.7
$
1,187.2
EBITDA by segment:
West
$
49.2
17.0
%
$
60.7
19.1
%
$
71.4
14.2
%
$
85.7
16.3
%
Mountain
31.0
13.1
%
30.9
17.6
%
22.8
7.2
%
14.6
6.0
%
Central
53.6
16.5
%
44.4
17.4
%
26.8
6.3
%
20.1
6.2
%
Energy Services
19.8
19.2
%
17.1
17.5
%
15.2
12.3
%
9.3
8.3
%
Total segment EBITDA (a)
153.6
16.1
%
153.1
18.1
%
136.2
9.9
%
129.7
10.8
%
Corporate Services and Eliminations (b)
(13.4
)
N.M.
(13.4
)
N.M.
(31.4
)
N.M.
(31.5
)
N.M.
Consolidated EBITDA (a)
$
140.2
14.9
%
$
139.7
16.8
%
$
104.8
7.8
%
$
98.2
8.3
%
The following table summarizes backlog for the company.
June 30, 2026
June 30, 2025
(In millions)
West
$
235.7
$
282.4
Mountain
449.3
483.4
Central
531.0
487.6
$
1,216.0
$
1,253.4
Margins on backlog at June 30, 2026, are expected to be slightly lower than the margins on backlog at June 30, 2025. Approximately 85% of the company's contracting services backlog relates to publicly funded projects, including street and highway construction projects. Period over period increases or decreases should not be used as an indicator of future revenues or earnings.
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
2026
2025
Sales (thousands):
Aggregates (tons)
10,031
8,826
14,909
12,693
Ready-mix concrete (cubic yards)
1,193
1,041
1,917
1,585
Asphalt (tons)
2,030
1,643
2,313
1,842
Average selling price:*
Aggregates (per ton)
$
19.41
$
18.80
$
20.00
$
19.49
Ready-mix concrete (per cubic yard)
$
198.45
$
197.91
$
198.95
$
198.37
Asphalt (per ton)
$
65.77
$
67.45
$
66.79
$
68.92
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
2026
2025
Dollars
Margin
Dollars
Margin
Dollars
Margin
Dollars
Margin
(Dollars in millions)
Revenues by product line:
Aggregates
$
194.7
$
165.9
$
298.2
$
247.4
Ready-mix concrete
236.7
206.0
381.3
314.4
Asphalt
133.5
110.8
154.5
127.0
Liquid asphalt
91.4
85.9
109.5
98.1
Other*
83.7
79.6
130.3
123.0
Contracting services
406.5
340.2
554.3
480.2
Internal sales
(207.9
)
(154.6
)
(279.4
)
(202.9
)
Total revenues
$
938.6
$
833.8
$
1,348.7
$
1,187.2
Gross profit by product line:
Aggregates
$
38.8
19.9
%
$
34.6
20.8
%
$
35.1
11.8
%
$
28.6
11.6
%
Ready-mix concrete
39.1
16.5
%
32.4
15.7
%
54.6
14.3
%
41.1
13.1
%
Asphalt
20.9
15.7
%
16.8
15.2
%
16.0
10.3
%
11.2
8.8
%
Liquid asphalt
16.5
18.1
%
14.9
17.4
%
13.7
12.6
%
10.7
10.9
%
Other*
16.6
19.8
%
17.8
22.3
%
1.8
1.4
%
4.5
3.7
%
Contracting services
30.9
7.6
%
40.8
12.0
%
38.8
7.0
%
51.5
10.7
%
Total gross profit
$
162.8
17.3
%
$
157.3
18.9
%
$
160.0
11.9
%
$
147.6
12.4
%
NON-GAAP FINANCIAL MEASURES
EBITDA, EBITDA margin, Adjusted EBITDA, Adjusted EBITDA margin, as well as total segment measures, as applicable, net debt and net leverage are considered non-GAAP measures of financial performance. These non-GAAP financial measures are not measures of financial performance under GAAP. The items excluded from these non-GAAP financial measures are significant components in understanding and assessing financial performance. Therefore, these non-GAAP financial measures should not be considered substitutes for the applicable GAAP metric.
EBITDA, EBITDA margin, Adjusted EBITDA and Adjusted EBITDA margin are most directly comparable to the corresponding GAAP measures of net income and net income margin. Net debt and net leverage are most directly comparable to the corresponding GAAP measures of total debt. We believe these non-GAAP financial measures, in addition to corresponding GAAP measures, are useful to investors by providing meaningful information about operational efficiency compared to our peers by excluding the impacts of differences in tax jurisdictions and structures, debt levels and capital investment. We believe Adjusted EBITDA and Adjusted EBITDA margin are useful performance measures because they allow for an effective evaluation of our operating performance by excluding unrealized gains and losses on benefit plan investments, stock-based compensation, and the impact of selling acquired inventory after markup to fair value as part of acquisition accounting, as they are considered non-cash and not part of our core operations. We believe EBITDA and Adjusted EBITDA assist rating agencies and investors in comparing operating performance across operating periods on a consistent basis by excluding items management does not believe are indicative of the company's operating performance, including using EBITDA and Adjusted EBITDA to calculate Knife River’s leverage as a multiple of EBITDA and Adjusted EBITDA. Additionally, EBITDA and Adjusted EBITDA are important financial metrics for debt investors who utilize debt to EBITDA and debt to Adjusted EBITDA ratios. We believe EBITDA, EBITDA margin, Adjusted EBITDA and Adjusted EBITDA margin, including those measures by segment, are useful performance measures because they provide clarity as to the operational results of the company. Management believes net debt and net leverage are useful performance measures because they provide a measure of how long it would take the company to pay back its debt if net debt and Adjusted EBITDA were constant. Net leverage also allows management to assess our borrowing capacity and optimal leverage ratio. Our management uses these non-GAAP financial measures in conjunction with GAAP results when evaluating our operating results internally and calculating employee incentive compensation, and leverage as a multiple of Adjusted EBITDA to determine the appropriate method of funding our operations.
EBITDA is calculated by adding back income taxes, interest expense (net of interest income) and depreciation, depletion and amortization expense to net income. EBITDA margin is calculated by dividing EBITDA by revenues. Adjusted EBITDA is calculated by adding back unrealized gains and losses on benefit plan investments, stock-based compensation and the impact of selling acquired inventory after markup to fair value as part of acquisition accounting to EBITDA. Adjusted EBITDA margin is calculated by dividing Adjusted EBITDA by revenues. Net debt is calculated by adding unamortized debt issuance costs to the total debt balance presented on the balance sheet, less any unrestricted cash. Net leverage is calculated by dividing net debt by trailing-twelve-month Adjusted EBITDA. These non-GAAP financial measures are calculated the same for both the segment and consolidated metrics and should not be considered as alternatives to, or more meaningful than, GAAP financial measures such as net income, net income margin and total debt and are intended to be helpful supplemental financial measures for investors’ understanding of our operating performance. Our non-GAAP financial measures are not standardized; therefore, it may not be possible to compare these financial measures with other companies’ EBITDA, EBITDA margin, Adjusted EBITDA, Adjusted EBITDA margin, net debt and net leverage measures having the same or similar names.
The following information reconciles segment and consolidated net income (loss) to EBITDA and Adjusted EBITDA and provides the calculation of EBITDA margin, Adjusted EBITDA margin, net debt and net leverage. Interest expense, net, is net of interest income that is included in other income (expense) on the Consolidated Statements of Operations.
The following table provides the reconciliation of net income (loss) to EBITDA and Adjusted EBITDA.
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
2026
2025
(In millions)
Net income (loss)
$
43.9
$
50.6
$
(35.3
)
$
(18.1
)
Depreciation, depletion and amortization
56.4
50.2
108.5
88.9
Interest expense, net
23.9
21.5
44.1
34.7
Income taxes
16.0
17.4
(12.5
)
(7.3
)
EBITDA
$
140.2
$
139.7
$
104.8
$
98.2
Unrealized (gains) losses on benefit plan investments
(3.2
)
(1.8
)
(2.4
)
(1.1
)
Stock-based compensation expense
2.6
2.9
5.4
5.7
Impact of selling acquired inventory after markup to fair value as part of acquisition accounting
0.1
—
0.1
—
Adjusted EBITDA
$
139.7
$
140.8
$
107.9
$
102.8
Revenue
$
938.6
$
833.8
$
1,348.7
$
1,187.2
Net income (loss) margin
4.7
%
6.1
%
(2.6
)%
(1.5
)%
EBITDA margin
14.9
%
16.8
%
7.8
%
8.3
%
Adjusted EBITDA margin
14.9
%
16.9
%
8.0
%
8.7
%
The following table provides the reconciliation of consolidated net income (loss) to total segment EBITDA.
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
2026
2025
(In millions)
Net income (loss)
$
43.9
$
50.6
$
(35.3
)
$
(18.1
)
Depreciation, depletion and amortization
56.4
50.2
108.5
88.9
Interest expense, net
23.9
21.5
44.1
34.7
Income taxes
16.0
17.4
(12.5
)
(7.3
)
EBITDA
$
140.2
$
139.7
$
104.8
$
98.2
Less corporate services EBITDA
(13.4
)
(13.4
)
(31.4
)
(31.5
)
Total segment EBITDA
$
153.6
$
153.1
$
136.2
$
129.7
The following tables provide the reconciliation of the net leverage calculation of net debt to Adjusted EBITDA.
Twelve Months Ended
June 30, 2026
Six Months Ended June 30, 2026
Twelve Months Ended December 31, 2025
Six Months Ended June 30, 2025
(In millions)
Net income (loss)
$
139.9
$
(35.3
)
$
157.1
$
(18.1
)
Depreciation, depletion and amortization
213.3
108.5
193.7
88.9
Interest expense, net
86.8
44.1
77.4
34.7
Income taxes
50.9
(12.5
)
56.1
(7.3
)
EBITDA
$
490.9
$
104.8
$
484.3
$
98.2
Unrealized (gains) losses on benefit plan investments
(4.2
)
(2.4
)
(2.9
)
(1.1
)
Stock-based compensation expense
11.1
5.4
11.4
5.7
Impact of selling acquired inventory after markup to fair value as part of acquisition accounting
3.8
.1
3.7
—
Adjusted EBITDA
$
501.6
$
107.9
$
496.5
$
102.8
The following table provides the reconciliation of the net leverage calculation of net debt to Adjusted EBITDA.
Twelve Months Ended
June 30, 2026
(In millions)
Long-term debt
$
1,600.1
Long-term debt - current portion
17.2
Total debt
1,617.3
Add: Unamortized debt issuance costs
17.9
Total debt, gross
1,635.2
Less: Cash and cash equivalents, excluding restricted cash
40.7
Total debt, net
$
1,594.5
Trailing-twelve-months ended June 30, 2026, Adjusted EBITDA
$
501.6
Net leverage
3.2
x
Knife River’s projections for 2026 Adjusted EBITDA is a non-GAAP financial measure that excludes or otherwise has been adjusted for non-GAAP adjustment items from Knife River’s financial statements. When the company provides its forward-looking 2026 Adjusted EBITDA, it does not provide a reconciliation of these non-GAAP financial measures as Knife River is unable to predict with a reasonable degree of certainty the actual impact of the non-GAAP adjustment items. By their very nature, non-GAAP adjustment items are difficult to anticipate with precision because they are generally associated with unexpected and unplanned events that impact our company and its financial results, including, but not limited to, the potentially high variability, complexity and low visibility with respect to the items that would be excluded from the applicable GAAP measure in the relevant future period, such as unusual gains and losses, the impact and timing of potential acquisitions and divestitures, certain financing costs and other structural changes or their probable significance. Therefore, Knife River is unable to provide a reconciliation of these measures without unreasonable efforts.
FORWARD-LOOKING STATEMENTS
The information in this news release highlights the key growth strategies, projections and certain assumptions for the company and its subsidiaries. Many of these highlighted statements and other statements not historical in nature are “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Although the company believes that its expectations are expressed in good faith and based on reasonable assumptions, there is no assurance the company’s statements with respect to its EDGE strategy, shareholder value creation, financial guidance, expected long-term goals, expected backlog margin, or other proposed strategies will be achieved. Please refer to assumptions contained in this news release, as well as the various important factors listed in Part I, Item 1A - Risk Factors in the company's most recent Form 10-K and subsequent filings with the Securities and Exchange Commission.
Changes in such assumptions and factors could cause actual future results to differ materially from those expressed in the forward-looking statements. All forward-looking statements in this news release are expressly qualified by such cautionary statements and by reference to the underlying assumptions. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Except as required by law, the company does not undertake to update forward-looking statements, whether as a result of new information, future events or otherwise.
Bitzero oznámila spolupráci s Vertiv, která má posílit její technické, inženýrské a dodavatelské kapacity pro AI, HPC a hyperscale datová centra. Vertiv přidá odborné znalosti v oblasti napájení, chlazení a nasazení infrastruktury.
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - Bitzero Holdings Inc. (Nasdaq: AIBZ) (CSE: AIBZ.U) (FSE: 000) ("Bitzero" or the "Company"), a provider of sustainable high-performance compute ("HPC") and AI data center infrastructure, today announced a collaboration with Vertiv, a global leader in critical digital infrastructure, further strengthening Bitzero's growing ecosystem of technical, engineering, and supply chain providers supporting the delivery of next-generation data center infrastructure.
Further to Bitzero's previously announced partnerships, Vertiv adds deep expertise in critical power, thermal management, and infrastructure deployment to support the design and delivery of AI, HPC, and hyperscale data centers. The relationship expands Bitzero's access to proven technologies and engineering capabilities that can help accelerate project execution while supporting performance, efficiency, and scalability requirements.
Vertiv technologies and expertise are expected to serve as a key pillar within Bitzero's broader execution platform, bringing global expertise in critical power and cooling systems, including advanced liquid cooling design and engineering capabilities required for modern AI and HPC environments. As compute density increases and customer requirements evolve, integrated end-to-end infrastructure systems and modular solutions are becoming increasingly central to the successful deployment of resilient, scalable, and efficient digital infrastructure, helping customers accelerate deployment and reduce time to token.
The collaboration reflects Bitzero's continued focus on building an integrated network of industry-leading providers across technical design, project execution, and supply chain coordination. By deepening its relationships with specialized infrastructure leaders, the Company is positioning itself to deliver high-performance compute environments that meet the demands of hyperscale, AI, and other advanced workloads.
"Bitzero is intentionally building an ecosystem of leading providers across every critical layer of data center delivery," said Bitzero Founder & CEO, Mohammed Bakhashwain. "Following our previously announced relationships, Vertiv further enhances our technical depth across critical power, thermal management, and infrastructure solutions, while strengthening our supply chain capabilities as we continue advancing our platform for hyperscale, AI, and HPC applications."
"Successfully scaling AI requires more than advanced compute, it requires end-to-end infrastructure capable of supporting increasingly demanding power and thermal profiles," said Paul Ryan, president for Europe, Middle East and Africa (EMEA) at Vertiv. "Vertiv draws on decades of experience in critical digital infrastructure to help organizations deploy and operate the power and cooling systems that underpin AI and HPC environments, helping accelerate AI readiness and support faster time-to-token outcomes. We are pleased to support Mohammed and the Bitzero team as it expands its capabilities to meet growing customer demand."
As Bitzero continues to advance its development strategy, the Company remains focused on bringing together the expertise, infrastructure providers, and delivery capabilities necessary to support long-term growth across its portfolio of sites.
About Bitzero Holdings Inc.
Bitzero Holdings Inc. is a provider of IT energy infrastructure and high-efficiency power for data centers. The Company focuses on data center development, high-performance compute (HPC), and strategic data center hosting partnerships. Bitzero Holdings Inc. owns four data center locations in the North American and Nordic regions, with its Nordic assets powered by clean, low-carbon energy sources. Visit www.bitzero.com for more information.
About Vertiv
Vertiv brings together hardware, software, analytics and ongoing services to enable its customers' vital applications to run continuously, perform optimally and grow with their business needs. Vertiv solves the most important challenges facing today's data centers, communication networks and commercial and industrial facilities with a portfolio of power, cooling and IT infrastructure solutions and services that extends from the cloud to the edge of the network. Headquartered in Westerville, Ohio, USA, Vertiv does business in more than 130 countries. For more information, and for the latest news and content from Vertiv, visit Vertiv.com.
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27 of the Securities Act, and Section 21E of the Securities Exchange Act, and "forward-looking information" within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). Forward-looking statements are often, but not always, identified by words such as "anticipate", "plan", "expect", "intend", "may", "will", "would", "could", "should", "believe", "estimate", "project", "potential", "target" or similar expressions suggesting future outcomes or events.
Forward-looking statements in this release include, but are not limited to, statements regarding the anticipated benefits of the collaboration with Vertiv; the expected role of Vertiv's technologies and expertise within Bitzero's execution platform; and Bitzero's ability to design, deliver and scale AI, HPC and hyperscale data center infrastructure, accelerate project execution and reduce time to token. These statements are only a prediction and are based on assumptions including that the collaboration will proceed and deliver benefits as expected; that Vertiv will provide the anticipated technologies, expertise and support on commercially reasonable terms and on a timely basis; that Bitzero will have access to the capital, power, sites and personnel required to advance its development strategy; that Bitzero will secure customer demand for AI and HPC capacity at its sites; that Bitzero will complete site development in accordance with its expected timelines; that no unforeseen technological, competitive or regulatory developments will materially impair the anticipated benefits of the collaboration; and that there will be no material change in economic, market, supply chain or regulatory conditions. Bitzero believes that the assumptions on which its forward-looking statements are based were reasonable when made, but cautions readers that these assumptions may prove to be incorrect.
Actual events or results may differ materially from those in the forward-looking statements set forth herein as a result of a number of factors, including: risks relating to the execution of Bitzero's development strategy; the availability, cost and timing of financing, critical power, cooling and other data center infrastructure; supply chain and counterparty performance; risks that the Vertiv collaboration does not deliver the anticipated benefits, is terminated or modified, or does not proceed on the timelines or terms currently contemplated; risks associated with the evolution of AI and HPC customer requirements and compute density; competitive risks in the AI/HPC and data center infrastructure market; technology obsolescence risk; and general economic and market conditions. Readers are referred to Vertiv's filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and to Bitzero's continuous disclosure record, including its most recent Annual Information Form, Management's Discussion and Analysis, its CSE listing statement and its registration statement/annual report on Form 40-F, in each case available on SEDAR+ at www.sedarplus.ca or on EDGAR at www.sec.gov, for a discussion of the risk factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this release. The forward-looking statements in this release are made as of the date hereof, and neither Vertiv nor Bitzero undertakes any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/307656
Source: Bitzero Holdings Inc.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Timken ve 2. čtvrtletí zvýšil tržby o 7,5 % na 1,26 mld. USD, ale čistý zisk klesl na 28,9 mil. USD. Firma zároveň zvedla celoroční výhled EPS na 3,75–4,05 USD a upravený EPS na 6,05–6,35 USD.
Sales of $1.26 billion, up 7.5 percent from last year Second-quarter diluted EPS of $0.41; adjusted EPS of $1.83 Net income margin of 2.3 percent; adjusted EBITDA margin of 19.6 percent Updates 2026 EPS outlook; now expects 2026 EPS of $3.75-$4.05, raising adjusted EPS outlook to $6.05-$6.35 , /PRNewswire/ -- The Timken Company (NYSE: TKR) (www.timken.com), a leader in advanced motion technology, today reported second-quarter 2026 results.
2Q-26
2Q-25
% Change
Net Sales (mils.)
$1,260.9
$1,173.4
7.5 %
Net Income Margin
2.3 %
6.7 %
(440 bps)
Adjusted EBITDA Margin
19.6 %
17.7 %
190 bps
Diluted EPS
$0.41
$1.12
(63.4) %
Adjusted EPS
$1.83
$1.42
28.9 %
Net Cash from Operations (mils.)
$107.1
$111.3
(3.8) %
Free Cash Flow
$80.5
$78.2
2.9 %
"The Timken team is successfully advancing our Elevate to Outperform strategy to accelerate profitable growth, structurally increase margins and create long-term shareholder value," said Lucian Boldea, president and chief executive officer. "Second quarter results demonstrate our team's strong execution and continued progress against these objectives combined with our ability to capitalize on improving customer demand. Our performance during the first half of the year, continued momentum, and disciplined execution framework gives us the confidence to raise our 2026 outlook."
Second-Quarter 2026 Highlights
Timken delivered sales in the second quarter of $1.26 billion, up 7.5 percent from the same period a year ago. The increase was driven by higher volumes across both segments, higher pricing, revenue from the Bijur Delimon acquisition and favorable foreign currency translation. Organically, sales were up 4.4 percent as compared to the second quarter of 2025.
The company posted net income in the second quarter of $28.9 million or $0.41 per diluted share. This compares to net income of $78.5 million or $1.12 per diluted share for the same period a year ago. The company's net income margin in the quarter was 2.3 percent, compared to 6.7 percent in the second quarter of last year. Net income in the current period includes an impairment charge related to the anticipated divestiture of the company's belts business.
Excluding special items (detailed in the attached tables), adjusted net income in the second quarter was $128.4 million or $1.83 per diluted share. This compares to adjusted net income of $99.3 million or $1.42 per diluted share for the same period in 2025. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) in the quarter were $247.2 million or 19.6 percent of sales, compared with $208.2 million or 17.7 percent of sales in the second quarter of last year. Adjusted EBITDA in the current period includes a net benefit of $8.0 million for IEEPA tariff refunds.
Net cash provided by operations in the quarter was $107.1 million, and free cash flow was $80.5 million. During the quarter, Timken increased its quarterly dividend by 3 percent and repurchased approximately 155 thousand shares of company stock. In total, the company returned $45.0 million of cash to shareholders through dividends and share repurchases during the quarter. The company ended the quarter with a strong balance sheet; net debt to adjusted EBITDA was 2.0 times as of June 30, 2026.
Second-Quarter 2026 Segment Results
Engineered Bearings sales of $807.0 million increased 3.8 percent from the same period a year ago driven primarily by higher volumes, the impact of higher pricing and favorable foreign currency translation.
Adjusted EBITDA in the quarter was $161.3 million or 20.0 percent of sales, compared with $153.4 million or 19.7 percent of sales in the second quarter of last year. The increase in adjusted EBITDA was driven primarily by positive price/mix, the impact of higher volume, a net benefit for tariff refunds and favorable foreign currency, partially offset by higher operating costs.
Industrial Motion sales of $453.9 million increased 14.6 percent compared with the same period a year ago driven primarily by higher demand across most platforms and end-market sectors, revenue from the Bijur Delimon acquisition, higher pricing and favorable foreign currency translation.
Adjusted EBITDA in the quarter was $105.6 million or 23.3 percent of sales, compared with $72.6 million or 18.3 percent of sales in the second quarter of last year. The increase in adjusted EBITDA was driven primarily by the impact of higher volume, positive price/mix, a net benefit for tariff refunds and contribution from the Bijur Delimon acquisition, partially offset by higher operating costs.
2026 Outlook
Timken is updating its 2026 outlook, with full-year earnings per diluted share now forecasted to be in the range of $3.75 to $4.05 and is raising its adjusted earnings per diluted share to the range of $6.05 to $6.35. The company is planning for 2026 revenue to be up approximately 5.5 percent in total at the midpoint from 2025, a slight increase from its prior outlook of 5 percent growth at the midpoint.
Conference Call Information
Timken will host a conference call today at 11 a.m. Eastern Time to review its financial results. Presentation materials will be available online in advance of the call for interested investors and securities analysts.
Conference Call:
Tuesday, August 4, 2026
11:00 a.m. Eastern Time
Live Dial-In: 888-880-3330
Conference ID: 2764753
Live Webcast:
http://investors.timken.com
Replay:
https://tmkn.biz/4b21FiY
About The Timken Company
The Timken Company (NYSE: TKR; www.timken.com), a leader in advanced motion technology, designs and manufacturers highly engineered systems and components for customers in strategic end markets, including aerospace and defense, power and electrification, and automation and industrial solutions. With more than 125 years of specialized expertise and a multinational presence, Timken is a trusted partner worldwide, innovating and powering performance across the application lifecycle. The company posted $4.6 billion in sales in 2025 and employs approximately 19,000 people, operating from 45 countries. Learn more at www.timken.com or @TheTimkenCompany.
Certain statements in this release (including statements regarding the company's forecasts, beliefs, estimates, plans and expectations) that are not historical in nature are "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, the statements related to expectations regarding the company's future financial performance, including information under the heading "2026 Outlook," are forward-looking.
The company cautions that actual results may differ materially from those projected or implied in forward-looking statements due to a variety of important factors, including: the finalization of the company's financial statements for the second quarter of 2026; fluctuations in customer demand for the company's products or services; changes in customer preferences due to emergent technologies, evolving regulatory landscapes or other factors; unanticipated changes in business relationships with customers or their purchases from the company; changes in the financial health of the company's customers, which may have an impact on the company's revenues, earnings and impairment charges; logistical issues associated with port closures, delays or increased costs; costs associated with inclement weather events; the impact of changes to the company's accounting methods; political risks associated with government instability; recent world events that have increased the risks posed by international trade disputes, tariffs, sanctions and hostilities; strained geopolitical relations between countries in which we have significant operations; weakness in global or regional general economic conditions and capital markets (as a result of financial stress affecting the banking system or otherwise); changes in wages, shipping costs, raw material costs, energy and fuel prices, and other production costs; new technology, including artificial intelligence, that may impact the way the Company's products are produced, sold or distributed; changes in customer demand or tariff rates and other costs associated with tariffs; the company's ability to satisfy its obligations under its debt agreements and renew or refinance borrowings on favorable terms; fluctuations in currency valuations or interest rates; changes in the expected costs associated with product warranty claims; the ability to achieve satisfactory operating results in the integration of acquired companies, including realizing any accretion, synergies, and expected cashflow generation within expected timeframes or at all; the company's ability to effectively adjust prices for its products in response to changing dynamics; the impact on the company's pension obligations and assets due to changes in interest rates, investment performance and other tactics designed to reduce risk; the introduction of new disruptive technologies, such as artificial intelligence; unplanned plant shutdowns; the effects of government-imposed restrictions, commercial requirements, and company goals associated with climate change and emissions or other sustainability initiatives; unanticipated litigation, claims, investigations remediation, or assessments; the rapidly evolving global regulatory landscape and the corresponding heightened operational complexity and compliance risks; restrictions on the use of, or claims or remediation associated with, per- and polyfluoroalkyl substances or polytetrafluoroethylene; the company's ability to maintain positive relations with unions and works councils; the company's ability to compete for skilled labor and to attract, retain and develop management, other key employees, and skilled personnel; negative impacts to the company's operations or financial position as a result of pandemics, epidemics, or other public health concerns and associated governmental measures; and the company's ability to complete and achieve the benefits of announced plans, programs, initiatives, acquisitions, capital investments, and cost reduction actions. Additional factors are discussed in the company's filings with the Securities and Exchange Commission, including the company's Annual Report on Form 10-K for the year ended Dec. 31, 2025, quarterly reports on Form 10-Q and current reports on Form 8-K. Except as required by the federal securities laws, the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Media Relations:
Sarah Factor
234.262.4878
[email protected]
Investor Relations:
Neil Frohnapple
234.262.2310
[email protected]
The Timken Company
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in millions, except share data) (Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Net sales
$
1,260.9
$
1,173.4
$
2,492.2
$
2,313.7
Cost of products sold
861.6
813.1
1,698.9
1,594.7
Selling, general & administrative expenses
205.9
189.7
407.1
374.5
Amortization of intangible assets
20.7
19.9
41.3
38.9
Impairment and restructuring charges
87.9
2.9
91.5
13.8
Operating Income
84.8
147.8
253.4
291.8
Non-service pension and other postretirement expense
(0.7)
(1.2)
(1.4)
(2.4)
Other expense, net
(2.5)
(3.4)
(4.9)
(3.7)
Interest expense, net
(23.7)
(26.8)
(46.3)
(51.0)
Income Before Income Taxes
57.9
116.4
200.8
234.7
Provision for income taxes
20.7
30.7
57.7
57.6
Net Income
37.2
85.7
143.1
177.1
Less: Net income attributable to noncontrolling interest
8.3
7.2
16.0
20.3
Net Income Attributable to The Timken Company
$
28.9
$
78.5
$
127.1
$
156.8
Net Income per Common Share Attributable to The Timken Company Common Shareholders
Basic Earnings per share
$
0.42
$
1.13
$
1.83
$
2.24
Diluted Earnings per share
$
0.41
$
1.12
$
1.81
$
2.23
Average Shares Outstanding
69,468,880
69,751,965
69,531,059
69,877,737
Average Shares Outstanding - assuming dilution
70,090,431
70,075,084
70,152,767
70,283,847
BUSINESS SEGMENTS
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
(Dollars in millions)
2026
2025
2026
2025
Engineered Bearings
Net sales
$
807.0
$
777.4
$
1,613.2
$
1,538.1
Adjusted Earnings before interest, taxes, depreciation and amortization (EBITDA) (1)
$
161.3
$
153.4
$
320.3
$
312.6
Adjusted EBITDA Margin (1)
20.0
%
19.7
%
19.9
%
20.3
%
Industrial Motion
Net sales
$
453.9
$
396.0
$
879.0
$
775.6
Adjusted Earnings before interest, taxes, depreciation and amortization (EBITDA) (1)
$
105.6
$
72.6
$
196.9
$
139.7
Adjusted EBITDA Margin (1)
23.3
%
18.3
%
22.4
%
18.0
%
Unallocated corporate expense (1)
$
(19.7)
$
(17.8)
$
(39.0)
$
(36.0)
Consolidated
Net sales
$
1,260.9
$
1,173.4
$
2,492.2
$
2,313.7
Adjusted Earnings before interest, taxes, depreciation and amortization (EBITDA) (1)
$
247.2
$
208.2
$
478.2
$
416.3
Adjusted EBITDA Margin (1)
19.6
%
17.7
%
19.2
%
18.0
%
EBITDA is a non-GAAP measure defined as operating income plus other income (expense) and excluding depreciation and amortization. EBITDA Margin is a non-GAAP measure defined as EBITDA as a percentage of net sales. EBITDA and EBITDA Margin are important financial measures used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. Management believes that reporting EBITDA and EBITDA Margin is useful to investors as these measures are representative of the core operations of the Company. See the subsequent pages for the reconciliations of Consolidated EBITDA and Consolidated EBITDA Margin.
(1) Consolidated adjusted EBITDA is a non-GAAP measure defined as EBITDA less impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, property losses and recoveries, gains and losses on the sale of real estate and divestitures, and other items from time to time that are not part of the Company's core operations. Consolidated adjusted EBITDA Margin is a non-GAAP measure defined as Consolidated adjusted EBITDA as a percentage of net sales. Management believes Consolidated adjusted EBITDA and Consolidated adjusted EBITDA Margin are important financial measures used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. Management believes that reporting adjusted EBITDA and adjusted EBITDA Margin is useful to investors as these measures are representative of the core operations of the Company. See subsequent pages for the reconciliations of Consolidated Adjusted EBITDA and Consolidated Adjusted EBITDA Margin. Segment Adjusted EBITDA is the measurement of segment profit and loss. The Company's Chief Operating Decision Maker ("CODM") utilizes Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin to evaluate segment performance and allocates resources. See the Company's quarterly report on Form 10-Q for a reconciliation of Segment Adjusted EBITDA to income before income taxes.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in millions)
(Unaudited)
June 30,
2026
December 31,
2025
ASSETS
Cash and cash equivalents
$
399.1
$
364.4
Restricted cash
1.4
1.0
Accounts receivable, net
822.9
689.4
Unbilled receivables
174.0
137.6
Inventories, net
1,249.1
1,243.3
Other current assets
196.0
165.1
Total Current Assets
2,842.5
2,600.8
Property, plant and equipment, net
1,289.9
1,357.6
Operating lease assets
152.4
152.9
Goodwill and other intangible assets
2,473.0
2,488.7
Other assets
67.8
76.8
Total Assets
$
6,825.6
$
6,676.8
LIABILITIES
Accounts payable
$
371.1
$
353.2
Short-term debt, including current portion of long-term debt
40.2
38.9
Income taxes
17.3
31.4
Accrued expenses
489.7
498.6
Total Current Liabilities
918.3
922.1
Long-term debt
2,036.0
1,883.1
Accrued pension benefits
136.6
148.9
Accrued postretirement benefits
29.2
29.3
Long-term operating lease liabilities
94.3
100.8
Other non-current liabilities
248.1
246.9
Total Liabilities
3,462.5
3,331.1
EQUITY
The Timken Company shareholders' equity
3,194.5
3,184.6
Noncontrolling interest
168.6
161.1
Total Equity
3,363.1
3,345.7
Total Liabilities and Equity
$
6,825.6
$
6,676.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
(Dollars in millions)
2026
2025
2026
2025
Cash Provided by (Used in)
OPERATING ACTIVITIES
Net Income
$
37.2
$
85.7
$
143.1
$
177.1
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
59.7
57.2
118.6
112.3
Impairment charges
79.0
—
79.0
—
Stock-based compensation expense
6.9
6.9
14.5
14.4
Pension and other postretirement expense
1.3
1.9
2.6
3.7
Pension and other postretirement benefit contributions and payments
(7.3)
(4.6)
(18.1)
(28.4)
Changes in operating assets and liabilities:
Accounts receivable
(11.8)
(21.0)
(124.6)
(91.8)
Unbilled receivables
(18.4)
5.9
(36.6)
(12.3)
Inventories
(5.4)
5.2
(17.9)
20.5
Accounts payable
(8.0)
2.8
23.1
23.0
Accrued expenses
(5.6)
(11.4)
(24.1)
(27.4)
Income taxes
(25.0)
(25.5)
(9.0)
(22.0)
Other, net
4.5
8.2
(4.2)
0.8
Net Cash Provided by Operating Activities
$
107.1
$
111.3
$
146.4
$
169.9
INVESTING ACTIVITIES
Capital expenditures
$
(26.6)
$
(33.1)
$
(65.4)
$
(68.3)
Acquisitions, net of cash received
(0.1)
—
(124.4)
—
Investments in short-term marketable securities, net
2.9
3.9
9.0
4.7
Other, net
0.3
0.1
0.3
2.0
Net Cash Used in Investing Activities
$
(23.5)
$
(29.1)
$
(180.5)
$
(61.6)
FINANCING ACTIVITIES
Cash dividends paid to shareholders
$
(25.0)
$
(24.4)
$
(50.3)
$
(49.5)
Purchase of treasury shares
(20.0)
(22.6)
(48.0)
(45.7)
Proceeds from exercise of stock options
2.4
0.2
5.3
0.5
Payments related to tax withholding for stock-based compensation
(1.2)
(0.3)
(10.4)
(9.8)
Net proceeds (payments) from credit facilities
17.5
(1.1)
180.3
26.9
Net payments on long-term debt
(1.1)
(6.1)
(2.2)
(7.3)
Net Cash Provided by (Used in) Financing Activities
$
(27.4)
$
(54.3)
$
74.7
$
(84.9)
Effect of exchange rate changes on cash
(1.2)
16.4
(5.5)
23.8
Increase in Cash, Cash Equivalents and Restricted Cash
$
55.0
$
44.3
$
35.1
$
47.2
Cash, Cash Equivalents and Restricted Cash at Beginning of Period
345.5
376.5
365.4
373.6
Cash, Cash Equivalents and Restricted Cash at End of Period
$
400.5
$
420.8
$
400.5
$
420.8
Reconciliations of Adjusted Net Income to GAAP Net Income and Adjusted Earnings Per Share to GAAP Earnings Per Share:
(Unaudited)
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes that the non-GAAP measures of adjusted net income and adjusted diluted earnings per share are important financial measures used in the management of the business, including decisions concerning the allocation of resources and assessment of performance. Management believes that reporting adjusted net income and adjusted diluted earnings per share is useful to investors as these measures are representative of the Company's core operations.
(Dollars in millions, except share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
EPS
2025
EPS
2026
EPS
2025
EPS
Net Income Attributable to The Timken Company
$
28.9
$
0.41
$
78.5
$
1.12
$
127.1
$
1.81
$
156.8
$
2.23
Adjustments: (1)
Acquisition intangible amortization
$
20.7
$
19.9
$
41.3
$
38.9
Impairment, restructuring and reorganization charges (2)
9.0
5.0
13.9
8.2
Acquisition-related charges (3)
3.4
—
5.2
—
Belts impairment, restructuring and reorganization charges (4)
94.4
—
94.4
—
Gain on sale of certain assets (5)
—
(0.1)
—
(1.3)
CEO transition expenses (6)
—
3.2
—
11.8
Noncontrolling interest of above adjustments (7)
0.4
1.0
0.3
4.8
Provision for income taxes (8)
(28.4)
(8.2)
(36.5)
(21.3)
Total Adjustments:
99.5
1.42
20.8
0.30
118.6
1.69
41.1
0.59
Adjusted Net Income Attributable to The Timken Company
$
128.4
$
1.83
$
99.3
$
1.42
$
245.7
$
3.50
$
197.9
$
2.82
(1) Adjustments are pre-tax, with the net tax provision listed separately.
(2) Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; (iv) impairment of assets; and (v) related depreciation and amortization. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations.
(3) Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact.
(4) On April 29, 2026, the Company entered into a definitive agreement to sell certain assets of its belts business to Gates Industrial Corporation plc. The transaction, which is subject to customary closing conditions, is expected to close in the third quarter of 2026. In addition, the Company announced the closure of its belts manufacturing facility in Springfield, Missouri. As a result, the Company recorded impairment, restructuring and reorganization charges of $94.4 million during the second quarter of 2026.
(5) Represents the net gain resulting from the sale of certain assets.
(6) On March 31, 2025, the Company announced that Tarak B. Mehta, President and Chief Executive Officer ("CEO") of the Company would be departing from the Company, effective immediately, and Richard G. Kyle would be serving as interim President and CEO. CEO transition expenses primarily relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of the impact for stock awards forfeited, and incremental stock compensation expense related to a deferred share award issued to Mr. Kyle.
(7) Represents the noncontrolling interest impact of the adjustments listed above, as well as the reversal of uncertain tax positions related to Timken India Limited.
(8) Provision for income taxes includes the net tax impact on pre-tax adjustments (listed above), the impact of discrete tax items recorded during the respective periods as well as other adjustments to reflect the use of one overall effective tax rate on adjusted pre-tax income in interim periods.
Reconciliation of EBITDA to GAAP Net Income, EBITDA Margin to Net Income as a Percentage of Sales, and EBITDA Margin, After Adjustments, to Net Income as a Percentage of Sales, and EBITDA, After Adjustments, to Net Income:
(Unaudited)
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP measure that is useful to investors as it is representative of the Company's performance and that it is appropriate to compare GAAP net income to consolidated EBITDA. Management also believes that adjusted EBITDA, adjusted EBITDA margin and EBITDA margin are useful to investors as they are representative of the Company's core operations and are used in the management of the business, including decisions concerning the allocation of resources and assessment of performance.
(Dollars in millions)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
Percentage to
Net Sales
2025
Percentage to
Net Sales
2026
Percentage to
Net Sales
2025
Percentage to
Net Sales
Net Income
$
37.2
3.0
%
$
85.7
7.3
%
$
143.1
5.7
%
$
177.1
7.7
%
Provision for income taxes
20.7
30.7
57.7
57.6
Interest expense
26.2
29.8
50.5
56.3
Interest income
(2.5)
(3.0)
(4.2)
(5.3)
Depreciation and amortization
59.7
57.2
118.6
112.3
Consolidated EBITDA
$
141.3
11.2
%
$
200.4
17.1
%
$
365.7
14.7
%
$
398.0
17.2
%
Adjustments:
Impairment, restructuring and reorganization charges (1)
$
8.1
$
4.7
$
12.9
$
7.8
Acquisition-related charges (2)
3.4
—
5.2
—
Belts impairment, restructuring and reorganization charges (3)
94.4
—
94.4
—
Gain on sale of certain assets (4)
—
(0.1)
—
(1.3)
CEO transition expenses (5)
—
3.2
—
11.8
Total Adjustments
105.9
8.4
%
7.8
0.6
%
112.5
4.5
%
18.3
0.8
%
Adjusted EBITDA
$
247.2
19.6
%
$
208.2
17.7
%
$
478.2
19.2
%
$
416.3
18.0
%
(1) Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations.
(2) Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact.
(3) On April 29, 2026, the Company entered into a definitive agreement to sell certain assets of its belts business to Gates Industrial Corporation plc. The transaction, which is subject to customary closing conditions, is expected to close in the third quarter of 2026. In addition, the Company announced the closure of its belts manufacturing facility in Springfield, Missouri. As a result, the Company recorded impairment, restructuring and reorganization charges of $94.4 million during the second quarter of 2026.
(4) Represents the net gain resulting from the sale of certain assets.
(5) On March 31, 2025, the Company announced that Tarak B. Mehta, President and CEO of the Company would be departing from the Company, effective immediately, and Richard G. Kyle would be serving as interim President and CEO. CEO transition expenses primarily relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of the impact for stock awards forfeited, and incremental stock compensation expense related to a deferred share award issued to Mr. Kyle.
Reconciliation of Total Debt to Net Debt, the Ratio of Net Debt to Capital, and the Ratio of Net Debt to Adjusted EBITDA:
(Unaudited)
These reconciliations are provided as additional relevant information about the Company's financial position deemed useful to investors. Capital, used for the ratio of net debt to capital, is a non-GAAP measure defined as total debt less cash and cash equivalents plus total shareholders' equity. Management believes Net Debt, the Ratio of Net Debt to Capital, Adjusted EBITDA (see next page), and the Ratio of Net Debt to Adjusted EBITDA are important measures of the Company's financial position, due to the amount of cash and cash equivalents on hand. The Company presents net debt to adjusted EBITDA because it believes it is more representative of the Company's financial position as it is reflective of the ability to cover its net debt obligations with results from its core operations.
(Dollars in millions)
June 30,
2026
December 31,
2025
Short-term debt, including current portion of long-term debt
$
40.2
$
38.9
Long-term debt
2,036.0
1,883.1
Total Debt
$
2,076.2
$
1,922.0
Less: Cash and cash equivalents
(399.1)
(364.4)
Net Debt
$
1,677.1
$
1,557.6
Total Equity
$
3,363.1
$
3,345.7
Ratio of Net Debt to Capital
33.3
%
31.8
%
Adjusted EBITDA for the Twelve Months Ended
$
857.7
$
795.8
Ratio of Net Debt to Adjusted EBITDA
2.0
2.0
Reconciliation of Free Cash Flow to GAAP Net Cash Provided by Operating Activities:
(Unaudited)
Management believes that free cash flow is a non-GAAP measure that is useful to investors because it is a meaningful indicator of cash generated from operating activities available for the execution of its business strategy.
(Dollars in millions)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Net cash provided by operating activities
$
107.1
$
111.3
$
146.4
$
169.9
Less: capital expenditures
(26.6)
(33.1)
(65.4)
(68.3)
Free cash flow
$
80.5
$
78.2
$
81.0
$
101.6
Reconciliation of EBITDA, After Adjustments, to GAAP Net Income:
(Unaudited)
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) is a non-GAAP measure that is useful to investors as it is representative of the Company's performance and that it is appropriate to compare GAAP net income to consolidated EBITDA. Management also believes that the non-GAAP measure of adjusted EBITDA is useful to investors as it is representative of the Company's core operations and is used in the management of the business, including decisions concerning the allocation of resources and assessment of performance.
(Dollars in millions)
Twelve Months Ended
June 30, 2026
Twelve Months Ended
December 31, 2025
Net Income
$
283.3
$
317.3
Provision for income taxes
98.8
98.7
Interest expense
104.5
110.3
Interest income
(9.2)
(10.3)
Depreciation and amortization
236.4
230.1
Consolidated EBITDA
$
713.8
$
746.1
Adjustments:
Impairment, restructuring and reorganization charges (1)
$
25.8
$
20.7
Corporate pension and other postretirement benefit related expense (2)
10.8
10.8
Acquisition-related charges (3)
5.2
—
Belts impairment, restructuring and reorganization charges (4)
94.4
—
Gain on sale of certain assets (5)
(1.3)
(2.6)
CEO transition expenses (6)
9.0
20.8
Total Adjustments
143.9
49.7
Adjusted EBITDA
$
857.7
$
795.8
(1) Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; (iii) severance related to cost reduction initiatives; and (iv) impairment of assets. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company's core operations.
(2) Corporate pension and other postretirement benefit related expense represents actuarial losses that resulted from the remeasurement of plan assets and obligations as a result of changes in assumptions or experience. The Company recognizes actuarial losses and gains in connection with the annual remeasurement in the fourth quarter, or if specific events trigger a remeasurement.
(3) Acquisition-related charges represent deal-related expenses associated with completed transactions and any resulting inventory step-up impact.
(4) On April 29, 2026, the Company entered into a definitive agreement to sell certain assets of its belts business to Gates Industrial Corporation plc. The transaction, which is subject to customary closing conditions, is expected to close in the third quarter of 2026. In addition, the Company announced the closure of its belts manufacturing facility in Springfield, Missouri. As a result, the Company recorded impairment and restructuring charges of $94.4 million during the second quarter of 2026.
(5) Represents the net gain resulting from the sale of certain assets.
(6) On August 22, 2025, the Company announced the appointment of Lucian Boldea as President and CEO, effective September 1, 2025, and that Richard G. Kyle would retire from the role of interim President and CEO. On March 31, 2025, the Company announced that Tarak B. Mehta, President and CEO of the Company would be departing from the Company, effective immediately, and Mr. Kyle would be serving as interim President and CEO. CEO transition expenses for the twelve months ended December 31, 2025, primarily relate to the cost of the settlement agreement with Mr. Mehta in connection with his departure, net of the impact for stock awards forfeited, the acceleration of certain stock compensation awards issued to Mr. Kyle, and other one-time costs associated with the transition in 2025.
Reconciliation of Net Sales to Organic Sales
(Unaudited)
The following reconciliation is provided as additional relevant information about the Company's performance deemed useful to investors. Management believes that net sales, excluding the impact of acquisitions, divestitures and foreign currency exchange rate changes, allow investors and the Company to meaningfully evaluate the percentage change in net sales on a comparable basis from period to period.
Three Months Ended
June 30, 2026
Three Months Ended
June 30, 2025
$ Change
% Change
Net sales
$
1,260.9
$
1,173.4
$
87.5
7.5
%
Less: Acquisitions
20.6
—
20.6
NM
Currency
15.1
—
15.1
NM
Net sales, excluding the impact of acquisitions and currency
$
1,225.2
$
1,173.4
$
51.8
4.4
%
Reconciliation of Adjusted Earnings per Share to GAAP Earnings per Share for Full Year 2026 Outlook:
(Unaudited)
The following reconciliation is provided as additional relevant information about the Company's outlook deemed useful to investors. Forecasted full year adjusted diluted earnings per share is an important financial measure that management believes is useful to investors as it is representative of the Company's expectation for the performance of its core business operations.
Low End Earnings
Per Share
High End Earnings
Per Share
Forecasted full year GAAP diluted earnings per share
$
3.75
$
4.05
Forecasted Adjustments:
Impairment, restructuring and other special items, net (1)
1.45
1.45
Acquisition-related intangible amortization expense, net
0.85
0.85
Forecasted full year adjusted diluted earnings per share
$
6.05
$
6.35
(1) Impairment, restructuring and other special items, net do not include the impact of any potential future mark-to-market pension and other postretirement remeasurement adjustments, because the amounts will not be known until incurred.
Bruker ve 2. čtvrtletí zvýšil výnosy na 838,5 mil. USD a non-GAAP EPS na 0,49 USD. Firma zároveň snížila výhled tržeb pro FY26 na 3,54 až 3,57 mld. USD.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for the three and six months ended June 30, 2026.
Frank H. Laukien, Bruker’s President and CEO, commented: “We returned to organic revenue growth in the second quarter and our Scientific Instruments segment achieved 10% organic bookings growth year-over-year. Our focus on cost and profitability resulted in solid margin expansion and non-GAAP EPS growth in the quarter. In particular, we achieved strong order bookings growth for our differentiated products and solutions in the semiconductor tools, energy research and biopharma markets. In our academic and medical research business, US academic demand remained soft in Q2, while aca/gov bookings in Europe and China were up strongly. We are gaining confidence in a gradual market recovery, and we anticipate significant organic margin expansion and non-GAAP EPS growth not only this year, but in 2027 as well.”
Second Quarter 2026 (Q2-26) Financial Results
Bruker’s revenues for the second quarter of 2026 were $838.5 million, an increase of 5.2% compared to $797.4 million in the second quarter of 2025. In Q2-26, revenues increased organically yoy by 2.8%, or 3.4% excluding tariff refunds. Growth from acquisitions was 1.5%, with constant-exchange rate (CER) growth of 4.3%, while foreign currency translation had a favorable impact of 0.9% yoy.
Q2-26 Bruker Scientific Instruments (BSI) revenues of $767.3 million increased 4.7% yoy, with organic revenue increasing by 2.3%. Q2-26 Bruker Energy & Supercon Technologies (BEST) revenues of $74.2 million increased 11.9% yoy, with an organic revenue increase of 8.9%, net of intercompany eliminations.
Q2-26 GAAP operating loss was $(65.3) million, compared to GAAP operating income of $11.9 million in the second quarter of 2025. Second quarter 2026 GAAP financial results include non-cash goodwill impairment charges of $134.9 million. Bruker’s Q2-26 non-GAAP operating income was $118.5 million, compared to $72.0 million in the second quarter of 2025, and Q2-26 non-GAAP operating margin was 14.1%, compared to 9.0% in the second quarter of 2025.
Q2-26 GAAP diluted loss per share was $(0.41), compared to diluted earnings per share of $0.05 in the second quarter of 2025. Q2-26 non-GAAP diluted EPS was $0.49, compared to $0.32 in the second quarter of 2025.
First Half 2026 Financial Results
For the first half of 2026, Bruker’s revenues were $1.7 billion, an increase of 3.9% compared to $1.6 billion in the first half of 2025. In the first half of 2026, revenues decreased organically by 0.8% yoy, while growth from acquisitions was 2.0%, CER growth was 1.2%, and foreign currency translation had a favorable impact of 2.7%.
In the first half of 2026, BSI revenues of $1.5 billion increased 3.3% yoy, with revenue decreasing by 1.4% organically. First half 2026 BEST revenues of $141.0 million increased 12.3% yoy, with organic growth of 6.1%, net of intercompany eliminations.
In the first half of 2026, GAAP operating loss was $(55.1) million, which includes the impact of impairment charges noted above, compared to GAAP operating income of $43.7 million in the first half of 2025. Bruker's non-GAAP operating income in the first half of 2026 was $202.7 million, compared to $173.7 million in the first half of 2025. Bruker’s non-GAAP operating margin in the first half of 2026 improved to 12.2%, compared to 10.9% in the first half of 2025.
First half 2026 GAAP diluted loss per share was $(0.39), compared to diluted earnings per share of $0.16 in the first half of 2025. First half 2026 non-GAAP diluted EPS was $0.80, compared to $0.78 in the first half of 2025, including a currency headwind of 5 cents.
Updating Fiscal Year 2026 (FY26) Financial Outlook for Currency and Tax Only
Bruker now expects FY26 revenues of $3.54 to $3.57 billion, compared to FY25 revenues of $3.44 billion, with 3% to 4% year-over-year reported revenue growth, including:
Organic revenue growth of 1% to 2%, M&A revenue growth of approximately 1.5%, CER revenue growth of 2.5% to 3.5%, and Foreign currency translation revenue tailwind of approximately 0.5% (previously 1.5%). Bruker continues to expect FY26 non-GAAP EPS of $2.10 to $2.15 compared to $1.83 in FY25, an increase of 15% to 17% year-over-year, now at an effective non-GAAP tax rate of 27.5%. This includes a currency headwind of approximately $0.10, or 5%. Our FY26 revenue and non-GAAP EPS guidance is based on foreign currency exchange rates as of June 30, 2026.
For the Company’s outlook for 2026 organic revenue growth, M&A revenue growth, constant exchange rate revenue growth, and constant exchange rate non-GAAP EPS growth, and non-GAAP EPS, each of which are forward-looking non-GAAP measures, we are not able to provide without unreasonable effort the most directly comparable GAAP financial measures, or reconciliations to such GAAP financial measures on a forward-looking basis. Please see “Use of Non-GAAP Financial Measures” below for a description of items excluded from our expected non-GAAP EPS.
Quarterly Earnings Call
Bruker will host a conference call and webcast to discuss its financial results, business outlook, and related corporate and financial matters today, August 4, 2026, at 9:00 am Eastern Daylight Time. To listen to the webcast, investors can go to https://ir.bruker.com and click on the “Q2 2026 Earnings Webcast” hyperlink. A slide presentation will be referenced during the webcast and will be posted to our Investor Relations website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-412-317-6702 (international) and referencing “Bruker’s Second Quarter 2026 Earnings Conference Call.”
Bruker is enabling investors to pre-register for the earnings conference call so that they can expedite their entry into the call and avoid the need to wait for a live operator. In order to pre-register for the call, investors can visit https://dpregister.com/sreg/10210859/10488dbff5c and enter their contact information. Investors will then be issued a personalized phone number and PIN to dial into the live conference call. Individuals can pre-register any time prior to the start of the conference call.
A telephone replay of the conference call will be available by dialing 1-855-669-9658 (U.S. toll free) or +1-412-317-0088 (international) and entering replay access code: 2701950. The replay will be available beginning one hour after the end of the conference call through September 4, 2026.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in specialty diagnostics, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, clinical microbiology and molecular diagnostics, as well as in the semiconductor industry. For more information, please visit www.bruker.com.
Use of Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with U.S. generally accepted accounting principles (GAAP), we use the following non-GAAP financial measures: non-GAAP gross profit; non-GAAP gross profit margin; non-GAAP operating income; non-GAAP operating income margin; non-GAAP SG&A expense; non-GAAP interest and other income (expense), net; non-GAAP profit before income taxes; non-GAAP income tax rate; non-GAAP net income and non-GAAP diluted earnings per share. These non-GAAP measures exclude costs related to restructuring actions, impairments, acquisition and related integration expenses, amortization of acquired intangible assets, and other non-operational costs.
We also may refer to CER currency revenue growth, CER non-GAAP EPS growth, and free cash flow which are also non-GAAP financial measures. We define the term CER currency revenue as GAAP revenue excluding the effect of changes in foreign currency translation rates. We define the term CER EPS as non-GAAP EPS excluding the effect of changes in foreign currency translation rates. We define free cash flow as net cash provided by operating activities, less additions to property, plant, and equipment. We believe free cash flow is a useful measure to evaluate our business because it indicates the amount of cash generated after additions to property, plant, and equipment that is available for, among other things, acquisitions, investments in our business, repayment of debt and return of capital to shareholders.
The presentation of these non-GAAP financial measures is not intended to be a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP and may be different from non-GAAP financial measures used by other companies, and therefore, may not be comparable among companies. We believe these non-GAAP financial measures provide meaningful supplemental information regarding our performance. However, we urge investors to review the reconciliation of these financial measures to the comparable GAAP financial measures included in the accompanying tables, and not to rely on any single financial measure to evaluate our business. Specifically, management believes that the non-GAAP measures mentioned above provide relevant and useful information which is widely used by analysts, investors and competitors in our industry, as well as by our management, in assessing both consolidated and business unit performance.
We use these non-GAAP financial measures to evaluate our period-over-period operating performance because our management believes this provides a more comparable measure of our continuing business by adjusting for certain items that are not reflective of the underlying performance of our business. These measures may also be useful to investors in evaluating the underlying operating performance of our business and forecasting future results. We regularly use these non-GAAP financial measures internally to understand, manage, and evaluate our business results and make operating decisions. We also measure our employees and compensate them, in part, based on certain non-GAAP measures and use this information for our planning and forecasting activities.
Additional information relating to the non-GAAP financial measures used in this press release and reconciliations to the most directly comparable GAAP financial measures are provided in the tables accompanying this press release following our GAAP financial statements.
With respect to our outlook for 2026 non-GAAP organic revenue, non-GAAP M&A revenue, and non-GAAP EPS, we are not providing the most directly comparable GAAP financial measures or corresponding reconciliations to such GAAP financial measures on a forward-looking basis, because we are unable to predict with reasonable certainty certain items that may affect such measures calculated and presented in accordance with GAAP without unreasonable effort. Our expected non-GAAP organic revenue and EPS ranges exclude primarily the future impact of restructuring actions, unusual gains and losses, acquisition-related expenses and purchase accounting fair value adjustments. These reconciling items are uncertain, depend on various factors outside our management’s control and could significantly impact, either individually or in the aggregate, our future revenues and EPS presented in accordance with GAAP.
Forward-Looking Statements
Any statements contained in this press release which do not describe historical facts may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our fiscal year 2026 and beyond financial outlook, our outlook for reported revenue growth, organic revenue growth, M&A revenue growth contributions, CER currency revenue growth, margin improvements, foreign currency translation revenue impact, EPS, non-GAAP EPS, and CER Non-GAAP EPS growth; effects of academic market and tariff dynamics on our future financial results and our ability to mitigate such effects in the future; management’s expectations for the impact of foreign currency and acquisitions; the effects of our expanded cost savings initiatives; and for future financial and operational performance and business outlook; future economic conditions; and statements found under the “Use of Non-GAAP Financial Measures” section of this release. Any forward-looking statements contained herein are based on current expectations, but are subject to risks and uncertainties that could cause actual results to differ materially from those indicated, including, but not limited to, (1) the length and severity of any recession and the impact on global economic conditions, (2) the impact of supply chain challenges, including inflationary pressures, (3) the impact of geopolitical instability and tensions and any sanctions, including any reduction in natural gas exports from Russia resulting from the ongoing conflict with Ukraine and resulting market disruptions, such as higher prices for and reduced availability of key metals used in our products, (4) the conflict in Israel, Palestine and surrounding areas and hostilities in the Middle East, including heightened tensions in Iran, and the possible expansion of such conflicts and potential geopolitical consequences and global instability, (5) the ongoing tensions between the United States and China, tariff increases or uncertainties and trade policy changes and restrictions, and the increasing potential of conflict involving countries in Asia that are critical to our supply chain operations, such as Taiwan and China, (6) continued volatility in the capital markets, (7) the impact of increased interest rates, (8) the integration and assumption of liabilities of businesses we have acquired or may acquire in the future, (9) our restructuring and cost-control initiatives, changing technologies, product development and market acceptance of our products, (10) the cost and pricing of our products, manufacturing and outsourcing, competition, dependence on collaborative partners, key suppliers and third party distributors, capital spending and government funding policies, (11) changes in governmental regulations, intellectual property rights, and litigation, (12) exposure to foreign currency fluctuations, (13) the impact of foreign currency exchange rates, (14) our ability to service our debt obligations and fund our anticipated cash needs, (15) the effect of a concentrated ownership of our common stock, (16) the loss of key personnel, (17) payment of future dividends, (18) the impact (if any) of macroeconomic issues, including uncertainties related to trade policies or tariff regulations, and (19) other risk factors discussed from time to time in our filings with the Securities and Exchange Commission, or SEC. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2025, as may be updated by our quarterly reports on Form 10-Q. We expressly disclaim any intent or obligation to update these forward-looking statements other than as required by applicable law.
Bruker Corporation
PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
(in millions, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Revenue
$
838.5
$
797.4
$
1,661.9
$
1,598.8
Cost of revenue
422.5
439.5
866.1
849.7
Gross profit
416.0
357.9
795.8
749.1
Operating expenses:
Selling, general and administrative
238.9
231.4
481.0
456.8
Research and development
94.3
100.2
195.6
197.3
Goodwill impairment charge
134.9
—
134.9
—
Other charges, net
13.2
14.4
39.4
51.3
Total operating expenses
481.3
346.0
850.9
705.4
Operating (loss) income
(65.3
)
11.9
(55.1
)
43.7
Interest and other income (expense), net
24.6
(11.4
)
36.3
(18.1
)
(Loss) income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries (a)
(40.7
)
0.5
(18.8
)
25.6
Income tax provision (benefit)
14.2
(3.1
)
16.7
5.6
Equity in income of unconsolidated investees, net of tax
4.0
0.6
0.3
1.0
Consolidated net (loss) income
(50.9
)
4.2
(35.2
)
21.0
Net income (loss) attributable to noncontrolling interests in consolidated subsidiaries
1.1
(3.4
)
2.4
(4.0
)
Net (loss) income attributable to Bruker Corporation
$
(52.0
)
$
7.6
$
(37.6
)
$
25.0
Dividends on Series A Mandatory Convertible Preferred Stock
10.9
—
21.8
—
Net (loss) income attributable to Bruker Corporation common shareholders
$
(62.9
)
$
7.6
$
(59.4
)
$
25.0
Net (loss) income per common share attributable to Bruker Corporation shareholders:
Basic
$
(0.41
)
$
0.05
$
(0.39
)
$
0.16
Diluted
$
(0.41
)
$
0.05
$
(0.39
)
$
0.16
Weighted average common shares outstanding:
Basic
152.3
151.6
152.2
151.6
Diluted
152.3
151.7
152.2
151.8
Bruker Corporation
REVENUE
(unaudited and in millions)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Revenue by Segment:
Bruker BioSpin
$
195.7
$
195.3
$
393.2
$
403.1
Bruker CALID
310.3
285.8
626.6
565.9
Bruker Nano
261.3
252.1
507.3
508.7
BSI Revenue Total
767.3
733.2
1,527.1
1,477.7
BEST
74.2
66.3
141.0
125.6
Eliminations
(3.0
)
(2.1
)
(6.2
)
(4.5
)
Total revenue
$
838.5
$
797.4
$
1,661.9
$
1,598.8
Revenue by End Customer Geography:
United States
$
248.2
$
222.9
$
470.1
$
440.3
Europe
308.7
272.5
630.3
557.7
Asia Pacific
217.3
242.1
426.0
474.7
Other
64.3
59.9
135.5
126.1
Total revenue
$
838.5
$
797.4
$
1,661.9
$
1,598.8
Bruker Corporation
RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES
(unaudited and in millions, except per share data)
The tables below present the GAAP to Non-GAAP reconciliation for the three and six months ended June 30, 2026, and June 30, 2025, respectively, for the following measures: Gross Profit and Gross Profit Margin; Selling, General and Administrative (“SG&A”) Expenses; Operating (loss) income and Operating (loss) income margin; Interest and Other Income (Expense), net; Profit (loss) before Income Taxes; Net Income (loss) Attributable to Bruker Corporation Common Shareholders; Diluted net income (loss) per common share; and Income Tax rate.
Gross Profit
Gross Profit Margin
SG&A Expenses
Operating (Loss) income
Operating (Loss) income Margin
Interest and other income (expense), net
(Loss) profit before income tax (a)
Net (loss) income attributable to Bruker Corporation Common Shareholders
Diluted net (loss) income per common share attributable to Bruker Corporation Common Shareholders (b)
Income Tax Rate
Three Months Ended June 30, 2026:
GAAP
$416.0
49.6%
$238.9
$(65.3)
(7.8)%
$24.6
$(40.7)
$(62.9)
$(0.41)
(34.9)%
Non-GAAP adjustments:
Restructuring costs
0.3
—
—
4.2
0.5%
—
4.2
4.2
0.03
—
Acquisition-related costs
0.8
0.1%
—
4.4
0.5%
—
4.4
4.4
0.03
—
Purchased intangibles amortization
18.3
2.2%
(15.0)
33.3
4.0%
—
33.3
33.3
0.22
—
Goodwill and Intangible assets impairment charges
—
—
—
134.9
16.1%
—
134.9
134.9
0.88
—
Lease and fixed asset impairment charges
0.3
—
—
2.9
0.3%
—
2.9
2.9
0.02
—
Unrealized gain on equity interest investment
—
—
—
—
—
(27.6)
(27.6)
(27.6)
(0.18)
—
Other costs
0.9
0.2%
—
4.1
0.5%
1.5
5.6
1.4
—
—
Tax effect of above Non-GAAP adjustments
—
—
—
—
—
—
—
(15.0)
(0.10)
56.0%
Other Discrete Items
—
—
—
—
—
—
—
—
—
3.9%
Total Non-GAAP adjustments
20.6
2.5%
(15.0)
183.8
21.9%
(26.1)
157.7
138.5
0.90
59.9%
Non-GAAP
$436.6
52.1%
$223.9
$118.5
14.1%
$(1.5)
$117.0
$75.6
$0.49
25.0%
Three Months Ended June 30, 2025:
GAAP
$357.9
44.9%
$231.4
$11.9
1.5%
$(11.4)
$0.5
$7.6
$0.05
(620.0)%
Non-GAAP adjustments:
Restructuring costs
4.4
0.6%
—
7.3
0.9%
—
7.3
7.3
0.05
—
Acquisition-related costs
2.8
0.4%
—
5.5
0.7%
—
5.5
5.5
0.04
—
Purchased intangibles amortization
15.0
1.9%
(16.5)
31.5
4.0%
—
31.5
31.5
0.21
—
Acquisition-related litigation charges
—
—
—
4.0
0.5%
—
4.0
4.0
0.03
—
Other costs
7.1
0.8%
—
11.8
1.4%
0.4
12.2
9.9
0.07
—
Tax effect of above Non-GAAP adjustments
—
—
—
—
—
—
—
(17.5)
(0.13)
643.6%
Other Discrete Items
—
—
—
—
—
—
—
—
—
—
Total Non-GAAP adjustments
29.3
3.7%
(16.5)
60.1
7.5%
0.4
60.5
40.7
0.27
643.6%
Non-GAAP
$387.2
48.6%
$214.9
$72.0
9.0%
$(11.0)
$61.0
$48.3
$0.32
23.6%
Bruker Corporation
RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES - Continued
(unaudited and in millions, except per share data)
Gross Profit
Gross Profit Margin
SG&A Expenses
Operating (Loss) Income
Operating (Loss) income Margin
Interest and other income (expense), net
(Loss) Profit before income tax (a)
Net (loss) income attributable to Bruker Corporation Common Shareholders
Diluted net (loss) income per common share attributable to Bruker Corporation Common Shareholders (b)
Income Tax Rate
Six Months Ended June 30, 2026
GAAP
$795.8
47.9%
$481.0
$(55.1)
(3.3)%
$36.3
$(18.8)
$(59.4)
$(0.39)
(88.8)%
Non-GAAP adjustments:
Restructuring costs
9.8
0.6%
—
22.0
1.3%
—
22.0
22.0
0.14
—
Acquisition-related costs
4.2
0.3%
—
11.9
0.7%
—
11.9
11.9
0.08
—
Purchased intangibles amortization
35.0
2.1%
(30.7)
65.8
4.0%
—
65.8
65.8
0.43
—
Gain on remeasurement of previously held equity interest
—
—
—
—
—
(12.2)
(12.2)
(12.2)
(0.08)
—
Goodwill and Intangible assets impairment charges
0.7
—
—
137.6
8.3%
—
137.6
137.6
0.90
—
Lease and fixed asset impairment charges
2.1
0.1%
—
15.6
0.9%
—
15.6
15.6
0.10
—
Unrealized gain on equity interest investment
—
—
—
—
—
(27.6)
(27.6)
(27.6)
(0.18)
—
Other costs
0.8
0.1%
—
4.9
0.3%
0.3
5.2
4.2
0.03
—
Tax effect of above Non-GAAP adjustments
—
—
—
—
—
—
—
(35.3)
(0.23)
112.3%
Other Discrete Items
—
—
—
—
—
—
—
—
—
2.6%
Total Non-GAAP adjustments
52.6
3.2%
(30.7)
257.8
15.5%
(39.5)
218.3
182.0
1.19
114.9%
Non-GAAP
$848.4
51.1%
$450.3
$202.7
12.2%
$(3.2)
$199.5
$122.6
$0.80
26.1%
Six Months Ended June 30, 2025:
GAAP
$749.1
46.9%
$456.8
$43.7
2.7%
$(18.1)
$25.6
$25.0
$0.16
21.9%
Non-GAAP adjustments:
Restructuring costs
7.0
0.4%
—
17.5
1.1%
—
17.5
17.5
0.12
—
Acquisition-related costs
5.1
0.3%
—
14.1
0.9%
—
14.1
14.1
0.09
—
Purchased intangibles amortization
29.0
1.8%
(29.6)
58.8
3.7%
—
58.8
58.8
0.39
—
Acquisition-related litigation charges
—
—
—
22.6
1.4%
—
22.6
22.6
0.15
—
Other costs
7.9
0.5%
—
17.0
1.1%
2.4
19.4
16.7
0.11
—
Tax effect of above Non-GAAP adjustments
—
—
—
—
—
—
—
(35.7)
(0.24)
4.2%
Other Discrete Items
—
—
—
—
—
—
—
—
—
—
Total Non-GAAP adjustments
49.0
3.0%
(29.6)
130.0
8.2%
2.4
132.4
94.0
0.62
4.2%
Non-GAAP
$798.1
49.9%
$427.2
$173.7
10.9%
$(15.7)
$158.0
$119.0
$0.78
26.1%
Bruker Corporation
RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES - Continued
(unaudited and in millions, except per share data)
The tables below present the GAAP to Non-GAAP reconciliation for CER currency revenue, organic revenue, free cash flow, and weighted average common shares outstanding (Diluted):
Total Bruker
Bruker Scientific Instruments (a)
BEST
Three Months Ended June 30,
2026
yoy
growth
(c)
2025
2026
yoy
growth
(c)
2025
2026
yoy
growth
(c)
2025
GAAP revenue
$
838.5
5.2%
$
797.4
$
767.3
4.7%
$
733.2
$
71.2
10.9%
$
64.2
Effect of changes in foreign currency translation rates
7.0
23.4
5.7
21.2
1.3
2.2
Non-GAAP CER currency revenue
831.5
4.3%
774.0
761.6
3.9%
712.0
69.9
8.9%
62.0
Acquisitions (b)
11.4
29.6
11.4
29.6
—
—
Non-GAAP Organic revenue
$
820.1
2.8%
$
744.4
$
750.2
2.3%
$
682.4
$
69.9
8.9%
$
62.0
Total Bruker
Bruker Scientific Instruments (a)
BEST
Six Months Ended June 30,
2026
yoy
growth
(c)
2025
2026
yoy
growth
(c)
2025
2026
yoy
growth
(c)
2025
GAAP revenue
$
1,661.9
3.9%
$
1,598.8
$
1,527.1
3.3%
$
1,477.7
$
134.8
11.3%
$
121.1
Effect of changes in foreign currency translation rates
43.6
13.0
37.3
12.0
6.3
1.0
Non-GAAP CER currency revenue
1,618.3
1.2%
1,585.8
1,489.8
0.8%
1,465.7
128.5
6.1%
120.1
Acquisitions (b)
32.2
98.8
32.2
98.8
—
—
Non-GAAP Organic revenue
$
1,586.1
(0.8)%
$
1,487.0
$
1,457.6
(1.4)%
$
1,366.9
$
128.5
6.1%
$
120.1
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Net cash used in operating activities
$
(77.4
)
$
(127.5
)
$
(6.2
)
$
(62.5
)
Non-GAAP adjustments:
Purchases of property, plant and equipment and intangible assets
(28.8
)
(21.3
)
(53.0
)
(47.3
)
Non-GAAP free cash flow
$
(106.2
)
$
(148.8
)
$
(59.2
)
$
(109.8
)
Bruker Corporation
RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES - Continued
(unaudited and in millions, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
GAAP Weighted Average Common Shares Outstanding (Diluted)
152.3
151.7
152.2
151.8
Stock options, restricted stock units, and employee stock purchase plan (a)
0.5
—
0.5
—
Series A Mandatory Convertible Preferred Stock (b)
—
—
—
—
Non-GAAP Weighted Average Common Shares Outstanding (Diluted)
American Express Global Business Travel ve 2. čtvrtletí zvýšila tržby o 38 % na 870 milionů USD a upravený zisk před úroky, daněmi, odpisy a amortizací (EBITDA) vzrostl na 178 milionů USD. Akcionáři zároveň 3. srpna 2026 schválili plánované převzetí Long Lake Management.
NEW YORK--(BUSINESS WIRE)--American Express Global Business Travel, which is operated by Global Business Travel Group, Inc. (NYSE: GBTG) ("Amex GBT" or the "Company"), a leading software and services company for travel, expense and meetings & events, today reported second quarter 2026 financial results.
(in millions, except percentages; unaudited)
Three Months Ended
YOY
Inc / (Dec)
June 30,
2026
2025
Revenue
$
870
$
631
38
%
Total operating expenses
$
846
$
597
42
%
Gross Profit
$
494
$
371
33
%
Gross Profit Margin
57
%
59
%
(200)bps
Net income
$
17
$
15
14
%
Net income margin
2
%
2
%
(40)bps
Adjusted Gross Profit
$
514
$
389
32
%
Adjusted Gross Profit Margin
59
%
62
%
(250)bps
Adjusted Operating Expenses
$
696
$
500
39
%
Adjusted EBITDA
$
178
$
133
34
%
Adjusted EBITDA Margin
21
%
21
%
(60)bps
Net cash from operating activities
$
142
$
57
153
%
Free Cash Flow
$
103
$
27
281
%
Net Debt / LTM Adjusted EBITDA
1.7x
1.6x
A reconciliation of non-GAAP financial measures to the most comparable GAAP measure is provided at the end of this release.
Results include the impact of acquisitions for Q2 2026 only.
Paul Abbott, Chief Executive Officer:
"We delivered strong growth and commercial and product success. Total New Wins Value accelerated to $3.5 billion, with double-digit SME growth and major wins with Google, Koch and Pfizer, while maintaining an impressive 95% customer retention rate. Our new product innovations are clearly resonating with customers, including our proprietary agent-to-agent architecture, our Egencia AI connector in Claude and enhancements for Complete by SAP Concur and Amex GBT."
Business Highlights
Strong growth and financial performance. Delivered revenue growth of 38% with Adjusted Gross Profit Margin of 59% and Adjusted EBITDA of $178 million. Continued commercial progress. LTM Total New Wins Value accelerated to $3.5 billion, including major new wins with Google, Koch and Pfizer. Maintained strong customer retention rate of 95%, including CWT. Strong momentum in SME, with LTM SME New Wins Value of $2.3 billion, up 11% year-over-year. Product innovation. Launched Egencia AI connector in Claude, one of the business travel industry's first agentic integrations enabling both travelers and enterprise AI agents to book and manage policy-compliant air and hotel transactions without leaving the tools they already work in. Also expanded Egencia's conversational AI into Google Chat and a conversational AI pilot in Microsoft Teams for Neo customers. Egencia integration with Concur Expense is now live for all customers. SAP Strategic Alliance. 83% of eligible joint customers are now using Complete by SAP Concur and Amex GBT, the new, AI-powered flagship solution for travel and expense. A new set of innovations for Complete have been launched that help travelers navigate disruptions more easily, give travel managers greater visibility into program performance and make it easier for organizations to capture more value from their travel investments. Second Quarter 2026 Operational & Financial Highlights
(Changes compared to prior year period unless otherwise noted)
TTV growth of 57% and Transaction Growth of 45%. Revenue of $870 million increased 38%. Within this, Travel Revenue increased 38% due to acquisition impacts, growth in business travel demand and share gains. Product and Professional Services Revenue increased 38%. Excluding the impact of acquisitions, revenue growth was 10%. Total operating expenses of $846 million increased 42%, primarily due to the impact of acquisitions, increased cost of revenue to drive growth and increased investments in technology, content, sales and marketing, partially offset by $18 million of cost transformation benefits and $14 million of CWT net synergies, which was in line with expectations. Additionally, there were restructuring costs related to achievement of CWT synergies and broader cost transformation and higher depreciation and amortization. Net income of $17 million increased 14%. Revenue growth and higher benefit from income taxes were offset by higher operating expenses, including restructuring costs related to achieving CWT synergies and broader cost transformation initiatives, and unfavorable movement on earnout derivative liabilities. Net cash from operating activities of $142 million increased 153% primarily due to favorable working capital timing and lower cash taxes. Free Cash Flow of $103 million increased 281%, due to higher net cash from operating activities, partially offset by increased investments in purchase of property and equipment. Shareholder approval for the proposed acquisition of the Company by Long Lake Management (the "Merger") was obtained on August 3, 2026. The Merger is expected to close in the second half of 2026, subject to satisfaction of customary closing conditions, including receipt of regulatory approvals.
Glossary of Terms
See the "Glossary of Terms" for the definitions of certain terms used within this press release.
About American Express Global Business Travel
American Express Global Business Travel (Amex GBT) is a leading software and services company for travel, expense, and meetings & events. We have built the most valuable marketplace in travel with the most comprehensive and competitive content. A choice of solutions brought to you through a strong combination of technology and people, delivering the best experiences. With travel professionals and business partners in more than 140 countries, our solutions deliver savings, flexibility, and service from a brand you can trust – Amex GBT.
Visit amexglobalbusinesstravel.com for more information about Amex GBT. Follow @amexgbt on LinkedIn and Instagram.
GLOBAL BUSINESS TRAVEL GROUP, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
Three months ended
June 30,
(in $ millions, except share and per share data)
2026
2025
Revenue
$
870
$
631
Costs and expenses:
Cost of revenue (excluding depreciation and amortization shown separately below)
356
242
Sales and marketing
123
111
Technology and content
160
120
General and administrative
110
69
Restructuring and other exit charges
41
12
Depreciation and amortization
56
43
Total operating expenses
846
597
Operating income
24
34
Interest income
1
2
Interest expense
(25
)
(23
)
Fair value movement on earnout derivative liabilities
6
32
Other income (loss), net
9
(11
)
Income before income taxes
15
34
Provision for income taxes
(2
)
(21
)
Share of income from equity method investments
4
2
Net income
17
15
Less: net income attributable to non-controlling interests in subsidiaries
2
2
Net income attributable to the Company’s Class A common stockholders
$
15
$
13
Basic income per share attributable to the Company’s Class A common stockholders
$
0.03
$
0.03
Weighted average number of shares outstanding - Basic
513,798,712
470,877,173
Diluted income per share attributable to the Company’s Class A common stockholders
$
0.03
$
0.03
Weighted average number of shares outstanding - Diluted
520,372,250
474,839,915
GLOBAL BUSINESS TRAVEL GROUP, INC.
CONSOLIDATED BALANCE SHEETS
(in $ millions, except share and per share data)
June 30,
2026
December 31,
2025
(Unaudited)
Assets
Current assets:
Cash and cash equivalents
$
518
$
434
Accounts receivable (net of allowance for credit losses of $11 and $9 as of June 30, 2026 and December 31, 2025, respectively)
968
869
Due from affiliates
66
51
Prepaid expenses and other current assets
237
215
Total current assets
1,789
1,569
Property and equipment, net
308
308
Equity method investments
48
43
Goodwill
1,663
1,671
Other intangible assets, net
800
851
Operating lease right-of-use assets
60
66
Deferred tax assets
318
298
Other non-current assets
91
110
Total assets
$
5,077
$
4,916
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable
$
619
$
515
Due to affiliates
36
25
Accrued expenses and other current liabilities
758
757
Current portion of operating lease liabilities
23
26
Current portion of long-term debt
61
58
Total current liabilities
1,497
1,381
Long-term debt, net of unamortized debt discount and debt issuance costs
1,451
1,360
Deferred tax liabilities
98
99
Pension liabilities
148
163
Long-term operating lease liabilities
64
62
Earnout derivative liabilities
—
37
Other non-current liabilities
128
153
Total liabilities
3,386
3,255
Commitments and Contingencies
Redeemable non-controlling interest
46
49
Shareholders’ equity:
Class A common stock (par value $0.0001; 3,000,000,000 shares authorized; 547,016,649 and 538,342,297 shares issued, 522,285,480 and 521,088,517 shares outstanding as of June 30, 2026 and December 31, 2025, respectively)
—
—
Additional paid-in capital
3,293
3,277
Accumulated deficit
(1,399
)
(1,466
)
Accumulated other comprehensive loss
(80
)
(75
)
Treasury shares, at cost (24,731,169 and 17,253,780 shares as of June 30, 2026 and December 31, 2025, respectively)
(175
)
(128
)
Total equity of the Company’s shareholders
1,639
1,608
Equity attributable to non-controlling interest in subsidiaries
6
4
Total shareholders’ equity
1,645
1,612
Total liabilities, redeemable non-controlling interest and shareholders’ equity
$
5,077
$
4,916
GLOBAL BUSINESS TRAVEL GROUP, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Six months ended
June 30,
(in $ millions)
2026
2025
Operating activities:
Net income
$
71
$
90
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization
116
83
Deferred tax (benefit) charge
(26
)
10
Equity-based compensation
36
39
Allowance for credit losses
6
3
Loss on early extinguishment of debt
—
2
Fair value movement on earnout derivative liabilities
(37
)
(106
)
Other, net
(6
)
18
Changes in working capital:
Accounts receivable
(115
)
(123
)
Prepaid expenses and other current assets
(28
)
(3
)
Due from affiliates
(15
)
(13
)
Due to affiliates
11
(6
)
Accounts payable, accrued expenses and other current liabilities
129
98
Defined benefit pension funding
(15
)
(13
)
Proceeds from termination of interest rate swap contracts
—
31
Net cash from operating activities
127
110
Investing activities:
Business acquisition, net of cash and restricted cash acquired
10
—
Purchase of property and equipment
(76
)
(57
)
Proceeds from foreign exchange forward contracts
—
27
Net cash used in investing activities
(66
)
(30
)
Financing activities:
Proceeds from senior secured term loans
132
99
Repayment of senior secured term loans
(40
)
(106
)
Repurchase of common shares
(47
)
(1
)
Contributions from ESPP
4
4
Payment of taxes withheld on vesting of equity awards
(28
)
(41
)
Other
(1
)
(3
)
Net cash from (used in) financing activities
20
(48
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(8
)
25
Net increase in cash, cash equivalents and restricted cash
73
57
Cash, cash equivalents and restricted cash, beginning of period
479
561
Cash, cash equivalents and restricted cash, end of period
$
552
$
618
Supplemental cash flow information:
Cash paid for income taxes (net of refunds)
$
—
$
29
Cash paid for interest (net of interest received)
$
48
$
50
Issuance of shares to settle contingent consideration
$
4
$
—
Non-cash additions for operating lease right-of-use assets
$
10
$
2
Non-cash additions for finance lease
$
—
$
1
Additional Information and Disclosures
Glossary of Terms
AI refers to Artificial Intelligence. CWT refers to CWT Holdings, LLC. Customer retention rate is calculated based on traded Total Transaction Value in the quarter versus the same period in the prior year. LTM refers to the last twelve months ended June 30, 2026. GMN refers to Global & Multinational Enterprises and SME refers to Small and Medium-sized Enterprises. For organizational management purposes, Amex GBT divides the customer base into these two general categories, generally on the basis of annual TTV, although this measure can vary by country and by customer preference. Amex GBT offers all products and services to all sizes of customer, as customers of all sizes may prefer different solutions. SME New Wins Value is calculated using expected annual Total Transaction Value (TTV) over the contract term from all SME new client wins over the last twelve months. Total New Wins Value is calculated using expected annual Total Transaction Value (TTV) over the contract term from all new client wins over the last twelve months. Total Transaction Value or TTV refers to the sum of the total price paid by travelers for air, hotel, rail, car rental and cruise bookings, including taxes and other charges applied by suppliers at point of sale, less cancellations and refunds. Transaction Growth represents year-over-year increase or decrease as a percentage of the total transactions, including air, hotel, car rental, rail or other travel-related transactions, recorded at the time of booking, and is calculated on a net basis to exclude cancellations, refunds and exchanges. To calculate year-over-year growth or decline, we compare the total number of net transactions in the comparative previous period/ year to the total number of net transactions in the current period/year in percentage terms. We have presented Transaction Growth on a net basis to exclude cancellations, refunds and exchanges as management believes this better aligns Transaction Growth with the way we measure TTV and earn revenue. Prior period Transaction Growth percentages have been recalculated and represented to conform to current period presentation. Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. Our non-GAAP financial measures are provided in addition, and should not be considered as an alternative, to other performance or liquidity measures derived in accordance with GAAP. Non-GAAP financial measures have limitations as analytical tools, and you should not consider them either in isolation or as a substitute for analyzing our results as reported under GAAP. In addition, because not all companies use identical calculations, the presentations of our non-GAAP financial measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.
Management believes that these non-GAAP financial measures provide users of our financial information with useful supplemental information that enables a better comparison of our performance or liquidity across periods. In addition, we use certain of these non-GAAP financial measures as performance measures as they are important metrics used by management to evaluate and understand the underlying operations and business trends, forecast future results and determine future capital investment allocations. We also use certain of our non-GAAP financial measures as indicators of our ability to generate cash to meet our liquidity needs and to assist our management in evaluating our financial flexibility, capital structure and leverage. These non-GAAP financial measures supplement comparable GAAP measures in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, and/or to compare our performance and liquidity against that of other peer companies using similar measures.
We define Adjusted Gross Profit as revenue less cost of revenue (excluding depreciation and amortization).
We define Adjusted Gross Profit Margin as Adjusted Gross Profit divided by revenue.
We define EBITDA as net income (loss) before interest income, interest expense, gain (loss) on early extinguishment of debt, benefit from (provision for) income taxes and depreciation and amortization.
We define Adjusted EBITDA as net income (loss) before interest income, interest expense, gain (loss) on early extinguishment of debt, benefit from (provision for) income taxes and depreciation and amortization and as further adjusted to exclude costs that management believes are non-core to the underlying business of the Company, consisting of restructuring, exit and related charges, integration costs, costs related to mergers and acquisitions, non-cash equity-based compensation and related employer taxes, long-term incentive plan costs, certain corporate costs, fair value movements on earnout derivative liabilities, foreign currency gains (losses) and non-service components of net periodic pension benefit (costs).
We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue.
We define Adjusted Operating Expenses as total operating expenses excluding depreciation and amortization and costs that management believes are non-core to the underlying business of the Company, consisting of restructuring, exit and related charges, integration costs, costs related to mergers and acquisitions, non-cash equity-based compensation and related employer taxes, long-term incentive plan costs and certain corporate costs.
Adjusted Gross Profit, Adjusted Gross Profit Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses are supplemental non-GAAP financial measures of operating performance that do not represent and should not be considered as alternatives to gross profit, net income (loss) or total operating expenses, as determined under GAAP. In addition, these measures may not be comparable to similarly titled measures used by other companies.
These non-GAAP measures have limitations as analytical tools, and these measures should not be considered in isolation or as a substitute for analysis of the Company’s results or expenses as reported under GAAP. Some of these limitations are that these measures do not reflect:
changes in, or cash requirements for, our working capital needs or contractual commitments; our interest expense, or the cash requirements to service interest or principal payments on our indebtedness; our tax expense, or the cash requirements to pay our taxes; recurring, non-cash expenses of depreciation and amortization of property and equipment and definite-lived intangible assets and, although these are non-cash expenses, the assets being depreciated and amortized may have to be replaced in the future; the non-cash expense of stock-based compensation, which has been, and will continue to be for the foreseeable future, an important part of how we attract and retain our employees and a significant recurring expense in our business; restructuring, mergers and acquisition and integration costs, all of which are intrinsic to our acquisitive business model; and impact on earnings or changes resulting from matters that are non-core to our underlying business, as we believe they are not indicative of our underlying operations. Adjusted Gross Profit, Adjusted Gross Profit Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses should not be considered as a measure of liquidity or as a measure determining discretionary cash available to us to reinvest in the growth of our business or as measures of cash that will be available to us to meet our obligations.
We believe that the adjustments applied in presenting Adjusted Gross Profit, Adjusted Gross Profit Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses are appropriate to provide additional information to investors about certain material non-cash and other items that management believes are non-core to our underlying business.
We use these measures as performance measures as they are important metrics used by management to evaluate and understand the underlying operations and business trends, forecast future results and determine future capital investment allocations. These non-GAAP measures supplement comparable GAAP measures in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. We also believe that Adjusted Gross Profit, Adjusted Gross Profit Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Operating Expenses are helpful supplemental measures to assist potential investors and analysts in evaluating our operating results across reporting periods on a consistent basis.
We define Free Cash Flow as net cash from (used in) operating activities, less cash used for additions to property and equipment.
We believe Free Cash Flow is an important measure of our liquidity. This measure is a useful indicator of our ability to generate cash to meet our liquidity demands. We use this measure to conduct and evaluate our operating liquidity. We believe it typically presents an alternate measure of cash flow since purchases of property and equipment are a necessary component of our ongoing operations and it provides useful information regarding how cash provided by operating activities compares to the property and equipment investments required to maintain and grow our platform. We believe Free Cash Flow provides investors with an understanding of how assets are performing and measures management’s effectiveness in managing cash.
Free Cash Flow is a non-GAAP measure and may not be comparable to similarly named measures used by other companies. This measure has limitations in that it does not represent the total increase or decrease in the cash balance for the period, nor does it represent cash flow for discretionary expenditures. This measure should not be considered as a measure of liquidity or cash flow from operations as determined under GAAP. This measure is not a measurement of our financial performance under GAAP and should not be considered in isolation or as an alternative to net income (loss) or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as a measure of liquidity.
We define Net Debt as total debt outstanding consisting of the current and non-current portion of long-term debt, net of unamortized debt discount and unamortized debt issuance costs, minus cash and cash equivalents. Net Debt is a non-GAAP measure and may not be comparable to similarly named measures used by other companies. This measure is not a measurement of our indebtedness as determined under GAAP and should not be considered in isolation or as an alternative to assess our total debt or any other measures derived in accordance with GAAP or as an alternative to total debt. Management uses Net Debt to review our overall liquidity, financial flexibility, capital structure and leverage. Further, we believe that certain debt rating agencies, creditors and credit analysts monitor our Net Debt as part of their assessment of our business.
Reconciliation of Adjusted Gross Profit to Gross Profit:
Three months ended June 30,
(in $ millions)
2026
2025
Revenue
$
870
$
631
Cost of revenue (excluding depreciation and amortization)
356
242
Adjusted Gross Profit
514
389
Depreciation and amortization related to cost of revenue
20
18
Gross Profit
494
371
Gross Profit Margin
57
%
59
%
Adjusted Gross Profit Margin
59
%
62
%
Reconciliation of net income to EBITDA and Adjusted EBITDA:
Three months ended June 30,
(in $ millions)
2026
2025
Net income
$
17
$
15
Interest income
(1
)
(2
)
Interest expense
25
23
Provision for income taxes
2
21
Depreciation and amortization
56
43
EBITDA
99
100
Restructuring, exit and related charges (a)
45
13
Integration costs (b)
17
3
Mergers and acquisitions costs (c)
12
18
Equity-based compensation and related employer taxes (d)
20
20
Fair value movement on earnout derivative liabilities (e)
(6
)
(32
)
Other adjustments, net (f)
(9
)
11
Adjusted EBITDA
$
178
$
133
Net income Margin
2
%
2
%
Adjusted EBITDA Margin
21
%
21
%
Reconciliation of total operating expenses to Adjusted Operating Expenses:
Three months ended June 30,
(in $ millions)
2026
2025
Total operating expenses
$
846
$
597
Adjustments:
Depreciation and amortization
(56
)
(43
)
Restructuring, exit and related charges (a)
(45
)
(13
)
Integration costs (b)
(17
)
(3
)
Mergers and acquisitions costs (c)
(12
)
(18
)
Equity-based compensation and related employer taxes (d)
(20
)
(20
)
Adjusted Operating Expenses
$
696
$
500
a)
Includes (i) employee severance costs of $38 million and $11 million for the three months ended June 30, 2026 and 2025, respectively, (ii) accelerated amortization of operating lease ROU assets of $4 million and $1 million for the three months ended June 30, 2026 and 2025, respectively, and (iii) contract costs related to facility abandonment of $3 million and $1 million for the three months ended June 30, 2026 and 2025, respectively.
b)
Represents expenses related to the integration of business acquisitions.
c)
Represents expenses related to business acquisitions, including potential business acquisitions, and includes pre-acquisition due diligence and related activities costs.
d)
Represents non-cash equity-based compensation expense and employer taxes paid related to equity incentive awards to certain employees.
e)
Represents fair value movements on earnout derivative liabilities during the periods.
f)
Adjusted EBITDA excludes (i) unrealized foreign exchange gain (loss) of $9 million and $(10) million for the three months ended June 30, 2026 and 2025, respectively, and (ii) non-service component of our net periodic pension cost related to our defined benefit pension plans of $0 and $1 million for the three months ended June 30, 2026 and 2025, respectively.
Reconciliation of LTM Adjusted EBITDA:
Three months ended
Last twelve months ended
(in $ millions)
September 30, 2025
December 31, 2025
March 31, 2026
June 30, 2026
June 30, 2026
Net (loss) income
$
(62
)
$
83
$
54
$
17
$
92
Interest income
(2
)
(2
)
(1
)
(1
)
(6
)
Interest expense
24
24
27
25
100
Provision for (benefit from) income taxes
24
(26
)
(42
)
2
(42
)
Depreciation and amortization
49
60
60
56
225
EBITDA
33
139
98
99
369
Restructuring, exit and related charges
31
10
49
45
135
Integration costs
4
8
9
17
38
Mergers and acquisitions
10
1
3
12
26
Equity-based compensation and related employer taxes
19
20
25
20
84
Fair value movement on earnout derivative liabilities
26
(16
)
(31
)
(6
)
(27
)
Gain on remeasurement of equity method investment at fair value
—
(39
)
—
—
(39
)
Other adjustments, net
5
7
(3
)
(9
)
—
Adjusted EBITDA
$
128
$
130
$
150
$
178
$
586
Reconciliation of net cash from operating activities to Free Cash Flow:
Three months ended June 30,
(in $ millions)
2026
2025
Net cash from operating activities
$
142
$
57
Less: Purchase of property and equipment
(39
)
(30
)
Free Cash Flow
$
103
$
27
Reconciliation of Net Debt:
As of
(in $ millions)
June 30, 2026
December 31, 2025
June 30, 2025
Current portion of long-term debt
$
61
$
58
$
19
Long-term debt, net of unamortized debt discount and debt issuance costs
1,451
1,360
1,362
Total debt, net of unamortized debt discount and debt issuance costs
1,512
1,418
1,381
Less: Cash and cash equivalents
(518
)
(434
)
(601
)
Net Debt
$
994
$
984
$
780
LTM Adjusted EBITDA
$
586
$
532
$
502
Net Debt / LTM Adjusted EBITDA
1.7x
1.9x
1.6x
Forward-Looking Statements
Certain statements made in this release are “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide our current expectations or forecasts of future events. Forward-looking statements include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.
The forward-looking statements contained in this release are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the following risks, uncertainties and other factors: (1) changes to projected financial information or our ability to achieve our anticipated growth rate and execute on industry opportunities; (2) our ability to maintain our existing relationships with clients and suppliers and to compete with existing and new competitors; (3) various conflicts of interest that could arise among us, affiliates and investors; (4) our success in retaining or recruiting, or changes required in, our officers, key employees or directors; (5) factors relating to our business, operations and financial performance, including market conditions and global and economic factors beyond our control; (6) the impact of geopolitical conflicts, including the war in Ukraine, the conflicts in the Middle East, tensions between China and Taiwan and military operations in Venezuela, as well as related changes in base interest rates, inflation and significant market volatility on our business, the travel industry, travel trends and the global economy generally; (7) the sufficiency of our cash, cash equivalents and investments to meet our liquidity needs; (8) the effect of a prolonged or substantial decrease in global travel on the global travel industry; (9) political, social and macroeconomic conditions (including the widespread adoption of teleconference and virtual meeting technologies which could reduce the number of in-person business meetings and demand for travel and our services); (10) the effect of legal, tax and regulatory changes; (11) the impact of any future acquisitions including the integration of any acquisition; (12) costs related to, or the inability to recognize the anticipated benefits of our merger with CWT; (13) risks related to the business of CWT or unexpected liabilities that may arise in connection with the integration of CWT into our business; (14) the outcome of any legal proceedings that may be instituted against the Company in connection with the merger with CWT or the proposed Merger; (15) the ability to complete the proposed Merger on the anticipated terms and timing, or at all, including obtaining required regulatory approvals and the satisfaction of other conditions to the completion of the proposed Merger; (16) the ability to achieve the cost reductions contemplated by our business strategy after the completion of the Merger; (17) the risk that disruptions from the proposed Merger (such as the ability of certain customers of the Company to terminate or amend contracts upon a change of control, or to withhold consent to such change of control) will harm the Company’s business, including current plans and operations, during the pendency, and following the completion of, the proposed Merger; (18) the diversion of management’s time and attention from ordinary course business operations to completion of the proposed Merger; (19) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed Merger; (20) contractual provisions that may impact the Company’s ability to pursue certain business opportunities or strategic transactions during the pendency, and/or following the completion of, the proposed Merger; (21) the occurrence of any event, change, or other circumstance that could give rise to the termination of the proposed Merger; (22) those risks and uncertainties found in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including the risk factors discussed in the Company’s most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC from time to time, which are available via the SEC’s website at www.sec.gov; and (23) those risks and uncertainties that are described in the definitive proxy statement that was filed with the SEC on July 6, 2026 in connection with the Merger. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. These factors should not be construed as exhaustive and should be read in conjunction with the other forward-looking statements. The forward-looking statements relate only to events as of the date on which the statements are made. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.
Disclaimer
An investment in Global Business Travel Group, Inc. is not an investment in American Express. American Express shall not be responsible in any manner whatsoever for, and in respect of, the statements herein, all of which are made solely by Global Business Travel Group, Inc.
NOG oznámila čtvrtletní hotovostní dividendu 0,45 USD na akcii, stejně jako v předchozím čtvrtletí. Splatná je 30. října 2026 akcionářům k 29. září 2026.
MINNEAPOLIS--(BUSINESS WIRE)--Northern Oil and Gas, Inc. (NYSE: NOG) (“NOG” or the “Company”) today announced that its Board of Directors has declared a cash dividend on the Company’s common stock.
DIVIDEND DECLARATION
NOG’s Board of Directors has declared a cash dividend in the amount of $0.45 per share, representing an equal amount to the prior quarterly dividend. The dividend is payable on October 30, 2026, to stockholders of record as of the close of business on September 29, 2026.
ABOUT NOG
Northern Oil and Gas (NOG) is the largest publicly traded dedicated non-operator in the United States, built on a differentiated strategy of acquiring non-operated minority working interests and mineral rights across the premier basins of North America. By combining deep industry relationships with disciplined capital allocation, NOG has built a scaled, diversified portfolio that generates durable production and strong cash flow for its shareholders. More information about NOG can be found at www.noginc.com.
Labcorp spustila celostátní dostupnost FDA schváleného testu VENTANA PTEN (SP218) RxDx pro rakovinu prostaty. Test pomáhá určit pacienty, kteří mohou být vhodní pro léčbu TRUQAP v kombinaci s abirateronem a prednisonem.
First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib)
, /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche's VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma. The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone acetate and prednisone.
Addressing an Unmet Need in Prostate Cancer Care
Excluding skin cancer, prostate cancer is the most common cancer among men in the United States, with more than 330,000 new cases expected each year. PTEN is a tumor suppressor protein that plays a critical role in regulating cell growth. Loss of PTEN protein expression has been associated with more aggressive disease progression and reduced benefit from current standard-of-care therapies in prostate cancer. Until recently, there were no approved treatment options specifically targeting this biology.
The VENTANA PTEN (SP218) RxDx Assay is a companion diagnostic designed to detect PTEN protein loss in prostate cancer tissue specimens, providing clinicians with important biomarker information to help guide treatment decisions and support personalized patient care.
"Biomarker testing is essential to advancing precision oncology and helping connect patients with the therapies most appropriate for their disease," said Shakti Ramkissoon, M.D., Ph.D., vice president, medical lead for oncology at Labcorp. "The launch of the VENTANA PTEN (SP218) RxDx Assay underscores how Labcorp is expanding access to innovative companion diagnostics and delivering the timely insights physicians need to make personalized treatment decisions."
Advancing Access to FDA-Approved Companion Diagnostics
Labcorp participated in Roche's early access program to support Day 1 laboratory readiness for the assay, reinforcing the company's commitment to helping patients gain timely access to newly approved targeted therapies and the companion diagnostics needed to identify eligible patients.
The VENTANA PTEN (SP218) RxDx Assay is now available through Labcorp's national network of laboratories and complements the company's comprehensive portfolio of genomic, molecular and companion diagnostic testing services that support precision oncology care. As one of the nation's largest providers of oncology testing services, Labcorp enables physicians across community and academic settings to access FDA-approved companion diagnostics at scale, helping bring precision medicine to more patients regardless of where they receive care. The assay can also be ordered alongside Labcorp's broader portfolio of oncology testing services, providing clinicians with comprehensive biomarker insights from a single laboratory partner.
To learn more about the assay, visit https://oncology.labcorp.com/tests/484680/PTEN-IHC-with-interpretation-for-prostate-adenocarcinoma
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 71,000 employees serve clients in approximately 100 countries, provided support for more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients around the world. Learn more at www.labcorp.com.
Resideo dokončila odštěpení ADI Global Distribution a stává se čistě stavebně-technologickou firmou. V souvislosti s transakcí splatila dluh ve výši 900 milionů USD.
Positioned To Accelerate Profitable Growth and Innovation as a Pure-Play Building Technologies Company
Repaid $900 Million of Indebtedness and Preferred Stock Reduced to 350,000 Shares Outstanding
ADI Begins Trading Today on the New York Stock Exchange Under Ticker "ADIG"
, /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI) ("Resideo"), a leading global developer and manufacturer of critical control and sensing solutions for residential end markets, today announced the completion of its spin-off of ADI Global Distribution Inc. ("ADI"), establishing Resideo as a pure-play building technologies company. Resideo will continue to trade on the New York Stock Exchange under the ticker symbol "REZI" and ADI's common stock will begin "regular-way" trading today on the New York Stock Exchange under the ticker symbol "ADIG".
"With trusted and iconic brands, deep relationships with pros and a 140-year heritage of innovation, Resideo is poised to start this next chapter as a pure-play building technologies company," said Tom Surran, President and Chief Executive Officer of Resideo. "With dedicated strategic, operational and financial focus, we are ready to capture the profitable growth opportunities ahead and drive above market growth and sustained margin expansion."
The spin-off was completed through the distribution of all of the issued and outstanding shares of ADI common stock to Resideo common shareholders on the basis of one share of ADI common stock for every two shares of Resideo common stock held of record as of the close of business on July 20, 2026. Resideo shareholders of record will also receive cash in lieu of any fractional shares to which they would otherwise be entitled.
In connection with the spin-off, Resideo repaid $900 million of outstanding principal under its Term Loan B credit facility. Resideo expects to make a further repayment of approximately $200 million under its Term Loan B credit facility following the completion of the post-closing cash adjustment under the separation agreement with ADI. Resideo expects to make this repayment by the end of the third fiscal quarter. Additionally, the outstanding Resideo Series A Cumulative Convertible Participating Preferred Stock was reduced by 150,000 shares in connection with the completion of the spin-off, leaving 350,000 shares outstanding, with a proportional adjustment to the conversion price thereof.
About Resideo
Resideo is a global building technologies company that is a leading developer and manufacturer of critical control and sensing solutions for residential markets. The company serves professional installers and integrators across diverse product segments, such as heating, ventilation, and air conditioning controls, combustion, life safety, security, and water. Its comfort and protection solutions can be found in more than 150 million residential and commercial spaces globally, with tens of millions of new devices sold annually. More information about Resideo and its trusted brands, including BRK, First Alert, and Honeywell Home, is available at www.resideo.com.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, those regarding our anticipated market positioning and financial and operational performance following the separation of our ADI Global Distribution business from Resideo Technologies, Inc. and other future events or developments. Forward-looking statements are typically identified by such words as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "project," "should," "will," and similar expressions, although not all forward-looking statements contain these words. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Among the factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements are the possibility that the separation may not achieve the intended strategic, operational, or financial benefits for Resideo, its businesses, or its shareholders; that Resideo may experience operational or other disruptions as a result of the separation, including those relating to information technology systems, business processes, internal controls, customer and vendor relationships, and workforce alignment. Resideo's ability to succeed as an independent enterprise without ADI will depend on numerous factors, including the execution of its strategies and plans, access to capital markets, the competitive landscape, and general business and economic conditions. Other risks and uncertainties include, but are not limited to, our ability to recognize the expected savings from, and the timing and impact of, our existing and anticipated cost reduction actions, and our ability to optimize our portfolio and operational footprint, the ability of Resideo to drive increased customer value and financial returns and enhance strategic and operational capabilities, risks and uncertainties relating to tariffs that have been or may be imposed by the United States and other governments, and the other risks described under the headings "Risk Factors" and "Cautionary Statement Concerning Forward-Looking Statements" in our Annual Report on Form 10-K for the year ended December 31, 2025 and other periodic reports.
All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks and uncertainties, which may cause the actual results or performance of Resideo to differ materially from such forward-looking statements. Forward-looking statements are not guarantees of future performance, and actual results, developments, and business decisions may differ from those envisaged by our forward-looking statements. Except as required by law, we undertake no obligation to update such statements to reflect events or circumstances arising after the date of this press release and we caution investors not to place undue reliance on any such forward-looking statements.
Contacts:
Investors:
Christopher T. Lee
Global Head of Strategic Finance
[email protected]
Media:
Kevin Hunt
Communications Director
[email protected]
Or
Dan Moore, Tali Epstein
Collected Strategies
[email protected]
, /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30, 2026.
AMETEK's second quarter 2026 sales were a record $2.04 billion, a 15% increase over the second quarter of 2025. On a GAAP basis, second quarter earnings were a record $1.77 per diluted share. Adjusted earnings in the quarter were a record $2.09 per diluted share, up 17% from the second quarter of 2025. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization, financing fees and integration costs of $0.32 per diluted share.
GAAP operating income was a record $528.2 million. Adjusted operating income increased 18% to a record $544.4 million and operating margins were 26.6% in the quarter, up 60 basis points from the prior year. Operating cash flow in the quarter was up 35% to $483.7 million and free cash flow to net income conversion was 111%. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.
"AMETEK delivered superb results in the second quarter. Strong organic sales growth, contributions from recent acquisitions, and outstanding operating performance led to high-teens earnings growth, excellent 110 basis points of core margin expansion and record operating performance," stated David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Notably, for the second quarter in a row, orders were exceptional, growing 28% in the quarter."
Electronic Instruments Group (EIG)
EIG sales in the second quarter were $1.32 billion, an increase of 14% over the same period in 2025. On a GAAP basis, EIG's second quarter operating income was $369.8 million. On an adjusted basis, EIG's operating income was up 12% to $384.7 million.
"EIG generated outstanding results in the second quarter with mid-teens sales growth, sizeable orders growth and excellent operating performance," commented Mr. Zapico. "Sales growth in the quarter was balanced between organic growth and contributions from recent acquisitions, with excellent orders growth highlighted by our semiconductor and commercial aerospace markets. Further, EIG's strong operating performance drove core margins up 40 basis points to 30.1%."
Electromechanical Group (EMG)
EMG sales in the second quarter were a record $723.2 million, up 17% from the second quarter of 2025. In the quarter, EMG's GAAP operating income was $189.3 million. On an adjusted basis, EMG's operating income increased 32% to a record $190.5 million and operating income margins were 26.3%.
"EMG delivered exceptional results in the second quarter. Strong organic sales growth resulted in sizeable profit growth and 290 basis points of core margin expansion," noted Mr. Zapico. "Orders growth was also outstanding and broad-based in the quarter with notable strength in medtech, defense and automation markets."
Third Quarter and Full Year 2026 Outlook
"Our businesses performed exceptionally well in the second quarter highlighting the strength of the AMETEK Growth Model, the quality of our business and the attractiveness of our markets. Our broad-based sales and orders growth reflects our unique position as a mission critical provider of highly differentiated solutions supporting strong secular growth markets including the global infrastructure build-out," added Mr. Zapico.
"For 2026, we now expect overall sales to be up approximately 10% versus 2025. Adjusted earnings per diluted share are now expected to be in the range of $8.20 to $8.30, up 10% to 12% over the comparable basis for 2025. This is an increase from our prior guidance range of $7.94 to $8.14 per diluted share reflecting our strong underlying performance and outlook for the balance of the year," he added.
"For the third quarter of 2026, overall sales are expected to be up high single digits on a percentage basis compared to the third quarter of 2025. Adjusted earnings in the quarter are anticipated to be in the range of $2.08 to $2.10 per share, up 10% to 11% compared to the third quarter of 2025," concluded Mr. Zapico.
Conference Call
AMETEK will webcast its second quarter 2026 investor conference call on Tuesday, August 4, 2026, beginning at 8:30 AM ET. The live audio webcast will be available and later archived in the Investors section of www.ametek.com.
Corporate Profile
AMETEK (NYSE: AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $8.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for over 95 years and is a component of the S&P 500. For more information, visit www.ametek.com.
Forward-looking Information
Statements in this news release relating to future events, such as AMETEK's expected business and financial performance, are "forward-looking statements." Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ materially from expectations. These factors and uncertainties include risks related to AMETEK's ability to consummate and successfully integrate future acquisitions; risks with international sales and operations, including supply chain disruptions, tariffs, trade disputes and currency conditions; AMETEK's ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Forms 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.
Contact:
Kevin Coleman
Vice President, Investor Relations and Treasurer
[email protected]
Phone: 610.889.5247
AMETEK, Inc.
Consolidated Statement of Income
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Net sales
$ 2,044,397
$ 1,778,056
$ 3,972,834
$ 3,510,027
Cost of sales
1,309,356
1,142,167
2,520,234
2,249,138
Selling, general and administrative
206,848
174,263
409,471
344,434
Total operating expenses
1,516,204
1,316,430
2,929,705
2,593,572
Operating income
528,193
461,626
1,043,129
916,455
Interest expense
(30,101)
(16,857)
(51,010)
(35,850)
Other (expense) income, net
(5,720)
(2,600)
(6,767)
(4,214)
Income before income taxes
492,372
442,169
985,352
876,391
Provision for income taxes
85,476
83,802
179,099
166,266
Net income
$ 406,896
$ 358,367
$ 806,253
$ 710,125
Diluted earnings per share
$ 1.77
$ 1.55
$ 3.51
$ 3.07
Basic earnings per share
$ 1.78
$ 1.55
$ 3.52
$ 3.08
Weighted average common shares
outstanding:
Diluted shares
229,855
231,472
229,845
231,507
Basic shares
229,086
230,818
228,994
230,743
Dividends per share
$ 0.34
$ 0.31
$ 0.68
$ 0.62
AMETEK, Inc.
Information by Business Segment
(In thousands)
(Unaudited)
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Net sales:
Electronic Instruments
$ 1,321,153
$ 1,159,571
$ 2,585,689
$ 2,303,244
Electromechanical
723,244
618,485
1,387,145
1,206,783
Consolidated net sales
$ 2,044,397
$ 1,778,056
$ 3,972,834
$ 3,510,027
Operating income:
Segment operating income:
Electronic Instruments
$ 369,722
$ 344,428
$ 743,660
$ 698,478
Electromechanical
189,317
143,888
360,083
272,606
Total segment operating income
559,039
488,316
1,103,743
971,084
Corporate administrative expenses
(30,846)
(26,690)
(60,614)
(54,629)
Consolidated operating income
$ 528,193
$ 461,626
$ 1,043,129
$ 916,455
AMETEK, Inc.
Condensed Consolidated Balance Sheet
(In thousands)
June 30,
December 31,
2026
2025
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents
$ 495,446
$ 457,951
Receivables, net
1,170,497
1,119,257
Inventories, net
1,195,383
1,106,405
Other current assets
365,475
336,229
Total current assets
3,226,801
3,019,842
Property, plant and equipment, net
850,173
855,215
Right of use assets, net
259,308
273,142
Goodwill
7,418,304
7,170,770
Other intangibles, investments and other assets
4,840,127
4,748,574
Total assets
$ 16,594,713
$ 16,067,543
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Short-term borrowings and current portion of long-term debt, net
$ 980,633
$ 1,208,975
Accounts payable and accruals
1,677,965
1,633,777
Total current liabilities
2,658,598
2,842,752
Long-term debt, net
1,055,541
1,074,334
Deferred income taxes and other long-term liabilities
1,619,811
1,521,671
Stockholders' equity
11,260,763
10,628,786
Total liabilities and stockholders' equity
$ 16,594,713
$ 16,067,543
AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended June 30,
2026
2025
EIG Segment operating income (GAAP)
$ 369,722
$ 344,428
Acquisition-related costs(1)
14,996
—
Adjusted EIG Segment operating income (Non-GAAP)
$ 384,718
$ 344,428
EMG Segment operating income (GAAP)
$ 189,317
$ 143,888
Acquisition-related costs(1)
1,208
—
Adjusted EMG Segment operating income (Non-GAAP)
$ 190,525
$ 143,888
Operating income (GAAP)
$ 528,193
$ 461,626
Acquisition-related costs(1)
16,204
—
Adjusted Operating income (Non-GAAP)
$ 544,397
$ 461,626
Interest expense (GAAP)
$ 30,101
$ 16,857
Acquisition-related costs(1)
(10,006)
—
Adjusted interest expense (non-GAAP)
$ 20,095
$ 16,857
Diluted earnings per share (GAAP)
$ 1.77
$ 1.55
Acquisition-related costs(1)
0.11
—
Income tax benefit on acquisition-related costs(1)
(0.02)
—
Pretax amortization of acquisition-related intangible assets
0.30
0.31
Income tax benefit on amortization of acquisition-related intangible assets
(0.07)
(0.08)
Rounding
—
—
Adjusted Diluted earnings per share (Non-GAAP)
$ 2.09
$ 1.78
Cash provided by operating activities (GAAP)
$ 483,693
$ 359,089
Deduct: Capital expenditures
(32,012)
(29,269)
Free cash flow (Non-GAAP)
$ 451,681
$ 329,820
Free cash flow conversion (Non-GAAP)
111 %
92 %
(1)
-
Acquisition-related costs comprise integration costs in Cost of Sales and one-time Indicor bridge financing fees in interest expense.
AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
June 30,
2026
2025
Change
EIG Segment operating margin (GAAP)
28.0 %
29.7 %
Acquisition-related costs(1)
1.1 %
— %
Adjusted EIG Segment operating margin (Non-GAAP)
29.1 %
29.7 %
Dilutive impact of acquisitions and foreign exchange(2)
Dilutive impact of acquisitions and foreign exchange(2)
0.5 %
— %
Adjusted core operating income margin (Non-GAAP)
27.1 %
26.0 %
1.1 %
(1)
-
Acquisition-related costs comprise integration costs in Cost of Sales and one-time Indicor bridge financing fees in interest expense.
(2)
-
Operating income margins adjusted for dilutive impact from acquisitions completed in the last twelve months and the foreign exchange gain or loss.
AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(Unaudited)
Forecasted Diluted Earnings Per Share
Three Months Ended
Year Ended
September 30, 2026
December 31,2026
Low
High
Low
High
Diluted earnings per share (GAAP)
$ 1.85
$ 1.87
$ 7.19
$ 7.29
Pretax amortization of acquisition-related intangible
assets
0.31
0.31
1.21
1.21
Income tax benefit on amortization of acquisition-related
intangible assets
(0.08)
(0.08)
(0.30)
(0.30)
Acquisition-related costs(3)
—
—
0.12
0.12
Income tax benefit on acquisition-related costs(3)
—
—
(0.02)
(0.02)
Adjusted Diluted earnings per share (Non-GAAP)
$ 2.08
$ 2.10
$ 8.20
$ 8.30
(3)
-
In providing forward-looking guidance for quarterly and full-year GAAP and non-GAAP measures, the Company has not included adjustments, such as acquisition-related costs, whose timing and/or magnitude are contingent on future events. Acquisition-related costs reflected in the table above are actual June 30, 2026 year-to-date adjustments.
Use of Non-GAAP Financial Information
The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles ("GAAP") basis with certain non-GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non-GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
The non-GAAP financial measures referenced in this press release include adjusted operating income, adjusted operating margin, and adjusted earnings per share. These measures are adjusted to exclude items that management does not consider indicative of AMETEK's ongoing operational performance, such as after-tax acquisition-related intangible amortization, one-time acquisition-related costs (including transaction related costs, purchase accounting adjustments, and integration related costs).
In providing forward-looking guidance for quarterly and full-year GAAP and non-GAAP measures, the Company has not included adjustments, such as acquisition-related costs, whose timing and/or magnitude are contingent on future events.
The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEK's operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.
Graphic Packaging ve 2. čtvrtletí vykázala tržby 2,188 miliardy USD a čistý zisk 24 milionů USD, ale kvůli vyšší inflaci snížila výhled Adjusted EPS a očekává Adjusted EBITDA 247 milionů USD na spodní hraně cíle.
Net Sales were $2,188 million; Innovation Sales Growth added $40 million. Net Income of $24 million; Adjusted EBITDA of $247 million, strong execution despite elevated inflation. Structural cost actions expected to generate approximately $85 million of in-year savings, partially offsetting full-year 2026 expected inflation of $150 million. On track to achieve full-year 2026 Net Sales at the high end of guidance range, while Adjusted EBITDA is expected at the low end of guidance range due to the heightened inflationary environment; Adjusted EPS range lowered to reflect higher interest expense and Adjusted Cash Flow guidance updated to $600 million to $700 million. , /PRNewswire/ -- Graphic Packaging Holding Company (NYSE: GPK) ("Graphic Packaging" or the "Company"), a global leader in sustainable consumer packaging, today reported second quarter 2026 results.
Net Sales in second quarter 2026 were $2,188 million, versus $2,204 million in second quarter 2025. Net Income in second quarter 2026 was $24 million, or $0.08 per diluted share, versus Net Income of $104 million, or $0.34 per diluted share in second quarter 2025. Second quarter 2026 and 2025 Net Income were impacted by a net charge from non-recurring and special items and amortization of purchased intangibles of $17 million and $24 million, respectively. Excluding non-recurring and special items and amortization of purchased intangibles, Adjusted Net Income for the second quarter of 2026 was $41 million, or $0.14 per diluted share, and $128 million, or $0.42 per diluted share in second quarter 2025.
"We continued to execute against our near-term strategic priorities and delivered solid second quarter performance, with Adjusted EBITDA at the top of our guidance range despite greater than anticipated inflation," said Robbert Rietbroek, President and Chief Executive Officer. "Our business demonstrated resilience, with both sales and volumes increasing in the first half of 2026 compared with the same period in 2025. We are beginning to realize the benefits of our productivity initiatives, disciplined cost management, and improving operational efficiencies, which helped mitigate higher than expected inflationary pressures in the quarter. As a result, we achieved 50 basis points of sequential Adjusted EBITDA margin expansion in the second quarter relative to the first quarter."
"In response to incremental inflation, we implemented additional productivity, cost reduction, and pricing initiatives. The combination of these recent actions and our disciplined execution against strategic priorities positions us to drive continued sequential profitability and margin improvement in the second half of 2026 and provides positive momentum into next year."
Financial and Operating Results
Net Sales
Second quarter 2026 Net Sales decreased 1% to $2,188 million, versus $2,204 million in the same quarter last year. The $16 million decline was driven by a 1% decrease, or $27 million, in price, flat, or $2 million decrease, in volume/mix, partially offset by a $13 million favorable foreign exchange/other impact. Innovation Sales Growth in the second quarter was $40 million.
EBITDA
Second quarter 2026 EBITDA decreased 26% to $240 million from $323 million in the same quarter last year. Excluding the impact of business combinations and other non-recurring and special items, Adjusted EBITDA was $247 million versus $336 million in the same quarter last year. The $89 million decline in Adjusted EBITDA was driven by the impact of commodity input and operating cost inflation of $60 million, lower price of $27 million, lower volume/mix of $8 million, as well as an unfavorable foreign exchange impact of $3 million, partially offset by positive Net Performance of $9 million. Second quarter Adjusted EBITDA Margin was 11.3% in 2026, and 15.3% in 2025.
Other Results
Total Debt (Long-Term, Short-Term and Current Portion) was $5,688 million in second quarter 2026 compared to $5,592 million in fourth quarter 2025 and $5,772 million in the first quarter 2026. Net Debt (Total Debt less Cash and Cash Equivalents) was $5,483 million in second quarter 2026 compared to $5,331 million in fourth quarter 2025 and $5,583 million in the first quarter 2026. The Company's second quarter 2026 Net Leverage Ratio was 4.7x compared to 3.8x in fourth quarter 2025.
Capital expenditures in second quarter 2026 were $83 million, versus $228 million in the same quarter last year.
The Company returned approximately $65 million to stockholders during the first six months of 2026 through regular dividends.
2026 Annual Guidance
The Company now expects 2026 Net Sales at the high-end of the range of $8.4 billion to $8.6 billion, Adjusted EBITDA at the low-end of the range of $1.05 billion to $1.25 billion, and Adjusted EPS in the range of $0.65 to $0.90.
The Company now expects 2026 Adjusted Cash Flow in the range of $600 million to $700 million, and 2026 capital spending below $450 million.
Optimizing Operations
Furthering our footprint optimization initiative, we completed the divestiture of our Croatia facility and announced plans to close our facility in Lebanon, Tennessee, to consolidate volumes across fewer facilities. Additionally, we notified employees of our intention to evaluate the potential closure of our site in Winsford, UK.
Innovation Sales Growth, Net Performance, and Non-GAAP Reconciliations
We define Innovation Sales Growth as incremental sales of a product that delivers a significant change in materials used, package functionality or design to a new or existing customer. We define Net Performance as the impact of cost and productivity initiatives, production efficiencies and/or disruptions and other operating impacts. A tabular reconciliation of EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted EPS, Adjusted Net Cash Used in Operating Activities, Adjusted Cash Flow, Net Debt and Net Leverage is attached to this release.
Earnings Call
The Company will host a conference call at 10:00 a.m. ET today (August 4, 2026) to discuss the results of second quarter 2026. The conference call will be webcast and can be accessed from the Investors website at https://investors.graphicpkg.com. Participants may also listen via telephone by using the following dial-in numbers:
Any statements of the Company's expectations in this press release, including but not limited to savings resulting from structural cost actions in 2026, 2026 Net Sales, Adjusted EBITDA and Adjusted Earnings per Diluted Share, Adjusted Cash Flow guidance, and profitability and margin improvement in the second half of 2026 constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on currently available information and are subject to various risks and uncertainties that could cause actual results to differ materially from the Company's present expectations. These risks and uncertainties include, but are not limited to, inflation of and volatility in raw material and energy costs, continuing pressure for lower cost products, the Company's ability to implement its business strategies, including productivity initiatives, cost reduction plans, as well as the Company's debt level, currency movements and other risks of conducting business internationally, the impact of regulatory and litigation matters, including the continued availability of the Company's U.S. federal income tax attributes to offset U.S. federal income taxes and the timing related to the Company's future U.S. federal income tax payments. Undue reliance should not be placed on such forward-looking statements, as such statements speak only as of the date on which they are made and the Company undertakes no obligation to update such statements, except as may be required by law. Additional information regarding these and other risks is contained in the Company's periodic filings with the Securities and Exchange Commission.
About Graphic Packaging Holding Company
Graphic Packaging Holding Company (NYSE: GPK), headquartered in Atlanta, Georgia, designs and produces consumer packaging made primarily from renewable or recycled materials. An industry leader in innovation, the Company is committed to reducing the environmental footprint of consumer packaging. Graphic Packaging operates a global network of design and manufacturing facilities serving the world's most widely recognized brands in food, beverage, foodservice, household, and other consumer products. Learn more at www.graphicpkg.com.
Graphic Packaging Holding Company
Consolidated Statements of Operations
(Unaudited)
Three Months Ended June 30,
Six Months Ended June 30,
In millions, except per share amounts
2026
2025
2026
2025
Net Sales
$ 2,188
$ 2,204
$ 4,344
$ 4,324
Cost of Sales
1,896
1,784
3,746
3,459
Selling, General and Administrative
180
204
382
400
Other Expense, Net
11
10
25
26
Business Combinations, Exit Activities and Other Special Items, Net
6
13
77
25
Income from Operations
95
193
114
414
Nonoperating Pension and Postretirement Benefit Expense
(1)
(1)
(1)
(1)
Interest Expense, Net
(68)
(53)
(132)
(104)
Income (Loss) before Income Taxes
26
139
(19)
309
Income Tax Expense
(2)
(35)
—
(78)
Net Income (Loss)
$ 24
$ 104
$ (19)
$ 231
Net Income (Loss) Per Share - Basic
$ 0.08
$ 0.35
$ (0.06)
$ 0.77
Net Income (Loss) Per Share - Diluted
$ 0.08
$ 0.34
$ (0.06)
$ 0.76
Weighted Average Number of Shares Outstanding - Basic
296.6
301.2
296.6
301.7
Weighted Average Number of Shares Outstanding - Diluted
296.7
301.6
296.6
302.4
Graphic Packaging Holding Company
Condensed Consolidated Balance Sheets
(Unaudited)
In millions, except share and per share amounts
June 30, 2026
December 31, 2025
Assets
Current Assets:
Cash and Cash Equivalents
$ 205
$ 261
Receivables, Net
888
760
Inventories, Net
1,691
1,766
Assets Held for Sale
8
10
Other Current Assets
220
126
Total Current Assets
3,012
2,923
Property, Plant and Equipment, Net
5,532
5,669
Goodwill
2,048
2,065
Intangible Assets, Net
626
670
Other Assets
442
448
Total Assets
$ 11,660
$ 11,775
Liabilities
Current Liabilities:
Short-Term Debt and Current Portion of Long-Term Debt
$ 552
$ 549
Accounts Payable
955
1,027
Liabilities Held for Sale
2
—
Other Accrued Liabilities
675
668
Total Current Liabilities
2,184
2,244
Long-Term Debt
5,115
5,022
Deferred Income Tax Liabilities
681
688
Other Noncurrent Liabilities
443
484
Shareholders' Equity
Preferred Stock, par value $0.01 per share; 100,000,000 shares authorized; no shares issued or
outstanding
—
—
Common Stock, par value $0.01 per share; 1,000,000,000 shares authorized; 296,054,676 and
295,128,049 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
3
3
Capital in Excess of Par Value
1,994
1,981
Retained Earnings
1,530
1,614
Accumulated Other Comprehensive Loss
(291)
(262)
Total Graphic Packaging Holding Company Shareholders' Equity
3,236
3,336
Noncontrolling Interest
1
1
Total Equity
3,237
3,337
Total Liabilities and Shareholders' Equity
$ 11,660
$ 11,775
Graphic Packaging Holding Company
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Six Months Ended June 30,
In millions
2026
2025
Cash Flows from Operating Activities:
Net (Loss) Income
$ (19)
$ 231
Adjustments to Reconcile Net (Loss) Income to Net Cash Provided by Operating Activities:
Depreciation and Amortization
284
261
Amortization of Deferred Debt Issuance Costs
3
3
Deferred Income Taxes
(7)
16
Amount of Postretirement Expense Less Than Funding
(1)
—
Share-Based Compensation Expense, Net
18
(1)
Asset Impairment Charges
53
—
Other, Net
(2)
(13)
Changes in Operating Assets and Liabilities
(284)
(404)
Net Cash Provided by Operating Activities
45
93
Cash Flows from Investing Activities:
Capital Spending
(223)
(541)
Acquisition of Businesses
—
(29)
Proceeds from the Sale of Business and Properties, Net of Cash and Cash Equivalents Sold
8
12
Beneficial Interest on Sold Receivables
240
110
Beneficial Interest Obtained in Exchange for Proceeds
(164)
(54)
Other, Net
6
(3)
Net Cash Used in Investing Activities
(133)
(505)
Cash Flows from Financing Activities:
Repurchase of Common Stock
—
(110)
Retirement of Long-Term Debt
(400)
—
Payments on Debt
(9)
(6)
Proceeds from Issuance of Debt
544
99
Borrowings under Revolving Credit Facilities
1,829
2,077
Payments on Revolving Credit Facilities
(1,847)
(1,599)
Repurchase of Common Stock related to Share-Based Payments
(4)
(32)
Debt Issuance Costs
(4)
(1)
Dividends Paid
(65)
(63)
Other, Net
(12)
(3)
Net Cash Provided by Financing Activities
32
362
Decrease in Cash and Cash Equivalents
(56)
(50)
Effect of Exchange Rate Changes on Cash
—
13
Net Decrease in Cash and Cash Equivalents
(56)
(37)
Cash and Cash Equivalents at Beginning of Period
261
157
Cash and Cash Equivalents at End of Period
$ 205
$ 120
Graphic Packaging Holding Company
Reconciliation of Non-GAAP Financial Measures
The tables below set forth the calculation of the Company's earnings before interest expense, income tax expense, depreciation and amortization, including pension amortization ("EBITDA"), Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Income, Adjusted Earnings Per Share, Adjusted Net Cash Provided by Operating Activities, Adjusted Cash Flow, Net Leverage Ratio, and Total Net Debt. Adjusted EBITDA and Adjusted Net Income exclude charges associated with: the Company's business combinations, facility shutdowns, certain extended mill outages, sales of assets, non-recurring and other special items. The Company's management believes that the presentation of EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share, Adjusted Net Cash Provided by Operating Activities, Adjusted Cash Flow, and Net Leverage Ratio provides useful information to investors because these measures are regularly used by management in assessing the Company's performance. EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share, Adjusted Net Cash Provided by Operating Activities, Adjusted Cash Flow, and Net Leverage Ratio are financial measures not calculated in accordance with generally accepted accounting principles in the United States ("GAAP"), and are not measures of net income, operating income, operating performance, liquidity or net sales presented in accordance with GAAP. The Company's guidance for 2026 Adjusted EBITDA, Adjusted Earnings per Share, and Adjusted Cash Flow are non-GAAP financial measures. The Company is unable to present a quantitative reconciliation of these forward-looking non-GAAP financial measures to their most directly comparable GAAP financial measures (Net Income, Net Income per Share, and Net Cash Provided by Operating Activities, respectively) because the information necessary to prepare such a reconciliation is not available without unreasonable efforts.
EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share, Adjusted Net Cash Provided by Operating Activities, Adjusted Cash Flow, and Net Leverage Ratio should be considered in addition to results prepared in accordance with GAAP, but should not be considered substitutes for or superior to GAAP results. In addition, our EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted Earnings Per Share, Adjusted Net Cash Provided by Operating Activities, Adjusted Cash Flow, and Net Leverage Ratio may not be comparable to Adjusted EBITDA or similarly titled measures utilized by other companies since such other companies may not calculate such measures in the same manner as we do.
Three Months Ended June 30,
Six Months Ended June 30,
In millions, except per share amounts
2026
2025
2026
2025
Net Income (Loss)
$ 24
$ 104
$ (19)
$ 231
Add (Subtract):
Income Tax Expense
2
35
—
78
Interest Expense, Net
68
53
132
104
Depreciation and Amortization
146
131
286
263
EBITDA
240
323
399
676
Charges Associated with Business Combinations, Exit Activities and Other Special Items, Net(a)
Beam Therapeutics oznámila podání první dávky pacientovi v globální pivotní kohortě probíhající studie BEAM-302 pro AATD. Firma zároveň uvedla, že má 1,2 miliardy USD v hotovosti a cenných papírech.
August 04, 2026 07:00 ET | Source: Beam Therapeutics
Updated BEAM-302 Phase 1/2 Clinical Data Selected for Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026
Dosing Complete for All Adult and Adolescent Patients in Phase 1/2 BEACON Trial of Risto-cel in Sickle Cell Disease; U.S. Biologics License Application (BLA) Submission Expected as Early as Year-End 2026
Clinical Trial Start-up Activities Underway Following U.S. FDA Clearance of Investigational New Drug (IND) Application for BEAM-304 in Phenylketonuria (PKU)
Ended Second Quarter 2026 with $1.2 Billion in Cash, Cash Equivalents and Marketable Securities; Cash Runway Expected to Support Operating Plans into mid-2029
CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today reported second quarter 2026 financial results and provided updates across the company’s hematology and genetic disease franchises.
“The second quarter marked another period of rapid progress and disciplined execution on the clinical, regulatory and operational milestones we set for Beam,” said John Evans, chief executive officer of Beam Therapeutics. “Importantly, this progress enabled dosing of the first patient in the global pivotal cohort evaluating BEAM-302, the most advanced genetic medicine in development for AATD, which has the potential to fundamentally change the treatment paradigm for patients. In addition, we completed dosing for all adult and adolescent SCD patients in the BEACON trial of risto-cel and received FDA clearance of the IND for BEAM-304 in PKU, paving the way to the clinic for this next potentially high-value franchise. Looking ahead, we believe Beam is positioned to achieve several important milestones, including updated clinical data for BEAM-302 at the ERS Congress, rapid enrollment in the BEAM-302 pivotal cohort, first-in-human data for BEAM-301 in GSDIa, and the expected BLA submission for risto-cel. With the continued expansion and advancement of our base editing pipeline, we have the potential to deliver transformative therapies for many patients with serious genetic diseases.”
Second Quarter 2026 and Recent Progress and Anticipated Milestones
Liver-targeted Genetic Disease Franchise
BEAM-302: Beam’s lead genetic disease program is designed to be a best-in-class and first-in-class liver-targeting therapy for alpha-1 antitrypsin deficiency (AATD) that directly corrects the root cause of the disease and therefore has the potential to address both liver and lung manifestations of AATD.
In July, Beam dosed the first patient in the global pivotal cohort of the ongoing Phase 1/2 trial evaluating BEAM-302 in patients with AATD-associated lung disease, with or without liver disease. The cohort is designed to support a potential accelerated approval path in the United States.Detailed and updated clinical data for BEAM-302 were selected for a late-breaking oral presentation at the European Respiratory Society (ERS) Congress, taking place September 5-9, 2026, in Barcelona, Spain. BEAM-304: BEAM-304 is designed to leverage Beam’s proprietary and clinically validated base editing technology and lipid nanoparticle (LNP) delivery capabilities to directly and durably correct mutations in the phenylalanine hydroxylase (PAH) gene that cause phenylketonuria (PKU). Beam aims to advance BEAM-304 using an innovative platform approach with the goal of creating mutation-specific base editors for the majority of patients with PKU.
In June, Beam announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND) application for BEAM-304.Beam has initiated clinical start-up activities for the planned Phase 1/2 trial for BEAM-304. The trial will initially evaluate safety, tolerability, and reduction of blood Phe levels in PKU patients with the R408W mutation, one of the most prevalent disease-causing mutations among patients with PKU in the U.S., with a goal of establishing clinical proof of concept for base editing in PKU. The trial will subsequently evaluate base editors for additional mutations within a single clinical program.In July, updated preclinical data for BEAM-304 were presented at the Federation of American Societies for Experimental Biology (FASEB) Genome Engineering: Research and Applications Conference. The presentation is available on the Presentation and Publications page of Beam’s website beamtx.com.
BEAM-301: BEAM-301 aims to correct one of the most common disease-causing mutations, R83C, in patients with glycogen storage disease type Ia (GSDIa).
BEAM-301 is currently being evaluated in an open-label Phase 1/2 dose-exploration trial in patients with GSDIa.Beam expects to report initial clinical data in 2026. Hematology Franchise
Risto-cel: Ristoglogene autogetemcel (risto-cel, formerly known as BEAM-101) is an investigational autologous cell therapy with a potential best-in-class profile for the treatment of sickle cell disease (SCD).
Dosing is complete in all adult and adolescent patients enrolled in the Phase 1/2 BEACON trial.Beam expects to report updated data for the BEACON trial by year-end 2026 and submit a biologics license application (BLA) for risto-cel as early as year-end 2026. Next-generation Programs in Sickle Cell Disease and Hematology:
Beam completed enrollment and dosing in the Phase 1 healthy volunteer clinical trial of BEAM-103, an anti-CD117 monoclonal antibody with the potential to enable non-genotoxic ex vivo and in vivo therapies for SCD. Treatment with BEAM-103 was well tolerated across all doses tested.Beam continues to make significant investments in developing targeted LNPs to deliver gene editing to hematopoietic stem cells (HSCs). Targeted LNPs for HSC delivery have been identified and are in lead optimization. Second Quarter 2026 Financial Results
Cash Position: Cash, cash equivalents and marketable securities were $1.2 billion as of June 30, 2026, compared to $1.2 billion as of December 31, 2025.Research & Development (R&D) Expenses: R&D expenses were $95.1 million for the second quarter of 2026, compared to $101.8 million for the second quarter of 2025.General & Administrative (G&A) Expenses: G&A expenses were $31.9 million for the second quarter of 2026, compared to $26.9 million for the second quarter of 2025.Net Income (Loss): Net loss was $122.7 million, or $1.18 per share, for the second quarter of 2026, compared to net loss of $102.1 million, or $1.00 per share, for the second quarter of 2025. Cash Runway
Beam expects that its cash, cash equivalents and marketable securities as of June 30, 2026, together with an additional $200 million expected to be drawn from the company’s facility with Sixth Street, will fund anticipated operating expenses and capital expenditure requirements into mid-2029, funding the company through the anticipated launch of risto-cel in SCD, execution of the BEAM-302 pivotal development plan in AATD, and clinical proof of concept for BEAM-304 in PKU.
About Beam Therapeutics
Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing lifelong cures to patients suffering from serious diseases.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Investors are cautioned not to place undue reliance on these forward-looking statements, including, but not limited to, statements related to: the therapeutic applications and potential of our technology, including with respect to SCD, AATD, PKU and GSDIa; our plans, and anticipated timing, to advance our programs and present data from ongoing clinical trials; the clinical trial designs and expectations for risto-cel, BEAM-103, BEAM-301, BEAM-302 and BEAM-304; our planned submission of a BLA for risto-cel; our expectations regarding the anticipated launch of risto-cel; the potential for an accelerated approval path for BEAM-302; our expected presentations at upcoming medical conferences, including at the ERS Congress; our anticipated regulatory interactions and filings; our expectations regarding the funds that will be available to draw under our credit facility; the sufficiency of our capital resources to fund operating expenses and capital expenditure requirements and the period in which such resources are expected to be available; and our ability to develop lifelong, curative, precision genetic medicines for patients through base editing. Each forward-looking statement is subject to important risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statement, including, without limitation, risks and uncertainties related to: our ability to develop, obtain regulatory approval for, and commercialize our product candidates, which may take longer or cost more than planned; our ability to raise additional funding, which may not be available; our ability to obtain, maintain and enforce patent and other intellectual property protection for our product candidates; the uncertainty that our product candidates will receive regulatory approval necessary to initiate or continue human clinical trials; that preclinical testing of our product candidates and preliminary or interim data from preclinical studies and clinical trials may not be predictive of the results or success of ongoing or later clinical trials; that initiation and enrollment of, and anticipated timing to advance, our clinical trials may take longer than expected; that our product candidates, including the delivery modalities we rely on to administer them, may cause serious adverse events; that we may not achieve the funding milestones under our credit facility; that our product candidates may experience manufacturing or supply interruptions or failures; risks related to competitive products; and the other risks and uncertainties identified under the headings “Risk Factors Summary” and “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, and in any subsequent filings with the Securities and Exchange Commission. These forward-looking statements speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.
Condensed Consolidated Balance Sheet Data (unaudited)(in thousands) June 30,
2026 December 31,
2025Cash, cash equivalents, and marketable securities$1,152,927 $1,245,210 Total assets 1,386,355 1,481,177 Total liabilities 318,913 242,819 Total stockholders’ equity 1,067,442 1,238,358 Condensed Consolidated Statement of Operations (unaudited)(in thousands, except share and per share data) Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025License and collaboration revenue$490 $8,466 $32,228 $15,936 Operating expenses: Research and development 95,096 101,758 199,620 200,574 General and administrative 31,947 26,859 66,376 54,799 Total operating expenses 127,043 128,617 265,996 255,373 Loss from operations (126,553) (120,151) (233,768) (239,437)Other income (expense): Change in fair value of derivative liabilities (4,200) 1,300 (1,700) 4,500 Change in fair value of non-controlling equity investments 338 4,415 354 2,334 Change in fair value of contingent consideration liabilities (205) (28) 309 (55)Gain on sale of equity method investment 455 — 455 — Interest and other income (expense), net 7,487 12,326 17,354 22,190 Total other income (expense) 3,875 18,013 16,772 28,969 Net loss$(122,678) $(102,138) $(216,996) $(210,468)Unrealized gain (loss) on marketable securities (1,119) (150) (3,300) (669)Comprehensive loss$(123,797) $(102,288) $(220,296) $(211,137)Net loss per common share, basic and diluted$(1.18) $(1.00) $(2.09) $(2.21)Weighted-average common shares outstanding, basic and diluted 104,325,436 101,995,184 103,797,276 95,023,977
Equinix po výsledcích za 2. čtvrtletí zůstává podle článku býčím příběhem. Pomáhá mu růst tržeb a FFO, silné krytí dividendy a rating investičního stupně od Fitch.
SummaryData center REIT Equinix gets prior buy rating reaffirmed after Q2 results in late July.Positives include an investment-grade rating from Fitch, strong dividend coverage, revenue and FFO growth, and global scale with few real competitors.Some downside is seen from a market pullback in EQIX stock and a low upside forecast in the near term, along with a rich valuation.This niche is dependent on high power and cooling needs, putting into question the durability of grids globally. Getty Images
A Prominent Data Center REIT Who Beat Q2 Earnings Estimates Recently Ahhh... the perfect combination of two sectors I've followed for many years, tech and real estate, and what better example of this than a mega data center REIT like
1.91K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Author does not hold any long positions in the Equinix stock directly, but does hold shares in REIT mutual funds who invest in a diversified portfolio that may include data center REITS, along with others.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Certara ve 2. čtvrtletí zvýšila tržby na 93,3 milionu USD a potvrdila celoroční výhled růstu tržeb o 0 % až 4 %. Společnost také dokončila zpětný odkup akcií za 100 milionů USD a schválila dalších 50 milionů USD.
Completes previously authorized $100 million share repurchase program; Board authorizes additional $50 million under repurchase program
Reaffirms 2026 revenue guidance
RADNOR, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its second quarter 2026 financial results.
Second Quarter Highlights from Continuing Operations:
Financial results of the Regulatory and Medical Writing business are reported as discontinued operations. The discussion in this earnings release presents the results of continuing operations and excludes amounts related to discontinued operations for all periods presented, unless otherwise noted.
Revenue was $93.3 million, compared to $92.4 million in the second quarter of 2025, representing growth of 1%.
Software revenue was $48.8 million, compared to $46.7 million in the second quarter of 2025, representing growth of 4%.Services revenue was $44.5 million, compared to $45.7 million in the second quarter of 2025, representing a decrease of 3%. Net loss was $6.1 million, compared to a net income of $1.5 million in the second quarter of 2025.
The change primarily reflects the absence of a $5.7 million favorable contingent consideration adjustment recorded in the prior-year period, a $2.9 million unfavorable swing in currency expense, and a $2.2 million increase in reorganization costs, partially offset by lower income tax expense. Adjusted EBITDA was $26.2 million, compared to $27.0 million in the second quarter of 2025, representing a decrease of 3%. “This second quarter was about continuing to execute on our commitments. Overall, we are pleased with our ongoing progress transforming Certara into a company we believe can deliver sustainable double-digit growth,” said Jon Resnick, Chief Executive Officer. “We completed the divestiture of our Regulatory and Medical Writing business, implemented our two new business units, and taken necessary actions to strengthen our leadership team and our commercial model. Our focus in the second half of the year is customer impact and speed of execution.”
“Our second quarter results were in line with our expectations, and we remain focused on executing against our full-year plan,” said Faiz Mohammed, Interim Chief Financial Officer. “We continue to expect full-year revenue growth of 0% to 4% on a comparable continuing operations basis, supported by continued strength in software and improving services performance as we move through the second half of the year.”
Second Quarter 2026 and Recent Corporate Updates
In May, Certara closed the divestiture of its global medical writing and related regulatory services business (“the Regulatory and Medical Writing business”) and announced the reorganization of its company around two business units, Model Informed Discovery and Drug Development (MID3) and Accelerated Clinical Evidence (ACE).In parallel with the reorganization, during the second quarter, Certara executed a reduction in force, focusing predominantly on overhead, impacting approximately 5% of its global employee base. This action, combined with other steps towards operational excellence, is expected to result in a run-rate savings of approximately $13 million. These reductions allow the Company to accelerate innovation and growth and streamline the Company’s cost base, including stranded costs from the divestiture. Certara has appointed Julien Perrier Chief Commercial Officer, effective August 1, 2026. Mr. Perrier brings nearly two decades of international commercial leadership in the life sciences. Most recently, he served as Chief Executive Officer of Ziwig, where he led the commercial development of the AI-powered diagnostic EndoTest. Prior to Ziwig, Mr. Perrier served as a Vice President at IQVIA, Head of the Immunology division, France at AbbVie, and Head of Office Specialty Care Division at Sanofi. As part of Certara’s move to align sales and marketing under a unified commercial leadership model in support of the business units, Mr. Perrier will focus on deepening customer engagement, sharpening go-to-market execution, and ensuring Certara’s products and services deliver clear, demonstrable value to customers worldwide.Certara has appointed Eric Jahn as Chief Information Officer. Mr. Jahn previously served as Senior Vice President, IT. He joined Certara in 2022 and has helped scale the business globally by partnering with all functions as a strategic business partner. Prior to Certara, Mr. Jahn served as Vice President, IT Infrastructure at TIBCO Software and spent seven years at Rocket Software in various IT leadership roles. Second Quarter 2026 Results from Continuing Operations
Financial results of the Regulatory and Medical Writing business are reported as discontinued operations. The discussion in this earnings release presents the results of continuing operations and excludes amounts related to discontinued operations for all periods presented, unless otherwise noted. Refer to Note 4 "Divestiture and Discontinued Operation" in our Form 10-Q for the quarter ended June 30, 2026 for further details.
Total revenue for the second quarter of 2026 was $93.3 million, representing year-over-year growth of 1% on a reported basis. Software revenue for the second quarter of 2026 was $48.8 million, representing year-over-year growth of 4% on a reported basis. Services revenue for the second quarter of 2026 was $44.5 million, representing a year-over-year decrease of 3% on a reported basis.
Total Bookings for the second quarter of 2026 were $98.3 million, representing a year-over-year increase of 1%.
Software Bookings for the second quarter of 2026 were $50.7 million, representing a year-over-year increase of 9%.
Services Bookings for the second quarter of 2026 were $47.6 million, representing a year-over-year decrease of 6%.
Total cost of revenues for the second quarter of 2026 was $35.1 million, an increase of $0.8 million from $34.3 million in the second quarter of 2025. The increase in cost of revenues was primarily due to a $1.0 million increase in employee-related costs and a $0.9 million increase in professional and consulting expenses, partially offset by a decrease in equity-based compensation expense and other miscellaneous expenses.
Total operating expenses for the second quarter of 2026 were $58.3 million, which increased by $7.9 million from $50.4 million in the second quarter of 2025. Higher operating expenses were primarily attributable to a $5.7 million increase related to the remeasurement of the fair value of business acquisition contingent consideration, primarily due to the absence of a non-recurring favorable change recognized in the prior year that reduced expenses in that period, a $1.1 million increase in professional and consulting expenses, a $1.0 million increase in employee-related costs, a $0.8 million increase in depreciation expense, and a $0.6 million increase in executive recruiting expenses, partially offset by a decrease in equity-based compensation expense.
Net loss for the second quarter of 2026 was $6.1 million, compared to net income of $1.5 million in the second quarter of 2025. The $7.6 million increase in loss was primarily driven by higher operating expenses, including a $5.7 million increase related to the remeasurement of the fair value of acquisition-related contingent consideration, $1.1 million aggregate increase in executive recruiting and lease abandonment charges, increased total other expenses, and a higher cost of revenue, partially offset by lower tax expense and higher revenue.
Diluted loss per share for the second quarter of 2026 was $(0.04), as compared to diluted earnings per share of $0.01 for the second quarter of 2025.
Adjusted EBITDA for the second quarter of 2026 was $26.2 million compared to $27.0 million for the second quarter of 2025, a decrease of $0.8 million. See note (1) in the section titled “A Note on Non-GAAP Financial Measures” below for more information on adjusted EBITDA.
Adjusted net income for the second quarter of 2026 was $12.5 million compared to $12.7 million for the second quarter of 2025, a decrease of $0.2 million. Adjusted diluted earnings per share for the second quarter of 2026 was $0.08, compared to $0.08 for the second quarter of 2025. See note (2) in the section titled “A Note on Non-GAAP Financial Measures” below for more information on adjusted net income and adjusted diluted earnings per share.
THREE MONTHS ENDED
JUNE 30, SIX MONTHS ENDED
JUNE 30, 2026 2025 2026 2025 Key Financials(in millions, except per share data)
Revenue$93.3 $92.4 $187.4 $184.5 Software revenue$48.8 $46.7 $98.5 $93.1 Service revenue$44.5 $45.7 $88.8 $91.4 Total bookings$98.3 $97.4 $195.5 $195.7 Software bookings$50.7 $46.6 $99.4 $87.3 Services bookings$47.6 $50.8 $96.1 $108.4 Net income (loss)$(6.1) $1.5 $(17.9) $3.0 Diluted earnings (loss) per share$(0.04) $0.01 $(0.11) $0.02 Adjusted EBITDA$26.2 $27.0 $52.9 $55.4 Adjusted net income$12.5 $12.7 $21.6 $29.5 Adjusted diluted earnings per share$0.08 $0.08 $0.14 $0.18 Cash and cash equivalents $184.1 $162.3
2026 Financial Outlook
Certara is reaffirming its revenue growth and updating its adjusted EBITDA margin, adjusted diluted earnings per share, and fully diluted share guidance for the full year 2026, to reflect the divestiture of the Regulatory and Medical Writing business and Continuing Operations reporting:
Revenue growth for Continuing Operations, excluding the Regulatory and Medical Writing business, is expected to be 0% to 4%, or revenue of $367 million to $382 million.
Full year 2026 adjusted EBITDA margin for Continuing Operations, excluding the Regulatory and Medical writing business, is expected to be approximately 29% to 31%.
Full year adjusted diluted earnings per share for Continuing Operations, excluding the Regulatory and Medical Writing business is expected to be in the range of $0.31 to $0.36.
Fully diluted shares are expected to be in the range of 155 million to 157 million. Financial results of the Regulatory and Medical Writing business will be reported as discontinued operations for 2026. Through the transaction closing on May 8, 2026, the year-to-date discontinued operations Revenue was $19.2 million.
In the second quarter, the Company repurchased $17.4 million in shares, which completed a $100 million share repurchase program under terms previously authorized by the Board. In the third quarter, the Board approved an additional $50 million under the share repurchase program, reflecting the Company’s continued confidence in the business and its disciplined approach to capital allocation. The program does not have an express expiration date, and all repurchase plans must be brought in advance to the Board.
Please note that the Company has not reconciled adjusted EBITDA, adjusted EBITDA margin or adjusted diluted earnings per share forward-looking guidance included in this press release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to costs related to acquisitions, financings, and employee stock compensation programs, which are potential adjustments to future earnings. The Company expects the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.
Webcast and Conference Call Details
Certara will host a conference call today, August 4, 2026, at 8:30 a.m. ET to discuss its second quarter 2026 financial results. Investors interested in listening to the conference call are required to register online in advance of the call. A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com.
About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.
Please visit our website at www.certara.com. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD.
Such disclosures will be included in the Investor Relations section of our website at https://ir.certara.com. Accordingly, investors should monitor such portion of our website, in addition to following our press releases, Securities and Exchange Commission filings and public conference calls and webcasts.
Forward-Looking Statements
This press release contains certain statements that constitute forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, with respect to the Company’s full-year guidance. These statements typically contain words such as “believe,” “may,” “potential,” “will,” “plan,” “could,” “estimate,” “expects” and “anticipates” or the negative of these words or other similar terms or expressions. Any statement in this press release that is not a statement of historical fact is a forward-looking statement and involves significant risks and uncertainties. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot provide any assurance that these expectations will prove to be correct. You should not rely upon forward-looking statements as predictions of future events and actual results, events, or circumstances. Actual results may differ materially from those described in the forward-looking statements and are subject to a variety of assumptions, uncertainties, risks and factors that are beyond our control, including our ability to realize the expected benefits of the divestiture of our regulatory and medical writing business; any deceleration in, or resistance to, the acceptance of model-informed biopharmaceutical discovery and development; our ability to compete within our market; changes or delays in government regulation relating to the biopharmaceutical industry; trends in research and development spending; operational disruptions, funding constraints and policy changes at the Food and Drug Administration and other government agencies; consolidation within the biopharmaceutical industry; our ability to increase successfully our customer base, expand relationships and the products and services we provide and enter new markets; our ability to retain key personnel or recruit additional qualified personnel; risks related to the mischaracterization of our independent contractors; any delays or defects in our release of new or enhanced software or other biosimulation tools; issues relating to implementation, use and development of artificial intelligence and machine learning in our products and services; failure of our existing customers to renew their software licenses or any delays or terminations of contracts or reductions in scope of work by our existing customers; risks related to our contracts with government customers and receipt of government grants; risks related to any future acquisitions and other strategic transactions; the accuracy of our addressable market estimates; our ability to operate successfully a global business and adverse global economic conditions; our ability to comply with applicable trade compliance and economic sanctions laws and regulations; the impact of litigation; the sufficiency of our insurance coverage; our ability to perform our services in accordance with contractual requirements, regulatory standards and ethical considerations; the loss of more than one of our major customers; our ability to raise capital or generate sufficient cash flows; the ability or inability of our bookings to accurately predict our future revenue and our ability to realize the anticipated revenue reflected in our bookings; our ability to comply with anti-corruption laws; risks related to catastrophic events; the application of evolving corporate governance and public disclosure requirements; disruptions in the operations of the third-party providers who host our software solutions or any limitations on their capacity or interference with our use; any unauthorized access to or use of customer or other proprietary or confidential data or other breach of our cybersecurity measures, compliance with privacy and cybersecurity laws and related contractual requirements; our ability to reliably meet our data storage and management requirements, or the experience of any failures or interruptions in the delivery of our services over the internet; our ability to comply with the terms of any licenses governing our use of third-party open source software; our ability to adequately enforce or defend our ownership and use of our intellectual property and other proprietary rights; any allegations that we are infringing, misappropriating or otherwise violating a third party’s intellectual property rights; our ability to comply with healthcare laws; risks related to our indebtedness; any additional impairment of goodwill or other intangible assets; our ability to use net operating losses; the volatility of the market price of our common stock; future sales of our common stock by existing stockholders; the substantial holdings of our largest stockholder; and the other factors detailed under the captions “Risk Factors” and “Special Note Regarding Forward-Looking Statements” and elsewhere in our Securities and Exchange Commission (“SEC”) filings, and reports, including the Form 10-K filed by the Company with the Securities and Exchange Commission on February 26, 2026, and subsequent reports filed with the SEC. Any forward-looking statements speak only as of the date of this release and, except to the extent required by applicable securities laws, we expressly disclaim any obligation to update or revise any of them to reflect actual results, any changes in expectations or any change in events.
A Note on Non-GAAP Financial Measures
This press release contains “non-GAAP measures” which are financial measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with U.S. generally accepted accounting principles (“GAAP”). Specifically, the Company makes use of the non-GAAP financial measures adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss) and adjusted diluted earnings per share which are not recognized terms under GAAP. These measures should not be considered as alternatives to net income (loss), net income (loss) margin, or GAAP diluted earnings per share or revenue as measures of financial performance or any other performance measure derived in accordance with GAAP and should not be considered a measure of discretionary cash available to the Company to invest in the growth of its business. The presentation of these measures has limitations as an analytical tool and should not be considered in isolation, or as a substitute for the Company’s results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.
You should refer to the footnotes below as well as the “Reconciliation of Non-GAAP Financial Measures” section in this press release below for a further explanation of these measures and reconciliations of these non-GAAP measures in specific periods to their most directly comparable financial measure calculated and presented in accordance with GAAP for those periods.
Management uses various financial metrics, including total revenues, income (loss) from operations, net income (loss), and certain non-GAAP measures, such as adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss) and adjusted diluted earnings per share, to make budgeting decisions, to make certain compensation decisions, and to compare the Company’s performance against that of other peer companies using similar measures. In addition, management believes these metrics provide useful measures for period-to-period comparisons of the Company’s business, as they remove the effect of certain non-cash expenses and other items not indicative of its ongoing operating performance.
Management believes that adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss) and adjusted diluted earnings per share are helpful to investors, analysts, and other interested parties because they can assist in providing a more consistent and comparable overview of our operations across our historical periods. In addition, these non-GAAP measures are frequently used by analysts, investors, and other interested parties to evaluate and assess performance.
(1) Adjusted EBITDA represents net income (loss) excluding interest expense, provision for (benefit from) for income taxes, depreciation and amortization expense, intangible asset amortization, equity-based compensation expense, goodwill impairment, change in fair value of contingent consideration, acquisition and integration expense and other items not indicative of our ongoing operating performance. Adjusted EBITDA margin represents adjusted EBITDA divided by revenue.
(2) Adjusted net income and adjusted diluted earnings per share exclude the effect of equity-based compensation expense, amortization of acquisition-related intangible assets, goodwill impairment, change in fair value of contingent consideration, acquisition and integration expense, and other items not indicative of our ongoing operating performance as well as income tax provision adjustment for such charges.
In evaluating adjusted EBITDA, adjusted EBITDA margin, adjusted net income, and adjusted diluted earnings per share, you should be aware that in the future the Company may incur expenses similar to those eliminated in this presentation and this presentation should not be construed as an inference that future results will be unaffected by unusual items.
CERTARA, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(UNAUDITED)
THREE MONTHS ENDED
JUNE 30, SIX MONTHS ENDED
JUNE 30,(IN THOUSANDS, EXCEPT PER SHARE AND SHARE DATA) 2026 2025 2026 2025 Total revenue$93,271 $92,356 $187,363 $184,455 Cost of revenues 35,122 34,285 69,794 69,005 Operating expenses: Sales and marketing 14,978 13,658 27,928 26,044 Research and development 9,705 8,972 21,991 19,494 General and administrative 21,933 16,700 50,875 35,985 Depreciation and amortization 11,729 11,070 23,235 21,961 Total operating expenses 58,345 50,400 124,029 103,484 Income (loss) from operations (196) 7,671 (6,460) 11,966 Other income (expenses): Interest expense (4,987) (4,802) (9,928) (9,608)Net other income (expenses) (1,205) 1,501 96 3,226 Total other expenses (6,192) (3,301) (9,832) (6,382)Income (loss) before income taxes (6,388) 4,370 (16,292) 5,584 Provision (benefits) for income taxes on continuing operations (307) 2,874 1,614 2,583 income (loss) from continuing operations, net of tax (6,081) 1,496 (17,906) 3,001 Loss from discontinued operations, net of tax (49,189) (3,464) (46,127) (226)Net income (loss) attributable to common stockholders$(55,270) $(1,968) $(64,033) $2,775 Net income (loss) per share attributable to common stockholders: Basic - Earnings (loss) per common share from continuing operations$(0.04) $0.01 $(0.11) $0.02 Basic - Earnings (loss) per common share from discontinued operations$(0.32) $(0.02) $(0.30) $— Basic - Earnings (loss) per common share$(0.36) $(0.01) $(0.41) $0.02 Diluted - Earnings (loss) per common share from continuing operations$(0.04) $0.01 $(0.11) $0.02 Diluted - Earnings (loss) per common share from discontinued operations$(0.32) $(0.02) $(0.30) $— Diluted - Earnings (loss) per common share$(0.36) $(0.01) $(0.41) $0.02 Weighted average common shares outstanding: Basic 154,356,779 160,916,057 156,046,326 160,955,936 Diluted 154,356,779 161,849,002 156,046,326 161,601,024 CERTARA, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(UNAUDITED) (IN THOUSANDS, EXCEPT PER SHARE AND SHARE DATA) JUNE 30,
2026 DECEMBER 31,
2025Assets Current assets: Cash and cash equivalents $184,138 $189,392 Accounts receivable, net of allowances for credit losses of $1,940 and $2,235 100,759 101,574 Prepaid expenses and other current assets 27,289 21,887 Current assets of discontinued operations — 2,266 Total current assets 312,186 315,119 Other assets: Property and equipment, net 1,673 1,805 Operating lease right-of-use assets 8,952 11,840 Goodwill 718,125 745,056 Intangible assets, net of accumulated amortization of $345,829 and $415,804 345,207 361,835 Deferred income taxes 11,115 3,856 Other long-term assets 2,540 1,509 Other assets of discontinued operations — 115,562 Total assets $1,399,798 $1,556,582 Liabilities and stockholders' equity Current liabilities: Accounts payable $2,723 $3,040 Accrued expenses 36,211 59,658 Current portion of deferred revenue 77,341 75,398 Current portion of long-term debt 2,963 2,963 Other current liabilities 3,161 4,365 Current liabilities of discontinued operations — 7,961 Total current liabilities 122,399 153,385 Long-term liabilities: Deferred revenue, net of current portion 2,704 2,350 Deferred income taxes 8,947 34,366 Operating lease liabilities, net of current portion 6,945 8,438 Long-term debt, net of current portion and debt discount 288,876 290,131 Other long-term liabilities 3,412 5,117 Total liabilities 433,283 493,787 Commitments and contingencies Stockholders' equity Preferred shares, $0.01 par value, 50,000,000 shares authorized; no shares issued, and outstanding as of June 30, 2026 and December 31, 2025, respectively — — Common shares, $0.01 par value, 600,000,000 shares authorized, 166,959,761 and 164,005,450 shares issued as of June 30, 2026 and December 31, 2025; 152,499,023 and 159,139,562 shares outstanding as of June 30,2026 and December 31, 2025, respectively 1,671 1,641 Additional paid-in capital 1,277,660 1,255,653 Accumulated deficit (193,909) (129,876)Accumulated other comprehensive income 9,057 2,040 Treasury stock at cost, 14,460,738 and 4,865,888 shares at June 30, 2026 and December 31, 2025, respectively (127,964) (66,663)Total stockholders' equity 966,515 1,062,795 Total liabilities and stockholders' equity $1,399,798 $1,556,582 CERTARA, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED) SIX MONTHS ENDED JUNE 30,(IN THOUSANDS) 2026 2025 Cash flows from operating activities: Net income (loss) from continuing operations $(17,906) $3,001 Adjustments to reconcile net income (loss) to net cash provided by operating activities: Depreciation and amortization 32,342 31,271 Amortization of debt issuance costs 270 289 Provision for credit losses (22) 401 Equity-based compensation expense 13,414 15,315 Change in fair value of contingent considerations 7,230 (5,901)Deferred income taxes (8,698) (1,969)Changes in assets and liabilities: Accounts receivable 8,231 5,575 Prepaid expenses and other assets (5,622) 5,873 Accounts payable, accrued expenses, and other liabilities (15,682) (19,487)Deferred revenues 2,041 (9,863)Other operating activities, net (14) (1,176)Cash provided by operating activities - continuing operations 15,584 23,329 Cash provided by operating activities - discontinued operations 6,148 11,865 Net cash provided by operating activities 21,732 35,194 Cash flows from investing activities: Capital expenditures (1,252) (536)Capitalized software development costs (13,223) (12,199)Cash used in investing activities - continuing operations (14,475) (12,735)Cash provided by investing activities - discontinued operations 69,435 — Net cash provided (used) in investing activities 54,960 (12,735)Cash flows from financing activities: Payments on long-term debt (1,481) (1,500)Common stock repurchase program (57,389) (25,000)Payments for business acquisition related contingent consideration (20,121) (13,230)Payment of taxes on shares withheld for employee taxes (3,339) (4,960)Net cash used in financing activities (82,330) (44,690)Effect of foreign exchange rate on cash and cash equivalents 384 5,314 Net decrease in cash and cash equivalents (5,254) (16,917)Cash and cash equivalents at beginning of period 189,392 179,183 Cash and cash equivalents at end of period $184,138 $162,266 NON-GAAP FINANCIAL MEASURES
The following table reconciles net income (loss) from continuing operations to Adjusted EBITDA:
THREE MONTHS ENDED
JUNE 30, SIX MONTHS ENDED
JUNE 30, 2026 2025 2026 2025 (in thousands)Net income (loss) from continuing operations(a)$(6,081) $1,496 $(17,906) $3,001 Interest expense(a) 4,987 4,802 9,928 9,608 Interest income(a) (943) (1,243) (2,069) (2,885)(Benefit from) Provision for income taxes(a) (307) 2,874 1,614 2,583 Intangible asset amortization and fixed assets depreciation(a) 16,329 15,733 32,342 31,271 Currency (gain) loss(a) 2,358 (577) 2,418 (639)Equity-based compensation expense(b) 6,094 8,245 13,414 15,315 Change in fair value of contingent consideration(d) — (5,722) 7,230 (5,901)Acquisition-related (income) expenses(e) (132) 428 (114) 1,304 Reorganization expense(f) 3,182 934 4,187 1,085 Loss (gain) on disposal of fixed assets(g) (24) (1) (14) 5 Executive recruiting expense(h) 735 — 1,851 661 Adjusted EBITDA$26,198 $26,969 $52,881 $55,408
The following table reconciles net income (loss) from continuing operations to adjusted net income:
THREE MONTHS ENDED
JUNE 30, SIX MONTHS ENDED
JUNE 30, 2026 2025 2026 2025 ( in thousands)Net income (loss) from continuing operations(a)$(6,081) $1,496 $(17,906) $3,001 Currency (gain) loss(a) 2,358 (577) 2,418 (639)Equity-based compensation expense(b) 6,094 8,245 13,414 15,315 Amortization of acquisition-related intangible assets(c) 10,849 10,947 21,640 21,938 Change in fair value of contingent consideration(d) — (5,722) 7,230 (5,901)Acquisition-related (income) expenses(e) (132) 428 (114) 1,304 Reorganization expense(f) 3,182 934 4,187 1,085 Loss (gain) on disposal of fixed assets(g) (24) (1) (14) 5 Executive recruiting expense(h) 735 — 1,851 661 Income tax expense impact of adjustments(i) (4,441) (3,023) (11,132) (7,319) Adjusted net income$12,540 $12,727 $21,574 $29,450
The following tables reconciles diluted earnings per share from continuing operations to adjusted diluted earnings per share:
THREE MONTHS ENDED
JUNE 30, SIX MONTHS ENDED
JUNE 30, 2026 2025 2026 2025 Diluted earnings per share from continuing operations (a)$(0.04) $0.01 $(0.11) $0.02 Currency (gain) loss(a) 0.02 - 0.02 - Equity-based compensation expense(b) 0.04 0.05 0.08 0.09 Amortization of acquisition-related intangible assets(c) 0.07 0.07 0.13 0.14 Change in fair value of contingent consideration(d) - (0.04) 0.05 (0.04)Acquisition-related expenses(e) - - - 0.01 Reorganization expense(f) 0.02 0.01 0.03 0.01 Loss (gain) on disposal of fixed assets(g) - - - - Executive recruiting expense(h) - - 0.01 - Income tax expense impact of adjustments(i) (0.03) (0.02) (0.07) (0.05) Adjusted diluted earnings per share$0.08 $0.08 $0.14 $0.18 Basic weighted average common shares outstanding 154,356,779 160,916,057 156,046,326 160,955,936 Effect of potentially dilutive shares outstanding (j) 595,507 932,945 433,412 645,088 Adjusted diluted weighted average common shares outstanding 154,952,286 161,849,002 156,479,738 161,601,024
(a) Represents a measure determined under GAAP.
(b) Represents expense related to equity-based compensation. Equity-based compensation has been, and will continue to be for the foreseeable future, a recurring expense in our business and an important part of our compensation strategy.
(c) Represents amortization costs associated with acquired intangible assets in connection with business acquisitions.
(d) Represents expense associated with fair value adjustment or adjustment of contingent consideration of business acquisition.
(e) Represents costs associated with mergers and acquisitions and any retention bonuses pursuant to the acquisitions.
(f) Represents expenses related to reorganization, including legal entity reorganization and lease abandonment costs associated with the evaluation of our office space footprint.
(g) Represents the gain/loss related to disposal of fixed assets.
(h) Represents recruiting, relocation expenses, and retention costs related to senior executives.
(i) Represents the income tax effect of the non-GAAP adjustments calculated using the applicable statutory rate by jurisdiction.
(j) Represents potentially dilutive shares that were included from our GAAP diluted weighted average common shares outstanding.
Revvity ve 2. čtvrtletí zvýšila tržby na 730 milionů USD a upravený zisk na akcii na 1,41 USD. Firma zároveň uzavřela dohodu o prodeji čínské divize Immunodiagnostics.
WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the second quarter ended July 5, 2026.
The Company reported GAAP earnings per share from continuing operations of $0.48, as compared to $0.47 in the same period a year ago. Revenue for the quarter was $730 million, as compared to $720 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $89 million (which includes $16 million of tariff related refunds), as compared to $91 million for the same period a year ago. GAAP operating profit margin from continuing operations was 12.2% as a percentage of revenue, as compared to 12.6% in the same period a year ago.
Adjusted earnings per share from continuing operations for the quarter was $1.41, as compared to $1.18 in the same period a year ago. Adjusted operating income was $211 million, as compared to $192 million for the same period a year ago. Adjusted operating profit margin was 28.9% as a percentage of revenue, as compared to 26.6% in the same period a year ago.
Enters into Definitive Agreement to Divest China Immunodiagnostics Business
The Company recently entered into a definitive agreement to divest its Immunodiagnostics business in China (“China IDX”), which represented approximately 6% of the Company’s total revenue in fiscal year 2025. The transaction is expected to close by the end of 2027, subject to customary closing conditions and regulatory approvals. The Company is providing second quarter 2026 financial results on a reported and pro forma basis; forward-looking guidance is provided on a pro forma basis only and excludes China IDX.
Pro forma earnings per share from continuing operations for the quarter was $0.52, as compared to $0.48 in the same period a year ago. Pro forma revenue for the quarter was $711 million, as compared to $681 million in the same period a year ago. Pro forma operating income was $94 million, as compared to $85 million in the same period a year ago. Pro forma operating profit margin was 13.2% as a percentage of pro forma revenue, as compared to 12.4% in the same period a year ago.
On a pro forma adjusted basis, earnings per share for the quarter was $1.41 (which includes approximately $0.11 from tariff related refunds), as compared to $1.15 in the same period a year ago. Pro forma adjusted operating income was $209 million (which includes $16 million of tariff related refunds), as compared to $180 million for the same period a year ago. Pro forma adjusted operating profit margin was 29.3% as a percentage of pro forma revenue, as compared to 26.5% in the same period a year ago.
Adjustments for the Company’s non-GAAP financial measures have been noted in the attached reconciliations.
“Revvity delivered a strong second quarter, with results above our expectations and encouraging signs of increased demand across our customer base,” said Prahlad Singh, president and chief executive officer of Revvity. “As we enter the second half of the year, given the clear momentum in our end markets, we are utilizing a portion of recently received tariff refunds to increase investments across the business, capitalize on emerging opportunities, and support future growth.”
Financial Overview by Reporting Segment
Life Sciences
Second quarter 2026 revenue was $359 million, as compared to $366 million in the same period a year ago. Pro forma revenue decreased 2% and pro forma organic revenue decreased 3% as compared to the same period a year ago. Second quarter 2026 adjusted operating income was $112 million, as compared to $115 million in the same period a year ago. Adjusted operating profit margin was 31.1% as a percentage of revenue, as compared to 31.6% in the same period a year ago. Diagnostics
Second quarter 2026 revenue was $371 million, as compared to $354 million in the same period a year ago. Pro forma revenue increased 12% and pro forma organic revenue increased 11% as compared to the same period a year ago. Second quarter 2026 adjusted operating income was $113 million, as compared to $89 million in the same period a year ago. Adjusted operating profit margin was 30.4% as a percentage of revenue, as compared to 25.2% in the same period a year ago. Full Year 2026 Guidance
For the full year 2026, on a pro forma basis, the Company forecasts total revenue of $2.83-$2.86 billion, pro forma organic revenue growth of 4-5%, and pro forma adjusted earnings per share of $5.30-$5.40.
Guidance for the full year 2026 for pro forma organic revenue growth and pro forma adjusted EPS is provided on a non-GAAP basis and cannot be reconciled to the closest GAAP measures without unreasonable effort due to the unpredictability of the amounts and timing of events affecting the items the Company excludes from these non-GAAP measures. The timing and amounts of such events and items could be material to the Company’s results prepared in accordance with GAAP.
Webcast Information
The Company will discuss its second quarter 2026 results and its outlook for business trends during a webcast on August 4, 2026, at 7:30 a.m. Eastern Time. A live audio webcast and presentation will be available on the Investors section of the Company’s website, ir.revvity.com.
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.
Factors Affecting Future Performance
This press release contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as “believes”, “intends”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “will” and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) fluctuations in the global economic and political environments, including as the result of recently implemented and recently threatened tariff increases; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and divestitures, license technologies, or to successfully integrate acquired businesses or licensed technologies into our existing businesses or to make them profitable; (5) our ability to compete effectively; (6) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (7) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (8) disruptions in the supply of raw materials and supplies; (9) our ability to retain key personnel; (10) significant disruption in our information technology systems, or cybercrime; (11) uncertainties related to the development and use of AI in our product offerings and internal operations; (12) our ability to realize the full value of our intangible assets; (13) our failure to adequately protect our intellectual property; (14) the loss of any of our licenses or licensed rights; (15) the manufacture and sale of products exposing us to product liability claims; (16) our failure to maintain compliance with applicable government regulations; (17) our failure to comply with data privacy and information security laws and regulations; (18) regulatory changes; (19) our failure to comply with healthcare industry regulations; (20) economic, political and other risks associated with foreign operations; (21) our ability to obtain future financing; (22) restrictions in our credit agreements; (23) significant fluctuations in our stock price; (24) reduction or elimination of dividends on our common stock; and (25) other factors which we describe under the caption “Risk Factors” in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
About Revvity
At Revvity, “impossible” is inspiration, and “can’t be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
With 2025 revenue of $2.9 billion and approximately 11,000 employees, Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments. It is part of the S&P 500 index and has customers in more than 160 countries.
Stay updated by following our Newsroom, LinkedIn, X, YouTube, Facebook and Instagram.
Revvity, Inc. and Subsidiaries
CONDENSED CONSOLIDATED INCOME STATEMENTS
Three Months Ended July 5, 2026
Three Months Ended June 29, 2025
(In thousands, except per share data)
As Reported
Pro Forma
As Reported
Pro Forma
Revenue
$
729,688
$
711,109
$
720,284
$
680,547
Cost of revenue
312,822
302,876
327,728
306,814
Selling, general and administrative expenses
278,576
265,739
248,526
235,812
Research and development expenses
48,974
48,798
53,270
53,270
Operating income from continuing operations
89,316
93,696
90,760
84,651
Interest income
(5,259
)
(5,242
)
(8,345
)
(8,327
)
Interest expense
22,990
22,990
22,937
22,937
Change in fair value of investments
5,251
5,251
1,955
1,955
Other expense, net
2,803
4,003
5,563
4,868
Income from continuing operations, before income taxes
63,531
66,694
68,650
63,218
Provision for income taxes
10,050
8,214
13,428
6,754
Income from continuing operations
53,481
58,480
55,222
56,464
Loss from discontinued operations
(1,661
)
(1,661
)
(1,274
)
(1,274
)
Net income
$
51,820
$
56,819
$
53,948
$
55,190
Diluted earnings per share:
Income from continuing operations
$
0.48
$
0.52
$
0.47
$
0.48
Loss from discontinued operations
(0.01
)
(0.01
)
(0.01
)
(0.01
)
Net income
$
0.47
$
0.51
$
0.46
$
0.47
Weighted average diluted shares of common stock outstanding
111,629
111,629
117,538
117,538
ABOVE PREPARED IN ACCORDANCE WITH GAAP
Additional supplemental information(1):
(per share, continuing operations)
Three Months Ended July 5, 2026
Three Months Ended June 29, 2025
As Reported
Pro Forma
As Reported
Pro Forma
GAAP EPS from continuing operations
$
0.48
$
0.52
$
0.47
$
0.48
Amortization of intangible assets
0.76
0.70
0.73
0.68
Purchase accounting adjustments
0.02
0.02
0.02
0.02
Acquisition and divestiture-related costs
—
—
0.01
0.01
Transformation costs
(0.01
)
(0.01
)
—
—
Change in fair value of investments
0.05
0.05
0.02
0.02
Significant litigation matters and settlements
—
—
0.01
0.01
Restructuring and other
0.32
0.32
0.10
0.10
Tax on above items
(0.21
)
(0.19
)
(0.16
)
(0.16
)
Adjusted EPS from continuing operations
$
1.41
$
1.41
$
1.18
$
1.15
(1) amounts may not sum due to rounding
Revvity, Inc. and Subsidiaries
CONDENSED CONSOLIDATED INCOME STATEMENTS
Six Months Ended July 5, 2026
Six Months Ended June 29, 2025
(In thousands, except per share data)
As Reported
Pro Forma
As Reported
Pro Forma
Revenue
$
1,440,806
$
1,398,021
$
1,385,046
$
1,309,245
Cost of revenue
636,285
612,042
616,944
578,190
Selling, general and administrative expenses
532,458
505,515
498,245
507,149
Research and development expenses
106,861
106,684
106,867
106,867
Operating income from continuing operations
165,202
173,780
162,990
117,039
Interest income
(11,563
)
(11,535
)
(18,426
)
(18,395
)
Interest expense
47,708
47,708
45,901
45,901
Change in fair value of investments
9,455
9,455
(1,118
)
(1,118
)
Other expense, net
6,079
6,567
15,601
14,296
Income from continuing operations, before income taxes
113,523
121,585
121,032
76,355
Provision for income taxes
19,149
17,814
24,141
23,664
Income from continuing operations
94,374
103,771
96,891
52,691
Loss from discontinued operations
(1,836
)
(1,836
)
(706
)
(706
)
Net income
$
92,538
$
101,935
$
96,185
$
51,985
Diluted earnings per share:
Income from continuing operations
$
0.84
$
0.93
$
0.82
$
0.44
Loss from discontinued operations
(0.02
)
(0.02
)
(0.01
)
(0.01
)
Net income
$
0.82
$
0.91
$
0.81
$
0.43
Weighted average diluted shares of common stock outstanding
111,746
111,746
118,882
118,882
ABOVE PREPARED IN ACCORDANCE WITH GAAP
Additional supplemental information(1):
(per share, continuing operations)
Six Months Ended July 5, 2026
Six Months Ended June 29, 2025
As Reported
Pro Forma
As Reported
Pro Forma
GAAP EPS from continuing operations
$
0.84
$
0.93
$
0.82
$
0.44
Amortization of intangible assets
1.52
1.41
1.41
1.32
Purchase accounting adjustments
0.02
0.02
0.02
0.02
Acquisition and divestiture-related costs
0.01
0.01
0.03
0.03
Change in fair value of investments
0.08
0.08
(0.01
)
(0.01
)
Loss from probable dispositions
—
—
—
0.29
Significant litigation matters and settlements
—
—
0.10
0.10
Significant environmental matters
—
—
(0.01
)
(0.01
)
Disposition of businesses and assets, net
(0.05
)
(0.05
)
—
—
Mark to market on postretirement benefits
(0.02
)
(0.02
)
0.04
0.04
Restructuring and other
0.41
0.40
0.12
0.12
Tax on above items
(0.36
)
(0.34
)
(0.32
)
(0.23
)
Adjusted EPS from continuing operations
$
2.47
$
2.45
$
2.19
$
2.11
(1) amounts may not sum due to rounding
Revvity, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
Three Months Ended July 5, 2026
Three Months Ended June 29, 2025
(In thousands, except percentages)
As Reported
Pro Forma
As Reported
Pro Forma
Revenue and adjusted operating income
Revenue
$
729,688
$
711,109
$
720,284
$
680,547
Operating income from continuing operations
$
89,316
$
93,696
$
90,760
$
84,651
OP%
12.2
%
13.2
%
12.6
%
12.4
%
Amortization of intangible assets
84,871
78,383
85,289
79,903
Purchase accounting adjustments
1,866
1,866
2,178
2,178
Acquisition and divestiture-related costs
105
39
1,248
1,248
Transformation costs
(736
)
(736
)
—
—
Significant litigation matters and settlements
79
79
1,124
1,124
Restructuring and other
35,508
35,199
11,203
11,203
Adjusted operating income
$
211,009
$
208,526
$
191,802
$
180,307
OP%
28.9
%
29.3
%
26.6
%
26.5
%
Three Months Ended
July 5,
2026
June 29,
2025
(In thousands, except percentages)
Segment revenue:
Life Sciences
$
358,699
$
365,898
Diagnostics
370,989
354,386
Segment revenue
729,688
720,284
Segment operating income:
Life Sciences
$
111,534
$
115,469
31.1
%
31.6
%
Diagnostics
112,866
89,422
30.4
%
25.2
%
Segment operating income
224,400
204,891
Corporate
(13,391
)
(13,089
)
Adjusted operating income
211,009
191,802
Amortization of intangible assets
(84,871
)
(85,289
)
Purchase accounting adjustments
(1,866
)
(2,178
)
Acquisition and divestiture-related costs
(105
)
(1,248
)
Transformation costs
736
—
Significant litigation matters and settlements
(79
)
(1,124
)
Restructuring and other
(35,508
)
(11,203
)
Reported operating income from continuing operations
$
89,316
$
90,760
REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP
Revvity, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
Six Months Ended July 5, 2026
Six Months Ended June 29, 2025
(In thousands, except percentages)
As Reported
Pro Forma
As Reported
Pro Forma
Revenue and adjusted operating income
Revenue
$
1,440,806
$
1,398,021
$
1,385,046
$
1,309,245
Operating income from continuing operations
165,202
173,780
162,990
117,039
OP%
11.5
%
12.4
%
11.8
%
8.9
%
Amortization of intangible assets
169,952
157,092
167,989
157,246
Purchase accounting adjustments
2,007
2,007
2,001
2,001
Acquisition and divestiture-related costs
387
324
3,789
3,789
Disposition of businesses and assets, net
(5,074
)
(5,074
)
—
—
Transformation costs
58
58
—
—
Loss from probable dispositions
—
—
—
34,243
Significant litigation matters and settlements
148
148
11,710
11,710
Significant environmental matters
—
—
(1,208
)
(1,208
)
Restructuring and other
46,183
45,197
14,442
14,442
Adjusted operating income
$
378,863
$
373,532
$
361,713
$
339,262
OP%
26.3
%
26.7
%
26.1
%
25.9
%
Six Months Ended
July 5,
2026
June 29,
2025
(In thousands, except percentages)
Segment revenue:
Life Sciences
$
720,544
$
706,293
Diagnostics
720,262
678,753
Segment revenue
1,440,806
1,385,046
Segment operating income:
Life Sciences
$
215,513
$
221,180
29.9
%
31.3
%
Diagnostics
188,988
163,437
26.2
%
24.1
%
Segment operating income
404,501
384,617
Corporate
(25,638
)
(22,904
)
Adjusted operating income
378,863
361,713
Amortization of intangible assets
(169,952
)
(167,989
)
Purchase accounting adjustments
(2,007
)
(2,001
)
Acquisition and divestiture-related costs
(387
)
(3,789
)
Disposition of businesses and assets, net
5,074
—
Transformation costs
(58
)
—
Significant litigation matters and settlements
(148
)
(11,710
)
Significant environmental matters
—
1,208
Restructuring and other
(46,183
)
(14,442
)
Reported operating income from continuing operations
$
165,202
$
162,990
REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP
Revvity, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
July 5,
2026
December 28,
2025
Current assets:
Cash and cash equivalents
$
1,022,943
$
919,860
Accounts receivable, net
709,175
744,671
Inventories, net
378,502
379,497
Other current assets
187,101
195,719
Total current assets
2,297,721
2,239,747
Property, plant and equipment, net
456,251
479,249
Operating lease right-of-use assets, net
150,945
165,439
Intangible assets, net
2,224,001
2,347,003
Goodwill
6,607,802
6,613,493
Other assets, net
309,114
323,480
Total assets
$
12,045,834
$
12,168,411
Current liabilities:
Current portion of long-term debt
$
572,156
$
588,828
Accounts payable
165,740
185,464
Accrued expenses and other current liabilities
538,461
556,954
Total current liabilities
1,276,357
1,331,246
Long-term debt
2,633,094
2,631,236
Long-term liabilities
771,359
807,461
Operating lease liabilities
136,266
148,108
Total liabilities
4,817,076
4,918,051
Total stockholders' equity
7,228,758
7,250,360
Total liabilities and stockholders' equity
$
12,045,834
$
12,168,411
PREPARED IN ACCORDANCE WITH GAAP
Revvity, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended
Six Months Ended
(In thousands)
July 5,
2026
June 29,
2025
July 5,
2026
June 29,
2025
Operating activities:
Net income
$
51,820
$
53,948
$
92,538
$
96,185
Loss from discontinued operations, net of income taxes
1,661
1,274
1,836
706
Income from continuing operations
53,481
55,222
94,374
96,891
Adjustments to reconcile income from continuing operations to net cash provided by continuing operations:
Stock-based compensation
10,731
10,133
19,446
17,864
Restructuring and other
35,508
11,203
46,183
14,442
Depreciation and amortization
102,039
102,778
207,095
200,200
Change in fair value of contingent consideration
1,626
459
1,527
(166
)
Amortization of deferred debt financing costs and
accretion of discounts
1,301
1,218
2,440
2,320
Change in fair value of investments
5,251
1,955
9,455
(1,118
)
Unrealized foreign exchange loss
86
206
186
140
Gains on disposition of businesses and assets, net
—
—
(5,074
)
—
Changes in assets and liabilities which (used) provided cash:
Accounts receivable, net
(17,631
)
(40,041
)
43,916
(21,901
)
Inventories, net
8,060
11,128
(4,778
)
5,642
Accounts payable
(4,320
)
(5,576
)
(18,064
)
3,278
Accrued expenses and other
(4,189
)
(14,367
)
(78,876
)
(49,177
)
Net cash provided by operating activities of continuing operations
191,943
134,318
317,830
268,415
Net cash used in operating activities of discontinued operations
—
—
(10,657
)
(5,942
)
Net cash provided by operating activities
191,943
134,318
307,173
262,473
Investing activities:
Capital expenditures
(11,073
)
(18,868
)
(30,848
)
(34,850
)
Purchases of investments and notes receivables
(2,506
)
—
(3,561
)
—
Proceeds from investments and notes receivables
6,819
—
7,496
—
Proceeds from dispositions of property, plant and equipment
3,036
—
12,039
—
Proceeds from disposition of businesses and assets
—
—
158
229
Cash paid for acquisitions, net of cash acquired
219
—
(67,061
)
—
Net cash used in investing activities of continuing operations
(3,505
)
(18,868
)
(81,777
)
(34,621
)
Net cash provided by investing activities of discontinued operations
—
9,375
—
18,750
Net cash used in investing activities
(3,505
)
(9,493
)
(81,777
)
(15,871
)
Financing Activities:
Payments of debt financing costs
—
(72
)
—
(2,474
)
Payments on other credit facilities
—
(53
)
—
(103
)
Payments for acquisition-related contingent consideration
(350
)
(161
)
(350
)
(1,978
)
Proceeds from issuance of common stock under stock plans
996
—
6,437
2,632
Purchases of common stock
(15,992
)
(293,907
)
(102,488
)
(447,501
)
Dividends paid
(7,814
)
(8,282
)
(15,654
)
(16,715
)
Net cash used in financing activities
(23,160
)
(302,475
)
(112,055
)
(466,139
)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
(2,563
)
31,953
(10,190
)
48,075
Net increase (decrease) in cash, cash equivalents, and restricted cash
162,715
(145,697
)
103,151
(171,462
)
Cash, cash equivalents, and restricted cash at beginning of period
861,466
1,138,687
921,030
1,164,452
Cash, cash equivalents, and restricted cash at end of period
$
1,024,181
$
992,990
$
1,024,181
$
992,990
Supplemental disclosure of cash flow information:
Reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total shown in the consolidated statements of cash flows:
Cash and cash equivalents
$
1,022,943
$
991,849
$
1,022,943
$
991,849
Restricted cash included in other current assets
713
1,141
713
1,141
Restricted cash included in other assets
525
—
525
—
Total cash, cash equivalents and restricted cash
$
1,024,181
$
992,990
$
1,024,181
$
992,990
PREPARED IN ACCORDANCE WITH GAAP
Revvity, Inc. and Subsidiaries
RECONCILIATION OF FINANCIAL METRICS (1)
Continuing Operations
Three Months Ended
July 5, 2026
Pro forma organic revenue growth:
Pro forma revenue growth from continuing operations
4%
Less: effect of foreign exchange rates
0%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses
1%
Pro forma organic revenue growth from continuing operations
3%
Life Sciences
Three Months Ended
July 5, 2026
Pro forma organic revenue growth:
Pro forma revenue growth from continuing operations
-2%
Less: effect of foreign exchange rates
0%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses
1%
Pro forma organic revenue growth from continuing operations
-3%
Diagnostics
Three Months Ended
July 5, 2026
Pro forma organic revenue growth:
Pro forma revenue growth from continuing operations
12%
Less: effect of foreign exchange rates
1%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses
0%
Pro forma organic revenue growth from continuing operations
11%
(1) amounts may not sum due to rounding
Revvity, Inc. and Subsidiaries
RECONCILIATION OF FINANCIAL METRICS (1)
Continuing Operations
Six Months Ended
July 5, 2026
Pro forma organic revenue growth:
Pro forma revenue growth from continuing operations
7%
Less: effect of foreign exchange rates
2%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses
1%
Pro forma organic revenue growth from continuing operations
4%
Life Sciences
Six Months Ended
July 5, 2026
Pro forma organic revenue growth:
Pro forma revenue growth from continuing operations
2%
Less: effect of foreign exchange rates
1%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses
1%
Pro forma organic revenue growth from continuing operations
0%
Diagnostics
Six Months Ended
July 5, 2026
Pro forma organic revenue growth:
Pro forma revenue growth from continuing operations
12%
Less: effect of foreign exchange rates
2%
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses
0%
Pro forma organic revenue growth from continuing operations
10%
(1) amounts may not sum due to rounding
Explanation of Non-GAAP Financial Measures
We report our financial results in accordance with GAAP. However, management believes that, in order to more fully understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash, non-recurring or other items, which result from facts and circumstances that vary in frequency and impact on continuing operations. Accordingly, we present non-GAAP financial measures as a supplement to the financial measures we present in accordance with GAAP. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. Management believes these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.
We use the term “organic revenue” to refer to GAAP revenue, excluding the effect of foreign currency changes and revenue from recent acquisitions, divestitures and including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We use the related term “organic revenue growth” or “organic growth” to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year.
We use the term “adjusted gross margin” to refer to GAAP gross margin, excluding amortization of intangible assets and inventory fair value adjustments related to business acquisitions and asset impairments. We use the related term “adjusted gross margin percentage” to refer to adjusted gross margin as a percentage of revenue.
We use the term “adjusted SG&A expense” to refer to GAAP SG&A expense, excluding amortization of intangible assets, purchase accounting adjustments, acquisition and divestiture-related expenses, transformation costs, significant litigation matters and settlements, asset impairments, significant environmental charges, and restructuring and other charges. We use the related term “adjusted SG&A percentage” to refer to adjusted SG&A expense as a percentage of revenue.
We use the term “adjusted R&D expense” to refer to GAAP R&D expense, excluding amortization of intangible assets and purchase accounting adjustments. We use the related term “adjusted R&D percentage” to refer to adjusted R&D expense as a percentage of revenue.
We use the term “adjusted net interest and other expense” to refer to GAAP net interest and other expense, excluding adjustments for mark-to-market accounting on post-retirement benefits, changes in foreign exchange and interest associated with acquisitions and divestitures, changes in the value of investments and debt extinguishment costs.
We use the term “adjusted operating income” to refer to GAAP operating income, excluding amortization of intangible assets, purchase accounting adjustments, acquisition and divestiture-related expenses, transformation costs, significant litigation matters and settlements, significant environmental charges, asset impairments, and restructuring and other charges. We use the related terms “adjusted operating profit percentage,” “adjusted operating profit margin,” and “adjusted operating margin” to refer to adjusted operating income as a percentage of revenue.
We use the term “free cash flow” to refer to net cash provided by (used in) operating activities of continuing operations, less payments for additions to property, plant and equipment from continuing operations (“capital expenditures”) plus the proceeds from sales of plant, property and equipment from continuing operations (“capital disposals”).
We use the term “adjusted net income” to refer to GAAP income from continuing operations, excluding amortization of intangible assets, debt extinguishment costs, purchase accounting adjustments, acquisition and divestiture-related expenses, transformation costs, significant litigation matters and settlements, significant environmental charges, changes in the value of investments, disposition of businesses and assets, net, changes in foreign exchange and interest associated with acquisitions and divestitures, asset impairments and restructuring and other charges. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate this non-GAAP measure. We also adjust for any tax impact related to the above items and exclude the impact of significant tax events.
We use the term “adjusted earnings per share from continuing operations,” “adjusted earnings per share,” “adjusted EPS,” or “adjusted EPS from continuing operations” to refer to GAAP earnings per share from continuing operations, excluding amortization of intangible assets, debt extinguishment costs, purchase accounting adjustments, acquisition and divestiture-related expenses, transformation costs, significant litigation matters and settlements, significant environmental charges, changes in the value of investments, disposition of businesses and assets, net, changes in foreign exchange and interest associated with acquisitions and divestitures, asset impairments and restructuring and other charges. We also exclude adjustments for mark-to market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate this non-GAAP measure. We also adjust for any tax impact related to the above items and exclude the impact of significant tax events.
We use the term “pro forma organic revenue” to refer to organic revenue excluding revenue from probable dispositions. We use the related term “pro forma organic revenue growth”, “pro forma organic revenue growth from continuing operations” or “pro forma organic growth” to refer to the measure of comparing current period pro forma organic revenue with the corresponding period of the prior year.
We use the term “pro forma adjusted gross margin” to refer to adjusted gross margin, excluding gross margin from probable dispositions. We use the related term “pro forma adjusted gross margin percentage” to refer to pro forma adjusted gross margin as a percentage of pro forma revenue.
We use the term “pro forma adjusted SG&A expense” to refer to adjusted SG&A expense, excluding SG&A expense from probable dispositions and gains(losses) on sale of probable dispositions. We use the related term “pro forma adjusted SG&A percentage” to refer to pro forma adjusted SG&A expense as a percentage of pro forma revenue.
We use the term “pro forma adjusted R&D expense” to refer to adjusted R&D expense, excluding R&D expense from probable dispositions. We use the related term “pro forma adjusted R&D percentage” to refer to pro forma adjusted R&D expense as a percentage of pro forma revenue.
We use the term “pro forma adjusted net interest and other expense” to refer to adjusted net interest and other expense, excluding net interest and expense from probable dispositions.
We use the term “pro forma adjusted operating income” to refer to adjusted operating income, excluding operating income from probable dispositions. We use the related terms “pro forma adjusted operating profit percentage,” “pro forma adjusted operating profit margin,” and “pro forma adjusted operating margin” to refer to pro forma adjusted operating income as a percentage of pro forma revenue.
We use the term “pro forma adjusted earnings per share from continuing operations,” “pro forma adjusted earnings per share,” “pro forma adjusted EPS,” or “pro forma adjusted EPS from continuing operations” to refer to adjusted earnings per share from continuing operations, excluding net income from probable dispositions and gains (losses) on sale of probable dispositions.
Management includes or excludes the effect of each of the items identified below in the applicable non-GAAP financial measure referenced above for the reasons set forth below with respect to that item:
Amortization of intangible assets—purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred. Debt extinguishment costs—we incur costs and income related to the extinguishment of debt, including make-whole payments to debt holders, accelerated amortization of debt fees and discounts, and expense or income from hedges to lock in make-whole payments. We exclude the impact of these items from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations. Purchase accounting adjustments—accounting rules require us to adjust various balance sheet accounts, including inventory, fixed assets, deferred revenue and deferred rent balances to fair value at the time of the acquisition. As a result, the expenses for these items in our GAAP results are not the same as what would have been recorded by the acquired entity. Accounting rules also require us to estimate the fair value of contingent consideration at the time of the acquisition, and any subsequent changes to the estimate or payment of the contingent consideration and purchase accounting adjustments are charged to expense or income. We exclude the impact of any changes to contingent consideration from our non-GAAP measures because we believe these expenses or benefits do not accurately reflect the performance of our ongoing operations for the period in which such expenses or benefits are recorded. Acquisition and divestiture-related expenses—we incur legal, due diligence, stay bonuses, incentive awards, stock-based compensation, interest, foreign exchange gains and losses, integration expenses, rebranding expenses, and other costs related to acquisitions and divestitures. We exclude these expenses from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations. Transformation costs—transformation costs consist of external professional service costs related to transformation initiatives focused on business processes modernization, automation, and implementation of global systems to support the new Revvity Business Model. These costs are determined to be noncapitalizable in accordance with accounting standards. Management does not believe such costs accurately reflect the performance of our ongoing operations for the period in which such costs are reported. Asset impairments—we incur expenses related to asset impairments. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred. Restructuring and other charges—restructuring and other charges consist of employee severance, other exit costs, abandonments or associated asset write-downs, cost of terminating certain lease agreements or contracts as well as costs associated with relocating facilities. Management does not believe such costs accurately reflect the performance of our ongoing operations for the period in which such costs are reported. Adjustments for mark-to-market accounting on post-retirement benefits—we exclude adjustments for mark-to-market accounting on post-retirement benefits, and therefore only our projected costs are used to calculate our non-GAAP measures. We exclude these adjustments because they do not represent what we believe our investors consider to be costs of producing our products, investments in technology and production, and costs to support our internal operating structure. Significant litigation matters and settlements—we incur expenses related to significant litigation matters, including the costs to settle or resolve various claims and legal proceedings. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred. Significant environmental charges—we incur expenses related to significant environmental charges. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred. Disposition of businesses and assets, net—we exclude the impact of gains or losses from the disposition of businesses and assets from our adjusted earnings per share. Management does not believe such gains or losses accurately reflect the performance of our ongoing operations for the period in which such gains or losses are reported. Impact of foreign currency changes on the current period—we exclude the impact of foreign currency associated with acquisitions and divestitures from these measures by using the prior period’s foreign currency exchange rates for the current period because foreign currency exchange rates are subject to volatility and can obscure underlying trends. Impact of significant tax events—we exclude the impact of significant tax events. Management does not believe the impact of significant tax events accurately reflects the performance of our ongoing operations for the periods in which the impact of such events was recorded. Change in fair value of investments—we exclude the impact of changes in the value of investments. Management does not believe such gains or losses accurately reflect the performance of our ongoing operations for the period in which such gains or losses are reported. The tax effect for discontinued operations is calculated based on the authoritative guidance in the Financial Accounting Standards Board’s Accounting Standards Codification 740, Income Taxes. The tax effect for amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, debt extinguishment costs, other costs related to business acquisitions and divestitures, transformation costs, loss from probable dispositions, significant litigation matters and settlements, significant environmental charges, changes in the fair value of investments, adjustments for mark-to-market accounting on post-retirement benefits, disposition of businesses and assets, net, and restructuring and other charges is calculated based on operational results and a blended jurisdictional tax rate, which contemplates tax rates currently in effect to determine our tax provision. The tax effect for the impact from foreign currency exchange rates on the current period is calculated based on a blended jurisdictional tax rate currently in effect to determine our tax provision.
The non-GAAP financial measures described above are not meant to be considered superior to, or a substitute for, our financial statements prepared in accordance with GAAP. There are material limitations associated with non-GAAP financial measures because they exclude charges that have an effect on our reported results and, therefore, should not be relied upon as the sole financial measures by which to evaluate our financial results. Management compensates and believes that investors should compensate for these limitations by viewing the non-GAAP financial measures in conjunction with the GAAP financial measures. In addition, the non-GAAP financial measures included in this earnings announcement may be different from, and therefore may not be comparable to, similar measures used by other companies.
Each of the non-GAAP financial measures listed above is also used by our management to evaluate our operating performance, communicate our financial results to our Board of Directors, benchmark our results against our historical performance and the performance of our peers, evaluate investment opportunities including acquisitions and discontinued operations, and determine the bonus payments for senior management and employees.
Ares Commercial Real Estate vykázala za 2. čtvrtletí čistý zisk podle GAAP 4,4 mil. USD, tedy 0,08 USD na akcii, a distribuovatelný zisk 6,9 mil. USD, tedy 0,12 USD na akcii. Zároveň schválila dividendu 0,15 USD na akcii za 3. čtvrtletí 2026.
Second quarter GAAP net income of $4.4 million or $0.08 per diluted common share and
Distributable Earnings1 of $6.9 million or $0.12 per diluted common share
- Subsequent to the three months ended June 30, 2026 -
Declared third quarter 2026 dividend of $0.15 per common share
, /PRNewswire/ -- Ares Commercial Real Estate Corporation (the "Company") (NYSE: ACRE), a specialty finance company primarily engaged in directly originating and investing in commercial real estate loans and related investments, reported generally accepted accounting principles ("GAAP") net income of $4.4 million or $0.08 per diluted common share and Distributable Earnings1 of $6.9 million or $0.12 per diluted common share for the second quarter of 2026.
"We continue to make advancements in repositioning our portfolio, addressing risk rated 4 and 5 loans, and reducing office loans and REO properties, while investing in new loans," said Bryan Donohoe, Chief Executive Officer of Ares Commercial Real Estate Corporation. "Supported by the Ares platform, in the second quarter, we closed $130 million of new loan commitments, bringing the total new loan commitments to over $900 million in the last twelve months."
"During the second quarter, we maintained our balance sheet flexibility with moderate leverage and available capital of over $100 million to support our business priorities," said Jeff Gonzales, Chief Financial Officer of Ares Commercial Real Estate Corporation. "We continue to execute the goals we have outlined, which we believe will allow us to rebuild earnings to levels that are expected to meet or exceed the current dividend level."
________________________________________
(1)
Distributable Earnings (Loss) is a non-GAAP financial measure. Refer to Schedule I for the definition and reconciliation of Distributable Earnings (Loss).
COMMON STOCK DIVIDEND
On May 7, 2026, the Board of Directors of the Company declared a regular cash dividend of $0.15 per common share for the second quarter of 2026. The second quarter 2026 dividend was paid on July 15, 2026 to common stockholders of record as of June 30, 2026.
On August 4, 2026, the Board of Directors of the Company declared a regular cash dividend of $0.15 per common share for the third quarter of 2026. The third quarter 2026 dividend will be payable on October 15, 2026 to common stockholders of record as of September 30, 2026.
ADDITIONAL INFORMATION
The Company issued a presentation of its second quarter 2026 results, which can be viewed at www.arescre.com on the Investor Resources section of our home page under Events and Presentations. The presentation is titled "Second Quarter 2026 Earnings Presentation." The Company also filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 with the U.S. Securities and Exchange Commission on August 4, 2026.
CONFERENCE CALL AND WEBCAST INFORMATION
On Tuesday, August 4, 2026, the Company invites all interested persons to attend its webcast/conference call at 12:00 p.m. (Eastern Time) to discuss its second quarter 2026 financial results.
All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Home page of the Investor Resources section of the Company's website at www.arescre.com. Please visit the website to test your connection before the webcast. Domestic callers can access the conference call by dialing +1 (800) 343-5172. International callers can access the conference call by dialing +1 (203) 518-9856. Please provide passcode ACREQ226. All callers are asked to dial in 10-15 minutes prior to the call so that name and company information can be collected. For interested parties, an archived replay of the call will be available through September 4, 2026 at 5:00 p.m. (Eastern Time) to domestic callers by dialing +1 (800) 723-0532 and to international callers by dialing +1 (402) 220-2655. An archived replay will also be available through September 4, 2026 on a webcast link located on the Home page of the Investor Resources section of the Company's website.
ABOUT ARES COMMERCIAL REAL ESTATE CORPORATION
Ares Commercial Real Estate Corporation (the "Company") is a specialty finance company primarily engaged in directly originating and investing in commercial real estate loans and related investments. Through its national direct origination platform, the Company provides a broad offering of flexible and reliable financing solutions for commercial real estate owners and operators. The Company invests in whole and co-invested senior mortgage loans, as well as subordinate financings, mezzanine debt and preferred equity, with an emphasis on providing value added financing on a variety of properties located in liquid markets across the United States. Ares Commercial Real Estate Corporation elected and qualified to be taxed as a real estate investment trust and is externally managed by a subsidiary of Ares Management Corporation. For more information, please visit www.arescre.com. The contents of such website are not, and should not be deemed to be, incorporated by reference herein.
FORWARD-LOOKING STATEMENTS
Statements included herein or on the webcast / conference call may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. These statements relate to future events or the Company's future performance or financial condition and include, but are not limited to, statements about potential earnings, the resolution of underperforming loans, increased investment activity, liquidity management, reduction or increase of CECL reserve, reduction or increase of available borrowings, the industry and the loan market. These statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including global economic trends and economic conditions, including slower growth, changes to fiscal and monetary policy, inflation, labor shortages, changing interest rates, foreign currency exchange volatility and uncertainties caused by tariffs and trade disputes, as well as geopolitical instability, changes in interest rates and credit spreads, management's estimate of current expected credit losses and current expected credit loss reserve, the amount of commercial mortgage loans requiring refinancing, the demand for commercial real estate loans, the Company's expected investment capacity and available capital, rates of default or decreased recovery rates on the Company's target investments, the Company's business and investment strategy, the Company's projected operating results, the ability of Ares Commercial Real Estate Management LLC ("ACREM" or the Company's "Manager") to locate suitable investments for the Company, monitor, service and administer the Company's investments and execute its investment strategy, and the risks described from time to time in the Company's filings with the Securities and Exchange Commission (the "SEC"), including, but not limited to, the risk factors described in Part I, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K, filed with the SEC on February 10, 2026. Any forward-looking statement, including any contained herein, speaks only as of the time of this press release and Ares Commercial Real Estate Corporation undertakes no duty to update any forward-looking statements made herein or on the webcast/conference call. Projections and forward-looking statements are based on management's good faith and reasonable assumptions, including the assumptions described herein.
INVESTOR RELATIONS CONTACTS
Ares Commercial Real Estate Corporation
Carl Drake or John Stilmar
(888) 818-5298
[email protected]
ARES COMMERCIAL REAL ESTATE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except share and per share data)
As of
June 30, 2026
December 31, 2025
(unaudited)
ASSETS
Cash and cash equivalents
$ 17,558
$ 29,289
Restricted cash ($1,108 related to consolidated VIEs as of December 31, 2025)
41,017
37,868
Loans held for investment ($138,950 related to consolidated VIEs as of December
31, 2025)
1,748,835
1,528,806
Current expected credit loss reserve
(137,810)
(125,756)
Loans held for investment, net of current expected credit loss reserve
1,611,025
1,403,050
Real estate owned held for investment, net ($52,634 related to consolidated VIEs
as of December 31, 2025)
76,238
130,165
Real estate owned held for sale
53,934
—
Other assets ($76 of interest receivable related to consolidated VIEs as of
December 31, 2025)
Other liabilities ($257 of interest payable related to consolidated VIEs as of
December 31, 2025)
52,644
48,614
Total liabilities
1,328,050
1,108,574
Commitments and contingencies
STOCKHOLDERS' EQUITY
Common stock, par value $0.01 per share, 450,000,000 shares authorized at June
30, 2026 and December 31, 2025 and 55,481,113 and 55,026,453 shares issued
and outstanding at June 30, 2026 and December 31, 2025, respectively
532
532
Additional paid-in capital
822,606
820,827
Accumulated earnings (deficit)
(333,913)
(311,791)
Total stockholders' equity
489,225
509,568
Total liabilities and stockholders' equity
$ 1,817,275
$ 1,618,142
ARES COMMERCIAL REAL ESTATE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
For the Three Months Ended
June 30,
For the Six Months Ended
June 30,
2026
2025
2026
2025
Revenue:
Interest income
$ 27,754
$ 23,117
$ 52,660
$ 50,597
Interest expense
(19,182)
(16,101)
(36,543)
(34,290)
Net interest margin
8,572
7,016
16,117
16,307
Revenue from real estate owned
5,784
5,549
11,699
11,206
Total revenue
14,356
12,565
27,816
27,513
Expenses:
Management and incentive fees to affiliate
2,394
2,430
4,794
4,997
Professional fees
699
673
1,519
1,550
General and administrative expenses
1,723
1,995
3,140
3,715
General and administrative expenses reimbursed to affiliate
853
1,024
1,639
2,027
Expenses from real estate owned
3,301
4,628
6,435
9,123
Total expenses
8,970
10,750
17,527
21,412
(Provision for) reversal of current expected credit losses, net
(865)
20,150
(12,003)
25,490
Realized losses on loans
—
(33,000)
(3,340)
(33,000)
Income (loss) before income taxes
4,521
(11,035)
(5,054)
(1,409)
Income tax expense (benefit), including excise tax
138
—
169
281
Net income (loss) attributable to common stockholders
$ 4,383
$ (11,035)
$ (5,223)
$ (1,690)
Earnings (loss) per common share:
Basic earnings (loss) per common share
$ 0.08
$ (0.20)
$ (0.09)
$ (0.03)
Diluted earnings (loss) per common share
$ 0.08
$ (0.20)
$ (0.09)
$ (0.03)
Weighted average number of common shares outstanding:
Basic weighted average shares of common stock outstanding
55,367,375
54,856,949
55,344,923
54,842,959
Diluted weighted average shares of common stock outstanding
56,354,988
54,856,949
55,344,923
54,842,959
Dividends declared per share of common stock1
$ 0.15
$ 0.15
$ 0.30
$ 0.30
____________________________
(1)
There is no assurance dividends will continue at these levels or at all.
SCHEDULE I
Reconciliation of Net Income (Loss) to Non-GAAP Distributable Earnings (Loss)
Distributable Earnings (Loss) is a non-GAAP financial measure that helps the Company evaluate its financial performance excluding the effects of certain transactions and GAAP adjustments that it believes are not necessarily indicative of its current loan origination portfolio and operations. To maintain the Company's REIT status, the Company is generally required to annually distribute to its stockholders substantially all of its taxable income. The Company believes the disclosure of Distributable Earnings (Loss) provides useful information to investors regarding the Company's ability to pay dividends, which is one of the principal reasons the Company believes investors invest in the Company. The presentation of this additional information is not meant to be considered in isolation or as a substitute for financial results prepared in accordance with GAAP. Distributable Earnings (Loss) is defined as net income (loss) attributable to common stockholders computed in accordance with GAAP, excluding non-cash equity compensation expense, the incentive fees the Company pays to its Manager, depreciation and amortization (to the extent that any of the Company's target investments are structured as debt and the Company forecloses on any properties underlying such debt), any unrealized gains, losses or other non-cash items recorded in net income (loss) for the period, regardless of whether such items are included in other comprehensive income or loss, or in net income (loss), one-time events pursuant to changes in GAAP and certain non-cash charges after discussions between the Company's Manager and the Company's independent directors and after approval by a majority of the Company's independent directors. Loan balances that are deemed to be uncollectible are written-off as a realized loss and are included in Distributable Earnings (Loss). Distributable Earnings (Loss) is aligned with the calculation of "Core Earnings," which is defined in the Management Agreement and is used to calculate the incentive fees the Company pays to its Manager.
Reconciliation of net income (loss) attributable to common stockholders, the most directly comparable GAAP financial measure, to Distributable Earnings (Loss) is set forth in the table below for the three and twelve months ended June 30, 2026 ($ in thousands):
For the Three Months Ended
June 30, 2026
For the Twelve Months Ended
June 30, 2026
Net income (loss) attributable to common stockholders
$ 4,383
$ (4,434)
Stock-based compensation
882
3,696
Incentive fees to affiliate
—
—
Depreciation and amortization of real estate owned
749
5,104
Provision for (reversal of) current expected credit losses, net
865
19,648
Distributable Earnings (Loss)
$ 6,879
$ 24,014
Net income (loss) attributable to common stockholders
$ 0.08
$ (0.08)
Stock-based compensation
0.02
0.07
Incentive fees to affiliate
—
—
Depreciation and amortization of real estate owned
0.01
0.09
Provision for (reversal of) current expected credit losses, net
0.02
0.36
Basic Distributable Earnings (Loss) per common share
$ 0.12
$ 0.44
Net income (loss) attributable to common stockholders
$ 0.08
$ (0.08)
Stock-based compensation
0.02
0.07
Incentive fees to affiliate
—
—
Depreciation and amortization of real estate owned
0.01
0.09
Provision for (reversal of) current expected credit losses, net
0.02
0.35
Diluted Distributable Earnings (Loss) per common share
Everspin Technologies a MaxLinear podepsaly memorandum o porozumění na vyhodnocení paměťových architektur pro AI servery. Cílem je zlepšit efektivitu, výkon a trvanlivost dat pomocí MRAM.
Work will focus on persistent MRAM for metadata management, log data, write buffering and cache functions
CHANDLER, Ariz. & CARLSBAD, Calif.--(BUSINESS WIRE)--Everspin Technologies, Inc. (NASDAQ: MRAM), the world's leading developer and manufacturer of MRAM solutions, and MaxLinear, Inc., a leading provider of high-performance connectivity and storage acceleration solutions, today announced the signing of a memorandum of understanding (MOU) to evaluate next-generation memory architectures designed to improve efficiency and performance in AI servers.
AI models and inference workloads continue to grow while server architectures are under pressure to support larger data sets, expanding key-value (KV) caches and increased data movement across systems. These demands are driving interest in new approaches that combine persistent memory, acceleration and compression to improve performance, power efficiency and infrastructure utilization.
The MOU establishes a framework for the companies to evaluate the use of Everspin's persistent, low-latency MRAM technology with MaxLinear's storage compression, encryption and hardware acceleration platform. The work will focus on metadata management, log data, write buffering and cache functions, as well as other data-intensive workloads, with the goal of improving responsiveness, reliability and data persistence in next-generation server architectures.
"AI is forcing system architects to rethink where persistent memory fits in the server memory hierarchy," said Sanjeev Aggarwal, president and CEO of Everspin Technologies. "At Everspin, we continue to advance MRAM for applications where speed, persistence and endurance need to work together. We look forward to collaborating with MaxLinear to bring that innovation into AI server architectures that need persistent memory closer to critical data, creating a path for next-generation MRAM-based solutions.”
"The rapid growth of AI is driving the need for smarter ways to manage, move and access data across servers," said Vikas Choudhary, senior vice president, connectivity and storage at MaxLinear. "Combining acceleration, compression, and persistent memory creates an opportunity to improve resource utilization, reduce data movement and deliver more predictable performance for demanding AI workloads. Our collaboration with Everspin is focused on evaluating innovative architectures that can help customers scale efficiently as AI deployments continue to expand."
MOU Terms
Under the terms of the MOU, the companies will evaluate:
Technical validation of Everspin MRAM with MaxLinear’s acceleration, compression and encryption platform for AI and data-intensive server workloadsMarket development initiatives targeting hyperscale cloud, AI infrastructure and enterprise server customersLong-term manufacturing, supply and commercialization opportunitiesFor more information on Everspin Technologies, visit https://www.everspin.com
About Everspin Technologies
Everspin Technologies, Inc. (NASDAQ: MRAM) is the world’s leading provider of Magnetoresistive RAM (MRAM). Everspin MRAM delivers the industry’s most robust, highest-performance non-volatile memory for industrial, data center, automotive, aerospace and other mission-critical applications where data persistence is essential. Headquartered in Chandler, Arizona, Everspin provides commercially available MRAM solutions to a large and diverse customer base.
About MaxLinear, Inc.
MaxLinear, Inc. (Nasdaq: MXL) is a leading provider of radio frequency (RF), analog, digital, and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multimarket applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit https://www.maxlinear.com/.
MaxLinear, the MaxLinear logo, any other MaxLinear trademarks are all property of MaxLinear, Inc. or one of MaxLinear's subsidiaries in the U.S.A. and other countries. All rights reserved.
All third-party marks and logos are trademarks or registered trademarks of their respective holders/owners.
This press release contains forward-looking statements regarding future events or results. Forward-looking statements are identified by words such as “will,” “expects” or similar expressions and include, but are not limited to, statements regarding Everspin’s anticipated business plans and business strategy. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results or outcomes to be materially different from any future results or outcomes expressed or implied by the forward-looking statements, including, without limitation, the risks set forth under the caption “Risk Factors” in Everspin’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on March 5, 2026, as well as in Everspin’s subsequent filings with the SEC. Any forward-looking statements made by Everspin in this press release speak only as of the date on which they are made, and subsequent events may cause these expectations to change. Everspin disclaims any obligations to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law.
Objem perpetual futures na Trust Wallet přes Hyperliquid překročil 3 miliardy USD. Integrace zpřístupnila více než 200 trhů 220 milionům+ uživatelů přímo v aplikaci.
@Hyperliquidx perpetual futures volume on @TrustWallet has crossed the $3 billion mark, a milestone that underscores the rapid mainstream adoption of on-chain derivatives trading through mobile platforms.
Mobile Distribution Unlocks a New Retail Wave The integration, which went live in late April 2026, gave Trust Wallet's 220 million-plus users access to Hyperliquid's high-performance decentralized blockchain, which has executed over $4 trillion in total trading volume, delivering deeper liquidity, more markets, and faster execution without leaving the app.
The move gives those users access to over 200 perpetual futures markets covering cryptocurrencies and real-world assets like oil and gold, without connecting external applications. Hyperliquid launched in Trust Wallet with 0% markup on fees for the first three months, a clear effort to accelerate user onboarding and build trading habit on mobile.
Perp trading has long been dominated by desktop-first platforms, making the Trust Wallet integration a meaningful structural shift. Routing institutional-grade perpetuals through a self-custody mobile wallet removes one of the last friction points for retail participation in on-chain derivatives.
Hyperliquid Cements Its Lead in On-Chain Perps The $3 billion volume figure on Trust Wallet alone reflects broader momentum for the protocol. Hyperliquid processed $633 billion in trading volume during Q1 2026 alone, with daily volume running between $3 billion and $10 billion depending on market conditions. Its share of on-chain perpetual futures volume climbed to 44% by mid-2026, even as new competitors entered the space.
The protocol's edge is largely architectural. Hyperliquid's order book clears trades with sub-second finality at 100,000 orders per second, a throughput level that allows it to offer execution quality typically associated with centralised venues while remaining fully non-custodial.
The Trust Wallet channel adds a distribution layer that competitors have struggled to replicate. By embedding directly into a wallet with a nine-figure user base, @Hyperliquidx gains access to retail capital that would otherwise flow to centralised exchanges, without requiring users to bridge assets or navigate separate applications.
Sources:
Trust Wallet brings the perp DEX war to mobile with Hyperliquid integration (Crypto Briefing)
Trust Wallet Adds Hyperliquid Perps with 0% Fees for 3 Months (Crypto Times)
Hyperliquid captures 80% of decentralized perpetual trading volume (Crypto Briefing)
RPO increased to $894 million, up 12x from a year ago
Q2 2026 Revenue of $281 million grew 29% year-over-year
Million+ Dollar Customer ARR grew 214% year-over-year to $259 million
AI Customer ARR grew 212% year-over-year to $234 million
Record $93 million in incremental ARR
BROOMFIELD, Colo.--(BUSINESS WIRE)--DigitalOcean Holdings, Inc. (NYSE: DOCN), the AI-Native Cloud purpose-built for inference and agentic workloads, today announced results for its second quarter ended June 30, 2026.
"Our growth rate is accelerating, as revenue grew 29% year-over-year, more than double our growth rate a year ago," said Paddy Srinivasan, CEO of DigitalOcean. "The acceleration is coming from our highest spending customers and sophisticated AI Natives, and we are now beginning to land nine-figure annual commitments. Early Inference Engine customers drove their total token consumption up approximately 30x in the last 60-days, and 85% of our AI customer ARR now comes from inference and core cloud rather than bare metal. Just as important is how we are growing: attractive margins, positive free cash flow, capacity delivered on or ahead of schedule, and a stronger balance sheet. Our customer momentum and early product traction give us confidence to raise our 2026 revenue outlook to approximately 30%, reaching 35% or more by Q4 2026, and strengthen our conviction in our ability to exceed 50% growth in 2027."
Second Quarter 2026 Financial Highlights(1):
Revenue was $281 million, an increase of 29%. Annual Run-Rate Revenue (“ARR”) ended the quarter at $1,125 million, an increase of 29%. AI Customer ARR was $234 million, an increase of 212%. Record $93 million of incremental ARR added during the quarter, an increase of 191%. Net income attributable to common stockholders was $35 million, a decrease of 4%, and net income margin was 13%. Operating income was $29 million, a decrease of 18%, and operating income margin was 10%. Adjusted operating income was $67 million, an increase of 9%, and adjusted operating income margin was 24%. Adjusted EBITDA was $114 million, an increase of 27%, and adjusted EBITDA margin was 40%. Diluted net income per share was $0.29 and non-GAAP diluted net income per share was $0.45. Net cash from operating activities increased to $110 million at a 39% margin, from $92 million at a 42% margin in the second quarter of 2025. Adjusted free cash flow increased to $61 million at a 22% margin, from $57 million at a 26% margin in the second quarter of 2025. Cash and cash equivalents was $767 million as of June 30, 2026. Remaining Performance Obligation (“RPO”)(2) was $894 million, of which, $366 million is expected to be recognized over the next 12 months. RPO was $71 million in the second quarter of 2025. Second Quarter 2026 Operational Highlights(1):
Launched Inference Engine as part of AI-Native Cloud. Shipped more than 80 product releases since April. Signed first nine-figure annual customer commitments with leading AI-Natives, extending weighted average contract life from 1.6 years to over 3 years. Secured an incremental 20 MW of committed data center capacity expected to come online in 2027 and 2028, bringing total committed capacity to approximately 155 MW, with additional capacity actively being pursued. Added to the Russell 1000 Index, recognition of a business that has scaled with discipline, pairing durable growth with consistent execution. The number of $100K+ Customers(3) grew 9%, while the revenue from these customers, which now represents 35% of total revenue, grew 98%. The number of $500K+ and $1M+ Customers grew 35% and 73%, respectively. Revenue from these customers, which now represents 26% and 23% of total revenue, grew 160% and 214%, respectively. Recent Developments:
Repurchased approximately $472 million of our 0.00% Convertible Senior Notes due 2030, funded by a concurrent registered direct offering, reducing leverage with minimal cash usage and minimal dilution, with issued shares offset by the retired notes and an intended repurchase of approximately 500,000 shares. Financial Outlook:
DigitalOcean is initiating guidance for the third quarter ending September 30, 2026 as follows:
Total revenue of $304 to $307 million, up 32% to 34% year-over-year. Adjusted EBITDA margin of 38% to 39%. Non-GAAP diluted net income per share of $0.28 to $0.30. Fully diluted weighted average shares outstanding of approximately 126 to 127 million shares. For the full year 2026, we now expect:
Total revenue of $1.170 to $1.180 billion, up 30% to 31% year-over-year. Adjusted EBITDA margin of 38.5% to 39.5%. Adjusted free cash flow margin in the range of 11% to 13% of revenue. Non-GAAP diluted net income per share of $1.35 to $1.40. Fully diluted weighted average shares outstanding of approximately 122 to 123 million shares. A reconciliation of non-GAAP outlook measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty regarding, and the potential variability of, expenses that may be incurred in the future. For example, stock-based compensation expense-related charges are impacted by the timing of employee stock transactions, the future fair market value of our common stock, and our future hiring and retention needs, all of which are difficult to predict and subject to constant change. Accordingly, a reconciliation is not available without unreasonable effort and we are unable to assess the probable significance of the unavailable information, although it is important to note that these factors could be material to our results computed in accordance with GAAP.
The financial guidance presented in this release are estimates based on information available to management as of the date of this release. There can be no assurance that our actual results will not differ from the financial guidance presented in this release.
Conference Call Information:
DigitalOcean will host a conference call today, August 4, 2026, at 8:00 a.m. ET to review its results. The conference call and presentation can be accessed by registering for the webcast at https://events.q4inc.com/attendee/684389800. A live webcast and replay of the conference call in addition to the presentation can be accessed from the DigitalOcean investor relations website at investors.digitalocean.com.
About DigitalOcean
DigitalOcean (NYSE: DOCN) is the AI-Native Cloud, purpose-built for inference and agentic workloads. Its five-layer integrated platform, spanning GPU and CPU infrastructure, core cloud, inference, data, and managed agent orchestration, is open throughout with no vendor lock-in, giving builders everything they need to start fast, scale production AI workloads, and improve unit economics. More than 680,000 customers and millions of developers globally trust DigitalOcean to build, ship, and scale their applications. Learn more at digitalocean.com.
Forward-Looking Statements
This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding our expected future performance, including but not limited to statements in the section titled “Financial Outlook” and the quotations of our CEO. The forward-looking statements contained in this release and the accompanying earnings call referenced in this release are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause actual results or outcomes to be materially different from any future results or outcomes expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions, and other factors include, but are not limited to: (1) fluctuations in our financial results make it difficult to project future results; (2) our ability to sustain profitability in the future; (3) our ability to expand usage of our platform by existing customers and/or attract new customers and/or retain existing customers; (4) the speed at which the market for our platform and solutions develops; (5) the success of the development and use of our artificial intelligence and machine learning (“AI/ML”) product offerings or use of third-party AI/ML-based tools; (6) our ability to release updates and new features to our platform and adapt and respond effectively to rapidly changing technology or customer needs; (7) our ability to control costs, including our operating expenses, and the timing of payment for expenses; (8) the amount and timing of non-cash expenses, including stock-based compensation, goodwill impairments and other non-cash charges; (9) breaches in our security measures allowing unauthorized access to our platform, our data, or our customers’ data; (10) the competitive markets in which we participate; (11) our ability to effectively integrate and retain new members of our executive leadership team and senior management; (12) the effects of acquisitions and their integration; (13) general market, political, economic, and business conditions, including changes in trade policies, such as trade wars, tariffs and other restrictions or the threat of such actions; (14) the impact of new accounting pronouncements; (15) our ability to control fraudulent registrations and usage of our platform, reduce bad debt and lessen capacity constraints on our data centers, servers and equipment; (16) our customers’ ability to have continued and unimpeded access to our platform, including as a result of evolving laws and industry standards; and (17) our plans with respect to accelerating investments in data centers and GPU capacity.
Further information on these and additional risks, uncertainties, assumptions and other factors that could cause actual results or outcomes to differ materially from those included in or contemplated by the forward-looking statements contained in this release are included under the caption “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings and reports we make with the SEC.
We operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this release. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur. The forward-looking statements made in this release relate only to events as of the date on which the statements are made. We assume no obligation to, and do not currently intend to, update any such forward-looking statements after the date of this release, except as required by law.
About Non-GAAP Financial Measures
To supplement our consolidated financial statements, which are prepared and presented in accordance with generally accepted accounting principles in the United States, or GAAP, we provide investors with non-GAAP financial measures including: (i) adjusted operating income and adjusted operating income margin, (ii) adjusted EBITDA and adjusted EBITDA margin and (iii) non-GAAP net income and non-GAAP diluted net income per share. These measures are presented for supplemental informational purposes only, have limitations as analytical tools and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP.
We believe that adjusted operating income margin and adjusted EBITDA, when taken together with our GAAP financial results, provide meaningful supplemental information regarding our operating performance (including our long-term performance in the case of adjusted operating income) and facilitate internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. In particular, we believe that the use of adjusted operating income and adjusted EBITDA is helpful to our investors as they are measures used by management in assessing the health of our business, evaluating our operating performance, and for internal planning and forecasting purposes.
We believe non-GAAP net income and non-GAAP diluted net income per share provides our management and investors consistency and comparability with our past financial performance and facilitates period-to-period comparisons of operations, as this metric generally eliminates the effects of unusual or non-recurring items from period to period for reasons unrelated to overall operating performance.
Our calculations of each of these measures may differ from the calculations of measures with the same or similar titles by other companies and therefore comparability may be limited. Because of these limitations, when evaluating our performance, you should consider each of these non-GAAP financial measures alongside other financial performance measures, including the most directly comparable financial measure calculated in accordance with GAAP and our other GAAP results. A reconciliation of each of our non-GAAP financial measures to the most directly comparable financial measure calculated in accordance with GAAP is set forth in the tables in the section “Reconciliation of GAAP to Non-GAAP Data.”
Adjusted Operating Income and Adjusted Operating Income Margin
We define adjusted operating income as operating income, adjusted to exclude stock-based compensation, amortization of acquired intangible assets, acquisition related compensation, acquisition and integration related costs, restructuring and other charges, restructuring related charges, impairment of certain long-lived assets and other charges. We define adjusted operating income margin as adjusted operating income as a percentage of revenue.
Adjusted EBITDA and Adjusted EBITDA Margin
We define adjusted EBITDA as net income attributable to common stockholders, adjusted to exclude depreciation and amortization, stock-based compensation, interest expense, acquisition related compensation, acquisition and integration related costs, income tax expense (benefit), restructuring and other charges, restructuring related charges, impairment of certain long-lived assets, interest income and other income, net, (gain) loss on extinguishment of debt, net, and other charges. We define adjusted EBITDA margin as adjusted EBITDA as a percentage of revenue.
Non-GAAP Net Income and Non-GAAP Diluted Net Income Per Share
We define non-GAAP net income as net income attributable to common stockholders, excluding stock-based compensation, acquisition related compensation, amortization of acquired intangibles, acquisition and integration related costs, restructuring and other charges, restructuring related charges, impairment of certain long-lived assets, (gain) loss on extinguishment of debt, net, and other charges. In addition to these exclusions, we subtract an assumed non-GAAP provision for income taxes to calculate non-GAAP net income that excludes the current period income tax benefit (expense). We utilize a fixed long-term projected tax rate in our computation of the non-GAAP income tax provision in order to provide better consistency across reporting periods. We define non-GAAP diluted net income per share as non-GAAP net income divided by the weighted-average diluted shares outstanding, which includes the potentially dilutive effect of our stock options, RSUs, PRSUs, and Convertible Notes and, beginning in the first quarter of 2026, excludes the in-the-money portion of our 2030 Convertible Notes as they are covered by our capped call transactions, which are expected to mitigate the dilutive effect of our 2030 Convertible Notes.
Adjusted Free Cash Flow and Adjusted Free Cash Flow Margin
Adjusted free cash flow is a non-GAAP financial measure that we define as net cash provided by operating activities less purchases of property and equipment, capitalized internal-use software costs, purchase of intangible assets, and excluding cash paid for restructuring and other charges, acquisition related compensation, restructuring related charges, and acquisition and integration related costs. Adjusted free cash flow margin is calculated as adjusted free cash flow divided by total revenue.
We believe that adjusted free cash flow and adjusted free cash flow margin are useful indicators of liquidity that provide information to management and investors about the amount of cash generated from our core operations that can be used for strategic initiatives, including investing in our business and selectively pursuing acquisitions and strategic investments. We further believe that historical and future trends in adjusted free cash flow and adjusted free cash flow margin, even if negative, provide useful information about the amount of net cash provided by operating activities that is available (or not available) to be used for strategic initiatives. Adjusted free cash flow and adjusted free cash flow margin exclude acquisitions of equipment under financing arrangements, finance leases, and our future contractual commitments. Additionally, adjusted free cash flow does not represent the residual cash flow available for discretionary expenses given our debt obligations and the total increase or decrease in our cash balance for a given period.
Unlevered adjusted free cash flow is a non-GAAP financial measure that we define as adjusted free cash flow excluding cash paid for interest and interest income. Unlevered adjusted free cash flow margin is calculated as unlevered adjusted free cash flow divided by total revenue.
We believe that unlevered adjusted free cash flow and unlevered adjusted free cash flow margin provide additional information to adjusted free cash flow about our liquidity and, measured over time, enable management and investors to monitor the underlying business’ growth pattern and ability to generate cash. We further believe that unlevered adjusted free cash flow is an important metric, as it provides a clear view of our cash generation before the impact of financing decisions and many investors and analysts use unlevered adjusted free cash flow as the basis of their enterprise value calculations as they assess the value of our business. Unlevered adjusted free cash flow and unlevered adjusted free cash flow margin exclude certain charges that will be settled in cash, such as interest paid to service our debt and equipment financing obligations. Additionally, unlevered adjusted free cash flow does not represent the residual cash flow available for discretionary expenses given our debt obligations and the total increase or decrease in our cash balance for a given period.
Key Business Metrics:
We utilize the key metrics set forth below to help us evaluate our business and growth, identify trends, formulate financial projections and make strategic decisions.
Customers
We calculate customer count as the average number of customers as of the last day of the month for each month in the most recent quarter. Customers are classified in the following categories based on the amount of their spend in a given month and individual customers may fall within different categories within a reporting period (customer spend in a month in whole dollars):
Digital Native Enterprise Customers: users that spend more than $500 in a month. $100K+ Customers: users that spend more than $8,333 in a month. $500K+ Customers: users that spend more than $41,667 in a month. $1M+ Customers: users that spend more than $83,333 in a month. ARR
We calculate ARR by multiplying total revenue for the most recent quarter by four.
AI Customer ARR
We calculate AI Customer ARR by multiplying total AI Customer Revenue for the most recent quarter by four. AI Customer Revenue is defined as the total revenue generated from customers who utilize one or more of our AI/ML offerings, inclusive of their revenue from our IaaS and PaaS/SaaS offerings during the period.
Other Metrics:
Remaining Performance Obligation
Remaining performance obligation (“RPO”) represents commitments in customer contracts for future services that have not yet been recognized in the condensed consolidated financial statements. RPO is not necessarily indicative of future revenue growth because it does not account for the timing of customers’ consumption or their usage beyond their contracted capacity. Additionally, RPO may increase when customers transition from usage-based to commitment-based agreements, which does not always reflect incremental revenue growth. RPO is influenced by a number of factors, including the timing and size of renewals, the timing and size of purchases of additional capacity and average contract term. Due to these factors, it is important to review RPO in conjunction with revenue and other financial metrics contained in this release and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings and reports we make with the SEC.
DIGITALOCEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share amounts)
(unaudited)
June 30, 2026
December 31, 2025
Current assets:
Cash and cash equivalents
$
767,026
$
254,475
Accounts receivable, less allowance for credit losses of $6,812 and $6,374, respectively
115,000
90,908
Prepaid expenses and other current assets
135,584
81,598
Total current assets
1,017,610
426,981
Property and equipment, net
1,049,332
589,094
Restricted cash
156
158
Goodwill
350,651
348,674
Intangible assets, net
93,373
99,504
Operating lease right-of-use assets, net
505,697
270,854
Deferred tax assets
93,991
90,310
Other assets
12,243
12,130
Total assets
$
3,123,053
$
1,837,705
Current liabilities:
Accounts payable
$
10,387
$
38,836
Accrued other expenses
70,883
42,679
Deferred revenue
53,039
5,882
Debt, current
311,654
325,109
Operating lease liabilities, current
126,233
108,037
Finance lease liabilities and equipment financing obligations, current
129,777
31,411
Other current liabilities
74,139
67,510
Total current liabilities
776,112
619,464
Deferred tax liabilities
3,952
4,092
Debt, long-term
609,399
970,653
Operating lease liabilities, long-term
352,854
166,895
Finance lease liabilities and equipment financing obligations, long-term
447,943
99,103
Other non-current liabilities
2,062
6,188
Total liabilities
2,192,322
1,866,395
Commitments and contingencies (Note 9)
Preferred stock ($0.000025 par value per share; 10,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025)
—
—
Common stock ($0.000025 par value per share; 750,000,000 shares authorized; 105,002,427 and 91,947,614 issued and outstanding as of June 30, 2026 and December 31, 2025, respectively)
2
2
Additional paid-in capital
925,014
16,005
Accumulated other comprehensive loss
(1,756
)
(960
)
Retained earnings (Accumulated deficit)
7,471
(43,737
)
Total stockholders’ equity (deficit)
930,731
(28,690
)
Total liabilities and stockholders’ equity
$
3,123,053
$
1,837,705
DIGITALOCEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
Three Months Ended
Six Months Ended
June 30,
June 30,
2026
2025
2026
2025
Revenue
$
281,184
$
218,700
$
539,089
$
429,403
Cost of revenue
126,522
87,755
239,717
169,014
Gross profit
154,662
130,945
299,372
260,389
Operating expenses:
Research and development
57,515
39,644
106,345
79,238
Sales and marketing
22,568
19,288
44,237
38,689
General and administrative
45,208
36,394
82,848
69,201
Total operating expenses
125,291
95,326
233,430
187,128
Operating income
29,371
35,619
65,942
73,261
Other (expense) income:
Interest expense
(7,463
)
(2,239
)
(18,016
)
(4,447
)
Loss on extinguishment of debt, net
—
(269
)
(2,700
)
(269
)
Interest income and other income, net
5,234
9,337
6,412
15,283
Other (expense) income, net
(2,229
)
6,829
(14,304
)
10,567
Income before income taxes
27,142
42,448
51,638
83,828
Income tax benefit (expense)
8,295
(5,421
)
(430
)
(8,597
)
Net income attributable to common stockholders
$
35,437
$
37,027
$
51,208
$
75,231
Net income per share attributable to common stockholders
Basic
$
0.34
$
0.41
$
0.52
$
0.82
Diluted
$
0.29
$
0.39
$
0.45
$
0.77
Weighted-average shares used to compute net income per share attributable to common stockholders
Basic
104,611
91,097
98,856
91,538
Diluted
126,548
100,617
118,708
101,521
DIGITALOCEAN HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Six Months Ended June 30,
2026
2025
Operating activities
Net income attributable to common stockholders
$
51,208
$
75,231
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
96,629
61,975
Stock-based compensation
55,231
40,513
Provision for expected credit losses
8,078
8,607
Loss on extinguishment of debt
2,700
269
Operating lease right-of-use assets and liabilities, net
(30,810
)
(13,816
)
Non-cash interest expense
2,960
4,005
Other
3,476
(7,853
)
Changes in operating assets and liabilities:
Accounts receivable
(32,230
)
(17,064
)
Prepaid expenses and other current assets
(53,906
)
1,201
Accounts payable and accrued expenses
6,536
(3,029
)
Deferred revenue
47,157
5,867
Other assets and liabilities
(140
)
631
Net cash provided by operating activities
156,889
156,537
Investing activities
Capital expenditures - property and equipment
(81,576
)
(95,160
)
Capital expenditures - internal-use software
(11,785
)
(3,412
)
Acquisition of equipment under financing arrangements
(51,544
)
—
Purchase of intangible assets
(754
)
(1,835
)
Cash paid for acquisition of businesses, net of cash acquired
(4,042
)
—
Net cash used in investing activities
(149,701
)
(100,407
)
Financing activities
Proceeds from follow-on public offering, net of underwriting discounts and issuance costs
887,888
—
Principal repayment of Term Loan Facility
(500,000
)
—
Proceeds from drawdown of Term Loan Facility
120,000
—
Payment of debt issuance costs
—
(4,081
)
Proceeds related to issuance of common stock under equity incentive plan
3,558
2,771
Proceeds from issuance of common stock under employee stock purchase plan
2,494
2,660
Employee payroll taxes paid related to net settlement of equity awards
(38,406
)
(16,294
)
Proceeds from financing arrangements
51,544
—
Principal repayments of finance leases and financing arrangements
(21,651
)
(2,733
)
Repurchase and retirement of common stock including related costs
—
(79,199
)
Net cash provided by (used in) financing activities
505,427
(96,876
)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
(66
)
45
Increase (decrease) in cash, cash equivalents and restricted cash
512,549
(40,701
)
Cash, cash equivalents and restricted cash - beginning of period
254,633
430,193
Cash, cash equivalents and restricted cash - end of period
$
767,182
$
389,492
DIGITALOCEAN HOLDINGS, INC.
RECONCILIATION OF GAAP TO NON-GAAP DATA
(unaudited)
Adjusted Operating Income and Operating Income Margin
Three Months Ended
Six Months Ended
June 30,
June 30,
(In thousands)
2026
2025
2026
2025
Operating income
$
29,371
$
35,619
$
65,942
$
73,261
Adjustments:
Stock-based compensation
32,724
21,081
55,231
40,513
Amortization of acquired intangible assets
5,070
5,031
10,008
10,228
Impairment of certain long-lived assets
311
—
311
—
Adjusted operating income
$
67,476
$
61,731
$
131,492
$
124,002
As a percentage of revenue:
Operating income margin
10
%
16
%
12
%
17
%
Adjusted operating income margin
24
%
28
%
24
%
29
%
Adjusted EBITDA and Adjusted EBITDA Margin
Three Months Ended
Six Months Ended
June 30,
June 30,
(In thousands)
2026
2025
2026
2025
GAAP Net income attributable to common stockholders
$
35,437
$
37,027
$
51,208
$
75,231
Adjustments:
Depreciation and amortization
51,154
32,765
96,629
61,975
Stock-based compensation
32,724
21,081
55,231
40,513
Interest expense
7,463
2,239
18,016
4,447
Income tax (benefit) expense
(8,295
)
5,421
430
8,597
Loss on extinguishment of debt
—
269
2,700
269
Impairment of certain long-lived assets
311
—
311
—
Interest income and other income, net(1)
(5,234
)
(9,337
)
(6,412
)
(15,283
)
Adjusted EBITDA
$
113,560
$
89,465
$
218,113
$
175,749
As a percentage of revenue:
Net income margin
13
%
17
%
9
%
18
%
Adjusted EBITDA margin
40
%
41
%
40
%
41
%
Non-GAAP Net Income and Non-GAAP Diluted Net Income Per Share
Three Months Ended
Six Months Ended
June 30,
June 30,
(In thousands, except per share amounts)
2026
2025
2026
2025
GAAP Net income attributable to common stockholders
$
35,437
$
37,027
$
51,208
$
75,231
Stock-based compensation
32,724
21,081
55,231
40,513
Amortization of acquired intangible assets
5,070
5,031
10,008
10,228
Loss on extinguishment of debt(1)
—
269
2,700
269
Impairment of certain long-lived assets
311
—
311
—
Non-GAAP income tax adjustment(2)
(18,735
)
(5,593
)
(18,752
)
(12,977
)
Non-GAAP Net income
$
54,807
$
57,815
$
100,706
$
113,264
Non-cash charges related to convertible notes(3)
$
1,118
$
1,596
$
2,190
$
3,191
Non-GAAP Net income used to compute net income per share, diluted
$
55,925
$
59,411
$
102,896
$
116,455
GAAP Net income per share attributable to common stockholders, diluted(6)
$
0.29
$
0.39
$
0.45
$
0.77
Stock-based compensation
0.27
0.21
0.48
0.40
Amortization of acquired intangible assets
0.04
0.05
0.09
0.10
Loss on extinguishment of debt(1)
—
—
0.02
—
Impairment of certain long-lived assets
—
—
—
—
Non-cash charges related to convertible notes(3)
0.01
0.02
0.02
0.03
Non-GAAP income tax adjustment(2)
(0.16
)
(0.08
)
(0.17
)
(0.15
)
Non-GAAP Net income per share, diluted(4)
$
0.45
$
0.59
$
0.89
$
1.15
GAAP Weighted-average shares used to compute net income per share, diluted
126,548
100,617
118,708
101,521
Add: Weighted-average dilutive effect of potentially dilutive securities
—
—
1,750
—
Less: Anti-dilutive impact of capped call transaction(5)
(3,227
)
—
(4,388
)
—
Non-GAAP Weighted-average shares used to compute net income per share, diluted(6)
123,321
100,617
116,070
101,521
____________________ (1)
For the three and six months ended June 30, 2026, excludes tax impact which is presented in Non-GAAP income tax adjustment.
(2)
For the periods in fiscal year 2026 and 2025, we used a tax rate of 16%, which we believe is a reasonable estimate of our long-term effective tax rate applicable to non-GAAP pre-tax income for each respective year.
(3)
Consists of non-cash interest expense for amortization of debt issuance costs related to our Convertible Notes.
(4)
May not foot due to rounding.
(5)
Excludes the in-the-money portion of our 2030 Convertible Notes for non-GAAP weighted-average diluted shares as they are covered by our capped call transactions. Our outstanding capped call transactions are antidilutive under GAAP, but are expected to mitigate the dilutive effect of our 2030 Convertible Notes, and therefore are included in the calculation of non-GAAP diluted shares outstanding. The capped calls have an antidilutive impact when the average stock price of our common stock in a given period is higher than their exercise price.
(6)
Includes 1,750 and 15,957 of potentially dilutive securities related to our 2026 and 2030 Convertible Notes, respectively, as if the entire principal amount outstanding were converted into shares for the three and six months ended June 30, 2026. Includes 8,403 of potentially dilutive securities related to our 2026 Convertible Notes as if the entire principal amount outstanding were converted into shares for the three and six months ended June 30, 2025. The Company has the election of settling any conversion in cash, shares of our common stock, or a combination of both. Refer to our Quarterly Report on Form 10-Q for the three months ended June 30, 2026 for further details.
Enlight Renewable Energy ve 2. čtvrtletí zvýšila tržby o 55 % na 210 mil. USD a čistý zisk na 31 mil. USD. Zároveň zvýšila celoroční výhled tržeb na 790 až 820 mil. USD.
All of the amounts disclosed in this press release are in U.S. dollars unless otherwise noted
TEL AVIV, Israel, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Enlight Renewable Energy (NASDAQ: ENLT, TASE: ENLT) today reported financial results for the quarter ended June 30, 2026. Registration links for the Company’s earnings English and Hebrew conference call and webcasts can be found at the end of this earnings release.
Financial Highlights
3 months ending June 30, 2026
Total revenues and income1 of $210 million, an increase of 55% compared to the same period last year.Net income of $31 million, compared to $6 million in the same period last year.Adjusted EBITDA2 of $160 million, compared to $96 million in the same period last year. Excluding a gain of approximately $17 million from the follow-on sale of a 15% stake from the Sunlight cluster in the second quarter of 2026, Adjusted EBITDA totaled $142 million, an increase of 50% from the second quarter of 2025.Cash flow from operating activities3 of about $84 million, an increase of 37% compared to the same period last year. 6 months ending June 30, 2026
Total revenues and income of $409 million, an increase of 55% compared to the same period last year.Net income of $69 million, compared to $107 million in the same period last year. Excluding a gain of approximately $81 million from the sale of 44% stake from the Sunlight cluster in and deconsolidation in the first quarter of 2025, net income increased by 160%, compared to $26 million in the comparable period.Adjusted EBITDA of $314 million, compared to $227 million in the first half of 2025. Excluding a gain of $42 million from the sale of 44% from the Sunlight cluster in the first half of 2025, and a gain of $30 million from follow-on sales of 26% from the Sunlight cluster during the first half of 2026, Adjusted EBITDA amounted to $284 million in the first half of 2026, an increase of 54% from the first half of 2025.Operating cash flow of $185 million, an increase of 48% from the first half of 2025. 1Total revenues and income include revenues from the sale of electricity, as well as income from tax benefits from U.S. projects
2Adjusted EBITDA is a non-IFRS measure. Please refer to the appendices for the reconciliation to net income. The Company is unable to provide a reconciliation of “Adjusted EBITDA” to net income on a forward-looking basis without unreasonable effort because items that impact this IFRS financial measure are not within the Company’s control and/or cannot be reasonably predicted
3Interest payments and receipts are classified as cash flows from financing and investing activities, respectively, instead of cash flows from operating activities. Adjustments were made to comparative figures due to a change in accounting policy; for further details, see Appendix No. 4
Raising full-year guidance ranges
Revenues & income4 guidance increased to $790 to $820 million, up from $755 to $785 million previously.Adjusted EBITDA guidance increased to $565 to $585 million, up from $545 to $565 million previously.The increase in guidance is primarily driven by strong first-half results, attributed to strong project operational performance, higher electricity prices in Europe and the depreciation of the USD. The increase in revenue guidance exceeded the increase in Adjusted EBITDA guidance, reflecting the growing contribution of our electricity trading operations in Israel, which are characterized by low margins.
4Total revenues and income include revenues from the sale of electricity along with income from tax benefits from US projects amounting to $160-180m.
Summary of key financial results:
For the three months endedFor the six months ended($ millions)June 30,
2026June 30,
2025% changeJune 30,
2026June 30,
2025% changeRevenues and Income21013555%40926555%Net Income316460%69107(36%)Net income excluding the Sunlight transactions316460%6926160%Adjusted EBITDA1609667%31422738%Adjusted EBITDA excluding the Sunlight transactions1429650%28418554%Cash Flow from Operating Activities846237%18512548% Adi Leviatan, CEO of Enlight Renewable Energy: “We are concluding another quarter of strong growth and consistent execution, with revenue increasing by 55%, significant improvements in profitability and cash flow generation, and robust performance across all of our operating regions. Our first-half results, together with the continued advancement of projects under construction and the expansion of our energy storage business, enable us to raise our 2026 revenue and Adjusted EBITDA guidance, as well as the run-rate revenues reflected in our mature projects and our year-end 2028 target.
At the same time, the successful completion of $2.6 billion financing for the CO Bar complex, the largest in our history, along with additional milestones achieved during the quarter, highlights Enlight’s execution and financing capabilities and reflects the confidence of our financial partners.
We remain focused and disciplined in expanding our global portfolio and converting it into sustained high-growth performance while preserving long-term profitability. At the same time, we continue to strengthen our position as a leading energy platform across the markets in which we operate.”
Portfolio Review
During the second quarter and through the date of this release, Enlight continued to expand its portfolio and advance projects through the various phases of development. As of the earning release date, Enlight’s total portfolio is comprised of 21.8 GW of generation capacity and 74.6 GWh energy storage (totaling 43.1 FGW5), representing an increase of 4.6% compared to the total portfolio at the release date of the first quarter of 2026 (41.2 FGW). The generation component increased by approximately 1.5% and the storage component increased by approximately 8% compared to the previous quarter, reflecting Enlight’s strategy to lead in energy storage as a response to the market’s increasing demand.
The mature component of the portfolio (operating projects, projects under construction, and projects in pre-construction) comprises of 6.4 GW of generation capacity and 20.5 GWh of storage capacity, totaling 12.3 FGW, compared to 11.6 FGW at the end of the previous quarter, an increase of 6%. Approximately 53% of the capacity is located in the U.S., 32% in Europe, and approximately 15% in MENA.
The advanced development and development components comprise of 15.4 GW of generation capacity and 54.1 GWh of storage capacity, totaling 30.8 FGW, an increase of 4% sequentially. Approximately 72% of the capacity is located in the U.S., 15% in MENA, and 13% in Europe.
5FGW (Factored GW) is the company’s consolidated metric combining generation and storage capacity into a uniform figure based on the ratio of construction costs. Current weighted average construction cost ratio is 3.5 GWh of storage per 1 GW of generation: FGW = GW + GWh / 3.5.
The composition of Enlight’s portfolio appears in the following table:
ComponentStatusFGWAnnual revenues &
income run rate ($m)OperatingCommercial operation3.9~780-810Under constructionUnder construction4.5~840Pre-construction0-12 months to start of construction3.9~660Total Mature Portfolio 12.3~$2,300mAdvanced development13-24 months to start of construction7.8-Development24+ months to start of construction23.0-Total Portfolio 43.1- Operating component of the portfolio: 3.9 FGW Approximately 41% of the operating component is in the U.S., 34% in Europe, and 25% in Israel. 90% of operating capacity is contracted under PPAs, of which approximately 24% is under index-linked PPAs.The operating portfolio generates annualized revenues and income run rate of approximately $780 to $810 million. The increase in run-rate revenues from operating assets is driven mainly by higher revenues from electricity trade in Israel, good operational performance in the Company’s projects, higher electricity prices and exchange rates fluctuations. Under construction component of the portfolio: 4.5 FGW This component increased quarter-over-quarter by approximately 500 FMW (approximately 12%),The Bertikow project in Germany (storage capacity of 881 MWh) started construction during the quarter.As part of its strategy to expand energy storage capacity in Europe, the Company acquired and commenced construction of two energy storage projects in Finland, a key hub for data center development. The projects have a combined storage capacity of 902 MWh, are expected to achieve commercial operation during the first half of 2028 and are projected to generate an unlevered return6 of 19% to 20%.The under-construction component includes six projects in the U.S. (CO Bar Phases I-III, Country Acres, Crimson Orchard, and Snowflake A) with a total capacity of 3.4 GW, seven projects in Europe with an aggregate capacity of approximately 912 MW, and projects in Israel with a total capacity of approximately 142 MW.Energy storage projects (either standalone or paired with generation assets) account for approximately 42% of the under-construction component.During the second quarter, financing for the CO Bar complex in Arizona was successfully completed, totaling $2.6 billion. The financing was provided by a consortium of seven leading global financial institutions. The complex comprises five phases and includes 1.2 GW of solar generation capacity and 4 GWh of energy storage capacity. Total investment in the CO Bar complex is expected to range between $2.9 billion and $3.0 billion, including a term loan of approximately $1.7 billion. Tax equity proceeds are estimated at about $1.5 billion. The Company estimates that during the remainder of 2026 it will begin construction of projects totaling approximately 2.7 FGW, such that 87% of the mature component is expected to be either operating or under construction by the end of 2026.The under-construction component is expected to contribute approximately $840 million to the annual revenues and income in their first full year of operation, compared to $770 million in the previous quarter. The increase is mainly attributable to the inclusion of the projects mentioned above. 6 Calculated by dividing the projected EBITDA for the first full year of operations by the estimated net construction cost.
Pre-construction component of the portfolio: 3.9 FGW This component increased by approximately 220 FMW.During the quarter, the Karpen Cluster in Romania was acquired, with an aggregate storage capacity of 848 MWh. Commercial operation is expected to commence in several phases during the second half of 2028 and the first half of 2029. The portfolio is expected to generate an unlevered return of 16.8% to 17.2%.During the quarter, an additional energy storage project in Finland, Kajo, was acquired, with a storage capacity of 542 MWh. Commercial operation is expected during the first half of 2028, and the project is expected to generate an unlevered return of 16.9%–17.3%.In addition, projects in Israel and Hungary with an aggregate capacity of approximately 56 FMW advanced to pre-construction.The pre-construction component includes six projects in the U.S. totaling 1.5 FGW, eleven projects in Europe totaling approximately 1.7 FGW, and projects in Israel totaling 0.7 FGW.Storage projects account for 77% of total capacity. Pre-construction projects are expected to contribute approximately $660 million to the annual recurring revenues and income in their first full year of operation, an increase from $540 million in the previous quarter. The increase is mainly attributable to the inclusion of the projects mentioned above. Advanced development component of the portfolio: 7.8 FGW This component increased by 500 FMW sequentially.During the quarter projects with an aggregate capacity of 324 FMW in the U.S. (in SPP), 286 FMW in Poland and 245 FMW in Israel transitioned from development to advanced development.This component includes 5.5 FGW in the U.S., 1.2 FGW in Europe, and 1.1 FGW in MENA.Storage projects account for 48% of total capacity.As of the date of this report, the entire advanced development portfolio in the U.S. has successfully completed System Impact Study process and has a high likelihood of securing grid interconnection.Approximately 5 FGW of U.S. capacity met Safe Harbor7 requirements (approximately 91% of this component’s capacity in the U.S.), securing eligibility for tax benefits. 7Securing Safe Harbor status and grid interconnection agreement do not guarantee the project's completion. Actual project completion is subject to meeting development milestones and market conditions
Development component of the portfolio: 23 FGW This component includes 16.9 FGW in the U.S., 3.4 FGW in MENA, and 2.7 FGW in Europe.The main additions over the past three months include projects totaling planned capacity of approximately 2 FGW in the U.S., of which energy storage projects with aggregated capacity of 2.4 GWh in PJM and projects with aggregated electricity generation capacity of 478 MW and storage capacity of 1.4 GWh in CAISO. 240 MW planned electricity generation and 800 MWh of planned energy storage capacity were added in WECC.Storage projects account for approximately 51% of total capacity.As of the earnings release date, 8.1 FGW (approximately 48% of this component’s capacity in the U.S.) successfully completed System Impact Study and have a high likelihood of achieving grid interconnection.Approximately 6.4 FGW of U.S. capacity met Safe Harbor requirements (approximately 38% of this component’s capacity in the U.S.), securing eligibility for tax benefits.Under current U.S. legislation, energy storage projects that commence construction by the end of 2033 are eligible for the full value of available tax credits, with a gradual phase-down for projects beginning construction during the following three years. The Company currently has approximately 4.7 GW of energy storage capacity in its portfolio that is expected to begin construction over the coming years.The Company expects to pursue similar tax credit eligibility for future energy storage projects added to its portfolio, subject to their commencement of construction within the applicable qualification period.
With completion of the current mature portfolio by year-end 2028, Enlight’s operating capacity is expected to reach approximately 12 FGW, and total annual revenues and income8 run rate is expected to reach $2.2 to $2.3 billion by the end of 2028, reflecting a 41% compound annual growth rate between 2024 and 2028.
Project and Corporate Finance
During the first half of the year, the Company secured approximately $3.7 billion of financing sources (including project financing):
$2.6 billion financing for the CO-Bar complex, representing the largest financing transaction in the Company's history.Approximately $350 million raised through an expansion of Series G bonds on the Tel Aviv Stock Exchange, at an interest rate of approximately 4.4%, reflecting a spread of approximately 0.75% above comparable Israeli government bonds.Issuance of approximately 6 million shares, generating gross proceeds of approximately $420 million.$304 million financing secured for the Crimson Orchard project in Idaho, U.S.Follow-on transactions for the sale of additional stakes in the Sunlight portfolio, generating proceeds of $38 million.As of the balance sheet date, cash and cash equivalents at the “topco”8 level9 totaled $877 million. In addition, cash and cash equivalents held by subsidiaries amounted to approximately $287 million.As of the balance sheet date, the Company had available credit facilities of $550 million, of which $132 million had been utilized.As of the balance sheet date, the Company had approximately $1.7 billion of Letter of Credit and Surety Bond facilities, of which $674 million had been utilized. 8The expected growth in 2028 encompasses the Company’s operations in all geographies. Expected growth relies on business plans which rely on development conditions and assumptions regarding electricity prices and are contingent on current trends known to the Company at this time; Expected Adjusted EBITDA margin of approximately 70%-80% (including tax benefits) for the years shown. The company's revenues from tax benefits are estimated at approximately 22-24% of the total revenues & income run rate for December 2026 and approximately 28-30% of the total revenues & income run rate for December 2027 and December 2028.
9 Including Enlight Renewable Energy, headquarter companies in Europe and the U.S. and Clenera, and excluding other subsidiaries and project-linked entities.
Financial Results Analysis
Revenues & Income by Segment
($ millions)For the three months endedFor the six months endedSegment
June 30,
2026
June 30,
2025
% change
June 30,
2026
June 30,
2025
% change
MENA
77
53
46%
141
96
48%
Europe
52
48
9%
113
99
14%
U.S.
80
34
133%
154
69
122%
Other
1
0
-
1
1
-
Total Revenues & Income
210
135
55%
409
265
55%
Revenues & Income
In the second quarter of 2026, the Company's total revenues increased by 55% to approximately $210 million, compared to approximately $135 million in the corresponding quarter last year. Revenues from electricity sales grew by 43% to approximately $166 million.
The increase in revenues was primarily driven by new U.S. projects that commenced operations at the end of 2025, contributing approximately $20 million to the growth in electricity sales revenues. Foreign exchange fluctuations contributed an additional $13 million, electricity trading activities in Israel contributed $9 million, and higher power prices together with improved generation output contributed approximately $6 million to the increase in electricity sales revenues.
Tax credit income amounted to approximately $44 million, compared to approximately $19 million in the corresponding quarter last year. The increase was primarily attributable to new U.S. projects that commenced operations at the end of 2025, as well as additional tax credits recognized at the Atrisco project related to the use of domestic content, which became effective in the third quarter of 2025.
Net Income
The Company's net income for the second quarter of 2026 totaled $31 million, compared to $6 million in the corresponding quarter last year.
The $25 million increase was primarily driven by a $75 million increase in total revenues. This was partially offset by a $19 million increase in cost of revenues, mainly due to the expansion of electricity trading activities in Israel and the commencement of operations at new projects, a $10 million increase in depreciation and amortization expenses, an $8 million increase in general and administrative and development expenses, a $4 million increase in other expenses, primarily due to compensation for lost revenues received in the second quarter of 2025, and a $9 million increase in tax expenses.
Gross financing expenses increased by $18 million, primarily as a result of the commencement of operations at new projects. This was partially offset by a $7 million increase in financing income. In addition, during the corresponding period last year, the Company recorded $12 million of financing expenses related to foreign exchange adjustments.
Adjusted EBITDA
The Company's Adjusted EBITDA for the second quarter of 2026 amounted to approximately $160 million, compared to approximately $96 million in the corresponding quarter last year, representing an increase of 67%.
The increase compared to the second quarter of 2025 was primarily driven by a $75 million increase in revenues, partially offset by a $17 million increase in cost of revenues resulting from the commencement of operations of new projects and the expansion of electricity trading activities in Israel, a $6 million increase in general, administrative and development expenses (excluding share-based compensation expenses), and a $4 million decrease in other income.
Partially offsetting these factors, the follow-on sale of an additional 15% interest in the Sunlight portfolio contributed approximately $17 million to Adjusted EBITDA.
Conference Call Information
English Conference Call & Webcast at 8:00am ET / 3:00pm Israel:
Please pre-register to join the live conference call:
Upon registering, you will be emailed a dial-in number, direct passcode and unique PIN.
To join by webcast, which will feature a presentation, please use the following link:
The press release with the financial results as well as the investor presentation materials will be accessible from the Company’s website prior to the conference call. An archived version of the webcast will be available on the Company’s investor relations website at https://enlightenergy.com/info/investors/
Supplemental Financial and Other Information
We intend to announce material information to the public through the Enlight investor relations website at https://enlightenergy.com/info/investors, SEC filings, press releases, public conference calls, and public webcasts. We use these channels to communicate with our investors, customers, and the public about our company, our offerings, and other issues. As such, we encourage investors, the media, and others to follow the channels listed above, and to review the information disclosed through such channels. Any updates to the list of disclosure channels through which we will announce information will be posted on the investor relations page of our website.
Non-IFRS Financial Measures
This release presents Adjusted EBITDA, a non-IFRS financial metric, which is provided as a complement to the results provided in accordance with the International Financial Reporting Standards as issued by the International Accounting Standards Board (“IFRS”). A reconciliation of the non-IFRS financial information to the most directly comparable IFRS financial measure is provided in the accompanying tables found at the end of this release.
We define Adjusted EBITDA as net income (loss) plus depreciation and amortization, share based compensation, finance expenses, taxes on income and share in losses of equity accounted investees, minus finance income and adjusted to eliminate any non-recurring portions of other income (expenses), net. compensation received in respect of contractual performance shortfalls and recorded in other income (expenses), net, is included in adjusted EBITDA. Such compensation represents income the company would have generated had the contractual performance levels been achieved. With respect to gains (losses) from asset disposals, as part of Enlight’s strategy to accelerate growth and reduce the need for equity financing, the Company sells parts of or the entirety of selected renewable project assets from time to time, and therefore includes realized gains or losses from these asset disposals in Adjusted EBITDA. In the case of partial assets disposals, Adjusted EBITDA includes only the economic gain or loss attributable to the interest sold, calculated as the consideration received less the proportional book value attributable to such interest. Our management believes Adjusted EBITDA is indicative of operational performance and ongoing profitability and uses Adjusted EBITDA to evaluate the operating performance and for planning and forecasting purposes.
Non-IFRS financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under IFRS. There are a number of limitations related to the use of non-IFRS financial measures versus comparable financial measures determined under IFRS. For example, other companies in our industry may calculate the non-IFRS financial measures that we use differently or may use other measures to evaluate their performance. All of these limitations could reduce the usefulness of our non-IFRS financial measures as analytical tools. Investors are encouraged to review the related IFRS financial measure, Net Income, and the reconciliations of Adjusted EBITDA provided below to Net Income and to not rely on any single financial measure to evaluate our business.
Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding the Company’s business strategy and plans, capabilities of the Company’s project portfolio and the Company’s expectation relating to projects, including their timeline, financing and the achievement of operational and financial objectives, market opportunity, utility demand and potential growth, discussions with commercial counterparties and financing sources, pricing trends for materials, progress of Company projects, including anticipated timing of related approvals and project completion and anticipated production delays, the Company’s future financial results, expected impact from various regulatory developments and anticipated trade sanctions, expectations regarding wind production, electricity prices and windfall taxes, and expected Revenues, Income and Adjusted EBITDA guidance, the expected timing of completion of our ongoing projects, and the Company’s anticipated cash requirements and financing plans , are forward-looking statements. The words “may,” “might,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “target,” “seek,” “believe,” “estimate,” “predict,” “potential,” “continue,” “contemplate,” “possible,” “forecasts,” “aims” or the negative of these terms and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions.
These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: our ability to site suitable land for, and otherwise source, renewable energy projects and to successfully develop and convert them into Operational Projects, as well as timing of construction of any project; availability of, and access to, interconnection facilities and transmission systems; our ability to obtain and maintain governmental and other regulatory approvals and permits, including environmental approvals and permits; construction delays, operational delays and supply chain disruptions leading to increased cost of materials required for the construction of our projects, as well as cost overruns and delays related to disputes with contractors; disruptions in trade caused by political, social or economic instability in regions where our components and materials are made; our suppliers’ ability and willingness to perform both existing and future obligations; competition from traditional and renewable energy companies in developing renewable energy projects; potential slowed demand for renewable energy projects and our ability to enter into new offtake contracts on acceptable terms and prices as current offtake contracts expire; offtakers’ ability to terminate contracts or seek other remedies resulting from failure of our projects to meet development, operational or performance benchmarks; exposure to market prices in some of our offtake contracts; various technical and operational challenges leading to unplanned outages, reduced output, interconnection or termination issues; the dependence of our production and revenue on suitable meteorological and environmental conditions, and our ability to accurately predict such conditions; our ability to enforce warranties provided by our counterparties in the event that our projects do not perform as expected; government curtailment, energy price caps and other government actions that restrict or reduce the profitability of renewable energy production; electricity price volatility, unusual weather conditions (including the effects of climate change, could adversely affect wind and solar conditions), catastrophic weather-related or other damage to facilities, unscheduled generation outages, maintenance or repairs, unanticipated changes to availability due to higher demand, shortages, transportation problems or other developments, environmental incidents, or electric transmission system constraints and the possibility that we may not have adequate insurance to cover losses as a result of such hazards; our dependence on certain operational projects for a substantial portion of our cash flows; our ability to continue to grow our portfolio of projects through successful acquisitions; changes and advances in technology that impair or eliminate the competitive advantage of our projects or upsets the expectations underlying investments in our technologies; our ability to effectively anticipate and manage cost inflation, interest rate risk, currency exchange fluctuations and other macroeconomic conditions that impact our business; our ability to retain and attract key personnel; our ability to manage legal and regulatory compliance and litigation risk across our global corporate structure; our ability to protect our business from, and manage the impact of, cyber-attacks, disruptions and security incidents, as well as acts of terrorism or war; changes to existing renewable energy industry policies and regulations that present technical, regulatory and economic barriers to renewable energy projects; the reduction, elimination or expiration of government incentives for, or regulations mandating the use of, renewable energy; our ability to effectively manage the global expansion of the scale of our business operations; our ability to perform to expectations in our new line of business involving the construction of PV systems for municipalities in Israel; our ability to effectively manage our supply chain and comply with applicable regulations with respect to international trade relations, the impact of tariffs on the cost of construction and our ability to mitigate such impact, sanctions, export controls and anti-bribery and anti-corruption laws; our ability to effectively comply with Environmental Health and Safety and other laws and regulations and receive and maintain all necessary licenses, permits and authorizations; our performance of various obligations under the terms of our indebtedness (and the indebtedness of our subsidiaries that we guarantee) and our ability to continue to secure project financing on attractive terms for our projects; limitations on our management rights and operational flexibility due to our use of tax equity arrangements; potential claims and disagreements with partners, investors and other counterparties that could reduce our right to cash flows generated by our projects; our ability to comply with increasingly complex tax laws of various jurisdictions in which we currently operate as well as the tax laws in jurisdictions in which we intend to operate in the future; our ability to obtain tax benefits and credits in the U.S. or other jurisdictions; the unknown effect of the dual listing of our ordinary shares on the price of our ordinary shares; various risks related to our incorporation and location in Israel, including the ongoing war in Israel, where our headquarters and some of our wind energy and solar energy projects are located; the costs and requirements of being a public company, including the diversion of management’s attention with respect to such requirements; certain provisions in our Articles of Association and certain applicable regulations that may delay or prevent a change of control; and other risk factors set forth in the section titled “Risk factors” in our Annual Report on Form 20-F for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission (the “SEC”), as may be updated in our other documents filed with or furnished to the SEC.
These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by applicable law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
About Enlight
Founded in 2008, Enlight develops, finances, constructs, owns, and operates utility-scale renewable energy projects. Enlight operates across the three largest renewable segments today: solar, wind and energy storage. A global platform, Enlight operates in the United States, Israel and 12 European countries. Enlight has been traded on the Tel Aviv Stock Exchange since 2010 (TASE: ENLT) and completed its U.S. IPO (Nasdaq: ENLT) in 2023.
Erica Mannion or Mike Funari
Sapphire Investor Relations, LLC
+1 617 542 6180 [email protected]
Appendix 1 – Financial information
Consolidated Statements of Income
For the six months ended
June 30
For the three months ended
June 30
2026
2025 2026
2025 USD in
USD in USD in
USD in thousands
thousands thousands
thousands Revenues 322,477 225,875 165,990 116,117 Tax benefits 86,807 38,972 43,701 18,861 Total revenues and income 409,284 264,847 209,691 134,978 Cost of sales (*) (92,780) (56,484) (48,501) (29,846) Depreciation and amortization (98,106) (71,017) (47,384) (37,228) General and administrative expenses (37,081) (23,336) (18,118) (11,490) Development expenses (8,689) (5,469) (4,690) (2,905) Total operating expenses (236,656) (156,306) (118,693) (81,469) Gains from projects disposals 889 97,828 453 566 Other income (expenses), net 3,681 2,374 (519) 3,479 Operating profit 177,198 208,743 90,932 57,554 Finance income 20,260 8,166 11,264 1,471 Finance expenses (104,554) (82,286) (60,371) (52,083) Total finance expenses, net (84,294) (74,120) (49,107) (50,612) Profit before tax and equity loss 92,904 134,623 41,825 6,942 Share of losses of equity accounted investees (1,421) (1,645) (428) (418) Profit before income taxes 91,483 132,978 41,397 6,524 Taxes on income (22,498) (25,606) (10,220) (955) Profit for the period 68,985 107,372 31,177 5,569 Profit for the period attributed to: Owners of the Company 53,442 95,815 29,369 1,357 Non-controlling interests 15,543 11,557 1,808 4,212 68,985 107,372 31,177 5,569 Earnings per ordinary share (in USD) with a par value of NIS 0.1, attributable to owners of the parent Company: Basic earnings per share 0.39 0.80 0.21 0.01 Diluted earnings per share 0.36 0.75 0.20 0.01 Weighted average of share capital used in the calculation of earnings: Basic per share 137,294,117 119,107,985 139,430,537 119,421,246 Diluted per share 148,712,951 127,192,179 150,455,906 129,204,402 .
(*) Excluding depreciation and amortization.
Consolidated Statements of Financial Position as of June 30 December 31 2026 2025 USD in USD in Thousands Thousands Assets Current assets Cash and cash equivalents 1,163,734 528,497 Bank deposits 2,280 - Restricted cash 122,735 409,424 Trade receivables 111,799 95,118 Other receivables 149,939 62,286 Other financial assets 1,223 524 Total current assets 1,551,710 1,095,849 Non-current assets Restricted cash 133,009 130,358 Other long-term receivables 33,917 64,349 Deferred costs in respect of projects 378,466 235,615 Deferred borrowing costs 2,141 1,749 Loans to investee entities 91,852 85,131 Investments in equity accounted investees 36,027 59,310 Fixed assets, net 7,486,761 6,281,418 Intangible assets, net 318,289 303,971 Deferred taxes assets 4,223 4,692 Right-of-use asset, net 258,464 225,495 Financial assets at fair value through profit or loss 109,061 83,582 Other financial assets 58,137 58,383 Total non-current assets 8,910,347 7,534,053 Total assets 10,462,057 8,629,902 Consolidated Statements of Financial Position as of (Cont.)
June 30 December 31 2026 2025 USD in USD in Thousands Thousands Liabilities and equity Current liabilities Credit and current maturities of loans from 566,257 884,120 banks and other financial institutions Trade payables 78,457 137,230 Other payables 528,706 405,741 Current maturities of debentures 186,745 173,571 Current maturities of lease liability 13,142 12,396 Other financial liabilities 9,445 16,147 Total current liabilities 1,382,752 1,629,205 Non-current liabilities Debentures 854,480 477,315 Other financial liabilities 172,810 378,303 Convertible debentures 287,992 273,801 Loans from banks and other financial institutions 4,158,696 2,981,786 Loans from non-controlling interests 82,449 86,946 Financial liabilities through profit or loss 27,511 26,946 Deferred taxes liabilities 85,751 77,688 Employee benefits 2,096 1,645 Lease liability 265,505 231,135 Deferred income related to tax equity 596,401 370,734 Asset retirement obligation 100,623 99,460 Total non-current liabilities 6,634,314 5,005,759 Total liabilities 8,017,066 6,634,964 Equity Ordinary share capital 3,961 3,711 Share premium 1,743,180 1,319,716 Capital reserves 100,113 99,311 Proceeds on account of convertible options 24,994 25,380 Accumulated profit 293,465 240,023 Equity attributable to shareholders of the Company 2,165,713 1,688,141 Non-controlling interests 279,278 306,797 Total equity 2,444,991 1,994,938 Total liabilities and equity 10,462,057 8,629,902 Consolidated Statements of Cash Flows For the six months ended
June 30For the three months ended
June 30 2026202520262025 USD inUSD inUSD inUSD in ThousandsThousandsThousandsThousands Cash flows for operating activities Profit for the period68,985107,37231,1775,569 Income and expenses not associated with cash flows: Depreciation and amortization98,10671,01747,38437,228Finance expenses, net85,21571,07350,51248,685Share-based compensation10,0422,9944,9411,284Taxes on income22,49825,60610,220955Tax benefits(79,764)(38,972)(39,014)(18,861)Other income (expenses), net(1,063)(2,374)688(3,479)Company’s share in losses of investee partnerships1,4211,645428418Gains from projects disposals(889)(97,828)(453)(566) 135,56633,16174,70665,664 Changes in assets and liabilities items: Change in other receivables289(4,593)(1,747)(3,737)Change in trade receivables(20,153)(20,885)(18,676)(509)Change in other payables19,63121,47023,65712,866Change in trade payables(14,161)(2,650)(20,890)(10,452) (14,394)(6,658)(17,656)(1,832) Income Tax paid(5,359)(8,673)(3,774)(7,598) Net cash from operating activities184,798125,20284,45361,803 Cash flows for investing activities Sale (Acquisition) of consolidated entities, net(14,657)33,018(14,423)(3,205)Sale of investee entities29,208-29,208-Changes in restricted cash and bank deposits, net280,8838,18653,93710Purchase, development, and construction in respect of projects(1,332,696)(658,022)(723,463)(402,160)Interest receipts (*)15,5186,3348,9783,822Loans provided and Investment in investees(28,320)(26,324)(8,912)(18,894)Repayment of loans to investees22,50430,8158,134-Payments on account of acquisition of consolidated company(7,874)(7,447)(7,874)-Purchase of long-term financial assets measured at fair value through profit or loss, net(24,999)(3,247)(22,735)(207)Net cash used in investing activities(1,060,433)(616,687)(677,150)(420,634) Consolidated Statements of Cash Flows (Cont.) For the six months ended
June 30For the three months ended
June 30 2026202520262025 USD inUSD inUSD inUSD in ThousandsThousandsThousandsThousands Cash flows from financing activities Receipt of loans from banks and other financial institutions1,387,800674,684609,635531,106Repayment of loans from banks and other financial institutions(601,846)(223,361)(71,388)(114,439)Interest paid (*)(61,825)(40,387)(26,256)(18,089)Issuance of debentures345,933125,838345,933-Issuance of convertible debentures-114,685--Repayment of debentures-(21,994)--Dividends and distributions by subsidiaries to non-controlling interests(37,842)(8,682)(37,842)(8,682)Proceeds from investments by tax-equity investors121,068---Repayment of tax-equity investment(5,837)(10,952)(3,850)(10,952)Deferred borrowing costs(51,410)(46,618)(39,636)(11,419)Receipt of loans from non-controlling interests14182-182Repayment of loans from non-controlling interests(3,539)-(3,539)-Increase in holding rights of consolidated entity-(1,392)--Issuance of shares419,317---Exercise of share options35301819Repayment of lease liability(3,767)(5,803)(938)(1,745)Proceeds from investment in entities by non-controlling interest-12,799-5,067 Net cash from financing activities1,508,101569,029772,137371,048 Increase in cash and cash equivalents632,46677,544179,44012,217 Balance of cash and cash equivalents at beginning of period528,497387,427978,761449,530 Effect of exchange rate fluctuations on cash and cash equivalents2,77115,4885,53318,712 Cash and cash equivalents at end of period1,163,734480,4591,163,734480,459 (*) See Appendix 4 for additional information regarding the change in presentation of interest receipts and interest paid
Information related to Segmental Reporting
For the six months ended June 30, 2026 MENA Europe USA Total reportable segments Others Total USD in thousandsRevenues141,371 113,320 66,693 321,384 1,093 322,477Tax benefits- - 86,807 86,807 - 86,807Total revenues and income141,371 113,320 153,500 408,191 1,093 409,284 Segment adjusted EBITDA125,478 85,484 138,078 349,040 (1,400) 347,640 Reconciliations of unallocated amounts: Headquarter costs (*)(33,398)Intersegment profit9Gains from projects disposals (**)(28,905)Depreciation and amortization and share-based compensation(108,148)Operating profit177,198Finance income20,260Finance expenses(104,554)Share of the losses of equity accounted investees(1,421)Profit before income taxes91,483 (*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).
(**) Reconciliation between EBITDA and operating profit reflecting the realization of revaluation gains from an asset revalued in 2025.
Information related to Segmental Reporting
For the six months ended June 30, 2025 MENA Europe USA Total reportable
segments Others Total USD in thousandsRevenues95,637 99,184 30,008 224,829 1,046 225,875 Tax benefits- - 38,972 38,972 - 38,972 Total revenues and income95,637 99,184 68,980 263,801 1,046 264,847 Segment adjusted EBITDA107,031 82,226 59,913 249,170 1,079 250,249 Reconciliations of unallocated amounts: Headquarter costs (*) (22,958) Intersegment profit 127 Gains from projects disposals 55,336 Depreciation and amortization and share-based compensation (74,011) Operating profit 208,743 Finance income 8,166 Finance expenses (82,286) Share of the losses of equity accounted investees (1,645) Profit before income taxes 132,978 (*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).
Information related to Segmental Reporting
For the three months ended June 30, 2026 MENA Europe USA Total reportable
segments Others Total USD in thousandsRevenues76,869 52,259 36,160 165,288 702 165,990Tax benefits- - 43,701 43,701 - 43,701Total revenues and income76,869 52,259 79,861 208,989 702 209,691 Segment adjusted EBITDA66,703 38,900 72,044 177,647 (946) 176,701 Reconciliations of unallocated amounts: Headquarter costs (*)(16,441)Gains from projects disposals (**)(17,003)Depreciation and amortization and share-based compensation(52,325)Operating profit90,932Finance income11,264Finance expenses(60,371)Share of the losses of equity accounted investees(428)Profit before income taxes41,397 (*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).
(**) Reconciliation between EBITDA and operating profit reflecting the realization of revaluation gains from an asset revalued in 2025.
Information related to Segmental Reporting
For the three months ended June 30, 2025 MENA Europe USA Total reportable segments Others Total USD in thousandsRevenues52,770 47,800 15,330 115,900 217 116,117Tax benefits- - 18,861 18,861 - 18,861Total revenues and income52,770 47,800 34,191 134,761 217 134,978 Segment adjusted EBITDA39,014 37,563 29,364 105,941 998 106,939 Reconciliations of unallocated amounts: Headquarter costs (*) (11,257)Intersegment profit 21Gains from projects disposals 363Depreciation and amortization and share-based compensation (38,512)Operating profit 57,554Finance income 1,471Finance expenses (52,083)Share of the losses of equity accounted investees (418)Profit before income taxes 6,524 (*) Including general and administrative and development expenses (excluding depreciation and amortization and share based compensation).
Appendix 2 - Reconciliations between Net Income to Adjusted EBITDA ($ thousands) For the six months For the three months ended June 30 ended June 30 2026 2025 2026 2025 Net Income 68,985 107,372 31,177 5,569 Depreciation and amortization 98,106 71,017 47,384 37,228 Share based compensation 10,042 2,994 4,941 1,284 Finance income (20,260) (8,166) (11,264) (1,471) Finance expenses 104,554 82,286 60,371 52,083 Gains from projects disposals 28,905 (**) (55,336) (*) 17,003 (**) (363) (*)Share of losses of equity accounted investees 1,421 1,645 428 418 Taxes on income 22,498 25,606 10,220 955 Adjusted EBITDA 314,251 227,418 160,260 95,703 * Net profit from deconsolidation and revaluation following the partial sale of an asset (Sunlight cluster).** Contribution to Adjusted EBITDA from the sale of an additional stake in the deconsolidated asset (Sunlight cluster). For more information regarding the composition of Adjusted EBITDA, refer to the description appearing in the “Non-IFRS financial measures” section of this press release.
Appendix 3 – Debentures Covenants
Debentures Covenants
As of June 30, 2026, the Company was in compliance with all of its financial covenants under the indenture for the Series C, D, F, G and H Debentures, based on having achieved the following in its consolidated financial results:
Minimum equity
The company's equity shall be maintained at no less than NIS 375 million so long as debentures F remain outstanding, NIS 1,250 million so long as debentures C and D remain outstanding, and USD 600 million so long as debentures G and H remain outstanding.
As of June 30, 2026, the company’s equity amounted to NIS 7,280 million (USD 2,445 million).
Net financial debt to net CAP
The ratio of standalone net financial debt to net CAP shall not exceed 70% for two consecutive financial periods so long as debentures F remain outstanding and shall not exceed 65% for two consecutive financial periods so long as debentures C, D, G and H remain outstanding.
As of June 30, 2026, the net financial debt to net CAP ratio, as defined above, stands at 33%.
Net financial debt to EBITDA
So long as debentures F remain outstanding, standalone financial debt shall not exceed NIS 10 million, and the consolidated financial debt to EBITDA ratio shall not exceed 18 for more than two consecutive financial periods.
For as long as debentures C and D remain outstanding, the consolidated financial debt to EBITDA ratio shall not exceed 15 for more than two consecutive financial periods.
For as long as debentures G and H remain outstanding, the consolidated financial debt to EBITDA ratio shall not exceed 17 for more than two consecutive financial periods.
As of June 30, 2026, the net financial debt to EBITDA ratio, as defined above, stands at 5.5.
Equity to balance sheet
The standalone equity to total balance sheet ratio shall be maintained at no less than 20% ,25% and 28%, respectively, for two consecutive financial periods for as long as debentures F, debentures C and D and debentures G and H remain outstanding.
As of June 30, 2026, the equity to balance sheet ratio, as defined above, stands at 57%.
Appendix 4 – Change in accounting policy
Until September 30, 2025, interest paid and interest received were presented within cash flows from operating activities in the Consolidated Statements of Cash Flows. In accordance with IAS 7 Statement of Cash Flows, entities are permitted to classify interest paid and interest received as operating, investing, or financing cash flows, provided that the selected classification is applied consistently from period to period.
During the fourth quarter of 2025, management elected to change the classification of interest paid, including payments relating to interest rate swap (IRS) instruments to cash flows used in financing activities, and interest received to cash flows from investing activities. Management believes that this change in presentation provides a more comprehensive view of the cost of financing the Company's operations and better reflects management’s view of the financing nature of these transactions.
Accordingly, comparative information has been retrospectively adjusted to reflect this change in accounting policy in the Consolidated Statements of Cash Flows, as presented below:
($ thousands) For the six months ended June 30, 2025 As reported Adjustment As adjusted Net cash from operating activities 91,149 34,053 125,202 Net cash used in investing activities (623,021) 6,334 (616,687) Net cash from financing activities 609,416 (40,387) 569,029 Increase in cash and cash equivalents 77,544 - 77,544 ($ thousands) For the three months ended June 30, 2025 As reported Adjustment As adjusted Net cash from operating activities 47,536 14,267 61,803 Net cash used in investing activities (424,456) 3,822 (420,634) Net cash from financing activities 389,137 (18,089) 371,048 Increase in cash and cash equivalents 12,217 - 12,217 Appendix 5
a) Segment information: Operational projects
($ thousands)
6 Months ended June 30
3 Months ended June 30
Operational
Project
Segments
Installed
Capacity
(MW)
Installed
Storage
(MWh)
Generation
(GWh)
Revenues and
income
Segment Adjusted
EBITDA1
Generation
(GWh)Reported RevenueSegment Adjusted
EBITDA1 202620252026202520262025202620252026202520262025MENA676947766695
141,371
95,636
92,43964,387393
37876,86952,76949,24738,637Europe1,327-1,4831,353113,32199,18485,48482,226623
649
52,260
47,800
38,90037,563USA8962,5401,013519153,49968,980138,07859,913599
310
79,860
34,191
72,04429,364Total Consolidated2,8993,4873,2622,567408,191263,800316,002206,5261,615
1,337
208,989134,760160,192105,564Unconsolidated
at Share2847 Total2,9273,534 b) Operational Projects Further Detail
($ thousands) 6 Months ended June 30, 20263 Months ended June 30, 2026 Operational ProjectSegmentInstalled Capacity (MW)Installed Storage (MWh)Revenues and
incomeSegment Adjusted
EBITDA1Reported RevenueSegment Adjusted EBITDA1Debt balance as of June 30, 2026Ownership %2MENA WindMENA316-56,745 26,763 623,80349%MENA PVMENA36094784,626 50,106 638,05384%Total MENA 676947141,37192,43976,86949,2471,261,856 Europe WindEurope1,184-103,994 45,548 808,28565%Europe PVEurope143-9,327 6,712 71,49073%Total Europe 1,327-113,32185,48452,26038,900897,775 USA PVUSA8942,540153,499 79,860 785,440100%Total USA8942,540153,499138,07979,86072,045785,440 Total Consolidated Projects2,8993,487408,191316,002208,989160,1922,927,070 Uncons. Projects at share2847 50%Total 2,9273,534408,191316,002208,989160,1922,927,070 For the 6 month ended June 2026, EBITDA included $1.5m of compensation recognized from Bjorenberget and excluded $30m from Sunlight sale and $3m of compensation from Emek; For the 6 month ended June 2025 EBITDA exculded $42m from Sunlight saleOwnership % is calculated based on the project's share of total revenues c) Projects under construction
($ millions)
Consolidated ProjectsCountryGeneration and energy storage Capacity (MW/MWh)Est.
CODEst. Total
Project CostTax credit benefit- Qualifying categoryTax credit benefit- Adders3Discounted Value of Tax Benefit2
Est. Total
Project Cost net of tax benefitCapital Invested as of June 30, 2026Est. Equity Required (%)Equity Invested as of June 30, 2026Est. First Full Year Revenue4Est. First Full Year EBITDA4,5Ownership %1Country AcresUSA403/688Q4 2026814-855ITCDC (10%)399-419415-4366810%-10%69162-6548-50100%Co Bar 1USA258/824H2 2027-636-669ITCEC (10%)300-315336-3544270%-10%6244124-13097-102100%Co Bar 2+3USA953/0H1 20281,215-1,277PTCEC (10%)547-575668-702100%Crimson OrchardUSA120/400H1 2027319-335ITCEC (10%) +
DC (10% BESS only)164-173155-1621110%-10%63427-2820-21100%Snowflake AUSA594/1,900H2 20271,397-1,469ITCEC (10%)11627-659770-8108920%-10%6159123-130101-106100%Finland BESS10Finland0/902H1 2028173-182---173-1821215%-25%1247-4934-3551%BertikowGermany0/881H1 2028187-197---187-1971020%-30%1037-3831-3250%Gecama SolarSpain227/220Q4 2026197-207---197-20715323%-28%715336-3829-3172%SestanovacCroatia23/75Q4 202635-36---35-361615%-25%1675-6100%Tapolca BessHungary0/140Q4 2621-22---21-221545%
1576-7100%Bjornberget – BESSSweden0/100Q3 202624-25---24-2518100%
183255%Israel ConstructionIsrael7/256Q3 26-
Q1 2741-43---41-431620%-30%169-10568%Total Consolidated Projects 2,585/
6,386 5,059-5,317 2,037-2,1413,022-3,1752,352 769481-505378-397 Unconsolidated Projects at share10Israel13/171Q3 2026- Q1 202735-37---35-373615%-20%366-7552%Total 2,598/
6,557 5,094-5,354 2,037-2,1413,057-3,2122,388 805487-512383-402 d) Pre-Construction Projects (due to commence construction within 12 months of the Approval Date)
($ millions)
Consolidated ProjectsCountryGeneration and energy storage Capacity (MW/MWh)Est.
CODEst. Total
Project CostTax Credit Benefit Est. Total
Project Cost net of tax benefitCapital Invested as of June 30, 2026Est. Equity Required (%)Equity Invested as of June 30, 2026Est. First Full Year Revenue4Est. First Full Year EBITDA4,5Ownership %1Qualifying CategoryAdders3Discounted Value of Tax Benefit2Co Bar 4+5USA0/3,176H1 20281,044-1,098ITCEC (10%) +
DC (10%)604-635440-463190%-10%19124-131102-108100%NardoItaly104/8722029234-246---234-2461130%1139-4132-33100%JupiterGermany150/2,166H2 2028538-566---538-566735%795-10078-8251%KarpenRomania0/848H2 2028-H1 2029154-162---154-162325%-35%331-3326-28100%KajoFinland0/542H1 2028106-111---106-111020%025-2618-1951%Ohad HV storage9Israel0/675H2 2028117-123---117-1231520%1595100%Neot Smadar HV storage9Israel0/675H1 2029115-121---115-121520%573100% ($ millions)
Additional Pre-Construction ProjectsMW DeploymentMW/MWh
Est. Total
Project CostTax Credit BenefitDiscounted Value of Tax Benefit2Est. Total
Project Cost net of tax benefitCapital Invested as of June 30, 2026Est. Equity Required (%)Equity Invested as of June 30 2026Est. First Full Year Revenue4Est. First Full Year EBITDA4,5Ownership %1202720282029Qualifying CategoryAdders3United States128/0184/0255/0883-929ITCDC (10%) & EC (10%)8439-462444-4675310%-20%5361-6548-50100%Europe0/3160/208-94-99---94-99330%-100%320-2115-1687%MENA5/52686/356-301-316---301-3161420%-40%1459-6221-2295%Total Consolidated Projects133/842270/564255/03,586-3,771 1,043-1,0972,543-2,674131 131470-495358-378 Unconsolidated Projects at share100/260/7-5---5115%-20%11156%Total Pre-Construction912MW +10,393MWh3,591-3,776 1,043-1,0972,548-2,679132 132471-496359-379 1) The legal ownership share for all U.S. projects is 90%, but Enlight invests 100% of the equity in the project and entitled to 100% of the project distributions until full repayment of Enlight's capital plus a preferred return
2) Value of tax benefits under the IRA: The PTC value is estimated based on the project’s expected annual production and a yearly CPI indexation of 2%, discounted by 8% to COD. In assessing the value of the ITC, a step-up adjustment was made to reflect the full value of the tax credits, thus lowering net construction costs and enhancing the valuation and return of the project. The actual value attributed to tax benefits in a tax equity transaction may differ from the value presented, subject to the structure of the transaction and prevailing market conditions.
3) The Energy Community (EC) Adder provides extra credits for renewable energy projects in areas impacted by fossil fuel reliance or economic transition. The Domestic Content (DC) Adder rewards projects using U.S.-manufactured components, promoting local job creation and supply chain growth
4) Revenue and EBITDA for the first year of U.S. projects as presented above do not include income from tax benefits
5) EBITDA is a non-IFRS financial measure. This figure represents consolidated EBITDA for the project and excludes the share of project distributions to tax equity partners, as well as ITC and PTC proceeds. These components of the tax equity transaction may differ from project to project, are subject to market conditions and commercial terms agreed upon reaching financial close
6) The required equity during construction is estimated at 10% and is expected to decrease to 0% at COD
7) Gecama Solar’s debt is held under Gecama Wind. As of June 30, 2026, the solar project had $41m USD drawn
8) Rustic hills 1+2 - DC (10%) + EC (10%); Coggon - DC (10%); Gemstone - DC (10%);
9) Two high voltage projects with total capacity of 1,350MWh. Estimated revenue for the first 5 years is $14-15m million per year. From year 6, the projects will move to a deregulated market, with revenue expected to be $55 million per year
10) All numbers, beside equity invested, reflects Enlight share only
11) In the previous quarter, the Snowflake A BESS project was presented as expected to be eligible for the Domestic Content (“DC”) Adder. The project will not meet the applicable requirements for the DC adder. However, the removal of the DC adder is offset by significant savings capital expenditure of the new alternative equipment resulting in a negligible impact on the project’s economics
e) Additional information on tax equity investments
Tax equity investmentTax equity partner's share of project tax credits, cash flows, and taxable income($ millions)
Projects*Est. Total
Project CostUpfront tax equity investmentTax credit proceeds during the project's operation ("pay-go")Share of ITC/PTC tax credit allocated to tax equity partnerShare of taxable income initial periodDuration of initial period for share of taxable income (years)Share in project cash flow initial period (second period)Duration of initial period for share in project cash flow (years)Atrisco PV36919855ConfidentialConfidentialConfidential17.5% (5%)10Atrisco BESS458266-ConfidentialConfidentialConfidential23% (7%)5Quail Ranch2741311899%99%1010% (5%)10Roadrunner6213375599%99%5-1010%-12% (5%)10 * Apex financing was structured as a sale and leaseback and therefore not included in the table above
Appendix 6 – cash and cash equivalents
($ thousands) June 30, 2026Cash and Cash Equivalents: Enlight Renewable Energy Ltd, Enlight EU Energies Kft and Enlight Renewable LLC excluding subsidiaries (“Topco”) 876,801Subsidiaries 286,933Deposits: Short term deposits 2,280Restricted Cash: Projects under construction 122,735Reserves, including debt service, performance obligations and others 133,009Total Cash 1,421,758 Appendix 7 – Corporate level (TopCo) debt
($ thousands)June 30, 2026Debentures: Debentures1,041,225*Convertible debentures287,992Loans from banks and other financial institutions: Credit and short-term loans from banks and other financial institutions67,665Loans from banks and other financial institutions116,659Total corporate level debt1,513,541 * Including current maturities of debentures in the amount of 186,745
The financial statements of each of the Company’s subsidiaries were prepared in the currency of the main economic environment in which it operates (hereinafter: the “Functional Currency”). For the purpose of consolidating the financial statements, results and financial position of each of the Group’s member companies are translated into the Israeli shekel (“NIS”), which is the Company’s Functional Currency. The Group’s consolidated financial statements are presented in U.S. dollars (“USD”).
FX Rates to USD:
Date of the financial statements:
EuroNISAs of 30th June 2026 1.140.34As of 30th June 2025 1.130.28 Average for the 3 months period ended: June 2026 1.160.34June 2025 1.170.30 A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4e9351f7-7d30-4523-aa37-c0f12939ee6e